Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGRP,Agouti-related protein,29786,-0.171463585790211,0.00350096124243555,-0.178325469825384,-0.164601701755037,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOM,Apolipoprotein M,29545,0.0894698163254653,0.00184051778611411,0.0858624014646816,0.0930772311862489,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASGR1,Asialoglycoprotein receptor 1,29218,-0.0811861047982689,0.00199194636909931,-0.0850903196817035,-0.0772818899148342,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD4,T-cell surface glycoprotein CD4,29383,-0.0896789517568459,0.00199012798762092,-0.0935796026125829,-0.0857783009011089,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.109890746726694,0.00216530382514621,0.105646751229407,0.11413474222398,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCG,Pro-glucagon,28797,-0.373171282642076,0.00830247073353517,-0.389444125279805,-0.356898440004347,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GDF15,Growth/differentiation factor 15,29820,-0.124613734091165,0.0029770564496025,-0.130448764732386,-0.118778703449944,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR37,Prosaposin receptor GPR37,28916,-0.179302594328162,0.0044400471638103,-0.18800508676923,-0.170600101887094,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,29379,-0.145418111561861,0.00361876057724512,-0.152510882293262,-0.138325340830461,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LDLR,Low-density lipoprotein receptor,29500,-0.219416190908947,0.0033996787584031,-0.226079561275417,-0.212752820542477,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS4,Galectin-4,29454,-0.145351161911787,0.0036646064818252,-0.152533790616164,-0.138168533207409,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPL,Lipoprotein lipase,29478,0.128381437790569,0.00314884874670189,0.122209694247033,0.134553181334104,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFGE8,Lactadherin,29443,-0.182220586451989,0.00282159663397689,-0.187750915854583,-0.176690257049394,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOS3,"Nitric oxide synthase, endothelial",28774,-0.146273550982984,0.00353387998815364,-0.153199955759765,-0.139347146206202,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPY,Pro-neuropeptide Y,29725,-0.184937050581181,0.00440135966049081,-0.193563715515743,-0.176310385646619,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.0849794306215124,0.00213248390560707,0.0807997621665225,0.0891590990765023,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLTP,Phospholipid transfer protein,29702,0.097023665592955,0.00240602688034376,0.0923078529074812,0.101739478278429,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PON3,Serum paraoxonase/lactonase 3,29581,0.0984038677624726,0.00186660311393534,0.0947453256591594,0.102062409865786,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRAP1,Proline-rich acidic protein 1,24938,-0.115334464307343,0.00273531189210359,-0.120695675615866,-0.10997325299882,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS8,Prostasin,29347,-0.114367086271867,0.00274690281888293,-0.119751015796878,-0.108983156746857,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,29725,-0.086910006634972,0.00220258426668023,-0.0912270717976653,-0.0825929414722788,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,-0.0875111148308907,0.0022015212440825,-0.0918260964692924,-0.083196133192489,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,-0.178112790961092,0.00456893957085237,-0.187067912519963,-0.169157669402222,0
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,28967,-0.111380251339269,0.00294697229964484,-0.117156317046573,-0.105604185631965,3.63275982550597e-305
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADIPOQ,Adiponectin,24966,0.171126296743199,0.00455613866895525,0.162196264952047,0.180056328534351,2.25003360056888e-300
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOF,Apolipoprotein F,24951,0.0628613516058153,0.00169105652325029,0.0595468808202447,0.0661758223913858,2.01136869802341e-294
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,-0.136140947636744,0.00371268526772881,-0.143417810761493,-0.128864084511996,8.92580122433771e-288
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,-0.0954488574721258,0.00261666903947858,-0.100577528789504,-0.0903201861547478,4.85110989649675e-285
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,-0.0776567609283607,0.00214198794558951,-0.0818550573017161,-0.0734584645550053,1.39587008208514e-281
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL13,C-X-C motif chemokine 13,29694,-0.148421212165686,0.00409451778193682,-0.156446467018283,-0.14039595731309,1.45064176405226e-281
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOA1,Apolipoprotein A-I,24966,0.0672885809639091,0.00185861355386341,0.0636456983983368,0.0709314635294813,9.15538450835301e-280
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGF,Placenta growth factor,29786,-0.0638218725168254,0.00176833456819595,-0.0672878082704895,-0.0603559367631613,3.24417941975493e-279
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PYY,Peptide YY,24111,-0.235706850045681,0.00656350500847218,-0.248571319862287,-0.222842380229076,3.54780210232212e-275
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,-0.114121926122442,0.0031899091112848,-0.120374147980561,-0.107869704264324,2.33609003900938e-274
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTN4R,Reticulon-4 receptor,29725,-0.0812272635208713,0.00227956516314342,-0.0856952112406324,-0.0767593158011101,2.37972306648444e-272
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN1,CCN family member 1,29301,-0.178908863125079,0.00509189287867119,-0.188888973167275,-0.168928753082884,6.08203531717574e-265
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,29559,-0.0552728278324459,0.00157923891556132,-0.0583681361069461,-0.0521775195579457,5.40312679139486e-263
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KITLG,Kit ligand,29478,0.0878904908170108,0.00251937198009571,0.0829525217360232,0.0928284598979984,2.5495695890692e-261
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,-0.0843952095985979,0.00242034110760132,-0.0891390781694965,-0.0796513410276993,4.31218836960747e-261
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RARRES2,Retinoic acid receptor responder protein 2,29628,-0.11053392325045,0.00318840897928834,-0.116783204849855,-0.104284641651045,3.57029235447468e-258
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,-0.0693428411124545,0.00201503670469918,-0.0732923130536649,-0.0653933691712441,1.81804597920106e-254
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS9,Galectin-9,29453,-0.0739777119421267,0.00215401976368767,-0.0781995906789545,-0.0697558332052989,1.75558368226858e-253
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRIP2,Cysteine-rich protein 2,29218,-0.0836924706557799,0.00244770166443219,-0.088489965918067,-0.0788949753934928,2.86248565803511e-251
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF1,Macrophage colony-stimulating factor 1,29581,-0.0616511194874094,0.00182713771966217,-0.0652323094179473,-0.0580699295568715,6.26560361552496e-245
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MENT,Protein MENT,24381,0.0520040124386987,0.00153961796607058,0.0489863612252004,0.0550216636521971,1.83834785630655e-244
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,-0.144223562293511,0.00429011652207623,-0.152632190676781,-0.135814933910242,4.68601267218608e-243
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL23,C-C motif chemokine 23,29581,-0.0939757947430962,0.00280949360783635,-0.0994824022144555,-0.088469187271737,8.1645986781781e-241
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HGF,Hepatocyte growth factor,29786,-0.0776992703948042,0.00232489672465345,-0.0822560679751249,-0.0731424728144834,1.93113891872622e-240
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,-0.0878466599172411,0.00264746035847972,-0.0930356822198613,-0.0826576376146208,3.84232630025858e-236
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MXRA8,Matrix remodeling-associated protein 8,24381,0.0689799565558843,0.00207945776241343,0.064904219341554,0.0730556937702147,4.8130112233893e-236
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,-0.075675164613213,0.00229361952996295,-0.0801706588919404,-0.0711796703344856,1.84621690857976e-234
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPC2,NPC intracellular cholesterol transporter 2,24609,-0.0714777061224446,0.0021651215406054,-0.0757213443420311,-0.067234067902858,6.64688247787012e-234
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTH,Parathyroid hormone,24195,-0.181482113802544,0.00549908009501367,-0.192260310788771,-0.170703916816317,1.14363319194922e-233
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL27,C-C motif chemokine 27,29478,-0.136326723803653,0.00414396471129618,-0.144448894637793,-0.128204552969512,3.9500455393304e-233
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFNA4,Ephrin-A4,29169,-0.0683723190284976,0.00207902193791701,-0.072447202026815,-0.0642974360301803,6.17051744768141e-233
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST3,Cystatin-C,29530,-0.0630940063075201,0.00191911345828906,-0.0668554686857666,-0.0593325439292735,7.57058674787015e-233
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,-0.124843272680883,0.00379812115083191,-0.132287590136514,-0.117398955225253,1.0423294717737e-232
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,-0.0970409176042121,0.00296573098547847,-0.10285375033575,-0.0912280848726743,1.27973358452075e-230
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARB2,Lysosome membrane protein 2,28762,-0.0703764603285696,0.00215288486992206,-0.0745961146736168,-0.0661568059835223,3.64089032610897e-230
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,29694,-0.0766252360995045,0.00234568498492476,-0.081222778669957,-0.0720276935290519,5.57210907533492e-230
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF9,Protein turtle homolog A,24922,-0.184037492902001,0.00562705470648565,-0.195066520126713,-0.173008465677289,9.31229082041315e-230
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGRN,Agrin,29581,-0.0757269225441474,0.00232957061299646,-0.0802928809456205,-0.0711609641426743,8.79706274652301e-228
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFF3,Trefoil factor 3,29426,-0.101336166743908,0.00314096397745039,-0.107492456139711,-0.0951798773481056,1.91643103507124e-224
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,29278,-0.0600322612393851,0.00186485449004805,-0.0636873760398792,-0.0563771464388909,1.8509854060392e-223
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,29349,-0.150515884934636,0.0046801810129979,-0.159689039720112,-0.14134273014916,4.7714097165431e-223
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,-0.0790550127381971,0.00247325173132223,-0.0839025861315886,-0.0742074393448055,2.0409962031805e-220
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD5,T-cell surface glycoprotein CD5,29683,-0.0743284010834803,0.00232829296074275,-0.0788918552865361,-0.0697649468804245,6.56318357211208e-220
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,-0.0819606029084087,0.00257289040124963,-0.087003468094858,-0.0769177377219594,5.28689593215834e-219
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFASC,Neurofascin,29786,-0.0610971552297458,0.00192006229034223,-0.0648604773188165,-0.057333833140675,1.55746413966426e-218
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF8,Immunoglobulin superfamily member 8,29478,-0.0653665339847156,0.00206258415498079,-0.069409198928478,-0.0613238690409533,8.90276768517063e-217
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,-0.117829678930707,0.00372580319230896,-0.125132253187632,-0.110527104673781,7.94585611808152e-216
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP5,Retinol-binding protein 5,29349,-0.120149897711462,0.00380106436555486,-0.12759998386795,-0.112699811554975,1.13923738154454e-215
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,-0.155479205028703,0.00493073549287496,-0.165143446594738,-0.145814963462668,4.98897680982719e-214
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL15,C-C motif chemokine 15,29820,-0.0932658317074642,0.00298607590267275,-0.0991185404767028,-0.0874131229382256,9.36784177348951e-211
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OCLN,Occludin,24867,-0.0929948896762641,0.00299117176271003,-0.0988575863311758,-0.0871321930213524,3.21177691461627e-208
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,-0.0816542964739423,0.0026363513658987,-0.0868215451511038,-0.0764870477967809,2.86893306214076e-207
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAV,Integrin alpha-V,29725,0.0347603753731157,0.00112623486705249,0.0325529550336928,0.0369677957125386,6.4731784177377e-206
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIGR,Polymeric immunoglobulin receptor,29115,-0.07547910830717,0.00244912237356762,-0.0802793881593625,-0.0706788284549774,2.93268807929251e-205
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.0854808867286092,0.00278042098717953,-0.0909305118634811,-0.0800312615937373,2.56057613267998e-204
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT18,"Keratin, type I cytoskeletal 18",29349,-0.168190516720638,0.00551041806427472,-0.178990936126617,-0.15739009731466,1.8750225314027e-201
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MVK,Mevalonate kinase,28931,-0.164504139648347,0.00539168803918848,-0.175071848205156,-0.153936431091537,2.92778862343156e-201
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA11,Integrin alpha-11,29434,0.0706607391895746,0.00232492829673261,0.0661038797279786,0.0752175986511705,8.47396638564166e-200
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,-0.0587338250930847,0.00194479905333872,-0.0625456312376286,-0.0549220189485408,2.41073689040323e-197
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS15,Enteropeptidase,29349,-0.183655626643602,0.0061290708423069,-0.195668605494524,-0.171642647792681,2.41629315663188e-194
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPY30,Protein dpy-30 homolog,29604,-0.12124475300683,0.00405320348976626,-0.129189031846772,-0.113300474166889,1.01694848968854e-193
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,-0.0616190563529501,0.00207336821055745,-0.0656828580456427,-0.0575552546602574,2.87774201794368e-191
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD27,CD27 antigen,29566,-0.0836987164011828,0.00282484567382041,-0.0892354139218708,-0.0781620188804948,3.78362599406665e-190
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AREG,Amphiregulin,29349,-0.0917115845326257,0.00310435274924201,-0.09779611592114,-0.0856270531441114,4.78186918492654e-189
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL16,C-C motif chemokine 16,29820,-0.104523124774447,0.00354959939707339,-0.111480339592711,-0.0975659099561836,6.89242233157465e-188
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL6A3,Collagen alpha-3(VI) chain,29820,-0.0698598162749403,0.00237850354230367,-0.0745216832178555,-0.0651979493320251,5.91420728691976e-187
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTRK3,NT-3 growth factor receptor,29694,0.0431964064384515,0.00147072825441194,0.0403137790598041,0.0460790338170989,6.16729642386914e-187
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSD,Cathepsin D,27442,-0.0807785961017604,0.00275515311021789,-0.0861786961977875,-0.0753784960057334,4.41079905476245e-186
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCS1,Neuronal calcium sensor 1,29725,-0.0568387737519729,0.00194117642218287,-0.0606434795394513,-0.0530340679644945,8.03257820783249e-186
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASET2,Ribonuclease T2,29697,-0.0527136708569535,0.00180530172674637,-0.0562520622413763,-0.0491752794725306,8.14503225348753e-185
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLUL1,Clusterin-like protein 1,29435,0.0892882641998732,0.00306264674754361,0.0832854765746877,0.0952910518250586,3.11652975904112e-184
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOD,Apolipoprotein D,23787,0.086479313173371,0.00296540513668215,0.080667119105474,0.092291507241268,9.87951236039082e-184
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTSL2,ADAMTS-like protein 2,24938,-0.0653011697217631,0.00224186465945785,-0.0696952244543005,-0.0609071149892257,1.87742883280033e-183
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18R1,Interleukin-18 receptor 1,29786,-0.0646281967696977,0.00222712130315121,-0.0689933545238741,-0.0602630390155213,1.33797803685515e-182
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMBP,Protein AMBP,29683,-0.0396171199074713,0.00136529205726068,-0.0422930923397022,-0.0369411474752404,1.41969426104828e-182
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFDC2,WAP four-disulfide core domain protein 2,27939,-0.0786637381113744,0.00271029599344933,-0.0839759182585351,-0.0733515579642137,1.68346197303864e-182
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300E,CMRF35-like molecule 2,29642,-0.0796013417291192,0.00276889525733905,-0.0850283764335037,-0.0741743070247347,2.75633818125518e-179
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP1,Metalloproteinase inhibitor 1,29173,-0.0554186876572265,0.00193025151288532,-0.0592019806224817,-0.0516353946919713,8.680033340208e-179
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18BP,Interleukin-18-binding protein,29594,-0.0602736091528553,0.0021015548447943,-0.0643926566486521,-0.0561545616570585,1.85945726435946e-178
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRA1,GDNF family receptor alpha-1,29674,-0.0550879816550472,0.00192190137242188,-0.0588549083449941,-0.0513210549651004,2.96281787285171e-178
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSO,Cathepsin O,29786,-0.0589447816178042,0.00206093398834875,-0.0629842122349677,-0.0549053510006406,1.64881959673224e-177
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFA,Protransforming growth factor alpha,29434,-0.0903481304836055,0.00317526803345288,-0.0965716558291731,-0.0841246051380379,1.0553974447997e-175
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF23,Fibroblast growth factor 23,29693,-0.109792189027107,0.00386162060784243,-0.117360965418478,-0.102223412635736,1.85642002156427e-175
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE6,Ribonuclease K6,24828,-0.0598464425995208,0.00210266517303196,-0.0639676663386634,-0.0557252188603781,2.26182120732186e-175
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CES1,Liver carboxylesterase 1,29489,-0.155633223850775,0.005483387596388,-0.166380663539695,-0.144885784161854,7.46962884594633e-175
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,29036,-0.283821693878916,0.0100082261482992,-0.303437817129582,-0.264205570628249,1.56856211239966e-174
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,-0.0746010483020497,0.00264945000785925,-0.0797939703174538,-0.0694081262866455,3.75622116728414e-172
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF3,Immunoglobulin superfamily member 3,29349,-0.0687011200149784,0.00244030243657029,-0.0734841127906561,-0.0639181272393006,4.32645672753177e-172
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD72,B-cell differentiation antigen CD72,24381,-0.0824785722806581,0.00292759590589014,-0.0882166602562027,-0.0767404843051134,7.15832905394458e-172
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUC13,Mucin-13,28774,-0.0981332497411012,0.0034970715474463,-0.104987509974096,-0.0912789895081064,5.82689595353711e-171
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,29443,-0.0669306449901102,0.00239025306740585,-0.0716155410022257,-0.0622457489779947,2.67317762668578e-170
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOC1,Apolipoprotein C-I,24914,0.0716059106897249,0.00255883246065623,0.0665905990668387,0.0766212223126111,1.08048036521152e-169
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFR2,Fibroblast growth factor receptor 2,29566,-0.0418337122652753,0.00149924261555256,-0.0447722277917583,-0.0388951967387923,3.81471482718876e-169
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HLA_E,,29434,-0.0549857575765779,0.00197277328623037,-0.0588523932175894,-0.0511191219355664,9.04484447874228e-169
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACE2,Angiotensin-converting enzyme 2,28916,-0.0979111300210676,0.00351610542563437,-0.104802696655311,-0.0910195633868243,1.99496473268903e-168
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UPB1,Beta-ureidopropionase,24922,-0.174080159450112,0.00624641659775163,-0.186323135981706,-0.161837182918519,2.43854089890304e-168
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECTIN2,Nectin-2,29433,-0.0564514322892061,0.00202807895068086,-0.0604264670325406,-0.0524763975458716,2.49844318613481e-168
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,-0.0762053059846355,0.00273465500363201,-0.0815652297917543,-0.0708453821775168,2.64160156730904e-168
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,29443,-0.0806049358891262,0.00290732297163492,-0.0863032889135306,-0.0749065828647217,4.93594205228838e-167
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE4,Ribonuclease 4,24194,-0.0520221415349953,0.00188395665448254,-0.0557146965777811,-0.0483295864922096,2.82600746628275e-165
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,-0.0933255525943933,0.00338205011800826,-0.0999543708256895,-0.0866967343630972,4.4820050246953e-165
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4A,C-type lectin domain family 4 member A,29434,0.0654751666541887,0.00237783673509635,0.0608146066533999,0.0701357266549776,8.12344098173186e-165
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FURIN,Furin,29566,-0.062193881980683,0.00227662894268569,-0.066656074708347,-0.0577316892530191,2.67145844464098e-162
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,-0.06477545574824,0.00237246416687102,-0.0694254855153072,-0.0601254259811728,4.02655674405842e-162
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PON1,Serum paraoxonase/arylesterase 1,24951,0.0494865051333619,0.00181070957763004,0.045937514361207,0.0530354959055168,4.57501965370872e-162
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA3F,Semaphorin-3F,29478,-0.0488627493802634,0.00179204743429463,-0.0523751623514809,-0.045350336409046,1.08221356031508e-161
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL10,C-X-C motif chemokine 10,29581,-0.123868940244503,0.00454427443811455,-0.132775718143208,-0.114962162345799,1.32492753623043e-161
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,29291,-0.0562109494029334,0.00207743507738578,-0.0602827221546095,-0.0521391766512573,2.81929405648431e-159
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,-0.0821613679597614,0.00304906276569921,-0.0881375309805318,-0.0761852049389909,4.9575485477408e-158
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPT2,Angiopoietin-2,29725,-0.0696975863367955,0.00259647806615736,-0.0747866833464639,-0.0646084893271271,7.56333941467156e-157
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,-0.152787827059778,0.00569459833732119,-0.163949239800928,-0.141626414318629,1.19186909014656e-156
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACY1,Aminoacylase-1,29478,-0.112358240298372,0.00419349480009088,-0.12057749010655,-0.104138990490194,2.88137279554759e-156
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL9,C-X-C motif chemokine 9,29581,-0.121174504036014,0.00452661319540299,-0.130046665899004,-0.112302342173025,5.33732358411902e-156
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSC2,Desmocollin-2,29135,-0.0624746953008096,0.00233731186214204,-0.067055826550608,-0.0578935640510112,1.62257662667268e-155
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,-0.0618007257750964,0.00231359875550357,-0.0663353793358834,-0.0572660722143094,2.44476955505039e-155
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL10RB,Interleukin-10 receptor subunit beta,29581,-0.0525032949376801,0.00197784292377121,-0.0563798670682717,-0.0486267228070886,1.81540344245957e-153
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHISA5,Protein shisa-5,24938,-0.045868957794876,0.00173183286340718,-0.0492633502071541,-0.042474565382598,1.82172514989782e-152
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CKAP4,Cytoskeleton-associated protein 4,29678,-0.0489705701254863,0.00185108252973062,-0.0525986918837583,-0.0453424483672143,1.87777116960036e-152
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,-0.0498245707301575,0.00188362736559736,-0.0535164803667283,-0.0461326610935867,2.13392036631791e-152
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NHLRC3,NHL repeat-containing protein 3,23825,-0.0581542676674813,0.00219866227854143,-0.0624636457334225,-0.05384488960154,5.74380369577963e-152
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GZMA,Granzyme A,29786,-0.0621560341253219,0.0023599057693568,-0.0667814494332613,-0.0575306188173826,3.77513093168171e-151
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,-0.0494486249024136,0.0018792967648713,-0.0531320465615613,-0.0457652032432658,7.58945169893075e-151
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,29434,-0.0675933315379249,0.00257382167620305,-0.0726380220232828,-0.0625486410525669,2.83323507237886e-150
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,-0.0743150898470563,0.00284467615240406,-0.0798906551057682,-0.0687395245883443,9.91503488928718e-149
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XCL1,Lymphotactin,29725,-0.0982476206361368,0.00377824719235539,-0.105652985133153,-0.0908422561391202,2.02345476327442e-147
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REN,Renin,29478,-0.134486311321659,0.00518340784200694,-0.144645790691993,-0.124326831951325,9.1154136189165e-147
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT19,"Keratin, type I cytoskeletal 19",29378,-0.11983902017597,0.00461980020081647,-0.12889382856957,-0.110784211782369,1.05453739862775e-146
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,28797,-0.0633112340385001,0.00244445973083807,-0.0681023751109427,-0.0585200929660575,3.17084261794895e-146
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12A_IL12B,Interleukin-12,29349,-0.136083904671326,0.0052924313880961,-0.146457070191995,-0.125710739150658,3.3268336424141e-144
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,-0.134271190479543,0.00521873758377723,-0.144499916143747,-0.12404246481534,4.31942015193616e-144
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELN,Elastin,24922,-0.0618380087983854,0.00240431160763187,-0.0665504595493439,-0.057125558047427,5.34844605377078e-144
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,29163,-0.126468800752432,0.00494818830217712,-0.136167249824699,-0.116770351680165,1.64009694569005e-142
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LSP1,Lymphocyte-specific protein 1,29434,-0.0698842886382436,0.00273515729250497,-0.0752451969315533,-0.0645233803449339,1.95050314865231e-142
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNF,Tumor necrosis factor,28868,-0.0664183477553258,0.00260906624913794,-0.0715321176036362,-0.0613045779070154,2.16698333116434e-141
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPPC,C-type natriuretic peptide,29434,-0.0829118840990799,0.00325779765047511,-0.0892971674940111,-0.0765266007041486,2.37826016839535e-141
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,-0.099288624467884,0.00390380191713127,-0.106940076225461,-0.0916371727103067,6.84800585782741e-141
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,24804,-0.148134232735888,0.00583160541244023,-0.159564179344271,-0.136704286127505,1.5069645929786e-140
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,-0.158407382026106,0.006259405039422,-0.170675815903373,-0.146138948148839,8.9015978029852e-140
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRELD1,Protein disulfide isomerase CRELD1,24381,-0.0650987340835728,0.00257114376949932,-0.0701381758717915,-0.0600592922953541,1.26081664108492e-139
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD80,T-lymphocyte activation antigen CD80,24922,-0.0592883006948291,0.00234292842093691,-0.0638804403998655,-0.0546961609897928,1.62132009985712e-139
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTA1,Glutathione S-transferase A1,29426,-0.144833130791034,0.00573436292343806,-0.156072482120973,-0.133593779461095,2.89759080784961e-139
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,-0.0946906959842828,0.00374946935682011,-0.10203965592365,-0.0873417360449154,3.39114644433075e-139
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,-0.0817398786213523,0.00323866580310951,-0.0880876635954469,-0.0753920936472577,9.14985770337308e-139
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,-0.0653609472762821,0.00259652722226091,-0.0704501406319135,-0.0602717539206507,2.26017680836624e-138
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B2M,Beta-2-microglobulin,24966,-0.0534571048376235,0.00213174038006643,-0.0576353159825537,-0.0492788936926933,4.44808883545479e-137
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,29683,-0.107409867939164,0.00428966249790425,-0.115817606435056,-0.0990021294432713,6.05833045652394e-137
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP12,Macrophage metalloelastase,29466,-0.0905729910958548,0.00362017265325585,-0.0976685294962362,-0.0834774526954733,1.02030270458161e-136
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,-0.0580961838847799,0.00233069870632584,-0.0626643533491785,-0.0535280144203813,9.55388554917764e-136
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,29655,-0.053310033006165,0.00214132501473895,-0.0575070300350534,-0.0491130359772767,2.03805138823031e-135
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB6A,Ras-related protein Rab-6A,29434,0.0785949295106474,0.00315707312061363,0.0724070661942447,0.0847827928270501,2.13572227929153e-135
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,0.0658496380096898,0.00266820438836295,0.0606199574084984,0.0710793186108812,4.03172638479624e-133
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300LG,CMRF35-like molecule 9,29443,0.0630073966379027,0.00255541441371505,0.0579987843870212,0.0680160088887842,7.02091795870692e-133
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ULBP2,UL16-binding protein 2,29218,-0.0639986163232295,0.0026027116259941,-0.069099931110178,-0.0588973015362811,3.64782590767922e-132
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",29820,-0.083690564291914,0.00340730984005221,-0.0903688915784163,-0.0770122370054117,6.60147953326223e-132
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UMOD,Uromodulin,29750,0.0903802887844778,0.00368181366233624,0.0831639340062988,0.0975966435626569,9.38469309576105e-132
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP1,"Fatty acid-binding protein, liver",29454,-0.157491934350998,0.00641621401571767,-0.170067713821805,-0.144916154880192,1.01071495876941e-131
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL16,Pro-interleukin-16,29786,-0.0690943880619711,0.00281673818405424,-0.0746151949027174,-0.0635735812212248,1.43697872171451e-131
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXNB2,Plexin-B2,29701,-0.0399016037865003,0.00162872378988565,-0.0430939024146761,-0.0367093051583244,3.07355637802862e-131
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL3,C-C motif chemokine 3,29434,-0.100713228904706,0.00412357125629402,-0.108795428567042,-0.0926310292423697,1.90766892236385e-130
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHI3L1,Chitinase-3-like protein 1,28935,-0.1311838616743,0.00537531209536957,-0.141719473381224,-0.120648249967376,3.15762716554171e-130
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300C,CMRF35-like molecule 6,29694,-0.0574437806991205,0.00235833840895217,-0.0620661239806668,-0.0528214374175742,9.04380618300034e-130
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12B,Interleukin-12 subunit beta,29786,-0.0903830257564905,0.00371444170055175,-0.0976633314895719,-0.083102720023409,1.62427885705525e-129
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRPB1,Signal-regulatory protein beta-1,29409,-0.0766957970354268,0.00315219830883491,-0.0828741057207433,-0.0705174883501104,1.76686139355137e-129
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGFR,Epidermal growth factor receptor,29820,0.0271243512991745,0.00111947545625436,0.024930179404916,0.0293185231934331,1.90440418678003e-128
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,-0.045736199946306,0.0018886959009061,-0.049438043912082,-0.0420343559805301,4.66734493497274e-128
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,-0.0978367788670719,0.00404365987074716,-0.105762352213736,-0.0899112055204074,4.77090174992795e-128
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,29349,-0.143090670689725,0.00592350083977479,-0.154700732335684,-0.131480609043767,1.13132805505741e-127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,29454,-0.0458427928945892,0.0018980080717906,-0.0495628887152987,-0.0421226970738796,1.21197982676719e-127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SULT2A1,Bile salt sulfotransferase,29434,-0.0920915184608065,0.00381766217673112,-0.0995741363271995,-0.0846089005944135,2.50953242894604e-127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPY,Pancreatic prohormone,29400,-0.16715387289696,0.00692968537402565,-0.18073605623005,-0.153571689563869,2.58218193585476e-127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH2,Cadherin-2,29478,-0.0581535078739364,0.00241481956003349,-0.062886554211602,-0.0534204615362708,6.52933533594335e-127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COLEC12,Collectin-12,29454,-0.0433395995348313,0.00180032247801749,-0.0468682315917456,-0.039810967477917,8.03648502714045e-127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THBS2,Thrombospondin-2,29443,-0.0613058177639209,0.00255109196041769,-0.0663059580063395,-0.0563056775215022,2.17216178881829e-126
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLL1,Delta-like protein 1,29566,-0.0489811431516284,0.0020404404479169,-0.0529804064295455,-0.0449818798737113,3.96838321706778e-126
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.0602680455102691,0.00251122694889966,-0.0651900503301125,-0.0553460406904258,4.59988649762652e-126
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,-0.0554393415727981,0.00231519589243143,-0.0599771255219637,-0.0509015576236325,1.61865628564598e-125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4D,C-type lectin domain family 4 member D,29434,-0.100436024202734,0.00419477649986336,-0.108657786142466,-0.0922142622630018,1.73335888187395e-125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGLN1,Egl nine homolog 1,29434,-0.0885430154282842,0.00370352677936656,-0.0958019279158427,-0.0812841029407258,3.98038622755768e-125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL21,C-C motif chemokine 21,29581,-0.0662671431344184,0.00277204416965332,-0.0717003497069389,-0.0608339365618979,4.13934121498454e-125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA1,Ephrin type-A receptor 1,29536,-0.0542179776333392,0.00227011983181067,-0.0586674125036882,-0.0497685427629903,7.00096717286654e-125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,-0.0686880750038371,0.00288350534786769,-0.0743397454856578,-0.0630364045220164,3.03991928440659e-124
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD160,CD160 antigen,29786,-0.0761293387908405,0.00320237775976857,-0.0824059991999869,-0.0698526783816941,9.11951941547063e-124
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD83,CD83 antigen,29434,-0.0551030583272082,0.00232013106069539,-0.0596505152061712,-0.0505556014482453,1.60191807196901e-123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,29478,-0.058457556617152,0.00246325712270411,-0.0632855405776521,-0.053629572656652,2.43788743755451e-123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC6A,C-type lectin domain family 6 member A,28797,-0.0763710472904436,0.00321958278103373,-0.0826814295412697,-0.0700606650396175,3.35478015543587e-123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA6,Carbonic anhydrase 6,29372,0.102093259460551,0.00430934044167312,0.0936469521948713,0.11053956672623,6.34848686339434e-123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD302,CD302 antigen,29349,-0.0493901455989759,0.00208490167607584,-0.0534765528840845,-0.0453037383138672,6.62158284810847e-123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMPER,BMP-binding endothelial regulator protein,24381,-0.0371806617985277,0.00156858084316397,-0.0402550802511291,-0.0341062433459263,8.17411059809322e-123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,29478,0.0438465766978926,0.00185222433811749,0.0402162169951823,0.0474769364006029,9.73449480453489e-123
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADA2,Adenosine deaminase 2,29328,-0.0691037076140641,0.00292595932001395,-0.0748385878812914,-0.0633688273468367,3.53730679230815e-122
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,29478,-0.0516119149686311,0.00218765506432285,-0.0558997188947039,-0.0473241110425584,6.25163531735477e-122
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,-0.043377644504259,0.00183988432289839,-0.0469838177771398,-0.0397714712313781,9.00285378840835e-122
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,28586,-0.0617485750001888,0.0026238443270546,-0.0668913098812158,-0.0566058401191618,2.63847181624871e-121
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INHBC,Inhibin beta C chain,29443,-0.0661861858105181,0.00281316572731277,-0.0716999906360511,-0.0606723809849851,2.82974345284362e-121
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSTB,Cystatin-B,29030,-0.0681883871818757,0.00290256229134741,-0.0738774092729166,-0.0624993650908347,6.56096263146707e-121
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCAM,Cell surface glycoprotein MUC18,29594,0.0530486417742326,0.0022727916828158,0.0485939700759137,0.0575033134725516,2.05828234487007e-119
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUCB2,Nucleobindin-2,29652,-0.0592495951349193,0.00254185756000929,-0.0642316359525375,-0.0542675543173011,4.1888870207321e-119
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OXT,Oxytocin-neurophysin 1,29694,-0.220877334718719,0.00948195889362791,-0.23946197415023,-0.202292695287209,5.89876243787666e-119
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100P,Protein S100-P,28916,-0.0851454736510459,0.003661203783742,-0.0923214330671802,-0.0779695142349115,1.51460832977462e-118
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MME,Neprilysin,29349,-0.127173653236196,0.00547779864013273,-0.137910138570856,-0.116437167901536,3.63876029755748e-118
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXADR,Coxsackievirus and adenovirus receptor,29434,-0.0810128133383009,0.00350066224595263,-0.0878741113403681,-0.0741515153362338,1.95617116536731e-117
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCG2,Secretogranin-2,29559,-0.0514643525482635,0.00222610175382011,-0.055827511985751,-0.0471011931107761,3.30919129784446e-117
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,-0.095587669941675,0.00413502598938337,-0.103692320880866,-0.0874830190024836,3.5237047706337e-117
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA2,Ephrin type-A receptor 2,28347,-0.0496550269665501,0.00215228523087349,-0.0538735060190621,-0.045436547914038,1.08331326611845e-116
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCLY,Selenocysteine lyase,29632,-0.0762222784470963,0.00330472937925782,-0.0826995480304417,-0.069745008863751,1.12222028398388e-116
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BPIFB1,BPI fold-containing family B member 1,29333,0.0990150530890904,0.00430085366960079,0.0905853798966728,0.107444726281508,3.00741456463433e-116
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCA,Calcitonin,29163,-0.0973984830491833,0.00423528486179589,-0.105699641378303,-0.0890973247200633,5.40304639342331e-116
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.0805003011757853,0.00350521313271641,-0.0873705189159095,-0.0736300834356612,1.05783027835662e-115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC1,Sialoadhesin,29581,-0.0666431962766135,0.00290198016821127,-0.0723310774063075,-0.0609553151469194,1.08232354841004e-115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,-0.0800796021018131,0.0034875618949653,-0.0869152234159451,-0.0732439807876811,1.24014969192455e-115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD48,CD48 antigen,29536,-0.0470012062423267,0.00204795414028078,-0.051015196357277,-0.0429872161273763,1.50419514375447e-115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUOM,Fucose mutarotase,24381,-0.100433056791676,0.00437591637920176,-0.109009852894912,-0.0918562606884408,2.3913815554072e-115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDCP1,CUB domain-containing protein 1,29218,-0.0814102347241011,0.00355087116525415,-0.0883699422079992,-0.0744505272402029,2.62103472247738e-115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL2,Angiopoietin-related protein 2,29491,-0.0618754912941549,0.00271681668602313,-0.0672004519987603,-0.0565505305895496,7.80876061566313e-114
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF21,Fibroblast growth factor 21,29674,-0.183872940507827,0.00808544760540994,-0.199720417814431,-0.168025463201224,1.64183440345059e-113
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THY1,Thy-1 membrane glycoprotein,29694,-0.0443209540945066,0.00195051881250847,-0.0481439709670232,-0.04049793722199,2.48444905492801e-113
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,29760,-0.0593060883862154,0.00261546021287538,-0.0644323904034511,-0.0541797863689796,7.14110445761682e-113
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,-0.0585121145300381,0.00258270328121945,-0.0635742129612283,-0.053450016098848,1.18308946852368e-112
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PXN,Paxillin,28774,-0.0794883181679828,0.00351418610902157,-0.0863761229416651,-0.0726005133943005,2.67770762317531e-112
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,-0.0534540316045065,0.00236373144589145,-0.0580869452384537,-0.0488211179705592,2.86571096316517e-112
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLA,Alpha-galactosidase A,24329,-0.0584715555302748,0.00258386043593588,-0.0635359219847091,-0.0534071890758405,3.20302026153002e-112
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEG1,Protein HEG homolog 1,24381,-0.0423064549143196,0.00187303383559215,-0.0459776012320803,-0.038635308596559,8.16062054398209e-112
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RETN,Resistin,29362,-0.0650363950745576,0.00288437578112138,-0.0706897716055555,-0.0593830185435596,1.25442892316491e-111
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSIP1,PC4 and SFRS1-interacting protein,29434,-0.0977635174464299,0.00435388098243788,-0.106297124172008,-0.0892299107208517,9.90836426600899e-111
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL7,C-C motif chemokine 7,29434,-0.0899507525955367,0.00400618445806025,-0.0978028741333348,-0.0820986310577386,1.0212136878879e-110
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,29581,-0.0405846773653917,0.00180811051359144,-0.0441285739720309,-0.0370407807587525,1.18148693912201e-110
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSS,Cathepsin S,23389,-0.0372866487018996,0.00166338795520918,-0.0405468890941096,-0.0340264083096896,3.97200785823595e-110
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FSTL3,Follistatin-related protein 3,29351,-0.04875427648258,0.00218133507107255,-0.0530296932218822,-0.0444788597432777,9.82506661806432e-110
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELOA,Elongin-A,29349,-0.079672879463154,0.00357055596876861,-0.0866711691619405,-0.0726745897643676,2.20828535935487e-109
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,-0.0517936327723698,0.00232292495143688,-0.0563465656771861,-0.0472406998675535,3.18433196392095e-109
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C9,Complement component C9,24951,0.0815677356868383,0.00365622760421226,0.0744015295825823,0.0887339417910943,3.51865318833881e-109
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KYNU,Kynureninase,29786,-0.0689002665407622,0.0030974310627975,-0.0749712314238452,-0.0628293016576791,9.86045162444823e-109
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD274,Programmed cell death 1 ligand 1,29218,-0.0519816597022127,0.00233764548820836,-0.0565634448591011,-0.0473998745453243,1.21050401265185e-108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELE,E-selectin,29820,-0.0764494106438164,0.0034402762919385,-0.0831923521760158,-0.0697064691116169,1.60883966961458e-108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSME1,Proteasome activator complex subunit 1,29192,-0.0561744566669406,0.00253064013855079,-0.0611345113385001,-0.051214401995381,2.85014166555552e-108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,28862,-0.0796908830227888,0.00359115240154835,-0.0867295417298236,-0.072652224315754,3.38758257113651e-108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,-0.0644397125978156,0.00290601036597914,-0.0701354929151347,-0.0587439322804964,4.59326972271147e-108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,24867,-0.0587144222881187,0.00264790377139192,-0.0639043136800468,-0.0535245308961905,6.82752281613862e-108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSME2,Proteasome activator complex subunit 2,29081,-0.0547044588679887,0.00247106686198837,-0.0595477499174859,-0.0498611678184915,1.05905923490052e-107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGR2,Anterior gradient protein 2 homolog,28553,-0.152351921466334,0.006889798171976,-0.165855925883407,-0.138847917049261,1.90895988232012e-107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,29761,0.18404074502128,0.00832434606892578,0.167725026726185,0.200356463316374,1.913868046383e-107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGBL1,Integrin beta-like protein 1,24938,-0.0565481236027204,0.00255878145214479,-0.0615633352489241,-0.0515329119565166,3.41383821283517e-107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSL,Cathepsin L1,29478,-0.036733067746598,0.00166398276954636,-0.0399944739749088,-0.0334716615182871,4.03165348956343e-107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE1,Ribonuclease pancreatic,24951,-0.0370272276176654,0.00167804026569958,-0.0403161865384365,-0.0337382686968942,7.11206097611875e-107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEL1L,Protein sel-1 homolog 1,24240,-0.0483818142709016,0.00219533482384589,-0.0526846705256395,-0.0440789580161636,1.37518606440637e-106
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,29375,-0.0557422298882042,0.00253172546811142,-0.0607044118057026,-0.0507800479707058,1.42887485361608e-106
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,-0.040542065574112,0.00184180052817186,-0.0441519946093288,-0.0369321365388951,1.581076780254e-106
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,-0.124303114775256,0.00565055450215796,-0.135378201599486,-0.113228027951027,2.24894651093132e-106
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,-0.0619519377092846,0.00282744260559432,-0.0674937252162495,-0.0564101502023198,1.47986345102771e-105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTA3,Glutathione S-transferase A3,28797,-0.114711594958685,0.00524119064268292,-0.124984328618343,-0.104438861299026,2.52573634598743e-105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN5,CCN family member 5,29443,-0.0581279270142534,0.00265670600578475,-0.0633350707855915,-0.0529207832429153,2.80509455793399e-105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBR2,TGF-beta receptor type-2,29566,-0.048956703699069,0.00223918260609415,-0.0533455016070135,-0.0445679057911244,3.93387027201619e-105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18,Interleukin-18,29335,-0.0685373957967707,0.00314261418643193,-0.0746969196021773,-0.0623778719913641,1.29416507917813e-104
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSR1,Macrophage scavenger receptor types I and II,29694,-0.0682413184655783,0.00313658108037288,-0.0743890173831092,-0.0620936195480475,3.90296021614982e-104
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STC1,Stanniocalcin-1,29694,-0.06447000756551,0.00296670916546619,-0.0702847575298237,-0.0586552576011962,6.7355476702891e-104
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL17,C-X-C motif chemokine 17,29786,-0.0622968635016696,0.00286797566522944,-0.0679180958055193,-0.0566756311978199,8.22832302337132e-104
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPO,Erythropoietin,29434,-0.112549791531379,0.00518774448305686,-0.12271777071817,-0.102381812344587,1.47469032615663e-103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM20A,Pseudokinase FAM20A,24922,-0.0422838360135235,0.00194803211118092,-0.0461019789514381,-0.0384656930756089,1.64356940263442e-103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL7,Angiopoietin-related protein 7,29725,-0.0547044546461609,0.00252349475087053,-0.0596505043578671,-0.0497584049344546,2.09545942015751e-103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMOT,Angiomotin,24381,-0.0601290798552954,0.00277224083986921,-0.0655626719014391,-0.0546954878091518,2.43834898711639e-103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,29394,-0.0444911680547763,0.00205462226183784,-0.0485182276879785,-0.0404641084215741,3.56254114053125e-103
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG4,Regenerating islet-derived protein 4,29497,-0.073157251947535,0.00339978337711976,-0.0798208273666898,-0.0664936765283803,6.40532774789893e-102
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAYN,Layilin,29163,-0.0513402423247147,0.00238794278258837,-0.0560206101785879,-0.0466598744708414,9.66673616152923e-102
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,29434,-0.0963045591499186,0.00448067402669701,-0.105086680242245,-0.0875224380575924,1.09035738118492e-101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,-0.100553979972537,0.00467951371896397,-0.109725826861706,-0.0913821330833677,1.80294913750586e-101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM1,Intercellular adhesion molecule 1,29391,-0.0422690059434422,0.00197334965336174,-0.0461367712640312,-0.0384012406228532,5.17027257795378e-101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,29434,-0.0823958206670125,0.00384995456877166,-0.0899417316218049,-0.07484990971222,7.56926075193417e-101
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH1A1,Retinal dehydrogenase 1,29443,-0.0776512392939015,0.00363170353066469,-0.0847693782140043,-0.0705331003737987,1.1605881979621e-100
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOMO1,Nodal modulator 1,29443,-0.0342687670296661,0.00160482097833852,-0.0374142161472096,-0.0311233179121226,2.08813193540244e-100
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,-0.0423268500100949,0.00198253312454209,-0.0462126149341974,-0.0384410850859924,2.2341446019006e-100
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,-0.0470280191226339,0.00220406287859472,-0.0513479823646796,-0.0427080558805883,2.91829714501701e-100
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM3B,Protein FAM3B,29349,-0.0520102995372699,0.00243884688175572,-0.0567904394255112,-0.0472301596490287,3.77587251894361e-100
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUSB,Beta-glucuronidase,29604,-0.0869892224399415,0.00408195650730927,-0.0949898571942677,-0.0789885876856153,5.11176421610094e-100
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDK,Midkine,29455,-0.0739345920808826,0.00347409290277318,-0.0807438141703181,-0.0671253699914472,9.48000613970141e-100
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGR3,Anterior gradient protein 3,28764,-0.0866817433696527,0.00407320994161082,-0.0946652348552099,-0.0786982518840955,1.0036558078589e-99
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,29370,-0.0294090478952026,0.0013827057814428,-0.0321191512268305,-0.0266989445635748,1.23855700393099e-99
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL11,C-X-C motif chemokine 11,29694,-0.11438540419856,0.00538105455378315,-0.124932271123975,-0.103838537273145,1.56839961161474e-99
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,0.0287241086413169,0.00135192900563994,0.0260743277902626,0.0313738894923712,1.98589946477923e-99
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIT,Mast/stem cell growth factor receptor Kit,29545,0.0427343689546569,0.00201362249736441,0.0387876688598226,0.0466810690494911,3.25584169324012e-99
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALM2,Paralemmin-2,24845,-0.0552898255621218,0.00260370914039168,-0.0603930954772895,-0.0501865556469541,3.45864962944199e-99
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOLM2,Protein GOLM2,29694,-0.0327166059536881,0.00154350521060322,-0.0357418761664704,-0.0296913357409058,5.60265123619989e-99
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPL,N-acetylneuraminate lyase,24922,-0.0653775176891793,0.00308337734231942,-0.0714209372801253,-0.0593340980982332,6.67971069080437e-99
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFNA1,Ephrin-A1,29390,-0.0407802714273541,0.00193078057662449,-0.0445646013575381,-0.0369959414971701,2.74047378920572e-98
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300A,CMRF35-like molecule 8,24381,-0.0436376199950266,0.00206469616337457,-0.0476844244752407,-0.0395908155148124,2.88384218534227e-98
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNCG,Gamma-synuclein,29218,-0.0960988933281472,0.00456263398053322,-0.105041655929992,-0.0871561307263021,9.44985329160412e-98
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,28797,-0.118508724761398,0.00562661192930832,-0.129536884142843,-0.107480565379954,9.67595287883166e-98
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNMT,Histamine N-methyltransferase,29082,-0.0675802475973675,0.00321533095818156,-0.0738822962754034,-0.0612781989193317,2.37631399542661e-97
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,29674,-0.0604372235950251,0.00287994913701557,-0.0660819239035757,-0.0547925232864746,4.5221565945191e-97
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAO1,Hydroxyacid oxidase 1,29725,-0.183456270878059,0.00874738125497383,-0.200601138137808,-0.166311403618311,5.88050057264423e-97
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA7A,Semaphorin-7A,29736,-0.0395942778194861,0.00189242930731134,-0.0433034392618163,-0.0358851163771558,1.66205987397132e-96
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,24240,-0.0444240489827531,0.00212244308888103,-0.0485840374369599,-0.0402640605285463,2.01259016766241e-96
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS2,Trypsin-2,29594,-0.0765566736759133,0.00366326916071955,-0.0837366812309236,-0.069376666120903,2.7495019154415e-96
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,-0.061423686927459,0.00294019470629863,-0.0671864685518043,-0.0556609053031137,3.20516164346016e-96
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH17,Protocadherin-17,29478,-0.0514646316256465,0.00246720195193863,-0.0563003474514462,-0.0466289157998468,6.17653848256221e-96
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFF2,Trefoil factor 2,29536,-0.082320848034005,0.00394794232228245,-0.0900588149856786,-0.0745828810823314,7.25001280751186e-96
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EZR,Ezrin,29694,-0.0342029184562232,0.0016412229637911,-0.0374197154652538,-0.0309861214471926,9.14528560284792e-96
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMMT,MICOS complex subunit MIC60,24793,-0.0638049652262786,0.00306066454152055,-0.0698038677276589,-0.0578060627248983,1.08180289500671e-95
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,28774,-0.0398086688424722,0.0019110082525088,-0.0435542450173894,-0.0360630926675549,1.14895775132829e-95
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,-0.0640913372769608,0.00307494686223195,-0.0701182331269354,-0.0580644414269862,1.21903714162242e-95
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD1,Programmed cell death protein 1,29661,-0.0610572414823843,0.00293608721341957,-0.0668119724206867,-0.0553025105440819,2.28541594587732e-95
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.0646533929316043,0.00311366052917972,-0.0707561675687965,-0.058550618294412,4.31240802954944e-95
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,-0.148713796772423,0.00716413310047955,-0.162755497649363,-0.134672095895483,5.01143814203604e-95
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM3C,Protein FAM3C,29433,-0.0425037319909602,0.00205317022879464,-0.0465279456393977,-0.0384795183425227,1.58609610565307e-94
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,-0.0471126316621466,0.00227644004419877,-0.0515744541487762,-0.042650809175517,1.79241063909289e-94
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,-0.0799651577929059,0.00386572885399202,-0.0875419863467303,-0.0723883292390815,3.0750366926884e-94
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,-0.112268675650776,0.00543734929452597,-0.122925880268047,-0.101611471033505,4.78334837480566e-94
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,-0.081395981995753,0.0039410427901094,-0.0891204258643674,-0.0736715381271386,5.87046879525711e-94
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMG3,Proteasome assembly chaperone 3,29434,-0.0709881712999413,0.00344489786623446,-0.0777401711177609,-0.0642361714821218,1.09669278614533e-93
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,-0.0844069671447693,0.00410145796438337,-0.0924458247549606,-0.0763681095345779,2.51420864804264e-93
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,-0.0619485663087419,0.00301375729749965,-0.0678555306118412,-0.0560416020056426,3.13893384778685e-93
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGN,Mimecan,29443,-0.0591442964718254,0.00287900628112762,-0.0647871487828356,-0.0535014441608153,3.9825366821482e-93
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRP14,Signal recognition particle 14 kDa protein,29349,-0.0835488997316643,0.00407039407088465,-0.0915268721105982,-0.0755709273527304,5.68500836883731e-93
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4M,C-type lectin domain family 4 member M,24888,0.0691306511363724,0.00336682123625505,0.0625316815133125,0.0757296207594323,6.45522367549945e-93
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G15,Phospholipase A2 group XV,29566,-0.0372175966174249,0.0018145490818049,-0.0407741128177625,-0.0336610804170872,7.67470440694791e-93
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,29517,-0.037763053238668,0.00184297394912825,-0.0413752821789594,-0.0341508242983767,1.16260482754052e-92
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEPH,Hephaestin,24922,-0.0372114051637236,0.00181798754179356,-0.040774660745639,-0.0336481495818083,2.36887267536952e-92
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL6,Interleukin-6,29349,-0.103154229369156,0.00504999173194587,-0.11305221316377,-0.093256245574542,4.24760932010254e-92
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPA2,Carboxypeptidase A2,29577,-0.0908312105582342,0.00445925361747549,-0.0995713476484862,-0.0820910734679823,1.3378940656107e-91
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.035609529162271,0.00174820650748733,0.0321830444075958,0.0390360139169461,1.34998280630377e-91
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,24793,-0.0731864100559918,0.00360691514327566,-0.0802559637368121,-0.0661168563751715,8.5222237336802e-91
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFF1,Trefoil factor 1,29319,-0.108919100997319,0.00539732734429214,-0.119497862592132,-0.0983403394025064,5.97980801006123e-90
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,-0.043572265646248,0.00216196882673386,-0.0478097245466464,-0.0393348067458497,1.29480515633027e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSZ,Cathepsin Z,29487,-0.0435533728012031,0.00216264765712448,-0.0477921622091671,-0.0393145833932391,1.35080612314274e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.0529251125371851,0.0026281053316173,-0.0580761989871551,-0.0477740260872152,1.35712987869234e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADM,Pro-adrenomedullin,29725,-0.0366070832708752,0.00181800872364657,-0.0401703803692225,-0.0330437861725279,1.42107063243439e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD59,CD59 glycoprotein,28277,-0.0317006500125208,0.00157911874801577,-0.0347957227586317,-0.0286055772664099,5.11260503150975e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,-0.0399919012684915,0.0019944144711679,-0.0439009536319806,-0.0360828489050024,7.49130221494404e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFA,Vascular endothelial growth factor A,29683,-0.0791039141185038,0.00394713513926704,-0.0868402989914672,-0.0713675292455404,9.39497553177106e-89
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRD1,Natural killer cells antigen CD94,29786,-0.0633879035877597,0.00317428813071818,-0.0696095083239673,-0.057166298851552,3.86218062387222e-88
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PENK,Proenkephalin-A,24381,-0.0424690173370308,0.00212916268684955,-0.0466421762032559,-0.0382958584708057,8.10451822087781e-88
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIPC2,PDZ domain-containing protein GIPC2,24845,-0.040879801461286,0.00204999141760417,-0.0448977846397902,-0.0368618182827818,8.66185130757417e-88
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL20,C-C motif chemokine 20,29786,-0.119313778312779,0.00600581799488788,-0.13108518158276,-0.107542375042799,2.92835699917181e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPM,Carboxypeptidase M,29584,-0.0464766936976103,0.00234045281364948,-0.0510639812123633,-0.0418894061828573,3.48271152422924e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLR2,Folate receptor beta,29694,-0.0397783354408717,0.00200397922699281,-0.0437061347257776,-0.0358505361559658,4.08116968208249e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LBR,Delta(14)-sterol reductase LBR,29694,-0.0904833770088321,0.00455994234175072,-0.0994208639986635,-0.0815458900190007,4.64385525058239e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPB1,Carboxypeptidase B,29820,-0.0801494790367637,0.00404095918337275,-0.0880697590361743,-0.0722291990373531,5.49226762077952e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA14,Carbonic anhydrase 14,29725,0.0482598906882939,0.00243567110016988,0.0434859753319609,0.0530338060446268,8.24038773149112e-87
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDC1,Syndecan-1,29478,-0.0545374303806932,0.00275388107420584,-0.0599350372861366,-0.0491398234752497,1.01232304104041e-86
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,-0.0810969068517439,0.00409812477239137,-0.089129231405631,-0.0730645822978568,1.73282792951368e-86
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAXX,Protein PAXX,24381,-0.0622663771339793,0.00315431999037356,-0.0684488443151115,-0.0560839099528471,4.60099611826961e-86
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL22,C-C motif chemokine 22,29169,-0.069721774267038,0.0035352575404972,-0.0766508790464125,-0.0627926694876635,5.09996669675721e-86
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,24922,-0.0892787016868407,0.00453626139910708,-0.0981697740290906,-0.0803876293445908,1.4002857875885e-85
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSM,Oncostatin-M,29293,-0.0955366162863502,0.00486290441253234,-0.105067908934914,-0.0860053236377868,2.22176395384456e-85
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHBG,Sex hormone-binding globulin,24951,0.0698063863736735,0.00355601387041201,0.0628365991876659,0.076776173559681,3.73202897093822e-85
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,-0.0772065489516282,0.00393850222038835,-0.0849260133035894,-0.0694870845996671,5.07878127544769e-85
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,-0.06708585649967,0.00341960163995333,-0.0737882757139785,-0.0603834372853615,5.12773132125109e-85
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAL,Galanin peptides,29581,0.086397405115779,0.00441830515744225,0.0777375270071922,0.0950572832243658,1.29688900041784e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F9,Coagulation factor IX,29545,-0.0242780685070633,0.00124480342898278,-0.0267178832278696,-0.0218382537862571,3.47329714326834e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,-0.0650080432759308,0.00333664228125356,-0.0715478621471877,-0.0584682244046738,5.29202957572846e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCOF1,Treacle protein,24922,-0.0419751964753785,0.00215443955502921,-0.0461978980032358,-0.0377524949475213,6.4399880624903e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,-0.0407755177781197,0.00209475925325941,-0.0448812459145081,-0.0366697896417312,7.20258517272425e-84
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGXT,Serine--pyruvate aminotransferase,29478,-0.102472626090145,0.00527832938769033,-0.112818151690018,-0.0921271004902716,1.96026414688069e-83
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD28,T-cell-specific surface glycoprotein CD28,28797,-0.0485238459890445,0.00250581249200228,-0.053435238473369,-0.0436124535047201,5.19513227736608e-83
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VCAM1,Vascular cell adhesion protein 1,29545,-0.0362705594852507,0.00187353974930939,-0.0399426973938971,-0.0325984215766043,5.56051020157994e-83
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMNB2,Lamin-B2,24845,-0.0373332887861156,0.00192838554098089,-0.0411129244464381,-0.0335536531257931,6.87873146937232e-83
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL6,C-X-C motif chemokine 6,29786,-0.101597535149746,0.00525627171961344,-0.111899827720188,-0.0912952425793036,9.88914329459577e-83
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG1B,Lithostathine-1-beta,29820,-0.0746554431892613,0.00386298614446008,-0.082226896032403,-0.0670839903461195,1.04563860878515e-82
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLR1,Folate receptor alpha,29383,-0.0380519338695954,0.00197759420131727,-0.0419280185041773,-0.0341758492350136,5.32073044954393e-82
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,-0.139232389320208,0.00723661032075144,-0.15341614554888,-0.125048633091535,5.48511646850501e-82
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINF1,Pigment epithelium-derived factor,24579,-0.0344937691382691,0.00180028926822787,-0.0380223361039957,-0.0309652021725424,3.12148917218219e-81
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBKS,Ribokinase,28795,-0.0651381229114481,0.00340432566785976,-0.0718106012204532,-0.058465644602443,4.2064298128523e-81
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MLN,Promotilin,29434,-0.116444735166067,0.00608815661449471,-0.128377522130477,-0.104511948201657,4.72831051347546e-81
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FMNL1,Formin-like protein 1,28774,-0.0799671326496715,0.00420236191155747,-0.0882037619963241,-0.0717305033030188,3.05165399795579e-80
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP7,Matrilysin,28870,-0.0650615370628664,0.00342360877019056,-0.0717718102524399,-0.0583512638732929,4.89626474793876e-80
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,24788,-0.0564478673539183,0.00297274162423235,-0.0622744409374137,-0.0506212937704229,7.84311255496451e-80
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,29223,-0.052577990478276,0.00277413098229218,-0.0580152872035686,-0.0471406937529833,1.25599058378497e-79
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BST2,Bone marrow stromal antigen 2,29694,-0.0679664017566653,0.00359300818627641,-0.0750086978017671,-0.0609241057115636,2.45572671872132e-79
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FETUB,Fetuin-B,29545,-0.0427624623335197,0.00226238578199017,-0.0471967384662205,-0.038328186200819,3.25817811781471e-79
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,-0.0673332103801648,0.00356991055322415,-0.0743302350644841,-0.0603361856958455,6.87184682506617e-79
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,-0.0355694885490089,0.0018868092761766,-0.0392676347303151,-0.0318713423677028,8.20370353455431e-79
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,-0.0661863680573173,0.00351727718220676,-0.0730802313344425,-0.059292504780192,1.55348088790311e-78
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRC1,Macrophage mannose receptor 1,24951,-0.036781279938898,0.00195431027982475,-0.0406117280873545,-0.0329508317904415,1.79287852380858e-78
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPB6,Heat shock protein beta-6,29725,-0.0494796502704956,0.00263229824023214,-0.0546389548213506,-0.0443203457196406,2.27374365578523e-78
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,-0.0542469839307188,0.0028869370302722,-0.0599053805100523,-0.0485885873513853,2.58451881801008e-78
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH1,Cadherin-1,28477,-0.0515985069068042,0.00274946763492914,-0.0569874634712653,-0.046209550342343,4.18971127348135e-78
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH2D1A,SH2 domain-containing protein 1A,29434,-0.0732878591794031,0.00390889266873009,-0.0809492888101141,-0.0656264295486922,5.62333552654722e-78
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL14,C-C motif chemokine 14,29435,-0.0509100212368175,0.00271561373913799,-0.056232624165528,-0.0455874183081071,5.8204922120952e-78
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,29673,-0.0544101227911113,0.00290397348251565,-0.060101910816842,-0.0487183347653807,7.04289004254721e-78
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFI,Complement factor I,24966,-0.0257011154358559,0.00137204570032142,-0.0283903250084859,-0.023011905863226,9.28678577199345e-78
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEP1A,Meprin A subunit alpha,24805,-0.0929835683495779,0.00496521131693778,-0.102715382530776,-0.0832517541683798,1.02603981255738e-77
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDT,D-dopachrome decarboxylase,24938,-0.0525172722226344,0.00281063216290361,-0.0580261112619255,-0.0470084331833434,2.20857246926091e-77
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD209,CD209 antigen,29527,0.0497478864389792,0.0026678792675847,0.0445188430745132,0.0549769298034452,3.71300344962852e-77
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN4,CCN family member 4,29725,-0.0510899536499139,0.00274547485999579,-0.0564710843755056,-0.0457088229243221,7.46575803597642e-77
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDUA,Alpha-L-iduronidase,29725,-0.0585277873182009,0.00315534064456477,-0.0647122549815478,-0.0523433196548539,2.25365349199722e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,-0.0568145663730076,0.00306407348223322,-0.0628201503981848,-0.0508089823478305,2.57831999316626e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP1,Guanylate-binding protein 1,24816,-0.0823688551283654,0.00445148420093057,-0.0910937641621893,-0.0736439460945415,6.26123482305519e-76
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTNB,Dystrobrevin beta,24752,-0.0553159087804363,0.00299485820415798,-0.0611858308605859,-0.0494459867002866,1.15657189775243e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F11R,Junctional adhesion molecule A,29443,-0.0707945270128968,0.00383881858388298,-0.0783186114373074,-0.0632704425884861,1.619848805366e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,-0.0482443623387042,0.00261819346480931,-0.0533760215297304,-0.0431127031476779,2.13719054766247e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,29736,-0.0411786820888942,0.00223540132140708,-0.045560068678852,-0.0367972954989363,2.33742572291456e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHB4,Ephrin type-B receptor 4,29820,-0.0314124092012543,0.00171099725864477,-0.034765963828198,-0.0280588545743106,7.22612552748332e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,-0.0353064483244877,0.00192317136995425,-0.039075864209598,-0.0315370324393773,7.39562062904581e-75
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,-0.0364161620166113,0.00198765767557431,-0.0403119710607369,-0.0325203529724856,1.77648349733008e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH3,Cadherin-3,29694,-0.0453890308215446,0.00248023547235867,-0.0502502923473676,-0.0405277692957217,2.1140076899738e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN8,Septin-8,24801,-0.0405721272506209,0.00221684276495823,-0.044917139069939,-0.0362271154313027,2.47565708803975e-74
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINT2,Kunitz-type protease inhibitor 2,29581,-0.0507693377548593,0.00279564708047834,-0.0562488060325968,-0.0452898694771218,2.67446062364604e-73
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF8,SLAM family member 8,28797,-0.0668572709410087,0.00368212463035092,-0.0740742352164965,-0.0596403066655209,2.88786852021054e-73
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT4,Vascular endothelial growth factor receptor 3,29566,-0.0417042141839558,0.00229921026447428,-0.0462106663023254,-0.0371977620655862,3.95057907277858e-73
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERMAP,Erythroid membrane-associated protein,24229,-0.0557632926639615,0.00308109508097356,-0.0618022390226696,-0.0497243463052533,9.87687495516225e-73
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWC2,Brorin,29114,-0.04928397394685,0.00272977801984029,-0.054634338865737,-0.0439336090279631,1.81904187504942e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKK4,Dickkopf-related protein 4,29169,-0.0565907433019791,0.00314021504783012,-0.0627455647957261,-0.050435921808232,3.27222816960787e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC80,Coiled-coil domain-containing protein 80,29478,-0.0434722743138629,0.00241418856053192,-0.0482040838925055,-0.0387404647352203,4.18582622184149e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB8,Serpin B8,29786,-0.0693537077355234,0.00385830150592716,-0.0769159786871406,-0.0617914367839061,7.31748783703209e-72
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KHK,Ketohexokinase,24240,-0.0791906649075528,0.00441683983947372,-0.0878476709929213,-0.0705336588221843,2.01915120423325e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,-0.0495626906018604,0.00276671622195366,-0.0549854543968895,-0.0441399268068312,2.57312909004783e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,-0.127599545444205,0.00713087165899709,-0.14157605389584,-0.113623036992571,3.68668115835179e-71
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,24240,0.0747310504901745,0.00419607575459938,0.0665067420111598,0.0829553589691893,1.67275880809083e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,-0.0367448139818666,0.00206752135341643,-0.0407971558345628,-0.0326924721291704,3.15575649365798e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,-0.0824664761329986,0.00465421707005591,-0.0915887415903082,-0.073344210675689,7.08038998368636e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNCA,Alpha-synuclein,24381,-0.141620549357786,0.00799117296387723,-0.157283248366985,-0.125957850348587,7.76945684126163e-70
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,24922,-0.0308517189776128,0.0017437937760586,-0.0342695547786877,-0.027433883176538,1.28283021449969e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,-0.0637851386425837,0.00361568205455268,-0.0708718754695069,-0.0566984018156604,3.22259994079378e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,-0.088736316105745,0.00503847682964795,-0.098611730691855,-0.0788609015196351,4.55985124308133e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,-0.0557457983937293,0.00316672196849176,-0.0619525734519731,-0.0495390233354854,6.21122362754463e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,29820,0.0411037435003725,0.00233740892133659,0.0365224220145528,0.0456850649861922,7.13401511838268e-69
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HJV,Hemojuvelin,24867,-0.0536570641762938,0.00305316007044354,-0.0596412579143631,-0.0476728704382245,1.01073949993411e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,-0.0696617218432679,0.00396785567108946,-0.0774387189586033,-0.0618847247279326,1.18300319002712e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC39A5,Zinc transporter ZIP5,29434,-0.0640988174426302,0.00365219127412366,-0.0712571123399126,-0.0569405225453478,1.31333584630281e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,-0.0299311182897135,0.00170537969331262,-0.0332736624886062,-0.0265885740908208,1.3179467430887e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFC1,Cryptic protein,28797,-0.0567398374558317,0.00323353999031372,-0.0630775758368466,-0.0504020990748169,1.42087405585553e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,-0.09067333003579,0.00517331654203031,-0.100813030458169,-0.0805336296134106,2.29031112251475e-68
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIP,Gastric inhibitory polypeptide,24240,-0.0614740873810599,0.00352727639648926,-0.0683875491181789,-0.054560625643941,1.3038724448088e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIAE,Sialate O-acetylesterase,29495,-0.0555645943224455,0.00319023557310208,-0.0618174560457255,-0.0493117325991654,1.33573720333995e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,29349,-0.0373314784710232,0.00214693778294994,-0.0415394765256051,-0.0331234804164414,2.20713201484181e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL7R,Interleukin-7 receptor subunit alpha,29443,0.0624155667405702,0.00359161486108287,0.0553760016128478,0.0694551318682926,2.62149498219938e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENO3,Beta-enolase,24240,-0.072026288769044,0.00415059817028133,-0.0801614611827954,-0.0638911163552926,4.74599495375446e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YAP1,Transcriptional coactivator YAP1,24845,-0.0323207334758834,0.00186512222294133,-0.0359763730328484,-0.0286650939189184,7.0355428457054e-67
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD2AP,CD2-associated protein,29478,-0.0751171298006701,0.00435212937831601,-0.0836473033821695,-0.0665869562191708,2.00325227165771e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUS,RNA-binding protein FUS,28765,-0.0468582943952049,0.00271569042836939,-0.0521810476348089,-0.0415355411556009,2.23112688425573e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAFA5,Chemokine-like protein TAFA-5,29349,-0.0427960382123673,0.002486026277603,-0.0476686497164691,-0.0379234267082654,4.35925682189329e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORD,Sorbitol dehydrogenase,29595,-0.0800879927873342,0.00466252118448828,-0.0892265343089312,-0.0709494512657372,8.24446259134377e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRELD2,Protein disulfide isomerase CRELD2,29536,-0.0611870158825958,0.00356413313780602,-0.0681727168326956,-0.0542013149324959,9.71555287940985e-66
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTN,Pleiotrophin,28916,-0.0588476809109634,0.00343435491478682,-0.0655790165439456,-0.0521163452779813,1.71478291623414e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EBI3_IL27,Interleukin-27,29674,-0.0363187083338641,0.00212121744982608,-0.0404762945355232,-0.0321611221322049,2.11248794486691e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRP,Gastrin-releasing peptide,24240,-0.0637260590162458,0.00372219172443124,-0.071021554796131,-0.0564305632363605,2.52709877011693e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,-0.0394481686787412,0.00230604960809556,-0.0439680259106085,-0.0349283114468739,2.73451732857524e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THOP1,Thimet oligopeptidase,29343,-0.03616020038077,0.00211393225308599,-0.0403035075968185,-0.0320168931647214,2.79441304878268e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAST,Gastrin,24845,-0.153529075949419,0.00898471272134143,-0.171139112883248,-0.13591903901559,4.31198631720131e-65
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABL1,Tyrosine-protein kinase ABL1,29349,-0.0789904210636004,0.00463937490043131,-0.0880835958684457,-0.069897246258755,1.07678996224943e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA5,Integrin alpha-5,29443,-0.029154524724715,0.00171311468400239,-0.0325122295053597,-0.0257968199440704,1.22295823894529e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG1A,Lithostathine-1-alpha,29353,-0.057386105784462,0.0033783685713562,-0.0640077081843201,-0.0507645033846038,2.10784267075346e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOP2B,DNA topoisomerase 2-beta,24229,-0.0932937432940833,0.0054917863335856,-0.104057644507911,-0.0825298420802555,2.38417565587435e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.071871949965914,0.00425061601573119,-0.0802031573567471,-0.0635407425750808,7.72187220125763e-64
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,-0.0486051360659078,0.00287707322562113,-0.0542441995881252,-0.0429660725436904,1.13135935918141e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADH1B,All-trans-retinol dehydrogenase,24381,-0.0881377277685673,0.00521835890598791,-0.0983657112243036,-0.077909744312831,1.22906251562328e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLO1,Lactoylglutathione lyase,28916,-0.0670691958180926,0.00397518169370774,-0.0748605519377598,-0.0592778396984254,1.45833144582124e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTYMK,Thymidylate kinase,24922,-0.0794822619079313,0.00471944931372264,-0.0887323825628276,-0.0702321412530349,2.71807480611867e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUOX,"Sulfite oxidase, mitochondrial",24867,-0.0726637445223293,0.00431655180116081,-0.0811241860526045,-0.0642033029920541,3.09561737403135e-63
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRN,Progranulin,29313,-0.0283082352247911,0.0016895901688527,-0.0316198319557424,-0.0249966384938399,1.0289677099755e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD5,Programmed cell death protein 5,29694,-0.0662710771756144,0.00396293059316263,-0.0740384211382131,-0.0585037332130156,1.73043521207415e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,-0.0500462094491945,0.00299337958906242,-0.0559132334437569,-0.0441791854546322,1.85688649758671e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,-0.0918845871385078,0.00549499172815184,-0.102654770925685,-0.0811144033513302,2.00686219768728e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0452197527822304,0.00270731931374956,0.0399134069272813,0.0505260986371796,2.45308389076429e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,29390,-0.0574224875525671,0.00344101947826117,-0.064166885729959,-0.0506780893751752,3.121042226362e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,-0.0800361919987203,0.00481043588907187,-0.0894646463413012,-0.0706077376561395,8.14978964879954e-62
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECTIN4,Nectin-4,29566,-0.0364327687123282,0.00219251143834036,-0.0407300911314753,-0.0321354462931811,1.00266147465391e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT8,"Keratin, type II cytoskeletal 8",24101,-0.0836759920650114,0.00503556467663586,-0.0935456988312177,-0.0738062852988051,1.15781573184176e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP5,Fatty acid-binding protein 5,29624,-0.0770783507189001,0.00465803172639804,-0.0862080929026403,-0.0679486085351599,3.15012411572889e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,24445,-0.0641302507904634,0.00388250794063956,-0.0717399663541169,-0.0565205352268098,5.85700873047798e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP5,Microfibrillar-associated protein 5,29820,-0.0461727344607844,0.0028012762038355,-0.051663235820302,-0.0406822331012668,9.07299833219042e-61
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL19,Interleukin-19,28654,-0.0797002219817668,0.00483823866326506,-0.0891831697617663,-0.0702172742017672,1.09177670500516e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUCA2A,Guanylin,29333,-0.0386219652983325,0.00234713142914912,-0.0432223428994647,-0.0340215876972002,1.44484195419982e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP3,"Fatty acid-binding protein, heart",24922,-0.0574829987556343,0.00349639377398617,-0.0643359305526472,-0.0506300669586214,2.03758202432412e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,29581,-0.0436006628168727,0.00265400896254146,-0.048802520383454,-0.0383988052502914,2.22555316097555e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESAM,Endothelial cell-selective adhesion molecule,29820,-0.0358836912791508,0.00218535123822266,-0.0401669797060672,-0.0316004028522344,2.52900342753697e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFPI,Tissue factor pathway inhibitor,29435,0.0356672149445697,0.00217229141457897,0.0314095237719949,0.0399249061171444,2.58842058508038e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MARCO,Macrophage receptor MARCO,29478,-0.0296115214207124,0.00180594832594566,-0.0331511801395659,-0.026071862701859,3.73384432499484e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALCAM,CD166 antigen,29820,-0.0219915988392724,0.00134330706394128,-0.0246244806845973,-0.0193587169939474,5.61124065388363e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTDH,Protein LYRIC,24229,-0.105187061441341,0.0064252139094027,-0.11778048070377,-0.0925936421789119,6.47029196492677e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANG,Angiogenin,29435,-0.037835496984584,0.00231376685267289,-0.0423704800158229,-0.0333005139533452,7.69215112163039e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHRDL1,Chordin-like protein 1,29536,-0.0353581849304481,0.00216271013265611,-0.0395970967904541,-0.0311192730704422,8.1022221282464e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLI1,Friend leukemia integration 1 transcription factor,28797,-0.123665973350728,0.00756550816101109,-0.13849436934631,-0.108837577355146,8.63884065038392e-60
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROBO1,Roundabout homolog 1,29497,-0.0270093243263837,0.0016534124159927,-0.0302500126617294,-0.023768635991038,1.01007371650527e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,-0.0312485568600645,0.00191649276177156,-0.0350048826731368,-0.0274922310469923,1.66036066055619e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,-0.0419274561433533,0.00257656485930408,-0.0469775232675893,-0.0368773890191173,2.80445689705817e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,-0.109116607696632,0.00670760835393432,-0.122263520070343,-0.0959696953229204,3.45386808916161e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSG2,Desmoglein-2,29443,0.0300423805906111,0.00184834813581741,0.026419618244409,0.0336651429368132,3.81183944017239e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POF1B,Protein POF1B,24229,-0.0515630799960925,0.00317174044165929,-0.0577796912617447,-0.0453464687304403,4.09716279334213e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPIND1,Heparin cofactor 2,24914,-0.0315898621256012,0.00194626242048403,-0.0354045364697498,-0.0277751877814525,6.11000299326937e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFRP4,Secreted frizzled-related protein 4,24381,-0.0464021765631303,0.00285876591278054,-0.0520053577521801,-0.0407989953740804,6.15326302275512e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL11,Eotaxin,29786,-0.041884893772711,0.00258194073164126,-0.0469454976067278,-0.0368242899386941,6.28628861232363e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BPIFA2,BPI fold-containing family A member 2,23405,0.124121241819826,0.00765076796262502,0.109125736613081,0.139116747026571,7.22898396946863e-59
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCAR,Immunoglobulin alpha Fc receptor,29434,-0.05296819298206,0.00327534790705424,-0.0593878748798863,-0.0465485110842337,1.42777379376063e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,-0.0437961046707648,0.0027158670836369,-0.0491192041546931,-0.0384730051868365,2.98354271559423e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL25,C-C motif chemokine 25,29786,-0.0542185200139105,0.00337208293784209,-0.060827802572081,-0.04760923745574,6.32008020562276e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL5A1,Collagen alpha-1(V) chain,24381,-0.0449080984142323,0.00279281965481788,-0.0503820249376753,-0.0394341718907892,7.01780150440159e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LATS1,Serine/threonine-protein kinase LATS1,24229,-0.0946386703344698,0.00589265862198241,-0.106188281233555,-0.0830890594353843,9.60676879393385e-58
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PI3,Elafin,29014,-0.0605129530604824,0.00377916871470274,-0.0679201237412998,-0.053105782379665,1.85190138660453e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGL1,Fibrinogen-like protein 1,24951,-0.0705999795486073,0.00440857437024266,-0.0792407853142829,-0.0619591737829317,1.96641769348569e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGR,Tyrosine-protein kinase Fgr,28774,-0.0623740932113152,0.0038966359599202,-0.0700114996927588,-0.0547366867298716,2.01729656231302e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPO,Myeloperoxidase,29443,-0.0502364451383601,0.00314636019974047,-0.0564033111298514,-0.0440695791468688,3.80155127379059e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFH,Complement factor H,23693,-0.0258153580729119,0.00161716434010982,-0.0289850001795272,-0.0226457159662967,4.56853905121437e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTSS1,Protein MTSS 1,24805,-0.122344014024169,0.00766549436677536,-0.137368382983049,-0.107319645065289,4.64645404336434e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RSPO3,R-spondin-3,29725,-0.0310449843352577,0.00194626969438568,-0.0348596729362537,-0.0272302957342618,4.83815773759108e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD300LF,CMRF35-like molecule 1,29725,-0.0660178497643746,0.00413960149967735,-0.0741314687037422,-0.057904230825007,5.08570333234598e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD7,T-cell antigen CD7,24177,-0.0481024589068807,0.00301761060689017,-0.0540169756963855,-0.042187942117376,6.46491365385281e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,-0.07037230219398,0.00441867755371237,-0.0790329101992563,-0.0617116941887038,8.11609106022591e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPA1,Carboxypeptidase A1,29820,-0.066358822037975,0.00417177496223533,-0.0745355009639562,-0.0581821431119938,9.76554619246445e-57
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,24381,-0.0407408614451863,0.0025609142900874,-0.0457602534537576,-0.035721469436615,1.06434899060427e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS1,Galectin-1,29478,-0.0373144969747955,0.00235062249984974,-0.041921717074501,-0.03270727687509,1.63815380861223e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,24867,-0.0576849830789873,0.00363873395526599,-0.0648169016313086,-0.0505530645266659,2.53046422325122e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC7A,C-type lectin domain family 7 member A,29786,-0.0639790469082867,0.0040437008701189,-0.0719047006137197,-0.0560533932028536,3.72388274005093e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS3,Galectin-3,29544,-0.0322867241783593,0.00204407248058134,-0.0362931062402987,-0.0282803421164199,5.68522066962234e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F7,Coagulation factor VII,29544,-0.0331436412985032,0.00210198294121837,-0.0372635278632912,-0.0290237547337152,8.75723420906424e-56
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAMDC4,Apical endosomal glycoprotein,24793,-0.0601581676846222,0.00383399929865638,-0.0676728063099887,-0.0526435290592557,3.23030883883686e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BSG,Basigin,29760,-0.0221033691233272,0.00140950446959557,-0.0248659978837345,-0.0193407403629199,3.36095784156066e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BECN1,Beclin-1,24240,-0.0650236863532479,0.00416028489095183,-0.0731778447395135,-0.0568695279669823,8.47668269452721e-55
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSN,Gelsolin,24845,0.0205874803363654,0.00131823322676118,0.0180037432119135,0.0231712174608173,1.00849045664277e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,-0.0518477977626503,0.00332019454866744,-0.0583553790780385,-0.0453402164472621,1.03312150445061e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,-0.0910858907766292,0.00583454838234616,-0.102521605606028,-0.0796501759472307,1.12364542116978e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,-0.0368722716879984,0.00236433362091879,-0.0415063655849992,-0.0322381777909976,1.29457492871356e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY9,T-lymphocyte surface antigen Ly-9,29116,-0.0315222855233375,0.00202333993573613,-0.0354880317973803,-0.0275565392492947,1.67096385079224e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLIN1,Perilipin-1,28774,-0.0372281144299298,0.00239037979148706,-0.0419132588212445,-0.0325429700386152,1.82193993978026e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,-0.0473165787111241,0.00303775978490989,-0.0532705878895475,-0.0413625695327007,1.93397872279186e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RASSF2,Ras association domain-containing protein 2,28797,-0.0597984014266684,0.0038421794251714,-0.0673290731000043,-0.0522677297533324,2.14229589640448e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,29349,-0.0901002578928784,0.00579776282441899,-0.10146387302874,-0.0787366427570172,3.03678101686365e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FSTL1,Follistatin-related protein 1,24240,-0.0245283053506192,0.00157816147230617,-0.0276215018363393,-0.0214351088648991,3.27818795355751e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP4,Metalloproteinase inhibitor 4,29443,0.0427356373974342,0.00275807583369525,0.0373298087633915,0.0481414660314769,6.15301834066837e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,-0.0302702901307475,0.00195610413030317,-0.0341042542261417,-0.0264363260353533,8.38534920175265e-54
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,29453,-0.0528316557040842,0.00342441957566891,-0.0595435180723952,-0.0461197933357731,1.72141477846376e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YTHDF3,YTH domain-containing family protein 3,28931,-0.0899091268821848,0.00583473829846153,-0.101345213947169,-0.0784730398172002,2.31164706464993e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NADK,NAD kinase,29478,-0.0571108374674438,0.00371062099325361,-0.0643836546142209,-0.0498380203206667,3.024143722324e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGFR,Opioid growth factor receptor,29349,-0.0345053235051085,0.00224259212353152,-0.0389008040672302,-0.0301098429429867,3.26302702240296e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL3A1,Collagen alpha-1(III) chain,24938,-0.0247469054125166,0.00160895573090057,-0.0279004586450818,-0.0215933521799515,3.86941271440835e-53
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,24805,-0.0579846091469821,0.00379083167695086,-0.0654146392338058,-0.0505545790601584,1.41350767395134e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCF2,Neutrophil cytosol factor 2,29395,-0.0867466977028431,0.00569360604580623,-0.0979061655526233,-0.0755872298530629,3.2407251180701e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FEN1,Flap endonuclease 1,28797,-0.0659825031287055,0.0043312077692383,-0.0744716703564125,-0.0574933359009984,3.35238380846016e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GM2A,Ganglioside GM2 activator,24421,-0.0403911508974488,0.00265330120384375,-0.0455916212569825,-0.0351906805379151,4.32034406611057e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLAT,Tissue-type plasminogen activator,29736,-0.0524316293005247,0.00344665062830788,-0.0591870645320081,-0.0456761940690412,4.60234534146117e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGFL7,Epidermal growth factor-like protein 7,28797,-0.0414312032358263,0.0027247201364793,-0.0467716547033257,-0.0360907517683268,5.16699371482212e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA2,Annexin A2,23907,-0.0745792860584353,0.00490524945116357,-0.0841935749827159,-0.0649649971341547,5.82824184326666e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCN1,Ficolin-1,24919,-0.0588739943580431,0.00387412133819734,-0.0664672721809099,-0.0512807165351763,6.35717744578201e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,-0.0727667448268186,0.00478834254729011,-0.0821518962195073,-0.06338159343413,6.46161545027026e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YOD1,Ubiquitin thioesterase OTU1,24111,-0.065405068028282,0.00430449337513651,-0.0738418750435495,-0.0569682610130144,6.68382099847235e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSAP,Prosaposin,24761,-0.029812302338817,0.00196369555893835,-0.0336611456343362,-0.0259634590432978,8.00218998340918e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAB2,Stabilin-2,24938,-0.0295097041330546,0.00194393446034377,-0.0333198156753284,-0.0256995925907808,8.13397020099023e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,-0.0272536284532705,0.00179647242713796,-0.0307747144104609,-0.0237325424960801,8.71457030590636e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTBS,Di-N-acetylchitobiase,24653,-0.0286151291753408,0.0018860115063383,-0.0323117117277639,-0.0249185466229178,9.24921691203615e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,-0.0527432265940604,0.00347842289697296,-0.0595609354721274,-0.0459255177159934,9.75948344314805e-52
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK11,Kallikrein-11,29296,-0.0321091698526429,0.00211833319310096,-0.0362611029111208,-0.027957236794165,1.05839029950763e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GDNF,Glial cell line-derived neurotrophic factor,28774,-0.0398368215558497,0.00262861777513394,-0.0449889123951123,-0.0346847307165872,1.11159145501477e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HYOU1,Hypoxia up-regulated protein 1,29820,-0.0231529880216562,0.00152889754963173,-0.0261496272189344,-0.020156348824378,1.30054363784172e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTBDN,Retbindin,29349,-0.0308058330104423,0.00203493553473637,-0.0347943066585256,-0.026817359362359,1.41459809954548e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,-0.065838210126727,0.00435032074553638,-0.0743648387879783,-0.0573115814654757,1.50817793844645e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPP1,Tripeptidyl-peptidase 1,29286,-0.047679047980378,0.00315200381151777,-0.0538569754509528,-0.0415011205098032,1.69422785233104e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WDR46,WD repeat-containing protein 46,24793,-0.0376129431360914,0.00248868073116369,-0.0424907573691722,-0.0327351289030105,2.23298872819075e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP8,Neutrophil collagenase,29640,-0.0750598771946877,0.00496953198980302,-0.0848001598947017,-0.0653195944946738,2.36766046951096e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,-0.0523311507196873,0.0034636727590866,-0.0591199493274971,-0.0455423521118776,2.44312241472923e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLF4,Krueppel-like factor 4,24101,-0.0414994747890503,0.00275238225637964,-0.0468941440115544,-0.0361048055665462,3.88979897610286e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP20,Centrosomal protein 20,28797,-0.0768767675176512,0.00510927389740738,-0.0868909443565696,-0.0668625906787327,5.68882079887455e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,-0.0673548118336877,0.00448316909799022,-0.0761418232657486,-0.0585678004016269,7.91047914559332e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,-0.0453788360889741,0.00302056572703265,-0.0512991449139581,-0.0394585272639901,8.00539599621193e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MET,Hepatocyte growth factor receptor,29507,0.0204136431571172,0.00135929711569389,0.0177494208103571,0.0230778655038772,8.65511837742696e-51
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBS,Cystathionine beta-synthase,24240,-0.0531124390187952,0.00353891600878864,-0.0600487143960209,-0.0461761636415694,1.09829080533267e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAPG,Macrophage-capping protein,29174,-0.0600442278439458,0.00400331157705861,-0.0678907185349807,-0.052197737152911,1.15835032012201e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COCH,Cochlin,24922,-0.0478642153791583,0.00319397035670526,-0.0541243972783006,-0.041604033480016,1.51050229633767e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLITRK2,SLIT and NTRK-like protein 2,29725,-0.0401103696360208,0.00268629739945615,-0.0453755125389548,-0.0348452267330867,3.13005616325367e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL32,Interleukin-32,29434,0.0445842612897266,0.00298859681766298,0.0387266115271071,0.050441911052346,3.83335033339523e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,-0.0234423911206734,0.00157360508223089,-0.0265266570818459,-0.0203581251595008,5.63674705694403e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EEF1D,Elongation factor 1-delta,24922,-0.0938729344581007,0.00630252192012815,-0.106225877421552,-0.0815199914946495,5.87309806517236e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RARRES1,Retinoic acid receptor responder protein 1,28797,-0.0342924241731831,0.00230365208899286,-0.0388075822676092,-0.0297772660787571,6.22490750195898e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINT1,Kunitz-type protease inhibitor 1,29333,-0.0266258359989994,0.00178879199408762,-0.0301318683074111,-0.0231198036905877,6.29679578009989e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD207,C-type lectin domain family 4 member K,28835,-0.0395015278309217,0.00265491339354483,-0.0447051580822695,-0.0342978975795738,6.94970545771243e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMN,Protein amnionless,28931,-0.0484000061016826,0.00325307398870463,-0.0547760311195436,-0.0420239810838215,6.9825725221537e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HYAL1,Hyaluronidase-1,29265,-0.0234929265734327,0.00158084737925367,-0.0265913874367699,-0.0203944657100955,8.9759269634075e-50
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHCHD6,MICOS complex subunit MIC25,24793,-0.0297496522585078,0.0020044254299892,-0.0336783261012866,-0.025820978415729,1.2811816394428e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD248,Endosialin,24938,0.0409627950231592,0.00277772044326619,0.0355184629543574,0.0464071270919609,5.18404006151055e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELPLG,P-selectin glycoprotein ligand 1,29434,-0.0280732744945158,0.00190434265202713,-0.031805786092489,-0.0243407628965427,5.20493940602924e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP3S2,AP-3 complex subunit sigma-2,24845,-0.0480736529459323,0.0032658065992992,-0.0544746338805587,-0.0416726720113059,7.67373169035233e-49
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,-0.0518759166607023,0.00353344667681798,-0.0588014721472655,-0.044950361174139,1.35745641392996e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,24845,-0.0322328045674384,0.00219695736051027,-0.0365388409940385,-0.0279267681408382,1.56595239775461e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.0346817354730346,0.00236807356764019,-0.0393231596656094,-0.0300403112804599,2.29124021701618e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREML2,Trem-like transcript 2 protein,29443,-0.0340381699941925,0.00232601012976757,-0.0385971498485369,-0.029479190139848,2.5315760902814e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD46,Membrane cofactor protein,29331,-0.028756919026827,0.00196836077926192,-0.0326149061541804,-0.0248989318994736,3.60504775623571e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD63,CD63 antigen,29169,-0.0512696670459366,0.00351764813795911,-0.0581642573963365,-0.0443750766955368,5.97720464982346e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C19orf12,Protein C19orf12,28774,-0.0644486063158187,0.0044237117297972,-0.0731190813062212,-0.0557781313254162,6.56474625312288e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,0.0214628935069824,0.00147505141192392,0.0185717927396115,0.0243539942743532,8.54548277843745e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAT2,Linker for activation of T-cells family member 2,29349,-0.123890981391863,0.00851592983454381,-0.140582203867569,-0.107199758916158,8.80582685617396e-48
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.024157693198224,0.001664732428352,0.020894817638654,0.0274205687577939,1.49399364507295e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JAM2,Junctional adhesion molecule B,29694,-0.0265259332049552,0.00183342111271557,-0.0301194385858777,-0.0229324278240327,2.79662459462977e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRLB,Fc receptor-like B,28797,-0.0609664894041241,0.00421606685902253,-0.0692299804478082,-0.0527029983604399,3.15159895107842e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TALDO1,Transaldolase,24888,-0.0443766341723683,0.00307190060864413,-0.0503975593653108,-0.0383557089794258,4.12364193871584e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,-0.0568755429313461,0.00394626889160528,-0.0646102299588925,-0.0491408559037998,6.25977060191871e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS7_LGALS7B,Galectin-7,29320,-0.0414328534569268,0.00288006827560087,-0.0470777872771045,-0.0357879196367491,9.13766424515891e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,-0.0370109154692324,0.00257272235126122,-0.0420534512777043,-0.0319683796607604,9.88889496591871e-47
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL19,C-C motif chemokine 19,29694,-0.121141052032668,0.00843405178297865,-0.137671793527307,-0.10461031053803,1.26032298623447e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD244,Natural killer cell receptor 2B4,29786,-0.0266615093743533,0.00185732597073641,-0.0303018682769967,-0.0230211504717099,1.42292382523753e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL3,Angiopoietin-related protein 3,29518,0.0351278293795786,0.00244749129469461,0.0303307464419772,0.03992491231718,1.47315391838221e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUMB,Protein numb homolog,24229,-0.0828848037520254,0.00577752608663753,-0.094208754881835,-0.0715608526222159,1.74896811435897e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAP18,Chromatin complexes subunit BAP18,24845,-0.0656707844492234,0.00458178842321129,-0.0746510897587175,-0.0566904791397293,2.08539414717601e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,-0.0413954352253518,0.00288869764639183,-0.0470572826122798,-0.0357335878384238,2.1690513851995e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP1,Interstitial collagenase,28424,-0.0902182853914607,0.00629752828209092,-0.102561440824359,-0.0778751299585625,2.18540490852583e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTRB1,Chymotrypsinogen B,29443,-0.054651161237751,0.00381573991110217,-0.0621300114635113,-0.0471723110119907,2.26575044852965e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,29694,-0.0228517966361536,0.00160043476133096,-0.0259886487683623,-0.019714944503945,4.23664095612256e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INHBB,Inhibin beta B chain,24381,-0.051255638660943,0.00358947454796721,-0.0582910087749587,-0.0442202685469272,4.51225499535532e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPR,Nucleoprotein TPR,24111,-0.0470049008186596,0.00329818260860654,-0.0534693387315284,-0.0405404629057907,6.71858298015205e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPON2,Spondin-2,29311,-0.034080608172194,0.00239386512737284,-0.0387725838218448,-0.0293886325225433,7.71970617469571e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTN1,Dynactin subunit 1,29725,-0.0633447068795461,0.00445130710966852,-0.0720692688144964,-0.0546201449445958,8.3726552240165e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NBN,Nibrin,28931,-0.0511922430497537,0.00360030038630918,-0.0582488318069197,-0.0441356542925877,9.98015062666167e-46
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKK1,Dickkopf-related protein 1,29694,-0.0577931890262628,0.00406687329999943,-0.0657642606942617,-0.0498221173582639,1.11042312273187e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NGRN,Neugrin,24845,-0.0217411396744506,0.00153173171572072,-0.0247433338372632,-0.018738945511638,1.50817130625828e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,-0.0278211151978217,0.00196071851175098,-0.0316641234808537,-0.0239781069147898,1.61029873018671e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,-0.0502612018453945,0.00354399429963203,-0.0572074306726733,-0.0433149730181158,1.68452096996867e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,28931,-0.0342362449726644,0.00241572817239203,-0.0389710721905528,-0.029501417754776,1.93278151731834e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,-0.0426952207487044,0.00301737656802773,-0.0486092788220387,-0.03678116267537,2.83896663807853e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC14A,C-type lectin domain family 14 member A,29443,-0.0307904223137621,0.00217847520490527,-0.0350602337153764,-0.0265206109121478,3.29974983718099e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTGR1,Prostaglandin reductase 1,24922,-0.0795331013546703,0.00563921467036536,-0.0905859621085864,-0.0684802406007542,5.37993659966209e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL6,Fc receptor-like protein 6,29434,-0.0657089311844516,0.00466552329386018,-0.0748533568404176,-0.0565645055284857,6.67319131047816e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFPI2,Tissue factor pathway inhibitor 2,29473,-0.0377191753051111,0.00268010851954304,-0.0429721880034155,-0.0324661626068068,7.69695445802798e-45
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CIT,Citron Rho-interacting kinase,24195,-0.0440597023777428,0.00313607877322898,-0.0502064167732716,-0.037912987982214,1.16611028836974e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,-0.0492344805660274,0.00350676388834184,-0.0561077377871774,-0.0423612233448774,1.3177114401146e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAP29,Synaptosomal-associated protein 29,29566,-0.0877641392071155,0.00626303127929592,-0.100039680514535,-0.0754885978996955,1.80089615799066e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL4,C-C motif chemokine 4,29498,-0.0626226704083268,0.00447933834016951,-0.0714021735550591,-0.0538431672615946,2.84648252231078e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,29694,-0.0649938118746329,0.00464983671876746,-0.0741074918434171,-0.0558801319058486,2.94885157027423e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,24793,-0.0669860429937959,0.00479190302700843,-0.0763781729267325,-0.0575939130608594,3.08392726164298e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPL14,60S ribosomal protein L14,24240,-0.038905249407386,0.00278330464350707,-0.0443605265086599,-0.0334499723061122,3.15167296875717e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,-0.0681834214619843,0.0048812804179345,-0.077750731081136,-0.0586161118428327,3.37536272436739e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,-0.0207094804799935,0.00148424973125855,-0.0236186099532603,-0.0178003510067268,4.43983162184958e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,29704,-0.0781947114145374,0.00561356302189876,-0.0891972949374589,-0.0671921278916158,5.75922603456094e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCXR,L-xylulose reductase,29566,-0.0511960276571003,0.00367872791226072,-0.0584063343651314,-0.0439857209490693,6.89403016820617e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53I3,Quinone oxidoreductase PIG3,23906,-0.0514295878079707,0.0036952835390543,-0.0586723435445171,-0.0441868320714242,7.34491045698092e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,29349,-0.0373027847431115,0.00268229231336827,-0.0425600776773133,-0.0320454918089097,7.90928925468689e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS3BP,Galectin-3-binding protein,24966,-0.0291662738943407,0.00209823503551074,-0.0332788145639418,-0.0250537332247396,9.1757907144937e-44
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,-0.0342554260937768,0.00246747563687082,-0.0390916783420436,-0.02941917384551,1.10651475570271e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-0.0290060115991309,0.00208940885277937,-0.0331012529505785,-0.0249107702476833,1.18006677601694e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,28797,-0.0471677174333743,0.00340262597919458,-0.0538368643525957,-0.0404985705141529,1.48299174449596e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,29542,0.0294835238313162,0.00212730940669155,0.0253139973942007,0.0336530502684316,1.52523281818271e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMSB10,Thymosin beta-10,29443,-0.0720588440265014,0.00520183078761092,-0.0822544323702188,-0.061863255682784,1.68083378987705e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARA5,Scavenger receptor class A member 5,29694,-0.0285950958712465,0.00206483447368501,-0.0326421714396691,-0.0245480203028239,1.7712337198739e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,29218,-0.0221531200454251,0.00159985496180221,-0.0252888357705575,-0.0190174043202928,1.82152596331118e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS22,Brain-specific serine protease 4,24229,-0.0335198053752864,0.00242069678446988,-0.0382643710728474,-0.0287752396777254,1.93782565999427e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,-0.0346613075951658,0.00250444694664762,-0.0395700236105951,-0.0297525915797364,2.11937810259782e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PQBP1,Polyglutamine-binding protein 1,28797,-0.0530168738708238,0.00383565640774322,-0.0605347604300005,-0.0454989873116471,2.57917585624275e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PVR,Poliovirus receptor,29694,-0.0351092385176625,0.00254157435739814,-0.0400907242581629,-0.0301277527771621,2.85824575854424e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXLNA,Alpha-taxilin,29218,-0.0838671571131744,0.00607352116943087,-0.0957712586052589,-0.0719630556210899,3.09121579895795e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHB6,Ephrin type-B receptor 6,29163,-0.0301963830465808,0.0021888319413959,-0.0344864936517168,-0.0259062724414448,3.6997258017672e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1RL,Complement C1r subcomponent-like protein,24925,-0.0185970119716433,0.00134792712992605,-0.0212389491462984,-0.0159550747969883,3.8427628365089e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACAN,Aggrecan core protein,29192,0.0268018743058312,0.00194554517410326,0.0229886057645888,0.0306151428470736,4.8468418335109e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRLF1,Cytokine receptor-like factor 1,29581,-0.0243681319834011,0.00177329192960734,-0.0278437841654315,-0.0208924798013707,7.73132755107656e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,-0.0841688961167007,0.00612814401961322,-0.0961800583951427,-0.0721577338382588,8.53993249507817e-43
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTA,Lymphotoxin-alpha,29434,-0.0377280723637426,0.00275334530718307,-0.0431246291658214,-0.0323315155616638,1.32364081934264e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC27,Cell division cycle protein 27 homolog,28797,-0.0571990168178975,0.00418470512049651,-0.0654010388540707,-0.0489969947817244,2.12193556558178e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6AP2,Renin receptor,28797,-0.0381570302074873,0.00279294572094262,-0.0436312038205348,-0.0326828565944397,2.32383740414238e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,-0.032443787314988,0.00237582488545177,-0.0371004040904734,-0.0277871705395025,2.50409838452407e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM3D,Protein FAM3D,24805,-0.0798510574709793,0.00585209176546181,-0.0913211573312844,-0.0683809576106741,3.07828064891624e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,-0.0297719349925052,0.00218761960682707,-0.0340596694218863,-0.0254842005631242,5.03496791473341e-42
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,28916,-0.0351046010415151,0.00259065594057095,-0.0401822866850342,-0.0300269153979961,1.05586952430955e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,29454,-0.0483796281659833,0.00357447084731917,-0.0553855910267288,-0.0413736653052377,1.29886223446918e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASAH2,Neutral ceramidase,29218,-0.0491226383927494,0.0036302299533665,-0.0562378891013478,-0.0420073876841511,1.35973225491344e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3GLB2,Endophilin-B2,24845,-0.0621487958489227,0.00459371228669893,-0.0711524719308526,-0.0531451197669928,1.47845809906972e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT5,ADP-sugar pyrophosphatase,29443,-0.0474289926573029,0.00350824732699585,-0.0543051574182147,-0.040552827896391,1.60136385747249e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH15,Cadherin-15,29639,-0.0536174603079073,0.00396764080439979,-0.0613940362845309,-0.0458408843312837,1.72384340972749e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,-0.058929611124879,0.00436035980331822,-0.0674759163393827,-0.0503833059103753,1.79196972246875e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST7,Cystatin-F,29498,-0.086314867020115,0.00639033683879256,-0.0988399272241484,-0.0737898068160815,1.88693642098803e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,24793,-0.074283229078879,0.00549862380159347,-0.0850605317300022,-0.0635059264277557,1.92944266381897e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAT,Linker for activation of T-cells family member 1,29786,-0.0700334805098713,0.00519145521398997,-0.0802087327292916,-0.0598582282904509,2.36511764760951e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,-0.0913706396629182,0.00678833919751261,-0.104675784490043,-0.0780654948357935,3.55220073209548e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.096474447894195,0.00717407781216181,-0.110535640406032,-0.0824132553823578,4.20287664813403e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APLP1,Amyloid-like protein 1,29478,0.0474368479013378,0.003535371375634,0.0405075200050952,0.0543661757975805,6.27533273649674e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDRKH,Tudor and KH domain-containing protein,28774,-0.0782639184958184,0.0058327500572064,-0.0896961086079429,-0.0668317283836938,6.29840113013984e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDHR2,Cadherin-related family member 2,29349,-0.0667587053820763,0.00497938230781414,-0.0765182947053921,-0.0569991160587606,7.25753618460597e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF1,Signaling lymphocytic activation molecule,28931,-0.0547329209785973,0.00408879046257431,-0.062746950285243,-0.0467188916719517,9.64354469705156e-41
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGLC2,Immunoglobulin lambda constant 2,24915,-0.0229333237153032,0.00171876500315219,-0.0263021031214815,-0.0195645443091249,1.79454096533837e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,29426,-0.0891805914961159,0.00669048511437979,-0.1022939423203,-0.0760672406719315,2.04421252001356e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,29820,-0.0277941984175591,0.00208751629888642,-0.0318857303633765,-0.0237026664717418,2.48678017680902e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,-0.0451081013801531,0.00339390802058145,-0.0517601611004928,-0.0384560416598135,3.40642766015955e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRCAM,Neuronal cell adhesion molecule,29478,-0.0258765969433421,0.00194781541322875,-0.0296943151532704,-0.0220588787334138,3.69468005359927e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL8,Interleukin-8,29218,-0.0617848075284724,0.00466095469397559,-0.0709202787286646,-0.0526493363282802,5.44852709412775e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,-0.0542737367822117,0.00409942868475613,-0.0623086170043337,-0.0462388565600896,6.79556396774178e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEFTY2,Left-right determination factor 2,29674,-0.047150813971532,0.0035629965962682,-0.0541342873002177,-0.0401673406428463,7.29560710126337e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALB2,Calretinin,28774,-0.0277365445336493,0.00209838195213212,-0.0318493731598282,-0.0236237159074703,9.01683713271612e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NSFL1C,NSFL1 cofactor p47,29694,-0.0589068065417091,0.00445862251613203,-0.0676457066733279,-0.0501679064100903,9.70330501592339e-40
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL5,Fc receptor-like protein 5,29443,-0.0521525052790901,0.00394831252205669,-0.0598911978223212,-0.044413812735859,1.01278167980808e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY96,Lymphocyte antigen 96,29218,-0.0322040709551092,0.00244291744955461,-0.0369921891562362,-0.0274159527539821,1.43344789675257e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,-0.0319908060364062,0.00243279874557533,-0.0367590915777339,-0.0272225204950786,2.32830545329136e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN8,Tetraspanin-8,24805,-0.090993735849904,0.00693298588885801,-0.104582388192066,-0.0774050835077423,3.21081436783558e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSCAM,Down syndrome cell adhesion molecule,24867,-0.0324574462117467,0.00247311676787882,-0.0373047550767892,-0.0276101373467042,3.23579953443197e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGMN,Legumain,29581,-0.0322921360635363,0.00246266320150948,-0.0371189559384949,-0.0274653161885777,3.58340391171526e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINH1,Serpin H1,24445,-0.116612037886502,0.0089035602641225,-0.134063016004182,-0.0991610597688217,4.62401427790911e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,QDPR,Dihydropteridine reductase,29345,-0.0386421964922787,0.00295997006706199,-0.0444437378237202,-0.0328406551608372,7.64471726551101e-39
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRPK2,SRSF protein kinase 2,29434,-0.0748464000899458,0.0057509345705127,-0.0861182318481507,-0.0635745683317409,1.29138882228762e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,-0.0511154286508893,0.00393083420211664,-0.0588198636870379,-0.0434109936147407,1.48880423602325e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL2,Fc receptor-like protein 2,29645,-0.0440552106353279,0.00338817705285929,-0.0506960376589321,-0.0374143836117237,1.50736857316858e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD6,T-cell differentiation antigen CD6,29760,-0.0468328014353179,0.00361436266977825,-0.0539169522680833,-0.0397486506025525,2.70855683744228e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD22,B-cell receptor CD22,29786,-0.0371540694214164,0.00287356881721567,-0.0427862643031591,-0.0315218745396737,3.88243178781989e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,-0.0408295921824021,0.00315855512270987,-0.0470203602229134,-0.0346388241418907,4.04309820770681e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNG,Interferon gamma,28931,-0.100684375128801,0.00781425099138865,-0.116000307071923,-0.0853684431856796,6.97816451172868e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,-0.0633328608824259,0.00491676987273772,-0.0729697298329919,-0.05369599193186,7.32921667600173e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17C,Interleukin-17C,28931,-0.0622940239312769,0.00483915906621247,-0.0717787757010533,-0.0528092721615004,8.1247222841046e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOST,Sclerostin,29433,-0.0341877249826807,0.00265770530001498,-0.03939682737071,-0.0289786225946513,9.11815838331125e-38
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZBP1,Z-DNA-binding protein 1,24229,-0.0361793772345273,0.00281638231735534,-0.0416994865765438,-0.0306592678925108,1.2016091851899e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADA,Adenosine deaminase,29786,-0.0306922880015964,0.00239115922392516,-0.0353789600804897,-0.0260056159227031,1.30139706290573e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,-0.026400971008453,0.00205926082061969,-0.0304371222168676,-0.0223648198000384,1.58156213803467e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OMD,Osteomodulin,29581,0.0379676039942693,0.00296559119932545,0.0321550452435914,0.0437801627449472,1.99089234741143e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,29216,-0.051349012005425,0.00401284085845689,-0.0592141800880006,-0.0434838439228495,2.17085382203242e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAMP5,Vesicle-associated membrane protein 5,28916,-0.0476241434689479,0.0037219294361794,-0.0549191251638595,-0.0403291617740362,2.19345225580188e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHRDL2,Chordin-like protein 2,29478,-0.0469722674644935,0.00367167879249939,-0.0541687578977924,-0.0397757770311947,2.25247705349182e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.0517499428770375,0.00404942134016977,-0.0596868087037703,-0.0438130770503048,2.683935483051e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDN1,Endothelin-1,24240,-0.0257842583136516,0.00201969795669923,-0.0297428663087821,-0.0218256503185211,3.32953274932729e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC16A1,Monocarboxylate transporter 1,28774,-0.0505595763971196,0.0039719568103312,-0.0583446117453688,-0.0427745410488705,5.12742083631784e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPPK1,Epiplakin,24240,-0.0648954811336988,0.00509945440356196,-0.0748904117646802,-0.0549005505027173,5.57231312957378e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF6,SLAM family member 6,28797,-0.0335057541609182,0.00263468108342612,-0.0386697290844334,-0.028341779237403,5.967974441116e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP3,Metalloproteinase inhibitor 3,29581,-0.113365775176621,0.00892189826634623,-0.13085269577866,-0.0958788545745826,6.7995977120627e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP9,Matrix metalloproteinase-9,29411,-0.0527761590877856,0.00415490877939739,-0.0609197802954045,-0.0446325378801668,7.19461474181821e-37
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,-0.0261933778012891,0.00206756544335803,-0.0302458060702708,-0.0221409495323073,1.10476078091901e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN1,Tetraspanin-1,28916,-0.0494791458727886,0.00390671577817367,-0.057136308798009,-0.0418219829475682,1.15459921973215e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLVRB,Flavin reductase,29443,-0.0565696989218648,0.00446901456937006,-0.0653289674778301,-0.0478104303658994,1.25579690541624e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POSTN,Periostin,24938,0.0331560826176403,0.00262012935966896,0.0280206290726892,0.0382915361625915,1.3714950001528e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASAH1,Acid ceramidase,24732,-0.040670327988704,0.0032221411581152,-0.0469857246586098,-0.0343549313187982,2.06516435902378e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAG3,Lymphocyte activation gene 3 protein,29349,-0.035436126095347,0.00281040252075693,-0.0409445150360306,-0.0299277371546634,2.34347702172486e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,-0.0318289666149946,0.0025256992075108,-0.0367793370617158,-0.0268785961682735,2.67855701861105e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEFL,Neurofilament light polypeptide,28674,-0.0388322549164935,0.00308294106815627,-0.0448748194100798,-0.0327896904229073,2.77743771389637e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL1,Angiopoietin-related protein 1,29030,-0.0252511511701265,0.00200644155695083,-0.0291837766217502,-0.0213185257185029,3.1739243627965e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,-0.0564906065266431,0.00448989788114869,-0.0652908063736945,-0.0476904066795916,3.29377601977053e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,29786,-0.0480232170036526,0.00381709047600667,-0.0555047143366256,-0.0405417196706795,3.31690534897989e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YES1,Tyrosine-protein kinase Yes,29349,-0.0982310650705107,0.00781169725169953,-0.113541991683842,-0.0829201384571797,3.59914488235736e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,28774,-0.0528427734701894,0.0042027489553313,-0.0610801614226388,-0.0446053855177401,3.68277855035986e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A12,Protein S100-A12,29023,-0.0648824828099859,0.00516208851624515,-0.0750001763018264,-0.0547647893181454,3.88246966636677e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNLIP,Pancreatic triacylglycerol lipase,24951,-0.0549426686871144,0.00437323103404608,-0.0635142015138447,-0.0463711358603841,4.31691909437106e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM4,Intercellular adhesion molecule 4,29434,0.045391718403881,0.00361567081311588,0.0383050036101738,0.0524784331975881,4.66678007139371e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPL,Periplakin,24229,-0.028404751222167,0.0022641277201949,-0.032842441553749,-0.023967060890585,5.44110677500589e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERP44,Endoplasmic reticulum resident protein 44,29301,-0.0222493133431098,0.0017750706550163,-0.0257284518269417,-0.0187701748592778,5.99241958585928e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN3,CCN family member 3,29795,-0.029174011314247,0.00232810736301503,-0.0337371017457564,-0.0246109208827375,6.20910613085416e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,-0.0525764354745328,0.00419694532155645,-0.0608024483047834,-0.0443504226442822,6.53733332537141e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBLIF,Cobalamin binding intrinsic factor,29433,-0.0641265442654121,0.00512126917249902,-0.0741642318435101,-0.054088856687314,7.02147631364325e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,-0.0493275481670579,0.00394014290693029,-0.0570502282646413,-0.0416048680694746,7.26801721135832e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,-0.0836832739831742,0.0066866357416302,-0.0967890800367694,-0.070577467929579,7.63215441751976e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QA,Complement C1q subcomponent subunit A,29646,-0.0195063688878934,0.00155944414075008,-0.0225628794037635,-0.0164498583720232,8.2583722488428e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDNF,Cerebral dopamine neurotrophic factor,29349,-0.0279981411314804,0.00223936560982739,-0.0323872977267421,-0.0236089845362187,8.9021453206488e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,-0.0464706814582773,0.00371740838923911,-0.053756801901186,-0.0391845610153686,9.11445485743504e-36
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,-0.0200995927421533,0.0016088635567465,-0.0232529653133764,-0.0169462201709301,1.00406729261535e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAG1,Dystroglycan,29581,-0.0406604810387854,0.00325713985313104,-0.0470444751509223,-0.0342764869266486,1.1302208811923e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,-0.0663465450301558,0.00532312156969879,-0.0767798633067655,-0.0559132267535462,1.5010404605416e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP4,Dipeptidyl peptidase 4,28990,0.0256685366995195,0.00206286066638888,0.0216253297933973,0.0297117436056417,1.87688070919243e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH9,Protocadherin-9,24805,-0.0291287845210319,0.00234380035041325,-0.0337226332078418,-0.0245349358342219,2.34730441497435e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRTAC1,Cartilage acidic protein 1,29820,0.0256974806501944,0.00206905567183714,0.0216421315333936,0.0297528297669952,2.49281933570547e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAN,Brevican core protein,29218,0.028993258254588,0.00233585705036052,0.0244149784358814,0.0335715380732946,2.75288844512294e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,-0.0734897099542932,0.00592344582496285,-0.0850996637712203,-0.061879756137366,2.94753995781218e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL5,C-C motif chemokine 5,29594,-0.0855130086975626,0.00690084649203721,-0.0990386678219556,-0.0719873495731697,3.54553669741071e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFC,Platelet-derived growth factor C,28797,-0.0246737995872329,0.00199147019278834,-0.028577081165098,-0.0207705180093677,3.65159215249159e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNXB,Tenascin-X,29443,0.0219209287004331,0.00177318117501005,0.0184454935974134,0.0253963638034528,5.09551479137349e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,-0.0694589423126442,0.00562402760852682,-0.0804820364253568,-0.0584358481999317,6.14221024115637e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,24240,-0.0619438647175363,0.00501543467409616,-0.0717741166787648,-0.0521136127563079,6.15658151484361e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINE1,Plasminogen activator inhibitor 1,29820,-0.056830847719264,0.00460307936490278,-0.0658528832744734,-0.0478088121640545,6.2120206358791e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,-0.0930924144393832,0.00754803701983948,-0.107886566998269,-0.0782982618804978,7.58724782280126e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,28774,-0.0434617759448751,0.00352594211074463,-0.0503726224819345,-0.0365509294078156,8.00756173778332e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLIN3,Perilipin-3,29478,-0.0360264215788229,0.00292681843182452,-0.0417629857051989,-0.0302898574524468,9.85413351096537e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA12,Carbonic anhydrase 12,29349,-0.0276054608925995,0.00224288957534157,-0.032001524460269,-0.02320939732493,9.99523985647554e-35
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,-0.0251283371525742,0.00204189956933662,-0.029130460308474,-0.0211262139966744,1.05614411365685e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA3G,Semaphorin-3G,24381,-0.0377278887473904,0.00306605232335042,-0.0437373513011572,-0.0317184261936236,1.07891498710769e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,-0.088244397823297,0.00718416878701531,-0.102325368645847,-0.074163427000747,1.35788907616449e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,0.0546694209430109,0.00445101323219707,0.0459454350079046,0.0633934068781171,1.36687321071166e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,-0.0238569489338623,0.00194190751993639,-0.0276630876729377,-0.020050810194787,1.36787073587241e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,28797,-0.0541219741483724,0.00440837678465523,-0.0627623926462967,-0.0454815556504482,1.46784125926719e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDHR5,Cadherin-related family member 5,29478,-0.0327427112931403,0.00267199055548256,-0.0379798127818861,-0.0275056098043945,1.93867857986495e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGMB,RGM domain family member B,29694,-0.0226569568775686,0.00185026939513713,-0.0262834848920373,-0.0190304288630998,2.15750204290273e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYH9,Myosin-9,24938,-0.0954706583534008,0.0077990356433145,-0.110756768214297,-0.0801845484925044,2.3462592623797e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLIT2,Slit homolog 2 protein,28774,-0.0437318937925843,0.00357777884911032,-0.0507443403368405,-0.0367194472483281,2.84302416902991e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOS1,"Nitric oxide synthase, brain",28774,-0.0454933544584076,0.00372405254816605,-0.052792497452813,-0.0381942114640021,3.10139224540686e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MILR1,Allergin-1,28931,-0.0423389977782032,0.00346759870592236,-0.049135491241811,-0.0355425043145953,3.34212026216168e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,-0.0230323853673735,0.00188777245449132,-0.0267324193781765,-0.0193323513565706,3.71221222301807e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,-0.0278770461412417,0.00228502142252042,-0.0323556881293817,-0.0233984041531017,3.77131731601482e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP85,Centrosomal protein of 85 kDa,28797,-0.05367459176165,0.00440090087910062,-0.0623003574846872,-0.0450488260386128,3.95074070724404e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLK1,Protein delta homolog 1,29820,-0.0466939846532933,0.00382887169419368,-0.0541985731739129,-0.0391893961326737,3.97478090855173e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,-0.0373634533212317,0.00306772706999322,-0.0433761983784184,-0.0313507082640449,4.84698463186986e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,28931,-0.0586720006309776,0.00481888778779834,-0.0681170206950623,-0.0492269805668928,5.09094644354098e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA10,Annexin A10,28774,-0.0687393743850035,0.00564626704871497,-0.0798060578004848,-0.0576726909695221,5.16628686736253e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK10,Kallikrein-10,29466,-0.0334333644514086,0.00274644863479838,-0.0388164037756134,-0.0280503251272038,5.20589604496547e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,24681,-0.0509380137963624,0.00418845269276108,-0.0591473810741741,-0.0427286465185507,6.23083337440285e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPE,Carboxypeptidase E,29468,0.0322511769905826,0.00265466467944009,0.02704803421888,0.0374543197622851,7.01080820168706e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1R1,Interleukin-1 receptor type 1,29390,-0.0191929965402418,0.0015805317670971,-0.0222908388037522,-0.0160951542767315,7.49888492551427e-34
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASGR2,Asialoglycoprotein receptor 2,24951,-0.0218927174395687,0.00180640704277146,-0.0254332752434007,-0.0183521596357366,1.03609098293222e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLSCR3,Phospholipid scramblase 3,24804,-0.049250904051524,0.00406901012721135,-0.0572261639008582,-0.0412756442021897,1.25305273452792e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,-0.0371222114119899,0.00307031651284854,-0.043140031777173,-0.0311043910468067,1.47532153379818e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPK9,Mitogen-activated protein kinase 9,29434,-0.0356102978104645,0.00294712823908436,-0.0413866691590698,-0.0298339264618592,1.55882829083466e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NIT2,Omega-amidase NIT2,24813,-0.0621388305206781,0.00514863125680087,-0.0722301477840078,-0.0520475132573484,1.91117861015114e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MERTK,Tyrosine-protein kinase Mer,29786,-0.0211186576761489,0.00175039313264888,-0.0245494282161407,-0.0176878871361571,1.93282629563707e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,-0.0718068204115276,0.00595176827162395,-0.0834722862239105,-0.0601413545991446,1.95453443888644e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STK11,Serine/threonine-protein kinase STK11,28916,-0.0604330871734957,0.00501516364166204,-0.0702628079111533,-0.0506033664358381,2.32987001026048e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,28797,-0.0471914595930848,0.00392055200610263,-0.054875741525046,-0.0395071776611236,2.73186028401364e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,-0.0244203276985615,0.00203319400580505,-0.0284053879499394,-0.0204352674471835,3.72689521950422e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,-0.0571840133238053,0.00476859103679248,-0.0665304517559186,-0.047837574891692,4.68732511352606e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM2,Intercellular adhesion molecule 2,29820,-0.0262515119168479,0.00219085654496712,-0.0305455907449834,-0.0219574330887123,5.23915885141824e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STC2,Stanniocalcin-2,29396,-0.0213523402673287,0.00178257486958766,-0.0248461870117206,-0.0178584935229369,5.50645350177168e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIMAP8,GTPase IMAP family member 8,24016,-0.0423025378091958,0.003533481232818,-0.0492281610255191,-0.0353769145928726,6.18918100524723e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,-0.0292266386126608,0.00244268216934699,-0.0340142956645808,-0.0244389815607407,6.47292333171032e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPON1,Spondin-1,29497,-0.0270118094622052,0.00225872800388596,-0.0314389163498217,-0.0225847025745887,6.95389018163167e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WNT9A,Protein Wnt-9a,28931,-0.0237147282780107,0.00198398245972324,-0.0276033338990682,-0.0198261226569531,7.4766389310568e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTSS2,Protein MTSS 2,24793,-0.0820624895637065,0.00686411561218378,-0.0955161561635867,-0.0686088229638263,7.50205297777735e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,29673,-0.0250200146266303,0.00209337711772342,-0.0291230337773682,-0.0209169954758924,7.54284449847518e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5E,5'-nucleotidase,29566,-0.0460427439968215,0.00385446484423653,-0.053597495091525,-0.0384879929021179,8.17653435753357e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,24111,-0.030160748717965,0.00252430812754712,-0.0351083926479573,-0.0252131047879726,8.22155173696396e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNMBP,Dynamin-binding protein,29218,-0.0500688589177417,0.00419360229181079,-0.0582883194096908,-0.0418493984257925,8.79891534821383e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB1,Integrin beta-1,29474,0.0178402883028355,0.0014952225629369,0.0149096520794792,0.0207709245261918,9.6465016385165e-33
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSNK2A1,Casein kinase II subunit alpha,24867,0.037093400700279,0.00310934789540879,0.0309990788252778,0.0431877225752803,1.01882767271621e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNDP1,Beta-Ala-His dipeptidase,29594,0.0376863430999754,0.00316144339745136,0.0314899140409707,0.0438827721589801,1.0982783720788e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNL1,Interferon lambda-1,28774,-0.0371644372667243,0.00311770906347288,-0.0432751470311311,-0.0310537275023175,1.10607056461113e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEP,Leptin,29478,-0.0549600444552034,0.00461557538124578,-0.0640065722024452,-0.0459135167079617,1.28501729782657e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFX1,Transcriptional repressor NF-X1,24111,-0.0556322502320279,0.0046773122328176,-0.0647997822083504,-0.0464647182557054,1.56722859143845e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY6D,Lymphocyte antigen 6D,29283,-0.0314265190633345,0.00264457377977647,-0.0366098836716963,-0.0262431544549726,1.7150732013001e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN5,Contactin-5,29511,0.0302399100966589,0.00254659694398175,0.0252485800864546,0.0352312401068631,1.90109967121463e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,28774,-0.0546588719271829,0.00460458074099694,-0.0636838501795369,-0.0456338936748289,2.00466418894501e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R9B,Neurabin-2,29786,-0.0767852401755826,0.00647300511649508,-0.0894723302039129,-0.0640981501472522,2.19604210275799e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCAN,Neurocan core protein,29694,0.0304449276391889,0.0025684035449961,0.0254108566909965,0.0354789985873812,2.43769747097038e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORT1,Sortilin,29433,-0.0303136192996057,0.00255758254575577,-0.035326481089287,-0.0253007575099244,2.47604280897249e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,-0.0466386025143264,0.00393897014279448,-0.0543589839942036,-0.0389182210344492,2.86877848484046e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM24,Transcription intermediary factor 1-alpha,24396,-0.0532773422266612,0.0045047229586028,-0.0621065992255227,-0.0444480852277997,3.46704710283329e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARF6,ADP-ribosylation factor 6,24805,-0.0872945139052398,0.00739694569016086,-0.101792527457955,-0.0727965003525245,4.67620062948141e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC3B,Tetranectin,24381,0.0174916645879281,0.00148271758524821,0.0145855381208416,0.0203977910550146,4.94243066047465e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLRX,Glutaredoxin-1,29291,-0.0454622234185887,0.00385744065946931,-0.0530228071111486,-0.0379016397260289,5.47105819982206e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MIA,Melanoma-derived growth regulatory protein,29566,-0.029897381079567,0.00253738987587055,-0.0348706652362732,-0.0249240969228607,5.65043588660927e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA2,Carbonic anhydrase 2,29368,-0.0554391842023546,0.0047128913153346,-0.0646764511804104,-0.0462019172242988,7.1140166896179e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,-0.051808257570119,0.00440439201879111,-0.0604408659269495,-0.0431756492132884,7.36415148111148e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD14,Monocyte differentiation antigen CD14,28954,-0.0335273522217877,0.00285091472125312,-0.0391151450754438,-0.0279395593681315,7.39598110145532e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRK1,NKG2-D type II integral membrane protein,24845,-0.0378068316994273,0.00321645814795065,-0.0441110896694105,-0.031502573729444,8.16177834398983e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCN2,CCN family member 2,29478,-0.0460802740692161,0.00392189224608824,-0.053767182871549,-0.0383933652668831,8.36584385924546e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,-0.0494460230524361,0.00420838118195834,-0.0576944501690744,-0.0411975959357977,8.37652344136971e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL18,C-C motif chemokine 18,29166,-0.0567497702378981,0.00483144727842694,-0.0662194069036149,-0.0472801335721813,8.74182501856766e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17RB,Interleukin-17 receptor B,29034,0.0432807835353021,0.00368787132387302,0.036052555740511,0.0505090113300932,9.83352365084582e-32
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP43,Centrosomal protein 43,28705,-0.0561668935622832,0.00478679645819413,-0.0655490146203437,-0.0467847725042227,1.0118400576379e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH17,Cadherin-17,29478,-0.0548147922930126,0.00467453353589022,-0.0639768780233575,-0.0456527065626678,1.0997088699476e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,-0.051043999704518,0.00435699937530344,-0.0595837184801127,-0.0425042809289232,1.28745971431763e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NELL1,Protein kinase C-binding protein NELL1,29566,0.0340304687248093,0.00290709605606981,0.0283325604549125,0.0397283769947062,1.3944700290672e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP3B1,AP-3 complex subunit beta-1,24805,-0.0620906468322687,0.00530354725257836,-0.0724855994473223,-0.0516956942172151,1.41492376588259e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX15,Sorting nexin-15,24381,-0.0438388225379541,0.00374470289622411,-0.0511784402145534,-0.0364992048613548,1.42783117374854e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,-0.0342572558589374,0.00292755177539139,-0.0399952573387045,-0.0285192543791703,1.47225914843342e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THBD,Thrombomodulin,29478,-0.0230513127536417,0.00197088700333809,-0.0269142512801844,-0.0191883742270991,1.57049387865774e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STIP1,Stress-induced-phosphoprotein 1,29386,-0.051884802775175,0.00444135146636004,-0.0605898516492407,-0.0431797539011093,1.84487032520977e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF19,Fibroblast growth factor 19,29581,-0.0617708995635842,0.00529547812147327,-0.0721500366816718,-0.0513917624454966,2.2584339678136e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GET3,ATPase GET3,24922,-0.0444858932180793,0.00381303657680915,-0.0519594449086252,-0.0370123415275334,2.27367181251018e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,-0.0497352278865767,0.00426600483966192,-0.0580965973723141,-0.0413738584008393,2.50480505633812e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GZMH,Granzyme H,28916,-0.0613510970807839,0.00526344444842608,-0.071667448199699,-0.0510347459618688,2.51121929770509e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RLN2,Prorelaxin H2,24326,-0.0916857842092162,0.00787000226168682,-0.107110988642122,-0.0762605797763101,2.77780653930523e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAL,Integrin alpha-L,24229,-0.0351757972284182,0.00301953459393403,-0.0410940850325289,-0.0292575094243075,2.80019764236053e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A4,Protein S100-A4,29566,-0.0454972791809168,0.00391182783986621,-0.0531644617470546,-0.0378300966147791,3.36525456166793e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRTN3,Myeloblastin,28671,-0.0379906939478711,0.00326747252562847,-0.0443949400981029,-0.0315864477976393,3.53322789533169e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,29581,-0.016345764134797,0.00140817496481507,-0.0191057870658345,-0.0135857412037595,4.39552100921213e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA7,Thyroxine-binding globulin,24966,-0.0148811213862416,0.00128181253192663,-0.0173934739488178,-0.0123687688236654,4.43605937645936e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,-0.0277758674363324,0.00239737762992093,-0.0324747275909774,-0.0230770072816874,5.67275462592549e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOD1,Superoxide dismutase [Cu-Zn],28826,-0.0384258320834874,0.00331984275011784,-0.0449327238737184,-0.0319189402932565,6.48931589762369e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RALY,RNA-binding protein Raly,24793,-0.0385653962500032,0.0033317657478297,-0.0450956571157494,-0.032035135384257,6.62121975120193e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C2,Complement C2,29545,-0.018581144633568,0.00160698695955137,-0.0217308390742887,-0.0154314501928473,7.41907643583206e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,-0.0208407477726548,0.00180587007205504,-0.0243802531138827,-0.0173012424314269,9.91433897316117e-31
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARF1,Scavenger receptor class F member 1,29820,-0.0335312754877145,0.00291373288128253,-0.0392421919350282,-0.0278203590404007,1.39515751818982e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AP2B1,AP-2 complex subunit beta,24195,-0.038870333494201,0.00337713788645508,-0.0454895237516529,-0.032251143236749,1.41395187589896e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,24229,-0.0245650633909916,0.00213470694803171,-0.0287490890091337,-0.0203810377728494,1.45293693923387e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSL5,Insulin-like peptide INSL5,24805,-0.0778798433790583,0.00676822844904021,-0.0911455711391771,-0.0646141156189395,1.45991882988032e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MATN2,Matrilin-2,29497,-0.0235021819498654,0.00204557352712525,-0.0275115060630309,-0.0194928578366999,1.73427325985361e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GHR,Growth hormone receptor,24381,-0.0228367203366185,0.00198940225054007,-0.026735948747677,-0.01893749192556,2.00994090526696e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYN,Tyrosine-protein kinase Lyn,29349,-0.0664723413920125,0.00579720701251338,-0.0778348671365388,-0.0551098156474863,2.26214398122608e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN3,Contactin-3,29443,-0.0253765906588766,0.00221335981564121,-0.0297147758975333,-0.0210384054202198,2.28933281580191e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSNL1,Visinin-like protein 1,24845,-0.030221528869761,0.00264179570092257,-0.0353994484435692,-0.0250436092959527,3.15021237241847e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNPEP,Aspartyl aminopeptidase,24845,-0.0461162531154735,0.00403421587804417,-0.05402331623644,-0.0382091899945069,3.4720449287988e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA9,Carbonic anhydrase 9,29725,-0.0358409084317277,0.00314515710250222,-0.042005416352632,-0.0296764005108233,5.07813022828428e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,-0.09295049691878,0.00816110672269307,-0.108946266095258,-0.0769547277423016,5.45465953742872e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RILP,Rab-interacting lysosomal protein,29632,-0.0465101433281834,0.00408443566399307,-0.0545156372296098,-0.038504649426757,5.59361391645608e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EREG,Proepiregulin,29163,-0.0626472860577811,0.00550283619550218,-0.0734328450009654,-0.0518617271145968,5.7768410854509e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL1,Fc receptor-like protein 1,29478,-0.0355478621473466,0.0031244305886767,-0.0416717461011529,-0.0294239781935403,6.2588992905965e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL10,Interleukin-10,28931,-0.063943635403364,0.00562735164404727,-0.0749732446256967,-0.0529140261810314,7.39466725284585e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDS,Iduronate 2-sulfatase,29786,0.00694431767492577,0.000611411994905844,0.00574595016491031,0.00814268518494122,7.81079790850793e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,29443,0.0341727175264063,0.00301161803775493,0.0282699461724067,0.040075488880406,8.85515781227195e-30
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BACH1,Transcription regulator protein BACH1,29434,-0.0573192396404914,0.00505753984845681,-0.0672320177434667,-0.047406461537516,1.03303512047301e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNM3,Dynamin-3,24867,-0.0430656162671983,0.00380039667424631,-0.0505143937487211,-0.0356168387856756,1.07907001661246e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,-0.0606206850657278,0.00536033979970594,-0.0711269510731514,-0.0501144190583041,1.3658119222413e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLAMF7,SLAM family member 7,29434,-0.0455550955033244,0.00402887821643262,-0.0534516968075323,-0.0376584941991165,1.39236796086212e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSE,Cathepsin E,24381,-0.0408862185444138,0.00362005772328288,-0.0479815316820483,-0.0337909054067794,1.65685214529152e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEPR,Leptin receptor,29478,0.0241075215173494,0.00213618882638737,0.0199205914176301,0.0282944516170686,1.7831965681549e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP7,Retinoid-binding protein 7,24805,-0.0470531195765556,0.00417153937806582,-0.0552293367575647,-0.0388769023955466,1.95324086572797e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCRG1,Scrapie-responsive protein 1,24922,-0.0214611947101928,0.001903065886247,-0.0251912038472369,-0.0177311855731486,2.00518108423333e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN3,Ataxin-3,24845,-0.0481703891320499,0.00427239646247581,-0.0565442861985024,-0.0397964920655973,2.06079016643839e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLMAP,Sarcolemmal membrane-associated protein,24805,-0.0649413788333579,0.00576260425590215,-0.0762360831749261,-0.0536466744917897,2.18967007696846e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2L15,Bcl-2-like protein 15,24229,-0.0440436708678636,0.00390899910314411,-0.0517053091100261,-0.0363820326257012,2.25353601579866e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AXL,Tyrosine-protein kinase receptor UFO,29594,-0.0214214498265723,0.00190174104203989,-0.0251488622689705,-0.0176940373841741,2.26452332488045e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,29327,-0.0340874840497716,0.00303771450726781,-0.0400414044840165,-0.0281335636155267,3.67060490810601e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,24381,-0.0416346482875982,0.0037113099919238,-0.0489088158717689,-0.0343604807034276,3.90803451504138e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,-0.0186492294593806,0.00166347473750422,-0.0219096399448889,-0.0153888189738724,4.12676453989436e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,-0.0590717229858083,0.00527310050734839,-0.0694069999802111,-0.0487364459914055,4.54296490501837e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROK1,Prokineticin-1,29434,-0.0472798935444909,0.00422191055492879,-0.0555548382321513,-0.0390049488568305,4.73769171537064e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGBP1,Immunoglobulin-binding protein 1,24867,-0.0470464277942272,0.00420101039920071,-0.0552804081766606,-0.0388124474117939,4.84899992007778e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,-0.0559058077254974,0.00499354143828369,-0.0656931489445334,-0.0461184665064614,5.02954061218879e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL17,C-C motif chemokine 17,29414,-0.0698989066024433,0.00624731038481905,-0.0821436349566887,-0.057654178248198,5.30479326792612e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FYB1,FYN-binding protein 1,29400,-0.0705119556605461,0.00630391176280856,-0.0828676227156508,-0.0581562886054413,5.49989101096659e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,25976,0.0239925567138367,0.00214803497668178,0.0197824081595404,0.0282027052681329,6.69012830154837e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VNN2,Vascular non-inflammatory molecule 2,29349,-0.0353251134804256,0.00316340260141004,-0.0415253825791892,-0.0291248443816619,6.77884242305084e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,-0.0735403449111833,0.00659273382577409,-0.0864621032097006,-0.0606185866126661,7.77414994977562e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TARBP2,RISC-loading complex subunit TARBP2,28774,-0.0604823377867585,0.00542498584308719,-0.0711153100392094,-0.0498493655343076,8.3112958782513e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,-0.0573142763690356,0.00514226895388731,-0.0673931235186548,-0.0472354292194165,8.83604219241398e-29
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C3,Complement C3,23779,-0.0359238370602078,0.00322817185845534,-0.0422510539027802,-0.0295966202176353,1.07659172133434e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSTN3,Calsyntenin-3,24845,-0.0234903492744375,0.00211290100994835,-0.0276316352539362,-0.0193490632949387,1.20393606514602e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17A,Interleukin-17A,28879,-0.0326372628422599,0.00293781578520983,-0.0383953817812712,-0.0268791439032487,1.291180180472e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CR2,Complement receptor type 2,29594,-0.0355863390357178,0.00320762212105892,-0.0418732783929933,-0.0292993996784423,1.52217751188928e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT5,"Keratin, type II cytoskeletal 5",28774,-0.0388116723773849,0.00350041374405075,-0.0456724833157243,-0.0319508614390454,1.64367218972721e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCAM2,Neural cell adhesion molecule 2,29443,0.0205274171081586,0.00185159409366423,0.0168982926845767,0.0241565415317405,1.66427043855868e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMPACT,Protein IMPACT,24845,-0.0426969089547271,0.0038539381393868,-0.0502506277079252,-0.0351431902015289,1.85445408407863e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,0.0256792784467609,0.00232020424101499,0.0211316781343716,0.0302268787591503,2.04773008145766e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,-0.0367509184136205,0.00332308126197777,-0.0432641576870969,-0.0302376791401441,2.31109830005348e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMIGO2,Amphoterin-induced protein 2,29349,-0.017450447131489,0.00157945510161204,-0.0205461791306486,-0.0143547151323294,2.53815568586912e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,29400,-0.0640525136725807,0.00579925539415666,-0.0754190542451278,-0.0526859731000337,2.63633295550421e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTK7,Inactive tyrosine-protein kinase 7,28774,-0.0291909045379422,0.00264306843827942,-0.0343713186769699,-0.0240104903989146,2.66223533355863e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBIN,Erbin,29349,-0.0777059380465947,0.00703764527179253,-0.091499722779308,-0.0639121533138813,2.74083372637133e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH7,Protocadherin-7,24805,-0.0266417031285806,0.00241251844049873,-0.0313702392719581,-0.0219131669852031,2.7553624813573e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,-0.0415828397329552,0.00376763376058186,-0.0489674019036957,-0.0341982775622148,2.88450537393297e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC5A,C-type lectin domain family 5 member A,29395,-0.0221427976885545,0.00201040743862279,-0.0260831962682552,-0.0182023991088539,3.71074567359309e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SARG,Specifically androgen-regulated gene protein,24820,-0.0830750614628229,0.00755353969589925,-0.0978799992667854,-0.0682701236588603,4.52838792595939e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,29536,-0.0535399555804181,0.00487216835062139,-0.063089405547636,-0.0439905056132002,4.89586343685831e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RL2,Interleukin-1 receptor-like 2,28931,-0.0296417584574427,0.0027012478847254,-0.0349362043115045,-0.0243473126033809,5.82858605526532e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOA2,Apolipoprotein A-II,24951,0.0367493965610573,0.0033509174412935,0.030181598376122,0.0433171947459925,6.38112045748701e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,-0.106203539217152,0.00968497626726194,-0.125186092700986,-0.087220985733319,6.46887322350413e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,28931,-0.0450540847590886,0.00410996316521183,-0.0531096125629038,-0.0369985569552734,6.59325470770223e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL16,C-X-C motif chemokine 16,29786,-0.0177461752354899,0.00162016027433139,-0.0209216893731794,-0.0145706610978004,7.23868045074037e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SWAP70,Switch-associated protein 70,24805,-0.027186858945834,0.0024819919252859,-0.0320515631193943,-0.0223221547722736,7.39414774256924e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,-0.0438924843281662,0.00400795950036304,-0.0517480849488777,-0.0360368837074546,7.43403146215018e-28
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,-0.0399861604766828,0.00367120440497305,-0.04718172111043,-0.0327905998429356,1.42453553502895e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMOX1,Heme oxygenase 1,29165,0.0359462189903297,0.0033047834022522,0.0294688435219154,0.042423594458744,1.6752218685133e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD5L,CD5 antigen-like,24833,-0.0355809195970232,0.00327459835289878,-0.0419991323687048,-0.0291627068253416,1.93540761745294e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RFC4,Replication factor C subunit 4,24793,-0.015977675648173,0.00147216843747919,-0.0188631257856322,-0.0130922255107138,2.22026404450553e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA3,Carbonic anhydrase 3,29761,-0.0448013208525003,0.00412961306715335,-0.0528953624641208,-0.0367072792408797,2.2740085384496e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,28797,-0.0386006399898861,0.00356004043231759,-0.0455783192372286,-0.0316229607425437,2.43825353990165e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A11,Protein S100-A11,29208,-0.0339306859571331,0.00313081428465329,-0.0400670819550536,-0.0277942899592127,2.57300581800114e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHAD,Chondroadherin,24381,0.0389373915041609,0.00359285033119951,0.0318954048550099,0.045979378153312,2.64005361341919e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCN2,Transcobalamin-2,29757,-0.0223669765222022,0.00206472830255774,-0.0264138439952154,-0.018320109049189,2.70396611559924e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,-0.0181843234433381,0.00167926364493018,-0.0214756801874012,-0.0148929666992749,2.8326541036363e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATG4A,Cysteine protease ATG4A,28797,-0.0439289870571833,0.00405671422930812,-0.0518801469466272,-0.0359778271677394,2.84080825685801e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFDC1,WAP four-disulfide core domain protein 1,24326,-0.04077313461256,0.00376507852041221,-0.0481526885125679,-0.0333935807125521,2.88632114283169e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,-0.0401024199706668,0.00370682322174162,-0.0473677934852804,-0.0328370464560533,3.17287807785168e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHMP6,Charged multivesicular body protein 6,24922,-0.0422758686153218,0.00390845990202209,-0.0499364500232851,-0.0346152872073585,3.30515911021407e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LGALS8,Galectin-8,29694,-0.0450064972856376,0.00416399806941212,-0.0531679335016853,-0.0368450610695898,3.52635259193371e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPOCK1,Testican-1,29218,0.0191155328621498,0.00176930946109696,0.0156476863183998,0.0225833794058999,3.71112560660346e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD164,Sialomucin core protein 24,29443,-0.0198658300919603,0.00183898377038531,-0.0234702382819155,-0.0162614219020051,3.76200589637477e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,-0.0533014883639773,0.00494984222001741,-0.0630031791152115,-0.0435997976127432,5.46583133920802e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HPSE,Heparanase,24688,-0.0699600125623972,0.00649598580205419,-0.0826921447344234,-0.057227880390371,5.49313741662306e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GDF2,Growth/differentiation factor 2,29478,0.0263631066015449,0.00245194238955638,0.0215572995180144,0.0311689136850754,6.51122786069264e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARSA,Arylsulfatase A,29443,-0.0330540580893191,0.00307527945914479,-0.0390816058292428,-0.0270265103493953,6.7715208798299e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CILP,Cartilage intermediate layer protein 1,24938,-0.040491027332142,0.00376793480980543,-0.0478761795593606,-0.0331058751049234,7.07162085196286e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAX1BP1,Tax1-binding protein 1,24845,-0.0469207210058133,0.00436770195959612,-0.0554814168466217,-0.0383600251650049,7.35183748790026e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAT,Catalase,24587,-0.0398278506093592,0.00371026247903352,-0.0470999650682649,-0.0325557361504535,8.03803399873783e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.0239633777983971,0.0022328302013346,-0.0283397249930129,-0.0195870306037812,8.24227832334425e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,-0.0512766056414747,0.00477926669741193,-0.060643968368402,-0.0419092429145473,8.55132168775699e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,-0.0700650539411521,0.0065319232928401,-0.0828676235951187,-0.0572624842871856,8.55819702252963e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ING1,Inhibitor of growth protein 1,28719,-0.033872017642613,0.00316072383293911,-0.0400670363551737,-0.0276769989300524,9.5653606430686e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,-0.0492177796278266,0.00459403949867021,-0.0582220970452202,-0.040213462210433,9.89094220545673e-27
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,29632,-0.0533495944979284,0.00498897242615511,-0.0631279804531924,-0.0435712085426644,1.22106398695129e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PEPD,Xaa-Pro dipeptidase,24951,0.019395575605277,0.00181535915429836,0.0158374716628522,0.0229536795477018,1.37854358382546e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PZP,Pregnancy zone protein,24966,-0.0394282800377611,0.00369369337487789,-0.0466679190525218,-0.0321886410230005,1.52897847692472e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOE,Apolipoprotein E,24966,-0.0536636354896691,0.00503206097569367,-0.0635264750020287,-0.0438007959773095,1.70444563691427e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,-0.0796507622007302,0.00747102105800164,-0.0942939634744134,-0.065007560927047,1.76214258558553e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,-0.0510585444870698,0.00479351093321571,-0.0604538259161726,-0.041663263057967,1.95483453720901e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NID1,Nidogen-1,29518,-0.0277687352788996,0.00261165070180214,-0.0328875706544318,-0.0226498999033674,2.3449676451683e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ORM1,Alpha-1-acid glycoprotein 1,24846,-0.0147264253026876,0.00138478106667226,-0.0174405961933653,-0.01201225441201,2.34721254752101e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNGR1,Interferon gamma receptor 1,29581,-0.0153864104057139,0.00144776954140219,-0.0182240387068622,-0.0125487821045656,2.47229840479332e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,-0.0690692428761447,0.0064998088994083,-0.0818088683189849,-0.0563296174333044,2.51068398877845e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,-0.0587008719607739,0.00552362891706355,-0.0695271846382184,-0.0478745592833293,2.54475882642106e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,-0.0328113066818731,0.00309189007375811,-0.038871411226439,-0.0267512021373072,2.99135655670125e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSLN,Mesothelin,29293,-0.0408622809903347,0.00385489586682056,-0.048417876889303,-0.0333066850913664,3.32085716979728e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DHPS,Deoxyhypusine synthase,24793,-0.0299178284685365,0.00282207183171759,-0.0354490892587029,-0.02438656767837,3.34181035243264e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,-0.0662504336588571,0.00625218671048333,-0.0785047196114044,-0.0539961477063097,3.52382901071689e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNLY,Granulysin,29443,-0.0378184801695059,0.00358609203868279,-0.0448472205653242,-0.0307897397736877,5.90518857678513e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESYT2,Extended synaptotagmin-2,24845,-0.0600592865360385,0.00569424242516319,-0.0712200016893584,-0.0488985713827187,5.92801406581883e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JAM3,Junctional adhesion molecule C,24381,-0.0370105781432394,0.00351089816761195,-0.0438919385517588,-0.0301292177347199,6.31492603349894e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPPB,Natriuretic peptides B,28916,-0.0970891835480958,0.00922704530542191,-0.115174192346723,-0.0790041747494688,7.59883944924957e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,-0.0710871092864656,0.00675651011595586,-0.0843298691137391,-0.0578443494591921,7.81205561891776e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGH,Gamma-glutamyl hydrolase,28984,-0.0246650340347737,0.00234667349874038,-0.0292645140923049,-0.0200655539772426,8.58809087598265e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,-0.0345841578577054,0.00329088343009769,-0.0410342893806969,-0.0281340263347139,8.88601151010395e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAA80,N-alpha-acetyltransferase 80,24195,-0.0879347568929739,0.008371763649444,-0.104343413645884,-0.0715261001400636,9.43444852568784e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIMAP7,GTPase IMAP family member 7,24381,0.0235294932483468,0.00224102394408119,0.0191370863179477,0.0279219001787459,9.86185256947844e-26
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE3,Eosinophil cationic protein,29343,-0.0783759287553626,0.00747377054704414,-0.0930245190275691,-0.0637273384831561,1.10301123201204e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3BP1,SH3 domain-binding protein 1,24805,-0.0347701921532285,0.00332008891540493,-0.0412775664274222,-0.0282628178790349,1.30459940129481e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,-0.0280317213662236,0.00267736742166581,-0.0332793615126886,-0.0227840812197586,1.31811327912361e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,-0.0367498901801633,0.00351059925359807,-0.0436306647172155,-0.0298691156431111,1.33982920859324e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,-0.0267875070713752,0.00256177391199908,-0.0318085839388934,-0.021766430203857,1.54398011045014e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,29218,-0.0415185567770109,0.00397159206552667,-0.0493028772254432,-0.0337342363285786,1.56037331570494e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOLGA3,Golgin subfamily A member 3,24867,-0.0564229707860467,0.00539952797672209,-0.067006045620422,-0.0458398959516714,1.66178665018803e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,-0.0160203137944908,0.00153339947565416,-0.0190257767667729,-0.0130148508222086,1.66597014212938e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCR,Breakpoint cluster region protein,29434,-0.0656996490263861,0.00629008905487012,-0.0780282235739315,-0.0533710744788407,1.71261814036143e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,-0.0518443019301791,0.00497185837679743,-0.0615891443487021,-0.0420994595116562,2.05555941553369e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA9,Serpin A9,29227,-0.0519016256692112,0.00497770639273001,-0.061657930198962,-0.0421453211394604,2.07294441531677e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAG4,BAG family molecular chaperone regulator 4,24229,-0.035749577225517,0.00342901004727926,-0.0424704369181843,-0.0290287175328496,2.14377664034808e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,P4HB,Protein disulfide-isomerase,29313,-0.0277082755831331,0.00266022833480091,-0.0329223231193429,-0.0224942280469233,2.32702134646342e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLOD4,Glyoxalase domain-containing protein 4,29408,-0.0253791840106974,0.0024367267881481,-0.0301551685154677,-0.0206031995059271,2.33783213685817e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAM,Integrin alpha-M,29443,0.0226453169867919,0.00217425285637374,0.0183837813882993,0.0269068525852844,2.33899569915841e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BOLA1,BolA-like protein 1,24101,-0.0394233064971253,0.00379168082350099,-0.0468550009111872,-0.0319916120830633,2.88437270510308e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,-0.0483092675453805,0.00464714976700508,-0.0574176810887105,-0.0392008540020506,2.92969627459115e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,-0.0272066936101913,0.00261983328964565,-0.0323415668578968,-0.0220718203624858,3.21266148665609e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,-0.0283273900756174,0.00272950251844352,-0.0336772150117667,-0.0229775651394681,3.50709330332217e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMPD3,AMP deaminase 3,24845,-0.0508771015071504,0.00490728438392406,-0.0604953788996416,-0.0412588241146593,3.91534891672834e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,-0.0462728456912504,0.00447810010628931,-0.0550499218995775,-0.0374957694829234,5.60795859110316e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,-0.0302712890395736,0.00293024160120057,-0.0360145625779267,-0.0245280155012205,5.64993361800181e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAMR1,Inactive serine protease PAMR1,29443,-0.0195561965867455,0.00189324320376942,-0.0232669532661335,-0.0158454399073574,5.72012015006284e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LONP1,"Lon protease homolog, mitochondrial",24240,-0.0622544175741437,0.00602774526157762,-0.0740687982868358,-0.0504400368614515,5.93289508273743e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,24922,-0.020343144752908,0.00197215716632291,-0.0242085727989009,-0.0164777167069151,6.75347080436605e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX8,Syntaxin-8,29434,-0.0342550426337891,0.00332225612043479,-0.0407666646298413,-0.0277434206377369,6.9448176739368e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4G,C-type lectin domain family 4 member G,29434,-0.0235272119101021,0.00228540266641137,-0.0280066011362684,-0.0190478226839358,8.21555187918835e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C7,Complement component C7,24374,-0.023175991421945,0.00225086831049189,-0.0275876933105091,-0.0187642895333809,8.2184048180703e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",24852,-0.0286020593396193,0.00277799484561057,-0.034046929237016,-0.0231571894422226,8.24506111158509e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELP,P-selectin,29594,-0.0401674058257571,0.00390762868984977,-0.0478263580578626,-0.0325084535936515,9.62253568802151e-25
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRR3,Small proline-rich protein 3,24845,-0.0482946719318217,0.00470436687717683,-0.0575152310110883,-0.0390741128525551,1.12430965373956e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP2,Microtubule-associated protein 2,24845,-0.0328360446309581,0.00319953732583845,-0.0391071377896014,-0.0265649514723147,1.16175717671921e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AZU1,Azurocidin,28534,-0.054026812760221,0.00526516340717225,-0.0643465330382786,-0.0437070924821634,1.16349049019713e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,-0.0239651712228297,0.00233810638375091,-0.0285478597349815,-0.0193824827106779,1.33116514975948e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,-0.0259322980118113,0.00253034974567709,-0.0308917835133384,-0.0209728125102842,1.34797416726894e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB1A1,Uteroglobin,29523,-0.0389749728322911,0.00380591564444211,-0.0464345674953977,-0.0315153781691846,1.43338707010826e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,-0.0799870186588593,0.00781039095040476,-0.0952953849216527,-0.064678652396066,1.45470021782252e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,-0.0197629301741519,0.00193501000582251,-0.0235555497855641,-0.0159703105627398,1.8969914234423e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,24195,-0.0442254237239747,0.00433107447145705,-0.0527143296880306,-0.0357365177599189,1.9806352109537e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,24805,-0.0539461649664672,0.0052870406830855,-0.0643087647053148,-0.0435835652276196,2.13788256375425e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFB,Vascular endothelial growth factor B,24229,-0.0204578287477682,0.00200518607245064,-0.0243879934497714,-0.0165276640457649,2.16587848488388e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATG16L1,Autophagy-related protein 16-1,24805,-0.0602795617685126,0.00590900002966609,-0.0718612018266582,-0.0486979217103671,2.18570770209109e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAT5B,Signal transducer and activator of transcription 5B,29349,-0.0963171573663314,0.00944400886981401,-0.114827414751167,-0.0778068999814959,2.20562371240709e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,24793,-0.0240513385161846,0.00235992428533377,-0.0286767901154387,-0.0194258869169304,2.41533900086404e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CES3,Carboxylesterase 3,29349,-0.048864362380966,0.00479678199761486,-0.0582660550962911,-0.0394626696656409,2.49062406916684e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,-0.0240856482740125,0.00236737022662272,-0.028725693918193,-0.0194456026298319,2.84222461407616e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDA,Cytidine deaminase,24890,-0.0329051434770668,0.00323375824397361,-0.0392433096352551,-0.0265669773188785,2.84575416822273e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGER,Advanced glycosylation end product-specific receptor,29378,-0.0285002429189633,0.00280398096690242,-0.033996045614092,-0.0230044402238345,3.14173798897292e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,-0.0143103757809111,0.00140927272851946,-0.0170725503288092,-0.0115482012330129,3.46767899144518e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFB,Platelet-derived growth factor subunit B,29581,-0.059635094697452,0.00588641847703548,-0.0711724749124416,-0.0480977144824625,4.40839415795475e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK4,Kallikrein-4,29725,-0.0436206947837691,0.0043293180220269,-0.0521061581069418,-0.0351352314605964,7.73197954632958e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNLR1,Interferon lambda receptor 1,29434,-0.0256531833072053,0.00254692154050445,-0.030645149526594,-0.0206612170878166,8.01160265011426e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEK,Angiopoietin-1 receptor,29566,-0.0151125494695599,0.00150241001716675,-0.0180572731032068,-0.0121678258359131,9.16880566539047e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRSF1,G-rich sequence factor 1,23862,-0.056350586646488,0.00560394089399851,-0.067334310798725,-0.0453668624942509,9.68548789762918e-24
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD276,CD276 antigen,29454,-0.0248756051177413,0.00247577185879797,-0.0297281179609853,-0.0200230922744973,1.02779791089502e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,28774,-0.0341060604108922,0.00339448133084227,-0.0407592438193431,-0.0274528770024414,1.03111588784634e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,METAP2,Methionine aminopeptidase 2,29674,-0.039659531853187,0.00394742391950779,-0.0473964827354223,-0.0319225809709517,1.03417173070938e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,29604,-0.0226410004878854,0.00225489929846904,-0.0270606031128847,-0.0182213978628861,1.10057412736556e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,-0.0272303710923547,0.00271564003002432,-0.0325530255512024,-0.021907716633507,1.26133524336326e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,0.0199079547491659,0.00198765957532956,0.01601214198152,0.0238037675168119,1.41590578026255e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX4,Syntaxin-4,29349,-0.0408738583276025,0.00408130349762341,-0.0488732131829443,-0.0328745034722606,1.43039905666293e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALPP,"Alkaline phosphatase, placental type",29349,-0.0709781156385958,0.00712617051989096,-0.0849454098575821,-0.0570108214196095,2.47876146218149e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GORASP2,Golgi reassembly-stacking protein 2,24805,-0.0325959719147117,0.00327360155121386,-0.0390122309550909,-0.0261797128743325,2.59414552910431e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DYNLT1,Dynein light chain Tctex-type 1,24195,-0.0553356012654459,0.00555730737405412,-0.0662279237185919,-0.0444432788122998,2.59948331752709e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCAM1,Neural cell adhesion molecule 1,29594,0.0207201112899463,0.0020814617183503,0.0166404463219797,0.0247997762579128,2.62022375228102e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,-0.0219654876147869,0.0022077791591466,-0.0262927347667142,-0.0176382404628595,2.76889941275536e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,-0.0337504562015381,0.00339718640896319,-0.040408941563106,-0.0270919708399703,3.24561457175289e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,-0.0320754256860205,0.00322974150967611,-0.0384057190449856,-0.0257451323270553,3.31774987995502e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,-0.0190594386402751,0.00192233024817298,-0.0228272059266942,-0.0152916713538561,3.97582440473976e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA3,Protein disulfide-isomerase A3,24381,-0.017227165959362,0.00173866166472949,-0.0206349428222318,-0.0138193890964922,4.237020323506e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BOLA2_BOLA2B,BolA-like protein 2,24240,-0.0374467980263711,0.00378169831353298,-0.0448589267208957,-0.0300346693318464,4.50874162403765e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA1,Carbonic anhydrase 1,28867,-0.0406890864276064,0.00411182053624182,-0.0487482546786403,-0.0326299181765724,4.73209966304259e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL15,Interleukin-15,29434,-0.0223105667226204,0.00225642921567194,-0.0267331679853374,-0.0178879654599034,5.12039990288944e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USO1,General vesicular transport factor p115,29349,-0.0610543187244079,0.00617663395935744,-0.0731605212847485,-0.0489481161640673,5.26797386451913e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNN,Tenascin-N,24938,-0.0297629051365308,0.00301092385678164,-0.0356643158958228,-0.0238614943772388,5.33224680926986e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,-0.0530202536012822,0.00536386392313186,-0.0635334268906207,-0.0425070803119438,5.3476279306817e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AFM,Afamin,24966,-0.0133151580687549,0.00134844238262165,-0.0159581051386933,-0.0106722109988165,5.91828487433181e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACYP1,Acylphosphatase-1,24297,-0.0449305368010839,0.00455112256927474,-0.0538507370368624,-0.0360103365653054,6.05707891788069e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,-0.0245554970708751,0.00248768641047429,-0.0294313624354047,-0.0196796317063455,6.15523557091238e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFC,Vascular endothelial growth factor C,29566,-0.0376852200653101,0.00382231762415722,-0.0451769626086582,-0.030193477521962,6.78094642138141e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSV,Cathepsin L2,29618,0.0280843324287711,0.00284981390778847,0.0224986971695057,0.0336699676880365,7.08708408088289e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BID,BH3-interacting domain death agonist,29434,-0.045086911335338,0.00457932673843748,-0.0540623917426755,-0.0361114309280005,7.75603426665325e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,29443,-0.0203330047040772,0.0020669124101047,-0.0243841530278824,-0.016281856380272,8.42651202926583e-23
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LIFR,Leukemia inhibitory factor receptor,29434,-0.0163900751507023,0.00167231352853695,-0.0196678096666347,-0.0131123406347699,1.2093686857668e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,-0.0572498828795432,0.00584838108852362,-0.0687127098130495,-0.0457870559460369,1.35896844667111e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMOX2,Heme oxygenase 2,28774,-0.0314015062528519,0.00320964244712506,-0.037692405449217,-0.0251106070564867,1.43759275285161e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFD,Complement factor D,24966,-0.013246209697144,0.00135505461453176,-0.0159021167416263,-0.0105903026526618,1.57598382829629e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA12,Serpin A12,28628,-0.0753038909918797,0.00770470799770908,-0.0904051186673895,-0.0602026633163699,1.58294242461643e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMB1,Laminin subunit beta-1,24240,-0.0205959288793185,0.00210704430975293,-0.0247257357264343,-0.0164661220322028,1.58989308319773e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGFLAM,Pikachurin,24805,-0.0208531994476185,0.00213595384255388,-0.0250396689790241,-0.0166667299162129,1.7824740092833e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JUN,Transcription factor AP-1,28931,-0.0336759012969753,0.00345026828199405,-0.0404384271296836,-0.026913375464267,1.80400948325945e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALB1,Calbindin,29349,-0.0293417223122673,0.00300699913614943,-0.0352354406191202,-0.0234480040054144,1.84792722525808e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASC3,Protein CASC3,24195,-0.0283779526603632,0.00290799039792401,-0.0340776138402942,-0.0226782914804321,1.86432546510019e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,-0.042418555879101,0.00434820807473029,-0.0509410437055724,-0.0338960680526297,1.92353353802381e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLNK,B-cell linker protein,24229,-0.0269060875596137,0.0027641675354805,-0.0323238559291555,-0.0214883191900719,2.3757414603187e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIGYF2,GRB10-interacting GYF protein 2,24867,-0.0512452196531238,0.00526513235261959,-0.0615648790642582,-0.0409255602419894,2.3920277730462e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDLIM7,PDZ and LIM domain protein 7,29581,-0.0836790912182128,0.00860212270581896,-0.100539251721618,-0.0668189307148076,2.48088840807646e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,-0.0191113172084928,0.00196514150199643,-0.0229629945524058,-0.0152596398645798,2.54644587675428e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OTUD7B,OTU domain-containing protein 7B,24867,-0.0425286505624252,0.00437698196581802,-0.0511075352154285,-0.0339497659094219,2.81151324606267e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAT2,Signal transducer and activator of transcription 2,24229,-0.052124834720564,0.00537149790786478,-0.0626529706199789,-0.041596698821149,3.18342272190832e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,-0.051335343520371,0.00529247699314116,-0.0617085984269276,-0.0409620886138143,3.31227712398641e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.0173402980524051,0.00178861499988663,0.0138346126526273,0.0208459834521829,3.42108476596142e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGA4,Pepsin A-4,24951,-0.047830419824936,0.0049333067624991,-0.0574997010794342,-0.0381611385704377,3.45157310208868e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OLFM4,Olfactomedin-4,23498,-0.0827749607796285,0.0085460138782893,-0.0995251479810755,-0.0660247735781814,3.81187651131528e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,-0.0146724187271016,0.00151520052200124,-0.017642211750224,-0.0117026257039792,3.88543229617174e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP10,Caspase-10,28774,-0.0475154918497639,0.00491621080918295,-0.0571512650357625,-0.0378797186637653,4.58459511971531e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,-0.0637592778796867,0.00659849588804219,-0.0766923298202494,-0.050826225939124,4.68654424117941e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PARK7,Parkinson disease protein 7,29443,-0.0346264199530556,0.00358504349569165,-0.0416531052046112,-0.0275997347014999,4.8747938578619e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGF1R,Insulin-like growth factor 1 receptor,29349,-0.0144613966224629,0.00149791664127868,-0.0173973132393691,-0.0115254800055566,5.08113674718695e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EHBP1,EH domain-binding protein 1,24922,-0.0498687470942395,0.0051701382562242,-0.0600022180764389,-0.03973527611204,5.60949084400711e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,24240,-0.0342300483564139,0.00354892792813125,-0.0411859470955512,-0.0272741496172767,5.64284721602686e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST13,Hsc70-interacting protein,24381,-0.0372863799419966,0.00386998718949825,-0.0448715548334131,-0.02970120505058,6.24030449103402e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCK2,Cytoplasmic protein NCK2,29581,-0.0697552067820922,0.0072561485082636,-0.0839772578582888,-0.0555331557058955,7.5660684083171e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,24381,-0.0447734361340846,0.0046614489539578,-0.0539098760838419,-0.0356369961843273,8.32075465775986e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTGES2,Prostaglandin E synthase 2,24037,-0.0366261676089581,0.0038196476088955,-0.0441126769223933,-0.0291396582955229,9.73926137286832e-22
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOXO3,Forkhead box protein O3,28797,-0.0635905625358767,0.00664677813472393,-0.0766182476799356,-0.0505628773918178,1.1838415537776e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DRAXIN,Draxin,29218,-0.0282089637857257,0.00295088656253104,-0.0339927014482865,-0.0224252261231648,1.2728957619146e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,-0.0279175846911287,0.00292142914636271,-0.0336435858179997,-0.0221915835642578,1.33369239183853e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARSB,Arylsulfatase B,29349,-0.0362154965660107,0.00379295066933947,-0.043649679877916,-0.0287813132541053,1.4198194234962e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANSC1,MANSC domain-containing protein 1,29566,-0.0180799479798856,0.00189667142280174,-0.021797423968577,-0.0143624719911941,1.64937463725946e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,-0.0251903273194043,0.0026433527823855,-0.0303712987728799,-0.0200093558659288,1.71929587231019e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPHOSPH8,M-phase phosphoprotein 8,28916,-0.049600233599523,0.00521005529736684,-0.059811941982362,-0.0393885252166841,1.860193906931e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LARP1,La-related protein 1,24793,-0.0414265356855327,0.00435136394072953,-0.0499552090093626,-0.0328978623617028,1.87803192249346e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBI,Acyl-CoA-binding protein,29329,-0.0512172856895813,0.00538372468572787,-0.0617693860736079,-0.0406651853055547,1.98241954895644e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACTA2,"Actin, aortic smooth muscle",28916,-0.0285575435661278,0.00300337893743565,-0.0344441662835017,-0.022670920848754,2.07952138005345e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMP10,Bone morphogenetic protein 10,24381,0.0188143683608949,0.00197951350193266,0.0149345218971069,0.0226942148246829,2.18836049075149e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOXO1,Forkhead box protein O1,29434,-0.0558104481144437,0.0058731209044771,-0.0673217650872188,-0.0442991311416686,2.19515541903989e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKD2,Polycystin-2,24111,-0.0388133643852867,0.00408709418952329,-0.0468240689967523,-0.0308026597738211,2.36411566794675e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLA2,Src-like-adapter 2,24867,-0.0688244298622039,0.00725235605504809,-0.0830390477300982,-0.0546098119943097,2.51218309155661e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,-0.0170761146924526,0.00179969734461769,-0.0206035214879032,-0.0135487078970019,2.55054993658823e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,-0.0381923527193455,0.00402570198331461,-0.0460827286066421,-0.0303019768320488,2.58488586905992e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,-0.0245187692994704,0.00258649467804337,-0.0295882988684354,-0.0194492397305054,2.73929445379686e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCRIB,Protein scribble homolog,24240,-0.0593805374508164,0.00626590614376647,-0.0716617134925987,-0.0470993614090341,2.85512949703335e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNRD2,Protein ZNRD2,24805,-0.0450718645278576,0.00476323560474398,-0.0544078063131558,-0.0357359227425594,3.26671770714355e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSB,Cathepsin B,29480,0.0341456628458952,0.00361156969093774,0.0270669862516572,0.0412243394401332,3.47740621575457e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAMBP,STAM-binding protein,29163,-0.041475378088373,0.00438688575612878,-0.0500736741703854,-0.0328770820063606,3.4840037759156e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,29581,-0.018361338690676,0.00194295123370973,-0.022169523108747,-0.0145531542726049,3.62162339501427e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA4,Ephrin type-A receptor 4,24381,-0.0187607253794757,0.00198580285490966,-0.0226528989750986,-0.0148685517838527,3.77450900056885e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOBR,Apolipoprotein B receptor,24240,0.0278652898545239,0.00295125675712426,0.0220808266105603,0.0336497530984874,3.98249348113561e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,-0.0770561457831877,0.00817067457692016,-0.0930706679539513,-0.0610416236124242,4.41393107085108e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,-0.0329103284967428,0.00349177464929099,-0.0397542068093532,-0.0260664501841325,4.6035389641208e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,-0.0127176506243555,0.00135000010992852,-0.0153636508398154,-0.0100716504088956,4.81723036697929e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP6,Gastrotropin,28872,-0.0365250910989663,0.0038773080325179,-0.0441246148427014,-0.0289255673552312,4.82598311740893e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TJAP1,Tight junction-associated protein 1,29566,-0.0535647829293329,0.00568820313046034,-0.0647136610650351,-0.0424159047936306,4.97615276408828e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN1,Contactin-1,29820,0.0176682110094956,0.00187727806466408,0.013988746002754,0.0213476760162371,5.22528184649374e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,-0.0405346712021058,0.00430745528813104,-0.0489772835668426,-0.0320920588373689,5.28919379968058e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,L1CAM,Neural cell adhesion molecule L1,29566,0.0187208089567254,0.00199219344327563,0.0148161098079052,0.0226255081055456,6.00025866125777e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,-0.0313242700771988,0.00333785031744749,-0.0378664566993959,-0.0247820834550017,6.8427801108293e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEXIM1,Protein HEXIM1,29434,-0.0522869555780896,0.00557983015194764,-0.063223422675907,-0.0413504884802722,7.70309341552477e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPK1,Thiamin pyrophosphokinase 1,24922,-0.0178651095819957,0.00190707505505663,-0.0216029766899067,-0.0141272424740847,8.01324516786543e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMG4,Proteasome assembly chaperone 4,24229,-0.0364498839064879,0.00389233612804626,-0.0440788627174586,-0.0288209050955173,8.28377299550343e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,28774,-0.0432518497196863,0.00462447813490444,-0.052315826864099,-0.0341878725752736,9.13480588145584e-21
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC1B,C-type lectin domain family 1 member B,29694,-0.0615040445264746,0.00658808069425094,-0.0744166826872065,-0.0485914063657428,1.0714373709602e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1R2,Interleukin-1 receptor type 2,29404,-0.0127840369296367,0.00136963130988394,-0.0154685142970092,-0.0100995595622642,1.08971255948358e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,0.0169763451097641,0.00183225462804885,0.0133851260387884,0.0205675641807398,2.09823763146286e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,0.0278693080857783,0.00301061742273056,0.0219684979372264,0.0337701182343302,2.23998502434111e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCBP2,Poly(rC)-binding protein 2,24867,-0.0463619206036298,0.00501127382581401,-0.0561840173022252,-0.0365398239050343,2.38606276738525e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APP,Amyloid-beta precursor protein,29395,-0.0422764877927231,0.00457193719568873,-0.051237484696273,-0.0333154908891732,2.46135558386032e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPME1,Protein phosphatase methylesterase 1,29349,-0.0380285144769613,0.00411575353772093,-0.0460953914108944,-0.0299616375430283,2.63267489956719e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,A1BG,Alpha-1B-glycoprotein,24966,-0.0109382326362979,0.00118367163163773,-0.0132582290343078,-0.00861823623828796,2.63277275716711e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPO,Lactoperoxidase,28452,-0.0382899610606736,0.00414735451898624,-0.0464187759178866,-0.0301611462034606,2.82520135371832e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,-0.0229499498399998,0.00248623714439097,-0.0278229746430061,-0.0180769250369935,2.90026479875239e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBXN1,UBX domain-containing protein 1,24381,-0.0441248782268622,0.00478168265793025,-0.0534969762364054,-0.0347527802173189,2.97776327929162e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBPL,FK506-binding protein-like,24805,-0.0378273563188329,0.00409983813574625,-0.0458630390648955,-0.0297916735727702,3.01145422793115e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,-0.0436892317434038,0.00473854165642295,-0.0529767733899928,-0.0344016900968148,3.20138942787414e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAB2,Disabled homolog 2,29725,-0.0699492352144474,0.00759319664390651,-0.0848319006365041,-0.0550665697923906,3.40249333785359e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LIF,Leukemia inhibitory factor,28774,-0.0325864440184531,0.00353847663123545,-0.0395218582156746,-0.0256510298212316,3.50319976600613e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPARCL1,SPARC-like protein 1,29489,0.0173940786874324,0.00189255031431698,0.0136846800713712,0.0211034773034937,4.14744533704677e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,-0.0284286391915565,0.00309375706210954,-0.0344924030332912,-0.0223648753498218,4.21769864851959e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,-0.0214510521719157,0.00233663191685337,-0.0260308507289483,-0.016871253614883,4.56775696705147e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELENOP,Selenoprotein P,24966,0.0143872421934223,0.0015680850012494,0.0113137955909735,0.0174606887958711,4.85358794441796e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL4,Myosin light chain 4,24240,-0.0330960757639012,0.00360747258270555,-0.040166722026004,-0.0260254295017983,4.89701373751483e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,24845,-0.0445380688676893,0.00486230162477713,-0.0540681800522525,-0.0350079576831261,5.58590879608024e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP1,Caspase-1,28774,-0.0428138692657876,0.00467548296205811,-0.0519778158714215,-0.0336499226601537,5.67455468738829e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,-0.0335330471053572,0.00367217971194314,-0.0407305193407658,-0.0263355748699487,7.24753197636846e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,29434,-0.0665698549147554,0.00729182949111941,-0.0808618407173495,-0.0522778691121614,7.31790310468136e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,-0.0343131893528429,0.00375970046015912,-0.0416822022547548,-0.026944176450931,7.51697373693625e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LBP,Lipopolysaccharide-binding protein,29594,-0.0366946487962106,0.0040213977647258,-0.0445765884150731,-0.028812709177348,7.62691057665362e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,-0.0275319590089741,0.00301838750786042,-0.0334479985243805,-0.0216159194935677,7.97647455367876e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,-0.0420987933057014,0.00461648004350006,-0.0511470941909615,-0.0330504924204413,8.14057531230475e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRELP,Prolargin,29454,-0.0145992146797964,0.00160225989009087,-0.0177396440643745,-0.0114587852952182,8.61486563365914e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DFFA,DNA fragmentation factor subunit alpha,29786,-0.0421808855924075,0.0046312747437356,-0.0512581840901293,-0.0331035870946857,8.91552600328658e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL22,Interleukin-22,24793,-0.0426924984269072,0.00468991698320866,-0.0518847357139962,-0.0335002611398182,9.42816671315061e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.0283302504538113,0.0031141291419164,0.0222265573356552,0.0344339435719675,9.82314366483827e-20
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,-0.0648183842398586,0.00713157026187438,-0.0787962619531324,-0.0508405065265848,1.06120704329202e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,-0.0432225859207543,0.00476967028168426,-0.0525711396728554,-0.0338740321686531,1.35989410443145e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC39A14,Zinc transporter ZIP14,28774,-0.0209131476931175,0.00230827613838466,-0.0254373689243514,-0.0163889264618835,1.3840880854305e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,24805,-0.025131538767399,0.00277656417077087,-0.0305736045421099,-0.0196894729926881,1.51383458198196e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,-0.0389321423396881,0.00430900715807,-0.0473777963695053,-0.0304864883098709,1.75912237729035e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,-0.0488298902128836,0.00540720544366693,-0.0594280128824708,-0.0382317675432965,1.81252687033957e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AXIN1,Axin-1,29434,-0.0590073589557413,0.00653586034829243,-0.0718176452383945,-0.0461970726730882,1.84810975733613e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAGK,N-acetyl-D-glucosamine kinase,24209,-0.0355692660168157,0.00393933226958809,-0.0432903572652084,-0.0278481747684231,1.85400657340864e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RSPO1,R-spondin-1,29218,-0.0217461273542232,0.00241151111671891,-0.0264726891429923,-0.0170195655654541,2.03646523074842e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CETN2,Centrin-2,28774,-0.0418594483713604,0.00464432312447113,-0.0509623216953239,-0.032756575047397,2.12539226078332e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFB,Complement factor B,24538,-0.0204827315746035,0.00227696514680568,-0.0249455832623426,-0.0160198798868644,2.51474707758618e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,-0.033227739391018,0.00369386580007062,-0.0404677163591564,-0.0259877624228796,2.52098781611155e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMP,Cartilage oligomeric matrix protein,29214,0.0208361046790204,0.00231805867478742,0.0162927096764371,0.0253794996816038,2.65126756221629e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,24793,-0.0709836364996878,0.00789779057626082,-0.086463306029159,-0.0555039669702165,2.69829992024836e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,-0.05451550901351,0.00607520858274187,-0.0664229178356841,-0.0426081001913359,3.04111352114033e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR1,Toll-like receptor 1,24229,-0.0164312708695078,0.00183098383194618,-0.0200199991801223,-0.0128425425588933,3.06164995521666e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDK2,Protein sidekick-2,24381,-0.0241164293223525,0.00268889548150285,-0.0293866644660981,-0.0188461941786069,3.20531867769655e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,-0.0462503748921639,0.00515753529960925,-0.056359144079398,-0.0361416057049297,3.2463878067259e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,-0.0333960270897578,0.0037296033467366,-0.0407060496493615,-0.026086004530154,3.6157176397806e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AK1,Adenylate kinase isoenzyme 1,29478,-0.0387212205118388,0.0043275394550555,-0.0472031978437476,-0.03023924317993,3.83976597757455e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,-0.0348550104138919,0.00390009271595732,-0.0424991921371683,-0.0272108286906156,4.22591898582671e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CENPF,Centromere protein F,24445,-0.033659357244559,0.00376591195781119,-0.0410405446818689,-0.0262781698072491,4.24016746335281e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PREB,Prolactin regulatory element-binding protein,28931,-0.0178238867689198,0.00199641980533508,-0.0217368695873765,-0.013910903950463,4.59163998137931e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADD1,Alpha-adducin,24381,-0.0433266329845256,0.00485361249435854,-0.0528397134734684,-0.0338135524955829,4.69241449986859e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYDGF,Myeloid-derived growth factor,24922,-0.0617248466777417,0.00691536903817614,-0.0752789699925669,-0.0481707233629165,4.72499814012081e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,-0.0513496995065371,0.00575294110264483,-0.062625464067721,-0.0400739349453533,4.72891693518367e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GMPR,GMP reductase 1,29786,-0.0303948072571637,0.00341222988936277,-0.0370827778403148,-0.0237068366740127,5.5043770288923e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBC1D17,TBC1 domain family member 17,28774,-0.0273110526954747,0.00307164640252018,-0.0333314796444143,-0.0212906257465352,6.38278333860774e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA5,Annexin A5,28650,-0.0186466795353239,0.00209723346486807,-0.0227572571264653,-0.0145361019441825,6.3989905979402e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT16,U8 snoRNA-decapping enzyme,24769,-0.0539138522815299,0.00606678590264673,-0.0658047526507174,-0.0420229519123423,6.71259612112268e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,24111,-0.0236369958783335,0.00266176807703692,-0.0288540613093259,-0.0184199304473412,7.13025937205703e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,24229,-0.0554665513264338,0.0062479942522651,-0.0677126200608734,-0.0432204825919942,7.30178160967091e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNIP1,TNFAIP3-interacting protein 1,24845,-0.0543412500980995,0.00612147223324361,-0.066339335675257,-0.042343164520942,7.31239775090109e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYAR,Cell growth-regulating nucleolar protein,28797,-0.0323219880434005,0.00364668116723863,-0.0394694831311882,-0.0251744929556127,8.19885617008007e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIF1,Allograft inflammatory factor 1,28797,-0.0320648831885319,0.00361865474960546,-0.0391574464977586,-0.0249723198793052,8.37705382913759e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RCOR1,REST corepressor 1,28916,-0.0272324801417917,0.0030778908776707,-0.0332651462620263,-0.0211998140215571,9.42610715608053e-19
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFA,Platelet-derived growth factor subunit A,29820,-0.0436247752563375,0.00493962240345643,-0.0533064351671121,-0.0339431153455629,1.08721195571571e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAEP,Glycodelin,29218,-0.0800010563193296,0.00906096457774937,-0.0977605468917184,-0.0622415657469409,1.1119501090296e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,-0.0250947476889593,0.00284268170827994,-0.0306664038371879,-0.0195230915407306,1.1373993211955e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL8,C-C motif chemokine 8,29683,-0.0366616293815688,0.00415963212759738,-0.0448145083516596,-0.0285087504114779,1.27584969868387e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASPN,Asporin,24922,0.0168148818762618,0.00190787223860606,0.0130754522885939,0.0205543114639297,1.29144837584967e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,-0.0283294989942174,0.00321497348093528,-0.0346308470168506,-0.0220281509715843,1.29798311875229e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFRC,Transferrin receptor protein 1,29565,-0.0234196511779078,0.00265847782741264,-0.0286302677196366,-0.0182090346361791,1.32529927203209e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS27,Serine protease 27,29395,-0.0243810694375181,0.00277134486472687,-0.0298129053723827,-0.0189492335026534,1.47315638098102e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SBSN,Suprabasin,24905,0.0210054751899079,0.00238758205137337,0.0163258143692161,0.0256851360105997,1.4838477800376e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IKBKG,NF-kappa-B essential modulator,29434,-0.0553752693167918,0.00629683770344307,-0.0677170712155403,-0.0430334674180434,1.51848506806033e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB44,Ras-related protein Rab-44,24793,-0.0255863889665175,0.00292022884833833,-0.0313100375092606,-0.0198627404237744,2.0426269704221e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEMIP2,Cell surface hyaluronidase,24229,-0.0201093375857682,0.00229623857874587,-0.0246099652001101,-0.0156087099714263,2.12410208711755e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB3A2,Secretoglobin family 3A member 2,29536,0.0493476973154751,0.00563863887502848,0.0382959651204193,0.0603994295105309,2.21124825834466e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECI2,Enoyl-CoA delta isomerase 2,24111,-0.0374265119494251,0.00427873352204444,-0.0458128296526322,-0.029040194246218,2.32948781528766e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,-0.0311903029934675,0.00356854415337495,-0.0381846495340824,-0.0241959564528526,2.4478637927714e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,-0.0178648035325426,0.00204674814706022,-0.0218764299007806,-0.0138531771643045,2.71825804282778e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASHC3,WASH complex subunit 3,24845,-0.0455513078293055,0.00521922324965529,-0.0557809853986299,-0.0353216302599812,2.7616240052481e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX7,Syntaxin-7,24229,-0.0300230481929183,0.0034438256199732,-0.0367729464080657,-0.0232731499777708,3.0116276910716e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AAMDC,Mth938 domain-containing protein,24240,-0.032201359511136,0.00369815036670535,-0.0394497342298785,-0.0249529847923936,3.3033210489124e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGN,Secretagogin,28931,-0.0264030334919641,0.00303542955249179,-0.032352475414848,-0.0204535915690802,3.54459496537456e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GMPR2,GMP reductase 2,24381,-0.0404959221674267,0.00465889069691321,-0.0496273479333766,-0.0313644964014768,3.77526441942882e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.03036069352523,0.00349497005140295,0.0235105522244802,0.0372108348259797,3.94669366305825e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAPIN,SNARE-associated protein Snapin,24867,-0.0347771226791853,0.00401165860226999,-0.0426399735396345,-0.0269142718187361,4.62000366463378e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC1A,C-type lectin domain family 1 member A,28916,-0.0200066627318797,0.00230908544271054,-0.0245324701995924,-0.0154808552641671,4.77467565667829e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DGKA,Diacylglycerol kinase alpha,24229,-0.0328507873041733,0.00379343383880938,-0.0402859176282397,-0.0254156569801069,5.01081924013117e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BGN,Biglycan,28750,0.0714903086271189,0.00826294114187262,0.0552949439890486,0.0876856732651893,5.32340733602495e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,-0.0504214481891598,0.00583140475405198,-0.0618510015071017,-0.0389918948712179,5.62343931490901e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,29820,-0.00943504702922642,0.00109174718463297,-0.011574871511107,-0.0072952225473458,5.78727902526449e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,24571,-0.0335531808947964,0.0038824713140188,-0.0411628246702733,-0.0259435371193196,5.84327519501977e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GYS1,"Glycogen [starch] synthase, muscle",28916,-0.0552716106121805,0.00639655504495349,-0.0678088585002894,-0.0427343627240717,5.86280569461512e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,-0.0210715501482011,0.00244070644122071,-0.0258553347729937,-0.0162877655234085,6.30852717163335e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,-0.0252241679684338,0.00292292399869556,-0.0309530990058771,-0.0194952369309905,6.45710020268078e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2,Apoptosis regulator Bcl-2,24805,-0.0321251645099514,0.0037232487035866,-0.0394227319689811,-0.0248275970509216,6.59628775833655e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,-0.0462725065031681,0.00538444462492783,-0.0568260179680266,-0.0357189950383095,8.83124988660852e-18
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR3,Toll-like receptor 3,29786,-0.0360652186389716,0.00420460180130884,-0.0443062381695369,-0.0278241991084062,1.01531481159129e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MB,Myoglobin,29820,-0.0310034668277198,0.00361461833025845,-0.0380881187550263,-0.0239188149004132,1.01802600490777e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53,Cellular tumor antigen p53,28797,-0.0258041127697991,0.00301117710986857,-0.0317060199051415,-0.0199022056344567,1.09102077798411e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSNAX,Translin-associated protein X,24111,-0.0233696307610522,0.00272716106033752,-0.0287148664393137,-0.0180243950827906,1.10341530047197e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPXM1,Probable carboxypeptidase X1,29566,-0.0404443634610159,0.00472108198310218,-0.0496976841478962,-0.0311910427741356,1.11530892466315e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TADA3,Transcriptional adapter 3,24793,-0.0234916857475237,0.00274212325159514,-0.0288662473206502,-0.0181171241743972,1.12330835972227e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RABEP1,Rab GTPase-binding effector protein 1,24381,-0.0462227675654608,0.00541072714381879,-0.0568277927673456,-0.0356177423635759,1.38554951573406e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSPN,Persephin,29434,-0.0552317905024143,0.00646740139649895,-0.0679078972395522,-0.0425556837652763,1.40555855855921e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,29434,-0.0658918769311201,0.00771659613148646,-0.0810164053488336,-0.0507673485134066,1.41830769801234e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,28916,-0.0313870291844828,0.00367617936461539,-0.0385923407391289,-0.0241817176298366,1.43220771801124e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRG2,Bone marrow proteoglycan,24938,-0.0306449014370789,0.00358889606472516,-0.0376791377239402,-0.0236106651502176,1.43231524235609e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTPP1,dCTP pyrophosphatase 1,29478,-0.0186379047883199,0.00218825342637173,-0.0229268815040085,-0.0143489280726313,1.71041662921039e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP25,Rho GTPase-activating protein 25,28797,-0.0351945817020416,0.00413371011513131,-0.043296653527699,-0.0270925098763843,1.76023445023469e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPT,Dermatopontin,29820,-0.0154434822306673,0.00181422064842741,-0.018999354701585,-0.0118876097597495,1.78149307213955e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,28931,-0.0185207239496431,0.0021767395392472,-0.0227871334465676,-0.0142543144527186,1.8462740761499e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMA4,Laminin subunit alpha-4,29581,-0.0195449152505986,0.0023008882515792,-0.0240546562236938,-0.0150351742775033,2.07954914017712e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAP,Prolyl endopeptidase FAP,29820,0.0160576665108899,0.00189221486440482,0.0123489253766564,0.0197664076451233,2.2329603983972e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLYR1,Putative oxidoreductase GLYR1,24793,-0.0348707318123864,0.00411266615668469,-0.0429315574794884,-0.0268099061452844,2.39899262404161e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,-0.0347425524073404,0.00410052493259985,-0.0427795812752361,-0.0267055235394447,2.50793751153518e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA4D,Semaphorin-4D,29694,-0.0174331548479156,0.00205944765827101,-0.0214696722581268,-0.0133966374377044,2.6785380238109e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINE2,Glia-derived nexin,24922,-0.0376692050386884,0.00445991840302147,-0.0464106451086105,-0.0289277649687663,3.17224360961294e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CR1,Complement receptor type 1,24903,-0.0210464466680018,0.00249395031673437,-0.0259345892888012,-0.0161583040472025,3.37237863029952e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAMDC2,MAM domain-containing protein 2,24922,-0.0202520907068897,0.00240175320920811,-0.0249595269969376,-0.0155446544168418,3.57320424560896e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,24240,-0.0346148812514238,0.00410808674465384,-0.0426667312709453,-0.0265630312319023,3.77178704376579e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOL1,Apolipoprotein L1,24951,0.0350933208301723,0.00416533360334515,0.0269292669676158,0.0432573746927288,3.79640431833114e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLB1,Beta-galactosidase,29218,-0.0242129052583798,0.00287584810773155,-0.0298495675495337,-0.018576242967226,3.95510878139336e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,-0.0303008151828352,0.00359979810533584,-0.0373564194692934,-0.0232452108963769,4.0558601290608e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAP23,Synaptosomal-associated protein 23,29478,-0.0502891403363928,0.00597680160877646,-0.0620036714895947,-0.038574609183191,4.13745467460056e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,24109,-0.0240758456299917,0.00286246265563981,-0.0296862724350457,-0.0184654188249376,4.29196107011238e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,-0.0382952102622086,0.00456126539224569,-0.0472352904310101,-0.029355130093407,4.87324833841062e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FDX1,"Adrenodoxin, mitochondrial",24111,-0.0365518997116134,0.00435408902715463,-0.0450859142048365,-0.0280178852183903,4.91843239467944e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,-0.0416572924712577,0.00496914518727878,-0.0513968170383241,-0.0319177679041912,5.42616833256325e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LUZP2,Leucine zipper protein 2,24793,-0.0260017696913651,0.0031048677740067,-0.0320873105284182,-0.019916228854312,5.8348100648053e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.0278891115888883,0.00333419184771975,-0.034424127610419,-0.0213540955673576,6.35406470999894e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,24867,-0.0390986473976505,0.0046799524017689,-0.0482713541051175,-0.0299259406901835,6.91025666715735e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,-0.0155280312955967,0.001858942824824,-0.0191715592322517,-0.0118845033589416,6.93570175431945e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DGCR6,Protein DGCR6,24101,-0.0254002398984412,0.00304303700727498,-0.0313645924327002,-0.0194358873641823,7.37333505605088e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREH,Trehalase,24938,-0.0432288520384533,0.00518673881596257,-0.0533948601177399,-0.0330628439591666,8.17944528569431e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,-0.0375497938479791,0.00450624193515731,-0.0463820280408874,-0.0287175596550707,8.23940629061686e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,24381,-0.0224191142955359,0.00269574784572107,-0.0277027800731492,-0.0171354485179227,9.53033186914188e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD4,Sushi domain-containing protein 4,24793,-0.0241602458500646,0.00290614775219543,-0.0298562954443676,-0.0184641962557615,9.76379482434765e-17
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYTL4,Synaptotagmin-like protein 4,24922,-0.0419374351455623,0.00504909777840694,-0.0518336667912399,-0.0320412034998847,1.04023314300605e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUB1,NEDD8 ultimate buster 1,29434,-0.0477705154272781,0.00575627096855102,-0.0590528065256381,-0.0364882243289181,1.0955422422683e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,-0.0440144133476304,0.00530579296739116,-0.054413767563717,-0.0336150591315437,1.136570409346e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,-0.0233672386364389,0.00281760459460916,-0.0288897436418728,-0.0178447336310049,1.15671317313422e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,-0.0525801075642312,0.00634177593866754,-0.0650099884040196,-0.0401502267244429,1.17998074045569e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,0.0240906603265406,0.00290861714507584,0.018389770722192,0.0297915499308893,1.25675437899528e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,-0.0842200006582834,0.01016744117466,-0.104148185360617,-0.0642918159559498,1.25791053431288e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINI2,Serpin I2,24805,-0.0325857338271263,0.00393793111647244,-0.0403040788154123,-0.0248673888388403,1.35033705092912e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DMD,Dystrophin,24240,-0.029620866392796,0.00358133069562347,-0.0366402745562181,-0.022601458229374,1.39699872583829e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA2,Integrin alpha-2,24381,0.0196658987717898,0.00238048737952612,0.0150001435079186,0.024331654035661,1.51355949137292e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA5,Plasma serine protease inhibitor,24644,-0.0182301617827361,0.00220708136332102,-0.0225560412548453,-0.0139042823106269,1.5310856769838e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,-0.0302921004973099,0.00366876730900287,-0.0374828844229556,-0.0231013165716643,1.57250061070568e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFTPD,Pulmonary surfactant-associated protein D,29478,-0.0379791006811311,0.00460493106789169,-0.0470047655741988,-0.0289534357880634,1.68422090874186e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,-0.027927573949503,0.00338902761647305,-0.0345700680777902,-0.0212850798212159,1.79959261168929e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSC22D1,TSC22 domain family protein 1,24867,-0.0380462087266166,0.00462046322901724,-0.0471023166554903,-0.0289901007977428,1.8942382457487e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKLR,Pyruvate kinase PKLR,29491,-0.0365903700029804,0.00444618469983702,-0.0453048920146609,-0.0278758479912998,1.95484342463793e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C8B,Complement component C8 beta chain,24966,0.0173341600451202,0.00210742048610435,0.0132036158923556,0.0214647041978847,2.04102075423866e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL13,C-C motif chemokine 13,29732,-0.0390012161500388,0.0047458471997167,-0.0483030766614835,-0.0296993556385941,2.1530781939534e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPI,Glucose-6-phosphate isomerase,24951,-0.0268959143578385,0.00327775389947558,-0.0333203120008106,-0.0204715167148663,2.40427147120539e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,0.0149889182107674,0.00182990846057577,0.0114022976280389,0.0185755387934959,2.69317347245721e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.0395699988509504,0.00484093219213421,-0.0490582259475335,-0.0300817717543673,3.12274356923303e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HGFAC,Hepatocyte growth factor activator,24720,0.0159356205849203,0.00195035516617216,0.0121129244592228,0.0197583167106177,3.21353040426336e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YJU2,Splicing factor YJU2,24793,-0.0183640528938113,0.00224976526807197,-0.0227735928192324,-0.0139545129683902,3.43188796512645e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMBS,Porphobilinogen deaminase,29725,-0.0241774960068774,0.00296564250543665,-0.0299901553175333,-0.0183648366962216,3.70268233114355e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOXJ3,Forkhead box protein J3,24229,-0.0250300711600844,0.00307458603548248,-0.0310562597896301,-0.0190038825305388,4.10884129368681e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NID2,Nidogen-2,29443,-0.0409833433571272,0.00503845115680004,-0.0508587076244553,-0.0311079790897992,4.31135647916117e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMP6,Bone morphogenetic protein 6,28884,-0.023099779437782,0.0028423882318727,-0.0286708603722525,-0.0175286985033116,4.57889361700773e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBCA,Tubulin-specific chaperone A,24381,-0.0482575782508661,0.00594279156221169,-0.059905449712801,-0.0366097067889312,4.86640401056569e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLTA,Clathrin light chain A,28916,-0.0263268982318401,0.0032429188635509,-0.0326830192043998,-0.0199707772592803,4.91499363674628e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,-0.0397751604902157,0.00490014795078249,-0.0493794504737494,-0.030170870506682,4.95654071653484e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,-0.0203355175461777,0.0025062497407674,-0.0252477670380818,-0.0154232680542736,5.1319174373407e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UROD,Uroporphyrinogen decarboxylase,24381,-0.0389285903202927,0.00479901032797791,-0.0483346505631294,-0.029522530077456,5.22085448419893e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD101,Immunoglobulin superfamily member 2,24805,-0.0240662170505396,0.00297131914635783,-0.029890002577401,-0.0182424315236782,5.77017188309658e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.0372672918767778,0.00460186717449971,-0.0462869515387972,-0.0282476322147583,5.78739922159987e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLITRK1,SLIT and NTRK-like protein 1,24229,0.0182033339027232,0.00224786398338276,0.013797520495293,0.0226091473101534,5.84523103280389e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLGN,Calmegin,24195,-0.0252361417508676,0.00311837770401781,-0.0313481620507425,-0.0191241214509927,6.10721423011042e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,-0.0427489003739462,0.00528329427487691,-0.053104157152705,-0.0323936435951875,6.12680375695869e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,-0.0483949164846543,0.0059868414649135,-0.0601291257558847,-0.0366607072134238,6.57597836819485e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM5,Tripartite motif-containing protein 5,29434,-0.0476661458414401,0.00590185911890276,-0.0592337897144895,-0.0360985019683907,6.91995729835475e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGA,Fibrinogen alpha chain,24407,-0.0173260644226591,0.00214521632620631,-0.0215306884220235,-0.0131214404232947,6.96503458346192e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL2,C-C motif chemokine 2,29169,-0.0291181449490002,0.00360771846621355,-0.0361892731427787,-0.0220470167552216,7.23438639550447e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.0236720004746827,0.00293344523711139,0.0179224478099444,0.029421553139421,7.31243643485897e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF3,Granulocyte colony-stimulating factor,28931,-0.0268797896243939,0.0033322935587278,-0.0334110849995004,-0.0203484942492874,7.51476259389231e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL5,C-X-C motif chemokine 5,29384,-0.0630756577013675,0.00782372298017971,-0.0784101547425197,-0.0477411606602152,7.78203433196373e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.0211453963299318,0.00262547785979181,-0.0262913329351237,-0.0159994597247398,8.37503893086173e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,-0.0185213222241687,0.0023023442786802,-0.0230339170103819,-0.0140087274379555,9.05650836568042e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LY75,Lymphocyte antigen 75,29434,-0.0215077620772079,0.00267404847064055,-0.0267488970796634,-0.0162666270747525,9.08252183821293e-16
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,29725,-0.0297428490613729,0.0037059854065357,-0.0370065804581829,-0.0224791176645629,1.04706066040161e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,24240,-0.0570628845973093,0.00711568069335926,-0.0710096187562934,-0.0431161504383251,1.11110830274885e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AZI2,5-azacytidine-induced protein 2,24867,-0.0306763437179298,0.00383059535788112,-0.0381843106193768,-0.0231683768164828,1.21419134722849e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,24922,-0.0263482105215282,0.0032943313990862,-0.0328051000637371,-0.0198913209793192,1.31868746708929e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,-0.023855636657989,0.00298340427680367,-0.0297031090405242,-0.0180081642754538,1.33084746890876e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM3,Intercellular adhesion molecule 3,29820,-0.0143594120170117,0.00179726751417585,-0.0178820563447964,-0.0108367676892271,1.40249175570423e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,-0.053523997657496,0.00669966115827474,-0.0666553335277145,-0.0403926617872775,1.40904789636652e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAM,Basal cell adhesion molecule,29443,-0.0132205765896661,0.00165574118260774,-0.0164658293075773,-0.00997532387175496,1.45977268022658e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,-0.0311652172021733,0.00390323776136835,-0.0388155632144553,-0.0235148711898913,1.46255096504795e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.0207151986978798,0.0026063806439329,0.0156066926357713,0.0258237047599883,1.96626441600191e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17D,Interleukin-17D,28931,-0.0186647238965027,0.00235026401171566,-0.0232712413594654,-0.01405820643354,2.06880020252314e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCN2,Ficolin-2,29381,-0.0224279198384263,0.00282630608147141,-0.0279674797581103,-0.0168883599187423,2.17210782318132e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHGA,Chromogranin-A,24938,-0.0482672350679299,0.00608266000550676,-0.0601892486787231,-0.0363452214571366,2.18909948530427e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITM2A,Integral membrane protein 2A,29434,-0.0329389305150518,0.00415587775024201,-0.0410844509055261,-0.0247934101245775,2.34525024237014e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,-0.0317225708065142,0.00400432222297422,-0.0395710423635437,-0.0238740992494848,2.41751294150528e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL1,Growth-regulated alpha protein,29420,-0.0519113366901959,0.00655354694890782,-0.0647562887100553,-0.0390663846703366,2.43666543923814e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCT5,T-complex protein 1 subunit epsilon,28797,-0.0247212704566647,0.00312438810806981,-0.0308450711484816,-0.0185974697648479,2.61578426993401e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,-0.0217860525767896,0.00275377237299567,-0.0271834464278611,-0.0163886587257181,2.65189937038831e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIF1C,Kinesin-like protein KIF1C,24111,-0.0199062870195431,0.00251737354927576,-0.0248403391761236,-0.0149722348629626,2.73677746595725e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,0.0130117702391648,0.00164786983615781,0.00978194536029544,0.0162415951180341,2.97647569840584e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP4,Guanylate-binding protein 4,28774,-0.026698760402385,0.00338224565097047,-0.0333279618782872,-0.0200695589264829,3.03502541138356e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLPS,Colipase,29400,-0.0384747724797479,0.00487654945037139,-0.0480328094024758,-0.02891673555702,3.13246273066386e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PF4,Platelet factor 4,24822,-0.0530447238771938,0.00673478741992477,-0.0662449072202464,-0.0398445405341412,3.51165978837064e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAP3,Cytosol aminopeptidase,28931,-0.0263021414392696,0.00334386925711739,-0.0328561251832197,-0.0197481576953195,3.79530178580347e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASS1,Argininosuccinate synthase,24111,-0.0431932044679989,0.00549556763745185,-0.0539645170374045,-0.0324218918985933,4.01266922547841e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL4A1,Collagen alpha-1(IV) chain,29478,-0.0214350302505503,0.00272776086575968,-0.0267814415474392,-0.0160886189536613,4.0321398998183e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KAZN,Kazrin,24805,-0.0566646821628905,0.00722301958225287,-0.0708218005441062,-0.0425075637816749,4.50289656104865e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,-0.0475353746218975,0.00608031149585036,-0.0594527851537642,-0.0356179640900308,5.5830750446624e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPT1,Angiopoietin-1,29322,-0.0452854628329436,0.00579690990054396,-0.0566474062380098,-0.0339235194278775,5.81617149556895e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM13A,Protein FAM13A,24805,-0.0365135262300884,0.00468336177529655,-0.0456929153096697,-0.0273341371505072,6.61743324464341e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,-0.0553310918114453,0.00710804061072949,-0.0692628514084751,-0.0413993322144155,7.28306640160866e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARG1,Arginase-1,29216,-0.027732214318004,0.00356382290139367,-0.0347173072047356,-0.0207471214312724,7.39743583421263e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,-0.0338956103881234,0.00436289098572486,-0.0424468767201441,-0.0253443440561027,8.1686883419714e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,-0.0220107569432548,0.00283366195728362,-0.0275647343795307,-0.0164567795069789,8.2545610526557e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN2L,Ataxin-2-like protein,24867,-0.0259215813604851,0.00333722700870398,-0.0324625462975449,-0.0193806164234253,8.31956005866069e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSC,Dipeptidyl peptidase 1,29446,-0.0231630576477391,0.0029858327150258,-0.0290152897691897,-0.0173108255262886,8.93043229238344e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEC31A,Protein transport protein Sec31A,24240,-0.0413261694338449,0.00532738386248383,-0.0517678418043132,-0.0308844970633765,9.01579241679348e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,24805,-0.0344874176060608,0.00445316807570949,-0.0432156270344514,-0.0257592081776702,9.96422309344259e-15
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XG,Glycoprotein Xg,29693,-0.0171618692153557,0.00221753111657291,-0.0215082302038387,-0.0128155082268728,1.03230076071737e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,29349,0.0349570656277762,0.00452651225155065,0.0260851016147369,0.0438290296408154,1.17475386871564e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,-0.0199507120228494,0.00258656174149121,-0.0250203730361722,-0.0148810510095266,1.2728819395436e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APRT,Adenine phosphoribosyltransferase,29192,-0.0253087920870549,0.00328506385053115,-0.031747517234096,-0.0188700669400139,1.35830800661718e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTNAP2,Contactin-associated protein-like 2,29434,-0.0219466553926783,0.00284966456411604,-0.0275319979383457,-0.0163613128470108,1.38705878750195e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DXO,Decapping and exoribonuclease protein,24845,-0.0243130399885241,0.00315702661450686,-0.0305008121529575,-0.0181252678240906,1.39760387294455e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",29478,-0.038810621260653,0.00504014989923212,-0.048689315063148,-0.0289319274581581,1.40001515844652e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NIT1,Deaminated glutathione amidase,24240,-0.0251962418938857,0.00327867296310649,-0.0316224409015745,-0.018770042886197,1.58922663863608e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAMP8,Vesicle-associated membrane protein 8,24229,-0.0470020376493556,0.00611800618622237,-0.0589933297743514,-0.0350107455243598,1.61818759834928e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLB1,"Phospholipase B1, membrane-associated",24845,0.0318571549387005,0.0041588289902038,0.023705850117901,0.0400084597594999,1.92517251824171e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPAG1,Sperm-associated antigen 1,24867,-0.0307462215088149,0.00401502768780334,-0.0386156757769095,-0.0228767672407204,1.96042842752099e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CMIP,C-Maf-inducing protein,24793,-0.0439494883300797,0.00574427993197039,-0.0552082769967417,-0.0326906996634177,2.06667323518762e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CES2,Cocaine esterase,29349,-0.0287408667370998,0.00376225267980807,-0.0361148819895236,-0.0213668514846759,2.2510221991612e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NACC1,Nucleus accumbens-associated protein 1,24793,-0.0291698182045729,0.00382055682827921,-0.0366581095880002,-0.0216815268211457,2.34019969270947e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,-0.0397325367268693,0.0052047402995896,-0.0499338277140649,-0.0295312457396737,2.34653963341168e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPBP,Platelet basic protein,24816,-0.0447309176052528,0.00586047677944929,-0.0562174520929735,-0.0332443831175322,2.3826064758202e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSR,Insulin receptor,24229,-0.00898975596579456,0.00117788695902358,-0.0112984144054808,-0.00668109752610835,2.39458111450754e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F2R,Proteinase-activated receptor 1,29536,-0.0301113658860068,0.00394625809313167,-0.0378460317485448,-0.0223767000234687,2.41144987146921e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,QSOX1,Sulfhydryl oxidase 1,24502,-0.0225556396090067,0.00295656964863357,-0.0283505161203285,-0.0167607630976849,2.45201012856917e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANGPTL4,Angiopoietin-related protein 4,29536,-0.0237302235785369,0.00311116696020527,-0.0298281108205392,-0.0176323363365345,2.46665223307842e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNST,Consortin,29478,-0.0568239426793588,0.00745027132890917,-0.0714264744840208,-0.0422214108746969,2.47325414714107e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YWHAQ,14-3-3 protein theta,24381,-0.0390030308513138,0.00512650147294196,-0.04905097373828,-0.0289550879643476,2.88164659028679e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R2,Protein phosphatase inhibitor 2,29478,-0.0417948002588062,0.00549448114717667,-0.0525639833072725,-0.03102561721034,2.89584483979037e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PON2,Serum paraoxonase/arylesterase 2,28916,-0.0181752132302068,0.00239044270000372,-0.0228604809222141,-0.0134899455381996,2.97461521072401e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC12A,C-type lectin domain family 12 member A,24229,-0.0107525349350074,0.00141535264672449,-0.0135266261225874,-0.00797844374742746,3.13859541346067e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ISM1,Isthmin-1,29434,-0.020520735302466,0.00270270188848154,-0.0258180310038898,-0.0152234396010422,3.2264671782179e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,-0.031272290060391,0.00412261869329231,-0.0393526226992439,-0.0231919574215381,3.41089231650574e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOK2,Docking protein 2,29478,-0.0634746284590462,0.00836917131385056,-0.0798782042341933,-0.0470710526838991,3.44023036790476e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,-0.030339746631149,0.00400548160522522,-0.0381904905773904,-0.0224890026849075,3.71002999538621e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATOX1,Copper transport protein ATOX1,29566,-0.0371765613994985,0.00490903478059718,-0.046798269569469,-0.027554853229528,3.75080742651809e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,-0.029865070409856,0.00394598641909367,-0.0375992037912796,-0.0221309370284324,3.88656129159658e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX9,Sorting nexin-9,29478,-0.0355081146065396,0.00470128654219451,-0.0447226362292408,-0.0262935929838383,4.38160069435327e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,-0.057919421861503,0.00766854872817254,-0.0729497773687212,-0.0428890663542848,4.3828651184098e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFRP1,Secreted frizzled-related protein 1,29120,-0.0224931323696017,0.00297864568226518,-0.0283312779068415,-0.016654986832362,4.43000741050627e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,-0.041830272591208,0.0055461062698335,-0.0527006408800816,-0.0309599043023343,4.77632197786623e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMNB1,Lamin-B1,24756,-0.0307754809787061,0.00408050893284371,-0.0387732784870798,-0.0227776834703325,4.78466108237142e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPARC,SPARC,29566,-0.0364249501702869,0.00483575244271515,-0.0459030249580086,-0.0269468753825652,5.12278764701612e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FBLN2,Fibulin-2,24938,-0.016385623483937,0.00217608216126095,-0.0206507445200085,-0.0121205024478655,5.25105309837922e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,-0.0157116661618529,0.00208665316239621,-0.0198015063601495,-0.0116218259635563,5.2621036975396e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGA,Protein O-GlcNAcase,24805,-0.0368358023398909,0.00490161440492101,-0.0464429665735361,-0.0272286381062457,5.88190856136369e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C7orf50,Uncharacterized protein C7orf50,24845,-0.0116089094291722,0.00154613608634648,-0.0146393361584113,-0.00857848269993308,6.18973300218998e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RWDD1,RWD domain-containing protein 1,29694,-0.0327446739786614,0.00436261561481986,-0.0412954005837084,-0.0241939473736145,6.27927338167416e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKD1,Polycystin-1,24922,-0.0138168219942053,0.00184172259744271,-0.017426598285193,-0.0102070457032176,6.48923929589148e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.0132978580777184,0.00177289516162672,0.00982298356093001,0.0167727325945067,6.5292454292716e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,28719,-0.0218752917958622,0.00291744178960111,-0.0275934777034803,-0.016157105888244,6.66152435379887e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MIF,Macrophage migration inhibitory factor,29386,-0.0350009415557831,0.00467158077818483,-0.0441572398810253,-0.0258446432305408,6.95737626618575e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAG6,Large proline-rich protein BAG6,28916,-0.0187886132111401,0.00250778399924676,-0.0237038698496638,-0.0138733565726165,6.97080825041092e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,28538,-0.0628990619620743,0.00840441138135894,-0.0793717082695378,-0.0464264156546108,7.41432358699736e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PADI2,Protein-arginine deiminase type-2,28931,-0.0290539925815555,0.0038849494308547,-0.0366684934660308,-0.0214394916970803,7.72475925581804e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS11D,Transmembrane protease serine 11D,24801,-0.019863983048398,0.00266305620936911,-0.0250835732187615,-0.0146443928780346,8.99791264052955e-14
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENAH,Protein enabled homolog,28931,-0.0244088588342782,0.00327987749612722,-0.0308374187266876,-0.0179802989418689,1.01928071815489e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFHR2,Complement factor H-related protein 2,24789,-0.0294117078277626,0.00395434521982415,-0.0371622244586179,-0.0216611911969073,1.05682887122429e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,24793,-0.0206200959033416,0.00277280672567929,-0.026054797085673,-0.0151853947210102,1.06706362864177e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHGB,Secretogranin-1,29590,-0.0210046773279317,0.00283168354657251,-0.0265547770792138,-0.0154545775766496,1.22337559568976e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,-0.0366993374729452,0.00494863328556222,-0.0463986587126471,-0.0270000162332432,1.24518833762501e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAX,Protein max,28774,-0.0536505159287198,0.00723668009052628,-0.0678344089061513,-0.0394666229512883,1.26214666417603e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERI1,3'-5' exoribonuclease 1,24445,-0.0174493008121378,0.00235566407451646,-0.0220664023981901,-0.0128321992260855,1.3299031411202e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSR,"Glutathione reductase, mitochondrial",24867,-0.0116443105086321,0.00157247217275721,-0.0147263559672362,-0.00856226505002799,1.35219974473035e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHSG,Alpha-2-HS-glycoprotein,24951,-0.0137947279839823,0.00186556882204318,-0.0174512428751869,-0.0101382130927776,1.46542847727571e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THBS4,Thrombospondin-4,29518,-0.0230303859300693,0.00311824168112631,-0.0291421396250768,-0.0169186322350617,1.55667735221437e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNASEH2A,Ribonuclease H2 subunit A,24867,-0.0249268999343502,0.0033800485843255,-0.0315517951596282,-0.0183020047090723,1.69845817721823e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,29374,-0.0166563840211692,0.00225919288785976,-0.0210844020813743,-0.0122283659609641,1.71600055931273e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRY2,Protein sprouty homolog 2,28931,-0.0467338606335545,0.00635165180463671,-0.0591830981706424,-0.0342846230964665,1.92008714918358e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,-0.0272015005881006,0.00369890105210499,-0.0344513466502263,-0.0199516545259748,1.98384391495954e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,-0.0307788787376542,0.0041946474800882,-0.0390003877986271,-0.0225573696766814,2.23026038964396e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,-0.0151755614130291,0.00206894990336716,-0.0192307032236287,-0.0111204196024294,2.27654808561995e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPTLC1,Serine palmitoyltransferase 1,24845,-0.0188539224775935,0.00257247618538482,-0.0238959758009478,-0.0138118691542393,2.3878777847902e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTSL4,ADAMTS-like protein 4,24240,-0.0121973825591873,0.00166547689007755,-0.0154617172637393,-0.00893304785463531,2.48834707543004e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,-0.047078807542604,0.00643589880711128,-0.0596931692045421,-0.0344644458806659,2.64006204459749e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRAF2,TNF receptor-associated factor 2,29434,-0.0353651415390703,0.00483913176933418,-0.0448498398069653,-0.0258804432711753,2.7771500516346e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,-0.0181447577348666,0.00248515868498196,-0.0230156687574313,-0.013273846712302,2.93952696602194e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMMD1,COMM domain-containing protein 1,24240,-0.0309261903526074,0.00424621255084438,-0.0392487669522624,-0.0226036137529524,3.35845405047249e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,-0.0457392628407778,0.00628712595919674,-0.0580620297208034,-0.0334164959607522,3.56531442045434e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNAS,Neuroendocrine secretory protein 55,24867,-0.044615063866664,0.00613484832330778,-0.0566393665803472,-0.0325907611529807,3.63605454451506e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAS2,Growth arrest-specific protein 2,24445,-0.02665235824513,0.00367075215239349,-0.0338470324638213,-0.0194576840264388,3.96506417412411e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MINK1,Misshapen-like kinase 1,24845,-0.0465475037560485,0.00642897693439989,-0.0591482985474723,-0.0339467089646247,4.60831469106424e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,-0.0446686363017606,0.00617056004393722,-0.0567629339878776,-0.0325743386156436,4.65192277700405e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,-0.029514387549792,0.00407731900973096,-0.0375059328088647,-0.0215228422907194,4.66245588313726e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA4,Kallistatin,24557,-0.0119716849075894,0.00165578225738094,-0.0152170181320561,-0.00872635168312281,4.96294964338406e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A13,Protein S100-A13,24229,-0.0176369461502511,0.0024398111782367,-0.022418976059595,-0.0128549162409072,5.01669752073915e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,-0.0175824716842768,0.00243485391865797,-0.0223547853648465,-0.0128101580037072,5.28180837011218e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,-0.0395142061965065,0.00547580858566708,-0.050246791024414,-0.028781621368599,5.48057783040464e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAGED1,Melanoma-associated antigen D1,28797,-0.0240613554207168,0.00333754813138061,-0.0306029497582228,-0.0175197610832108,5.76291163021393e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAX,Apoptosis regulator BAX,28722,-0.0446572158673259,0.00621888243753414,-0.0568462254448928,-0.032468206289759,7.09338580489173e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FSHB,Follitropin subunit beta,24240,0.0321926548673423,0.00448666831706212,0.0233987849659006,0.0409865247687841,7.42895464024609e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELOB,Elongin-B,24111,-0.0196887409277893,0.00274786450697926,-0.0250745553614686,-0.0143029264941099,7.9962223772269e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSMB,Beta-microseminoprotein,29313,-0.0343082642764474,0.00478966029092492,-0.0436959984466602,-0.0249205301062345,8.08002568652438e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPE,Ribulose-phosphate 3-epimerase,24445,-0.035117042741721,0.00490306357515987,-0.0447270473490343,-0.0255070381344076,8.16021998975192e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR15L,Protein GPR15L,24805,-0.030389167003997,0.004243411384294,-0.0387062533172133,-0.0220720806907807,8.20283703879617e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,24845,-0.0264194331386234,0.00369058326305402,-0.0336529763342093,-0.0191858899430375,8.37674541832221e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,-0.015464379423892,0.00216591769049409,-0.0197095780972604,-0.0112191807505236,9.60532605516025e-13
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPSAB1,Tryptase alpha/beta-1,29753,-0.0256738185611222,0.00360520622932243,-0.0327400227705942,-0.0186076143516502,1.09326105443118e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RANBP1,Ran-specific GTPase-activating protein,24240,-0.0258633627987593,0.00363311593900384,-0.0329842700392068,-0.0187424555583118,1.1192044270315e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX2,Peroxiredoxin-2,24556,-0.0303703774027561,0.0042762539372243,-0.0387518351197157,-0.0219889196857964,1.26226537711112e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,-0.0468984061834114,0.00660494859858625,-0.0598441054366405,-0.0339527069301824,1.27129639576096e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRISP2,Cysteine-rich secretory protein 2,29725,0.0281568584243115,0.00396631400106901,0.0203828829822162,0.0359308338664067,1.28483056824082e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,-0.0207719709436107,0.00292714991639629,-0.0265091847797474,-0.0150347571074739,1.31657434960277e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXN,Thioredoxin,24647,-0.0215817843165707,0.00304263157160246,-0.0275453421969115,-0.0156182264362299,1.34654637367469e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGCC,Regulator of cell cycle RGCC,24867,-0.0371493815442018,0.00524178692061044,-0.0474232839085982,-0.0268754791798053,1.40546530672942e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEO1,RNA polymerase-associated protein LEO1,24867,-0.0147828987947941,0.00208915169701951,-0.0188776361209524,-0.0106881614686359,1.52278693105931e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REEP4,Receptor expression-enhancing protein 4,24867,-0.0304875453679507,0.00431088838907998,-0.0389368866105475,-0.022038204125354,1.56512137552177e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,24170,-0.0414670325595585,0.00588280821898515,-0.0529973366687694,-0.0299367284503476,1.85253274417122e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX1,Peroxiredoxin-1,28669,0.0437419248756979,0.00620973480922243,0.031570844649622,0.0559130051017739,1.90890938762381e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH2B3,SH2B adapter protein 3,28797,-0.0475574442671813,0.006758465965715,-0.0608040375599827,-0.0343108509743799,2.01218017053022e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD58,Lymphocyte function-associated antigen 3,29409,0.00854800831282884,0.00121582572154727,0.00616498989859619,0.0109310267270615,2.10105599015915e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRPX,Sushi repeat-containing protein SRPX,24922,-0.0172836958233743,0.00245847484256467,-0.0221023065148011,-0.0124650851319476,2.11479954526894e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,24793,-0.0249546965695603,0.00355676581039315,-0.0319259575579309,-0.0179834355811897,2.33981928501786e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD36,Platelet glycoprotein 4,24229,-0.0220375579196387,0.00314157013582674,-0.0281950353858591,-0.0158800804534183,2.36298492898692e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSNK1D,Casein kinase I isoform delta,24229,-0.0309933226319887,0.00443213146677941,-0.0396803003068764,-0.0223063449571011,2.76316051360072e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MBL2,Mannose-binding protein C,24610,0.0524468330627758,0.0075006700494539,0.0377455197658462,0.0671481463597054,2.7735744203688e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFT20,Intraflagellar transport protein 20 homolog,24195,-0.0209705247335069,0.00300471635135227,-0.0268597687821573,-0.0150812806848564,3.04525143057508e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITPA,Inosine triphosphate pyrophosphatase,24111,-0.0326430921762941,0.00467770079490392,-0.0418113857343058,-0.0234747986182824,3.06189001615022e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD55,Complement decay-accelerating factor,28490,-0.0126404604840891,0.0018117023538715,-0.0161913970976773,-0.00908952387050099,3.07884719704335e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,24195,-0.0329167771532239,0.00472451542488882,-0.042176827386006,-0.0236567269204418,3.31536152724025e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,29478,-0.0323544013038322,0.00465151606189758,-0.0414713727851514,-0.0232374298225129,3.58217615296406e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYAP1,Synapse-associated protein 1,24381,-0.0277007353309622,0.0039892686674324,-0.0355197019191297,-0.0198817687427947,3.91239439400413e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB5,Integrin beta-5,29566,0.0180056335538094,0.00259485079159544,0.0129197260022823,0.0230915411053364,4.03062451464941e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSF,Cathepsin F,29566,-0.0191514061001509,0.00276004579688845,-0.0245610958620523,-0.0137417163382495,4.03592465210393e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD2,Sushi domain-containing protein 2,29443,0.0136313160239551,0.00196502247298551,0.00977987197690345,0.0174827600710067,4.08858838369033e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,-0.0203058401846926,0.00293235910148912,-0.0260532640236113,-0.0145584163457739,4.47394198442347e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,-0.0354550525505071,0.00512271236148629,-0.0454955687790203,-0.025414536321994,4.58857526420453e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGCT,Gamma-glutamylcyclotransferase,24904,-0.0229600217258078,0.00332146817848226,-0.0294700993556331,-0.0164499440959826,4.87296150172847e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDGF,Hepatoma-derived growth factor,29688,-0.0444486937408682,0.00643484887572817,-0.0570609975372954,-0.031836389944441,5.03224951800933e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD33,Myeloid cell surface antigen CD33,29566,-0.0376977735912054,0.00545857791336416,-0.0483965863013991,-0.0269989608810116,5.08044480175077e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALPI,Intestinal-type alkaline phosphatase,24229,-0.058627639790658,0.00853644973918866,-0.0753590812794678,-0.0418961983018482,6.67214957126931e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP2,Guanylate-binding protein 2,28931,-0.0283055921451968,0.00412706879236561,-0.0363946469782334,-0.0202165373121602,7.0976073088527e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KEL,Kell blood group glycoprotein,28774,-0.0169447549939343,0.00247289736309131,-0.0217916338255932,-0.0120978761622753,7.41949935532013e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,0.0232167555730663,0.00338875714897718,0.0165747915610711,0.0298587195850616,7.50268221839149e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB3A1,Secretoglobin family 3A member 1,24381,0.012134339829622,0.00177278272880285,0.00865968568116845,0.0156089939780756,7.84004141076963e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAFB2,Scaffold attachment factor B2,24867,-0.0130187410032275,0.00190473524622039,-0.0167520220858195,-0.00928545992063552,8.39391667533879e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CIAPIN1,Anamorsin,29566,-0.0294135739006446,0.00430912427234434,-0.0378594574744395,-0.0209676903268497,8.90741768876903e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,-0.0536139142879823,0.00785823624888759,-0.069016057335802,-0.0382117712401626,9.11132710159019e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNGR2,Interferon gamma receptor 2,29218,-0.0244373683842699,0.00358306370393843,-0.0314601732439892,-0.0174145635245506,9.26563950648408e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,-0.0264700455644541,0.00388506797965987,-0.0340847788045875,-0.0188553123243208,9.76359921668479e-12
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL1A1,Collagen alpha-1(I) chain,29820,0.0117153929091805,0.00172334563973825,0.00833763545529357,0.0150931503630675,1.08040926857426e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,29434,-0.0262549251517894,0.00386556848467188,-0.0338314393817463,-0.0186784109218325,1.12696148905081e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIL1,Nucleotide exchange factor SIL1,24240,-0.0152147315619805,0.00224109381100427,-0.0196072754315488,-0.0108221876924121,1.15540955874981e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XRCC4,DNA repair protein XRCC4,28774,-0.0172915403626656,0.00255048334192011,-0.022290487712829,-0.0122925930125022,1.22742952042943e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL15A1,Collagen alpha-1(XV) chain,24938,-0.0124311978369641,0.00183413973844675,-0.0160261117243197,-0.00883628394960847,1.24850715563607e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CETN3,Centrin-3,24805,-0.036458608078638,0.0053797633595872,-0.0470029442634289,-0.0259142718938471,1.25454217088739e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRAP,BRCA1-associated protein,24565,-0.0514330198681052,0.00760538362494894,-0.0663395717730051,-0.0365264679632053,1.38471615614183e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IST1,IST1 homolog,24636,-0.0465265061062029,0.00688955632380238,-0.0600300365008555,-0.0330229757115502,1.4784427689708e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CREG1,Protein CREG1,29079,-0.0176734241265289,0.00261748068837436,-0.0228036862757426,-0.0125431619773151,1.48487728134373e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,24229,-0.0424085069749886,0.00628967053118775,-0.0547362612161166,-0.0300807527338606,1.59115248969552e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRND,Prion-like protein doppel,24845,-0.0240976553403237,0.00357480474935641,-0.0311042726490623,-0.0170910380315852,1.60778036012763e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,-0.0436176486313049,0.00647431363812773,-0.0563073033620352,-0.0309279939005745,1.6465589614e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,28774,-0.0296184667268755,0.00439746153973147,-0.0382374913447492,-0.0209994421090018,1.66608262580352e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN9,Septin-9,29349,-0.0131656954453182,0.00195655977118997,-0.0170005525968505,-0.00933083829378581,1.7397100871333e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTN6,Dynactin subunit 6,28774,-0.0330389539101576,0.00491114256193999,-0.04266479333156,-0.0234131144887552,1.76023516660694e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP3R1,Calcineurin subunit B type 1,29218,-0.0189060708408838,0.00281499292377384,-0.0244234569714805,-0.013388684710287,1.89936682685543e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSL4,Early placenta insulin-like peptide,24793,-0.0239549047730613,0.00356816585870048,-0.0309485098561142,-0.0169612996900083,1.94106263188024e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OPLAH,5-oxoprolinase,24240,-0.0319308011407517,0.00475682573376254,-0.0412541795789262,-0.0226074227025771,1.95372046961028e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,24764,-0.019070033018424,0.00284451160055338,-0.0246452757555086,-0.0134947902813394,2.06938752790136e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,-0.012975976457731,0.00194163434104997,-0.0167815797661889,-0.00917037314927302,2.39179211497452e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TTF2,Transcription termination factor 2,24195,-0.022758458149256,0.0034066958964817,-0.0294355821063601,-0.0160813341921518,2.43285970438816e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST5,Cystatin-D,28890,-0.0255313591772349,0.00382224656751844,-0.033022962449571,-0.0180397559048987,2.43820438863997e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,-0.0218638396544261,0.00327752364762699,-0.028287786003775,-0.0154398933050771,2.58951042808142e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,28931,-0.0267184599021723,0.00401074299441257,-0.0345795161712209,-0.0188574036331236,2.75487127914137e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTF1,Cardiotrophin-1,28916,-0.0387324640016939,0.00581949675769641,-0.0501386776467789,-0.027326250356609,2.87115006275899e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIT1,ARF GTPase-activating protein GIT1,24229,-0.0449110824819691,0.00674808681385926,-0.0581373326371332,-0.0316848323268049,2.88604844593385e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD2,T-cell surface antigen CD2,24111,-0.0177121563506774,0.00266697846671123,-0.0229394341454314,-0.0124848785559234,3.17585863291388e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACRBP,Acrosin-binding protein,24793,-0.01783914726499,0.00268815855474059,-0.0231079380322815,-0.0125703564976984,3.28523159504879e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCTN3,Tectonic-3,24922,-0.0136796715051341,0.00206431384724629,-0.0177257266457369,-0.0096336163645314,3.50185357982548e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,-0.0683753150393138,0.010328889916696,-0.0886199392760379,-0.0481306908025897,3.65835441129576e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STK24,Serine/threonine-protein kinase 24,28774,-0.0281861087389172,0.00425951047247227,-0.0365347492649628,-0.0198374682128715,3.72447633346841e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRKL,Crk-like protein,29491,-0.0482710785731836,0.00729671776049643,-0.0625726453837566,-0.0339695117626106,3.7675765382768e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC134,Coiled-coil domain-containing protein 134,24793,-0.0222135751738199,0.00337741160013847,-0.0288333019100913,-0.0155938484375485,4.89265329364562e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRA2,GDNF family receptor alpha-2,29349,-0.00953567630416043,0.00145060942546833,-0.0123788707780784,-0.0066924818302425,4.9947985346143e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,-0.0302914877861449,0.00461606317859547,-0.039338971616192,-0.0212440039560978,5.40993960420403e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1RL1,Interleukin-1 receptor-like 1,29736,-0.0209855896082506,0.00320345018713253,-0.0272643519750304,-0.0147068272414709,5.81117327265917e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRAS,Ras-related protein R-Ras,24195,-0.0594292319281209,0.0090716449237879,-0.0772096559787452,-0.0416488078774966,5.82635461585939e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEDD9,Enhancer of filamentation 1,24229,-0.0151162152283418,0.00231466050459321,-0.0196529498173445,-0.0105794806393391,6.67872434816788e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,-0.0227341923814854,0.00349179442661617,-0.0295781094576531,-0.0158902753053177,7.60080945493112e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,24523,-0.0252071641072114,0.00387491235362434,-0.0328019923203151,-0.0176123358941077,7.90748401094875e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,24966,-0.011741135065023,0.00180543454323516,-0.0152797867697639,-0.0082024833602821,8.01066487394009e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HS1BP3,HCLS1-binding protein 3,24240,-0.0406431092414193,0.00625377786890731,-0.0529005138644776,-0.028385704618361,8.24441457704606e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHMP1A,Charged multivesicular body protein 1a,29218,-0.0354201048084618,0.00545311111943626,-0.0461082026025569,-0.0247320070143668,8.41469009400035e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,-0.04883343975744,0.00752461957588315,-0.0635816941261709,-0.034085185388709,8.75609100480915e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F3,Tissue factor,29541,0.0122014522484992,0.00188240930960145,0.00851193000168035,0.015890974495318,9.20462374162476e-11
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OPHN1,Oligophrenin-1,24845,-0.0481754656377051,0.00744703488536896,-0.0627716540130283,-0.033579277262382,1.00436991498582e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CMC1,COX assembly mitochondrial protein homolog,24922,-0.0405698859672701,0.00627458922998563,-0.0528680808580419,-0.0282716910764982,1.02668812919707e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA4,Protein disulfide-isomerase A4,24938,-0.0271724101377299,0.0042083658895439,-0.035420807281236,-0.0189240129942239,1.08937191344391e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FDX2,"Ferredoxin-2, mitochondrial",24111,-0.0252500927524397,0.00391238785498338,-0.0329183729482071,-0.0175818125566722,1.11092826231695e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,-0.0195137656859047,0.00302398113735615,-0.0254407687151227,-0.0135867626566866,1.1139572425381e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,-0.0221314036567691,0.00343754291743728,-0.0288689877749461,-0.015393819538592,1.23187465834382e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHACTR2,Phosphatase and actin regulator 2,24867,-0.0508805163149552,0.00790743392783763,-0.066379086813517,-0.0353819458163935,1.2612262031277e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MITD1,MIT domain-containing protein 1,29218,-0.0426608251216166,0.00663698893090771,-0.0556693234261957,-0.0296523268170375,1.31513489779931e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PADI4,Protein-arginine deiminase type-4,28722,-0.0312982263153978,0.00489387784609066,-0.0408902268937355,-0.0217062257370601,1.6260712428036e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBCC,Tubulin-specific chaperone C,29218,-0.0354835771196792,0.00555538329514211,-0.0463721283781578,-0.0245950258612007,1.71444201637176e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,-0.0396513933345653,0.00620873482188163,-0.0518205135854532,-0.0274822730836773,1.72845473229217e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,29757,0.0272755930835618,0.00428214828511206,0.0188825824447421,0.0356686037223814,1.9228323178705e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPD52L2,Tumor protein D54,24381,-0.0478656266650555,0.00751450025750181,-0.0625940471697591,-0.0331372061603519,1.92693451492727e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX6,Syntaxin-6,28797,-0.0295640942094661,0.00464350306056003,-0.0386653602081638,-0.0204628282107685,1.95965046450278e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TK1,"Thymidine kinase, cytosolic",24445,-0.020260591512907,0.0031823208652088,-0.0264979404087163,-0.0140232426170978,1.96687600178283e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,29478,-0.0124661359566879,0.0019628802212833,-0.0163133811904032,-0.00861889072297266,2.17120882867956e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,29566,-0.0119562325932709,0.00188276690970623,-0.0156464557362951,-0.00826600945024668,2.1794298684011e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCRL3,Fc receptor-like protein 3,28931,-0.0236307969470751,0.00372751488138173,-0.0309367261145833,-0.0163248677795669,2.33823135099044e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,-0.020722115874957,0.00327029524990904,-0.0271318945647787,-0.0143123371851352,2.39134794834453e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A14,Protein S100-A14,24867,-0.0231781443815857,0.00367063061513604,-0.0303725803872524,-0.0159837083759191,2.75645060068316e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,-0.0214459720935643,0.00339666667834869,-0.0281034387831278,-0.0147885054040009,2.76087697278242e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.0257869608494291,0.00409390501137255,0.0177629070271389,0.0338110146717193,3.04117785472626e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYO9B,Unconventional myosin-IXb,28931,-0.0286066716584555,0.0045446021968475,-0.0375140919642766,-0.0196992513526343,3.12516031749619e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SF3B4,Splicing factor 3B subunit 4,29349,-0.0315996933900468,0.00502025239040311,-0.0414393880752369,-0.0217599987048567,3.12865190958635e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,-0.0119572296053267,0.00190037327010488,-0.0156819612147323,-0.00823249799592114,3.1768499459382e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMS1,PMS1 protein homolog 1,24195,-0.0221853743035718,0.00352570156305269,-0.0290957493671551,-0.0152749992399886,3.17809297006833e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEP1B,Meprin A subunit beta,29478,0.0505988982845453,0.00804859258839548,0.0348236568112902,0.0663741397578004,3.28875472922318e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GHRL,Appetite-regulating hormone,29478,-0.0349392759159775,0.00556044569862659,-0.0458377494852856,-0.0240408023466694,3.35576620902952e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C9orf40,Uncharacterized protein C9orf40,24805,-0.0349805832173897,0.00556875976904972,-0.0458953523647272,-0.0240658140700523,3.40725726118133e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.0132940136662099,0.00212573490188996,-0.0174604540739142,-0.00912757325850555,4.06072678447022e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABHD14B,Protein ABHD14B,29121,-0.0246423680249057,0.00394188046092564,-0.0323684537283199,-0.0169162823214915,4.12364999999455e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,28797,-0.0217404478374373,0.00349654699256415,-0.0285936799428631,-0.0148872157320116,5.11450340504616e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,-0.0352800372564818,0.00567570062909869,-0.0464044104895152,-0.0241556640234484,5.16897167547612e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HPCAL1,Hippocalcin-like protein 1,29786,-0.031271500775865,0.00505092457199875,-0.0411713129369825,-0.0213716886147474,6.04705154378746e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,24229,-0.0388322525796364,0.00627784996518336,-0.0511368385113958,-0.026527666647877,6.28579547629043e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICA1,Islet cell autoantigen 1,28931,-0.0338284944519854,0.00547130982643254,-0.0445522617117932,-0.0231047271921776,6.3780669523597e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,-0.0327324535810076,0.00530146358851145,-0.04312332221449,-0.0223415849475251,6.73551188444746e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARF2,Scavenger receptor class F member 2,29694,-0.0123661372379138,0.00200807205656421,-0.0163019584687797,-0.00843031600704797,7.45128845847372e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH1,Protocadherin-1,29713,-0.00899761066098608,0.00146224631661261,-0.0118636134415468,-0.00613160788042537,7.6865829790285e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,-0.0390667115662874,0.00634980794596128,-0.0515123351403715,-0.0266210879922033,7.7472402987966e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDF1,Endothelial differentiation-related factor 1,24867,-0.0290318173200071,0.00472159526903383,-0.0382861440473134,-0.0197774905927007,7.92950669775497e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRL,Prolactin,29694,-0.0320709165107566,0.00521720517906192,-0.042296638661718,-0.0218451943597953,7.98940358016218e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,-0.0170480900118034,0.0027764134490396,-0.022489860371921,-0.0116063196516858,8.35958426346271e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDHB,Succinate dehydrogenase,24805,-0.029264218194594,0.00477328525098354,-0.0386198572865217,-0.0199085791026663,8.8739302740441e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCP1,Plastin-2,24938,-0.020135764786471,0.00328734897075274,-0.0265789687691464,-0.0136925608037957,9.19080058670694e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK6,Kallikrein-6,29519,-0.0129018081104081,0.00210787694489593,-0.0170332469224041,-0.00877036929841203,9.43026553909381e-10
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX16,Syntaxin-16,28797,-0.0244743362782884,0.00400869745914896,-0.0323313832982203,-0.0166172892583564,1.03913147853468e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPEP1,Dipeptidase 1,29163,0.0203918277236244,0.00334094867761763,0.0138435683154939,0.026940087131755,1.05010038738431e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDC,Nuclear migration protein nudC,29786,-0.0265928627819063,0.00435799946882472,-0.0351345417408028,-0.0180511838230099,1.05987243446793e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,-0.0282710586402263,0.00463883517650455,-0.0373631755861752,-0.0191789416942774,1.11500796004754e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST6,Cystatin-M,28830,-0.0204978859069477,0.00336530666761737,-0.0270938869754777,-0.0139018848384176,1.13668129009624e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,28797,-0.0167407586757678,0.00275138268390272,-0.0221334687362172,-0.0113480486153185,1.18336616493975e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2RG,Cytokine receptor common subunit gamma,24793,-0.0156794889343523,0.00258366140874097,-0.0207434652954846,-0.01061551257322,1.30813583073806e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1B,Interleukin-1 beta,28745,-0.0234974172354349,0.00387733427888517,-0.0310969924220498,-0.0158978420488199,1.37643801590066e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYBB1,Beta-crystallin B1,24922,-0.0274280908978142,0.00452694191018669,-0.0363008970417801,-0.0185552847538483,1.39058984380556e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDI2,Protein DDI1 homolog 2,24381,-0.0322281285173699,0.00532192974174128,-0.0426591108111828,-0.021797146223557,1.41834563901656e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOD3,Extracellular superoxide dismutase,24951,0.0251754245527724,0.00415999601061478,0.0170218323719674,0.0333290167335774,1.45287353990681e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.0154848930527487,0.00255982339559631,0.0104676391973799,0.0205021469081174,1.47697058692361e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFHR4,Complement factor H-related protein 4,24892,0.0307237590881077,0.00507926545600373,0.0207683987943404,0.040679119381875,1.47956756030039e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL6R,Interleukin-6 receptor subunit alpha,29361,-0.0141307254166357,0.00233675343495671,-0.0187107621491509,-0.0095506886841206,1.49199323789455e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB27B,Ras-related protein Rab-27B,24922,-0.0344067414683052,0.00569114666566052,-0.0455613889329998,-0.0232520940036106,1.50914971944809e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",29566,-0.0254371147567348,0.00420851596565341,-0.0336858060494155,-0.0171884234640541,1.51948848839712e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,-0.0432996966725617,0.00717899491089693,-0.0573705266979196,-0.0292288666472037,1.64438968169464e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,-0.0456198884928351,0.00756794389969048,-0.0604530585362285,-0.0307867184494418,1.67920877862539e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,-0.0390061696499777,0.00647978050269127,-0.0517065394352526,-0.0263057998647028,1.77217186041829e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,-0.0417129615454511,0.00694864638063229,-0.0553323084514904,-0.0280936146394118,1.95929581089497e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RCC1,Regulator of chromosome condensation,24793,-0.0213393880332416,0.00357269886702869,-0.0283418778126178,-0.0143368982538653,2.36243929251177e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,24445,-0.0288364517091195,0.00483642710651652,-0.0383158488378919,-0.0193570545803471,2.52056242630909e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1S,Complement C1s subcomponent,24966,-0.00862424994076526,0.00144992602732678,-0.0114661049543258,-0.00578239492720477,2.74949293029733e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICAM5,Intercellular adhesion molecule 5,29478,-0.0184159984849409,0.00309997207462636,-0.0244919437512086,-0.0123400532186732,2.8699329123536e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSDE1,Cold shock domain-containing protein E1,24111,-0.0487667710129497,0.00820926733345611,-0.0648569349865236,-0.0326766070393757,2.88135410934158e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPING1,Plasma protease C1 inhibitor,24914,0.00772720125210842,0.00130322931858647,0.00517287178767893,0.0102815307165379,3.08291206669676e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCD6,Programmed cell death protein 6,29478,0.0285773043417562,0.00482698307618169,0.01911641751244,0.0380381911710723,3.24862676596518e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCB,Calcitonin gene-related peptide 2,24845,-0.0164901467322677,0.00278603149532354,-0.0219507684631019,-0.0110295250014336,3.2842461933702e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,24229,-0.0153677027718435,0.00259985241669643,-0.0204634135085685,-0.0102719920351185,3.44611152600553e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,29581,-0.0423502644125762,0.00716852697455882,-0.0564005772827115,-0.0282999515424409,3.50485459855046e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JCHAIN,Immunoglobulin J chain,28931,-0.025051869337512,0.0042427319719284,-0.0333676240024916,-0.0167361146725323,3.57328124080656e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HLA_A,,24867,-0.013405509826445,0.00227055318438355,-0.0178557940678367,-0.0089552255850532,3.59242802074487e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FXN,"Frataxin, mitochondrial",29725,-0.0297707712834355,0.00504707108266284,-0.0396630306054547,-0.0198785119614164,3.70511118270844e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,-0.016207464160607,0.00275229548998798,-0.0216019633209835,-0.0108129650002306,3.94216157088514e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,24805,-0.0463659843269425,0.00789191931755458,-0.0618341461893495,-0.0308978224645355,4.27930077536889e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,-0.0351852926458873,0.00598972811402985,-0.0469251597493858,-0.0234454255423888,4.30117806100721e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRAL,GDNF family receptor alpha-like,24025,0.025513162105581,0.00435178020630391,0.0169836729012253,0.0340426513099367,4.6136992648447e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXNA4,Plexin-A4,29434,-0.0328667748981524,0.00561188109878472,-0.0438660618517704,-0.0218674879445343,4.77338355482865e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.0198196385915516,0.00338472888694162,-0.0264537072099572,-0.013185569973146,4.80304291249897e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,-0.0197409149167156,0.00337602114209604,-0.0263579163552238,-0.0131239134782074,5.04606644669672e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFIC,Nuclear factor 1 C-type,24867,-0.0180333579304071,0.00308995568382671,-0.0240896710707074,-0.0119770447901067,5.40929968581016e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LACTB2,Endoribonuclease LACTB2,29478,-0.0264909657600378,0.00454079145632295,-0.0353909170144308,-0.0175910145056448,5.46802397264876e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,24922,-0.0130671154788504,0.00224077172204194,-0.0174590280540526,-0.00867520290364826,5.56013059525475e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEXN,Nexilin,24951,-0.0278574598180086,0.0047806971339646,-0.0372276262005792,-0.0184872934354379,5.7102298329364e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBNL,Drebrin-like protein,29581,-0.0370672702169932,0.00636305404263823,-0.0495388561405641,-0.0245956842934223,5.75691584266764e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD226,CD226 antigen,24229,-0.0170086807800508,0.00292320695677027,-0.0227381664153206,-0.0112791951447811,6.01255503584595e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,-0.0267063958973864,0.00459519250593839,-0.0357129732090257,-0.0176998185857472,6.25547857866431e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH6,Cadherin-6,29478,-0.0153549744061617,0.00264415223324507,-0.020537512783322,-0.0101724360290013,6.41992013721694e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLMP,CXADR-like membrane protein,29725,-0.00843611296282608,0.00145897955407335,-0.0112957128888099,-0.00557651303684231,7.44671515061022e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,-0.0341550902700829,0.00592069333835603,-0.0457596492132608,-0.0225505313269051,8.08205676937911e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THTPA,Thiamine-triphosphatase,24755,-0.0352227771308133,0.00611071283240717,-0.0471997742823313,-0.0232457799792952,8.30684071546923e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,-0.0293853121709748,0.00509921535861868,-0.0393797742738674,-0.0193908500680822,8.37482955109727e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,-0.0266015147360489,0.00462025622351204,-0.0356572169341325,-0.0175458125379653,8.63480009468594e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,29594,0.0118009639999484,0.00205258817150607,0.00777789118379647,0.0158240368161003,9.04894163586997e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,24229,-0.0230528892084492,0.00401143809399803,-0.0309153078726853,-0.015190470544213,9.20449645219537e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLITRK6,SLIT and NTRK-like protein 6,28916,-0.0135934920645918,0.00236555535441793,-0.0182299805592509,-0.00895700356993266,9.20637791198232e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,-0.0273427121498815,0.00475803124648372,-0.0366684533929896,-0.0180169709067734,9.21170154061572e-09
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,-0.018756617867913,0.00327266281065965,-0.0251710369768059,-0.0123421987590201,1.00657193868869e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,-0.0340565806948021,0.00594873727950508,-0.0457161057626321,-0.0223970556269722,1.0464488103904e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.0337554396593142,0.0058977959905465,-0.0453151198007854,-0.0221957595178431,1.05645700549696e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPART,Spartin,24381,-0.0306773616544391,0.0053708047200551,-0.0412041389057471,-0.0201505844031311,1.13039114713086e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,-0.0387108632753911,0.00679488474648146,-0.0520288373784948,-0.0253928891722875,1.23265060945025e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,24111,-0.0273030601988759,0.00479972009909749,-0.036710511593107,-0.0178956088046448,1.29667900251618e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TWF2,Twinfilin-2,24938,-0.0329932507787818,0.00580715017117222,-0.0443752651142794,-0.0216112364432843,1.35016229604164e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PKN3,Serine/threonine-protein kinase N3,24445,-0.0297454525939632,0.00524237212373423,-0.0400205019564823,-0.0194704032314441,1.41042370675489e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,-0.019390810613543,0.00342596277203245,-0.0261056976467266,-0.0126759235803593,1.53080799790123e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PODXL2,Podocalyxin-like protein 2,29566,-0.0108467222759127,0.00192187253185124,-0.0146135924383411,-0.00707985211348423,1.67829888604471e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WIF1,Wnt inhibitory factor 1,29725,0.0132258873563384,0.00234659281395117,0.00862656544099415,0.0178252092716827,1.75408284493951e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMOTL2,Angiomotin-like protein 2,24711,-0.0189076785134111,0.00335501204365266,-0.0254835021189703,-0.0123318549078518,1.76297993931892e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17RA,Interleukin-17 receptor A,29443,-0.0170563250415667,0.00303247337774341,-0.0229999728619438,-0.0111126772211896,1.87668953126934e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,24845,-0.0129413929330899,0.00230588187679321,-0.0174609214116046,-0.00842186445457519,2.01737224079589e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRUNE2,Protein prune homolog 2,24445,-0.0113928818775438,0.00203199106285432,-0.0153755843607383,-0.00741017939434936,2.08377400549234e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,-0.0146521033122139,0.00261468937049434,-0.0197768944783828,-0.00952731214604496,2.12011424832819e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C5,Complement C5,24966,-0.00587828151307942,0.00105122330412225,-0.00793867918915903,-0.00381788383699981,2.27014861146759e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",29402,-0.0214428743834937,0.0038367545309731,-0.0289629132642009,-0.0139228355027864,2.30662024610122e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HLA_DRA,,29322,-0.0139125558072655,0.002490217122672,-0.0187933813677026,-0.00903173024682841,2.33229558313812e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F11,Coagulation factor XI,24606,0.0119701440931136,0.0021511893651391,0.00775381293744093,0.0161864752487862,2.65748325375778e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLG4,Disks large homolog 4,24845,-0.0273252026455298,0.00491758390519234,-0.0369636670997068,-0.0176867381913528,2.77850896662415e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,-0.0232010590650544,0.00419086021584735,-0.0314151450881152,-0.0149869730419936,3.12451250242187e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPI,Mannose-6-phosphate isomerase,29349,-0.0325725773174432,0.00588973372019469,-0.0441164554090248,-0.0210286992258616,3.22224493030844e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALM,Paralemmin-1,24657,-0.0114493986846811,0.0020747113090084,-0.0155158328503375,-0.00738296451902462,3.45246635234638e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,-0.0171734185810012,0.00311373328196873,-0.0232763358136599,-0.0110705013483425,3.51602719759399e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MKI67,Proliferation marker protein Ki-67,24229,-0.0149457290389263,0.00271008881903904,-0.0202575031242429,-0.00963395495360983,3.52645839790188e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,-0.0322653461331718,0.0058568513488951,-0.0437447747770061,-0.0207859174893374,3.6398064356872e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.0285894875955074,0.00519038163152572,-0.0387626355932978,-0.018416339597717,3.6629516514639e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,-0.0276716871245275,0.00502920769535253,-0.0375289342074185,-0.0178144400416366,3.7885227282376e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMEM106A,Transmembrane protein 106A,24793,-0.026954243455162,0.00490429297525009,-0.0365666576866522,-0.0173418292236718,3.92215343190124e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,-0.0313366199412199,0.00570754479221066,-0.0425234077339528,-0.020149832148487,4.04989629678188e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNR,Tenascin-R,29218,0.0159459564077478,0.00290537433878584,0.0102514227037276,0.0216404901117681,4.08879783695031e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,-0.0120405792769407,0.00219399707849367,-0.0163408135507883,-0.0077403450030931,4.10001650537646e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK8,Kallikrein-8,28443,-0.0135653190718689,0.00247778611591673,-0.0184217798590657,-0.00870885828467213,4.41772046138032e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFHD1,EF-hand domain-containing protein D1,24867,-0.0133780270986827,0.00244811655544526,-0.0181763355473554,-0.00857971865000994,4.68353075578723e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,28774,-0.0154981781664558,0.0028369646839226,-0.0210586289469441,-0.00993772738596752,4.72182086018281e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,0.00994049893707751,0.00181983398994095,0.00637362431679325,0.0135073735573618,4.74481161889666e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN4B,Sodium channel subunit beta-4,24240,-0.016136593854977,0.00296172820867632,-0.0219415811439826,-0.0103316065659714,5.13282367976371e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP5,Rho GTPase-activating protein 5,24016,-0.0290225427062778,0.00532830229930807,-0.0394660152129216,-0.018579070199634,5.17686930678703e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRH,Corticoliberin,28751,0.0326520867673699,0.00599654867308068,0.0208988513681318,0.0444053221666081,5.21863883809716e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF2,Fibroblast growth factor 2,29434,-0.0252421765614962,0.00464376932707689,-0.0343439644425669,-0.0161403886804255,5.50124812300366e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRSS53,Serine protease 53,24845,0.0140581611042936,0.00259132803203594,0.0089791581615032,0.0191371640470841,5.84698529425681e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL2A1,Collagen alpha-1(II) chain,24240,-0.0303663386567694,0.00559955023450392,-0.0413414571163971,-0.0193912201971418,5.91687015629024e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEK7,Serine/threonine-protein kinase Nek7,24445,-0.0282486030549325,0.00521080647087276,-0.0384617837378431,-0.0180354223720219,5.97750186980297e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TYMP,Thymidine phosphorylase,29301,-0.0247977692068457,0.00458400407816109,-0.0337824172000415,-0.01581312121365,6.36492583772388e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UNC79,Protein unc-79 homolog,24016,-0.0210780223997259,0.00389895867279557,-0.0287199813984052,-0.0134360634010465,6.50388433699406e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTA4H,Leukotriene A-4 hydrolase,29725,-0.0218210166656137,0.00403908543686868,-0.0297376241218763,-0.0139044092093511,6.62359901593997e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBCB,Tubulin-folding cofactor B,29218,-0.0373167139544486,0.00691195965135665,-0.0508641548711077,-0.0237692730377896,6.75875196433815e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,24195,-0.0270243120733567,0.00501744953924959,-0.0368585131702859,-0.0171901109764275,7.26885078854105e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELAVL4,ELAV-like protein 4,24101,-0.0316336296597404,0.00589310441472998,-0.0431841143126111,-0.0200831450068696,8.03923496367982e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB6,Serpin B6,29623,-0.0217941042721233,0.00407107206349797,-0.0297734055165793,-0.0138148030276672,8.69553151454917e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD99,CD99 antigen,29443,0.00721619320690836,0.00135381410025864,0.00456271757040144,0.00986966884341529,9.87888141621855e-08
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT1,Vascular endothelial growth factor receptor 1,29288,-0.0082585348903702,0.00155038260031256,-0.0112972847869828,-0.00521978499375759,1.00710840813801e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PI16,Peptidase inhibitor 16,24951,0.0090807729625817,0.00170476343300469,0.0057394366338925,0.0124221092912709,1.00876442778925e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,-0.0284564240675409,0.00534375900530831,-0.0389301917179452,-0.0179826564171366,1.0161456393865e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL34,Interleukin-34,28722,-0.0132308429554008,0.00249071367071218,-0.0181126417499967,-0.00834904416080489,1.09194104562962e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,-0.0291138057801187,0.00549243198093777,-0.0398789724627568,-0.0183486390974807,1.16335082509902e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL33,Interleukin-33,28931,-0.0142277349715666,0.00268481856042077,-0.0194899793499913,-0.00896549059314188,1.17080173623143e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,-0.0375447068964872,0.00708802877176849,-0.0514372432891534,-0.023652170503821,1.18614307406289e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,-0.0154301084562119,0.00291734846511696,-0.0211481114478412,-0.00971210546458266,1.23971372337097e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,-0.0303064731540833,0.00573134698835429,-0.0415399132512577,-0.0190730330569089,1.24647472516393e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LIPF,Gastric triacylglycerol lipase,24240,0.0223823514397948,0.00423625537903017,0.0140792908968956,0.0306854119826939,1.2781811444025e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UROS,Uroporphyrinogen-III synthase,24195,-0.0249665631557832,0.00474045406961728,-0.0342578531322331,-0.0156752731793333,1.40083302693227e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,0.0355433899121154,0.00677397575698622,0.0222663974284224,0.0488203823958084,1.55618947290587e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA3,Annexin A3,29640,-0.0251420567299959,0.00479438949494336,-0.0345390601400849,-0.0157450533199069,1.58160121348267e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,-0.0117261267021675,0.0022361864846358,-0.0161090522120536,-0.0073432011922813,1.58625663074133e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP1,Retinol-binding protein 1,24195,-0.0252902695846165,0.00482308084534305,-0.0347435080414888,-0.0158370311277441,1.58803650859307e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GASK1A,Golgi-associated kinase 1A,24111,-0.0156207203105209,0.00298447130231265,-0.0214702840630537,-0.00977115655798809,1.67270459625882e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA1,Annexin A1,24281,-0.0155315653122159,0.00297069657209381,-0.0213541305935198,-0.00970900003091206,1.72532466414815e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRRT3,Proline-rich transmembrane protein 3,24240,-0.0137795920853146,0.00263989993140207,-0.0189537959508627,-0.00860538821976657,1.80651040791555e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBM17,Splicing factor 45,24867,-0.0276929230941713,0.00530578131762659,-0.0380922544767194,-0.0172935917116232,1.80958683601616e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAPK2,Death-associated protein kinase 2,24229,-0.0193995975612198,0.00372401958166433,-0.0266986759412819,-0.0121005191811577,1.91088211154006e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KDR,Vascular endothelial growth factor receptor 2,29566,-0.00908639478675528,0.00174574872811664,-0.0125080622938639,-0.00566472727964667,1.95429238064535e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NME3,Nucleoside diphosphate kinase 3,29497,0.00855649766557847,0.00164727693083899,0.00532783488113405,0.0117851604500229,2.06824611924344e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB1,Leukocyte elastase inhibitor,29354,-0.0317593173839082,0.00612952448835532,-0.0437731853810846,-0.0197454493867318,2.21721294840543e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGN,Cingulin,24195,-0.0143535624608657,0.00277425084112152,-0.0197910941094639,-0.00891603081226757,2.31146754505625e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCN15,Lipocalin-15,24867,-0.022369630390017,0.00432593738286756,-0.0308484676604374,-0.0138907931195966,2.34588003407261e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBA,Lysosomal acid glucosylceramidase,24195,-0.0193598004862372,0.00374586894508156,-0.026701703618597,-0.0120178973538773,2.38101330004921e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC10A,C-type lectin domain family 10 member A,29218,0.0128798493528132,0.00249338257145361,0.00799281951276412,0.0177668791928623,2.41225056952661e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK13,Kallikrein-13,28845,-0.0156770105624855,0.00303744036061818,-0.0216303936692971,-0.0097236274556739,2.46922485290252e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,-0.0261718789775107,0.00507660742852252,-0.0361220295374149,-0.0162217284176066,2.54743514347221e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,0.00729740160195274,0.00141834178780283,0.00451745169785919,0.0100773515060463,2.69583615544345e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAVS,Mitochondrial antiviral-signaling protein,28797,-0.0325506021369339,0.00632815552277695,-0.0449537869615767,-0.0201474173122911,2.71037331204675e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEPACAM2,HEPACAM family member 2,24845,0.0149867365024356,0.00291457347130408,0.00927417249867962,0.0206993005061916,2.73891481452793e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIF22,Kinesin-like protein KIF22,24111,-0.0438112739693396,0.00852327007800391,-0.0605168833222273,-0.0271056646164519,2.76595681106303e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRAP2,GRB2-related adapter protein 2,29478,-0.0452018594544548,0.00880126891307787,-0.0624523465240875,-0.0279513723848222,2.82681677869171e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DENR,Density-regulated protein,24229,-0.0204575807132169,0.00398672698812729,-0.0282715656099464,-0.0126435958164874,2.89780020436712e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPP,Lipoma-preferred partner,24111,-0.023664181589676,0.0046122582857155,-0.0327042078296784,-0.0146241553496736,2.9088161493751e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFDC12,WAP four-disulfide core domain protein 12,29662,-0.0224792185132499,0.0043877833223147,-0.0310792738249867,-0.0138791632015131,3.02373965989656e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,24922,-0.0210991705570547,0.00412453485165727,-0.029183258866303,-0.0130150822478065,3.15185045183278e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,-0.023054198976959,0.00451027208363711,-0.0318943322608877,-0.0142140656930303,3.22040633150669e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXNB3,Plexin-B3,29383,-0.0166028087579725,0.00325891924017674,-0.0229902904687189,-0.0102153270472261,3.51686172669576e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1F,V-type proton ATPase subunit F,28719,-0.0232372943955925,0.00456401895126379,-0.0321827715400695,-0.0142918172511155,3.57653323683183e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIRREL2,Kin of IRRE-like protein 2,28774,-0.0140149393456997,0.00275528806629763,-0.019415303955643,-0.00861457473575633,3.66904615107507e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,29628,-0.0070991067244512,0.00139643725194007,-0.00983612373825373,-0.00436208971064867,3.72349934174296e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,-0.0122406147349972,0.00241041567228081,-0.0169650294526676,-0.00751620001732682,3.83288442293005e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THPO,Thrombopoietin,28916,0.0134962881865233,0.00265949869740882,0.00828367073960197,0.0187089056334446,3.90410213799324e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,-0.0257695165571013,0.00508662561510181,-0.0357393027627009,-0.0157997303515017,4.08489957303885e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TST,Thiosulfate sulfurtransferase,28706,-0.0263801125479768,0.0052090647125761,-0.0365898793846259,-0.0161703457113276,4.12503733363688e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA4C,Semaphorin-4C,29349,-0.00982171553637271,0.00194079607749473,-0.0136256758482624,-0.00601775522448303,4.20321551578876e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,24922,-0.0248405306607021,0.0049129512727399,-0.0344699151552724,-0.0152111461661319,4.3087645449769e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNPY4,Protein canopy homolog 4,29349,-0.026077796739082,0.0051600736998081,-0.0361915411907059,-0.0159640522874581,4.3578618239518e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPNMB,Transmembrane glycoprotein NMB,28733,-0.00997158259020892,0.00197424020468627,-0.013841093391394,-0.00610207178902383,4.42549398183227e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TTR,Transthyretin,24707,-0.00888147063016473,0.00175884193574342,-0.0123288008242218,-0.00543414043610763,4.45854989504194e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,0.0073579497716902,0.00145736596150967,0.00450151248713125,0.0102143870562491,4.47813971764564e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL26,C-C motif chemokine 26,29434,-0.030951541116762,0.00613650964730057,-0.0429791000254711,-0.0189239822080529,4.59003525493972e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,-0.0339863980752638,0.00674892999730211,-0.0472143008699759,-0.0207584952805516,4.78639056994535e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,24240,-0.0320496236553788,0.00638329582298897,-0.0445608834684372,-0.0195383638423204,5.18058572368084e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC37,Hsp90 co-chaperone Cdc37,29566,-0.0288738748258548,0.00575295752524289,-0.0401496715753309,-0.0175980780763788,5.22528272829331e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMS,Spermine synthase,24101,-0.0223167727024768,0.00444877500093908,-0.0310363717043174,-0.0135971737006362,5.30266994457874e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,24445,-0.0235257015421886,0.00470063398291296,-0.032738944148698,-0.0143124589356791,5.6310343497616e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OTUD6B,Deubiquitinase OTUD6B,24805,-0.0202760017965204,0.00405315208339602,-0.0282201798799766,-0.0123318237130642,5.69702611811357e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NXPH1,Neurexophilin-1,28774,-0.0131529679978659,0.00263298489799601,-0.0183136183979381,-0.00799231759779369,5.9039625453708e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APCS,Serum amyloid P-component,24726,-0.0120058607965763,0.00240608180362453,-0.0167217811316804,-0.00728994046147225,6.0852806005367e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROCR,Endothelial protein C receptor,24111,0.0124124808484253,0.00248772646742418,0.00753653697227391,0.0172884247245767,6.09608327787539e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDK1,Cyclin-dependent kinase 1,24016,-0.012642944305491,0.00253744156839914,-0.0176163297795533,-0.00766955883142864,6.31858698835735e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PARD3,Partitioning defective 3 homolog,24445,-0.0256529887100195,0.00514914281672372,-0.035745308630798,-0.015560668789241,6.33623938566194e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,-0.0187476509820968,0.00376469246296349,-0.0261264482095053,-0.0113688537546884,6.40567626692475e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MICALL2,MICAL-like protein 2,24195,-0.0236300362251299,0.00474575065921268,-0.0329317075171868,-0.0143283649330731,6.42872038390023e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYM,Ketimine reductase mu-crystallin,24101,-0.026418588995271,0.00530623979319233,-0.036818818989928,-0.0160183590006141,6.44287659209866e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,28916,-0.0380545083995293,0.00765420163353148,-0.053056743601251,-0.0230522731978075,6.67427827112145e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,-0.0368990765072723,0.0074266999766125,-0.0514554084614328,-0.0223427445531118,6.79433235808104e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHNAK2,Protein AHNAK2,24240,-0.0102471901666872,0.00206432178310362,-0.0142932608615703,-0.00620111947180407,6.95423816884495e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX2,Sorting nexin-2,24793,-0.0279903981927088,0.00564330678264043,-0.039051279486684,-0.0169295168987336,7.09854226822831e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA1,Alpha-1-antitrypsin,24548,-0.00279846919483507,0.000564240925011741,-0.00390438140785808,-0.00169255698181206,7.10713074397704e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.0126378220090991,0.00255593078974858,0.00762819766119185,0.0176474463570063,7.68338101352948e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP10,Stromelysin-2,29439,-0.0201001170274015,0.00406747595261763,-0.028072369894532,-0.0121278641602709,7.78819311383608e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACYBP,Calcyclin-binding protein,24329,-0.0352142675085624,0.00714530340938843,-0.0492190621909638,-0.0212094728261611,8.3489407066358e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,29443,-0.0114886815478446,0.00233375389383538,-0.016062839179762,-0.00691452391592731,8.57612273481127e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLC,Galectin-10,29426,-0.0224277838455963,0.00457218166675114,-0.0313892599124286,-0.0134663077787641,9.37968558691689e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CERT,Ceramide transfer protein,28774,-0.0207397354107493,0.00422822940177515,-0.0290270650382286,-0.01245240578327,9.39064556663115e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPVL,Probable serine carboxypeptidase CPVL,29662,-0.0137454129317402,0.00280466954381675,-0.0192425652376211,-0.00824826062585939,9.59003990314888e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,-0.0137732264852839,0.00281158918461964,-0.0192839412871384,-0.00826251168342937,9.70784335795979e-07
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,-0.0289147143833477,0.00591661433393234,-0.0405112784778551,-0.0173181502888403,1.03002094573729e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,-0.0236394665989833,0.00484305467624145,-0.0331318537644165,-0.01414707943355,1.06162847274725e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKAP12,A-kinase anchor protein 12,24381,0.00729176350580144,0.00149680567160349,0.0043580243894586,0.0102255026221443,1.11420816006578e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,-0.0164855771444161,0.00338920722554065,-0.0231284233064758,-0.00984273098235642,1.15658626684164e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,24195,-0.0209175936314015,0.0043007284061164,-0.0293470213073896,-0.0124881659554133,1.15916133132457e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRK5,G protein-coupled receptor kinase 5,28916,-0.0174262653146771,0.00358700614820674,-0.0244567973651624,-0.0103957332641919,1.19098836968711e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CKB,Creatine kinase B-type,24938,0.0199043897543005,0.00410178126770953,0.0118648984695898,0.0279438810390112,1.22576504555744e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBC1D23,TBC1 domain family member 23,29349,-0.0299643438116804,0.00618104793055097,-0.0420791977555603,-0.0178494898678005,1.25490614067178e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACE,Angiotensin-converting enzyme,24951,-0.00880668885278088,0.00181955084449209,-0.0123730085079854,-0.00524036919757638,1.305926381093e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,29349,-0.0187284608334227,0.00388566563560049,-0.0263443654791996,-0.0111125561876457,1.44359174061948e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CST1,Cystatin-SN,21656,-0.0351656604526895,0.00731277366550562,-0.0494986968370805,-0.0208326240682985,1.52860067309336e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,-0.023919615264729,0.00497725523037414,-0.0336750355162623,-0.0141641950131957,1.54902292799705e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CIRBP,Cold-inducible RNA-binding protein,24805,-0.0319178493901163,0.00664823260020829,-0.0449483852865246,-0.0188873134937081,1.58833020370263e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,24922,-0.0356480790110908,0.00743568354699944,-0.0502220187632097,-0.0210741392589719,1.64275823751371e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,-0.0294080640999134,0.0061359578136461,-0.0414345414146598,-0.017381586785167,1.6546500651236e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC11A,C-type lectin domain family 11 member A,29388,-0.0158390649336536,0.0033122199449694,-0.0223310160257937,-0.00934711384151362,1.74392555625266e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATRN,"Attractin, Isoform 2",24966,-0.00550927979815777,0.00115230347536588,-0.00776779460987489,-0.00325076498644065,1.7533087888824e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VNN1,Pantetheinase,24951,-0.024099235105385,0.00505012462591788,-0.0339974793721841,-0.014200990838586,1.83430737310119e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,-0.0106565457975298,0.00223358036847257,-0.015034363319736,-0.00627872827532354,1.84299067012713e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBR1,TGF-beta receptor type-1,24229,-0.00718032604787224,0.00150706018656403,-0.0101341640135377,-0.00422648808220673,1.90458489648095e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,24845,-0.0126674865273075,0.00266222102314237,-0.0178854397326665,-0.00744953332194843,1.96386121105704e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,-0.0141312960400156,0.00297359896247245,-0.0199595500064616,-0.00830304207356964,2.02289208345625e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNNI3,"Troponin I, cardiac muscle",28916,-0.0276074846913837,0.00581279936358109,-0.0390005714440026,-0.0162143979387647,2.04968579221739e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,-0.0102268791266561,0.00215738054581035,-0.0144553449964444,-0.0059984132568678,2.14273756565292e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,-0.0209119160429136,0.00441773663611401,-0.029570679849697,-0.0122531522361301,2.21606314835869e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRTN,Neurturin,28931,-0.0160607505164822,0.00340634492130879,-0.0227371865622474,-0.00938431447071692,2.42894976817844e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GH1,Somatotropin,29433,0.0575856383644909,0.0122164917969951,0.0336413144423805,0.0815299622866014,2.44296932508519e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUC16,Mucin-16,29349,-0.0613546181455125,0.0130304310253033,-0.086894262955107,-0.0358149733359181,2.50607832948787e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDH12,Protocadherin-12,24867,-0.00835419088130767,0.00177430235642885,-0.0118318234999082,-0.00487655826270713,2.50969923667828e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYTL1,Cytokine-like protein 1,24938,-0.00788177367312546,0.00167401017557148,-0.0111628336172456,-0.00460071372900536,2.51111436497551e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDHD2,Phospholipase DDHD2,24867,-0.0216429946595321,0.00459722623119347,-0.0306535580726713,-0.0126324312463929,2.517081346328e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGA,Glycoprotein hormones alpha chain,29443,0.0258900169760736,0.0055193459894512,0.0150720988367492,0.0367079351153979,2.73392104020297e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP8,Caspase-8,29632,-0.0198302247694114,0.00423857753468156,-0.0281378367373873,-0.0115226128014355,2.90243737536816e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA11,Annexin A11,29373,-0.0214509185816171,0.00459617085254123,-0.0304594134525979,-0.0124424237106363,3.06786518727994e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,0.0195920847587513,0.00420323992475455,0.0113537345062324,0.0278304350112702,3.15769438258261e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSPB1,Heat shock protein beta-1,29039,-0.0220014599783653,0.00473323172421709,-0.0312785941578308,-0.0127243257988998,3.36159927692151e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,-0.0266418123338143,0.00576050588174514,-0.0379324038620348,-0.0153512208055938,3.7665652807262e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB33A,Ras-related protein Rab-33A,24111,-0.0212848227226193,0.00460919552864088,-0.0303188459587554,-0.0122507994864832,3.89636862246837e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FZD8,Frizzled-8,24101,-0.0141353321378548,0.00306384163858396,-0.0201404617494794,-0.00813020252623028,3.97795420036236e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP7,Caspase-7,24845,-0.0268282734660646,0.00582422449426067,-0.0382437534748156,-0.0154127934573137,4.11880568047111e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYZL2,Lysozyme-like protein 2,24016,-0.0115155173539408,0.00250492314557802,-0.0164251667192737,-0.00660586798860789,4.30483270846944e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTSH,Pro-cathepsin H,28852,-0.0232519524393368,0.00505878201928928,-0.0331671651971438,-0.0133367396815298,4.31769571096322e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMT,Catechol O-methyltransferase,28591,-0.0266378261168436,0.00581068952319577,-0.0380267775823073,-0.0152488746513799,4.57481989447029e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AK2,"Adenylate kinase 2, mitochondrial",24845,-0.0336573018429585,0.00735623250137815,-0.0480755175456597,-0.0192390861402573,4.77734672402163e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,29725,-0.0103598366738126,0.00226583058121014,-0.0148008646129844,-0.00591880873464068,4.84568365546724e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,-0.0351584092924433,0.00769357320559993,-0.0502378127754192,-0.0200790058094675,4.90066341121204e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,-0.00872400844772923,0.00190909850307625,-0.0124658415137587,-0.00498217538169977,4.90764865239644e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,-0.0330317975897963,0.00722909117910064,-0.0472008163008335,-0.018862778878759,4.91783806873948e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN4,Contactin-4,29443,0.00756908597260692,0.00165683483217848,0.0043216897015371,0.0108164822436768,4.93451862064983e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCN1,Transcobalamin-1,24546,-0.010855554429849,0.00237781049387442,-0.0155160629978429,-0.00619504586185516,5.01064540454764e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,-0.0104926493973141,0.0023012376458826,-0.015003075183244,-0.00598222361138419,5.15096814983356e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,-0.012844176821423,0.00282228126274295,-0.0183758480963992,-0.00731250554644683,5.36530864166054e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERP29,Endoplasmic reticulum resident protein 29,24381,-0.0374460935864425,0.0082543714528441,-0.0536246616340169,-0.021267525538868,5.74637209435909e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,-0.00863791772522835,0.00190489777535686,-0.0123715173649278,-0.00490431808552889,5.79500741192246e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.0123835317048688,0.00273104895523341,0.00703067575261134,0.0177363876571263,5.80087482388126e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TIMP2,Metalloproteinase inhibitor 2,24922,-0.00834692349731696,0.00184414028137198,-0.011961438448806,-0.00473240854582788,6.03352289156823e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.0432779263366179,0.00956330101935366,-0.0620219963345511,-0.0245338563386848,6.05548930669648e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC51B,Organic solute transporter subunit beta,24111,-0.0239092675545994,0.00530389318084965,-0.0343048981890647,-0.0135136369201341,6.57895012352113e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,0.0284343341696875,0.00631280891693451,0.0160612286924959,0.0408074396468792,6.68704210323451e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIFBP,KIF-binding protein,29349,-0.0255422257838335,0.00567441803488181,-0.0366640851322018,-0.0144203664354651,6.78004971325094e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.0175862511325708,0.00391779702178169,0.0099073689698787,0.0252651332952629,7.18941107027925e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00923280109095186,0.00205997014092945,-0.0132703425671736,-0.00519525961473014,7.42743122411351e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,-0.0273232027392351,0.00610322323130602,-0.0392855202725949,-0.0153608852058753,7.61024340727793e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RP2,Protein XRP2,29349,-0.0129094235983251,0.00288480860555675,-0.0185636484652163,-0.00725519873143386,7.67102918044573e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,24195,-0.0150110649560723,0.00335715690090142,-0.0215910924818391,-0.00843103743030556,7.80762517371792e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GZMB,Granzyme B,29434,-0.0200433126709605,0.00449219972912229,-0.0288480241400402,-0.0112386012018808,8.15738569263695e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,29454,-0.0906728249391539,0.020358302210396,-0.13057509727153,-0.0507705526067777,8.46542034213646e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,-0.0317190400567147,0.00713118056835305,-0.0456961539706867,-0.0177419261427428,8.70758615062732e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,28797,-0.0161504474703607,0.00363263102380077,-0.0232704042770102,-0.00903049066371119,8.78366728554524e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MASP1,Mannan-binding lectin serine protease 1,29163,-0.00718678833379948,0.00162342938199412,-0.010368709922508,-0.004004866745091,9.59360651360242e-06
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FBN2,Fibrillin-2,24195,-0.0185552791167696,0.00420086171775702,-0.0267889680835734,-0.0103215901499659,1.00506369453257e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP7,Dipeptidyl peptidase 2,29279,-0.0183239392835286,0.00415015652311663,-0.0264582460688372,-0.01018963249822,1.01258784714664e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCDHB15,Protocadherin beta-15,24793,-0.0122513405513065,0.00277878604373211,-0.0176977611970214,-0.00680491990559157,1.04342295670807e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMCN2,Hemicentin-2,24343,-0.01765098846833,0.00400649866747258,-0.0255037258565763,-0.00979825108008379,1.0594701116139e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,-0.0194054410361167,0.004413398129017,-0.02805570136899,-0.0107551807032434,1.10181801489501e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,29789,-0.0174332224983793,0.00396882001934421,-0.025212109736294,-0.00965433526046469,1.124174973928e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,28931,-0.0136814066849925,0.0031214625629589,-0.019799473308392,-0.00756334006159309,1.17462048175473e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,28774,-0.0438106136956063,0.0100002390463169,-0.0634110822263874,-0.0242101451648253,1.18576996208224e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLKB1,Plasma kallikrein,24454,0.0076321477101157,0.00174326007248499,0.00421535796804512,0.0110489374521863,1.20221284655711e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL36G,Interleukin-36 gamma,24149,-0.0206822740833864,0.00472746305743318,-0.0299481016759554,-0.0114164464908173,1.21985907149247e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLH1,Glutamate carboxypeptidase 2,24229,-0.0322250402870217,0.00736837342290567,-0.0466670521959168,-0.0177830283781266,1.22821570507618e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.0145572887451193,0.00332996387957037,-0.0210840179490772,-0.00803055954116137,1.23758838026729e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,29820,-0.00684978699260143,0.00156781685347436,-0.00992270802541116,-0.00377686595979169,1.25239754367301e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS5,Transmembrane protease serine 5,29079,0.0114351323475405,0.00262437125272848,0.00629136469219264,0.0165789000028883,1.32137104615424e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARTN,Artemin,28931,-0.0134246851664986,0.0030843379278107,-0.0194699875050076,-0.0073793828279896,1.35034517562265e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C2orf69,UPF0565 protein C2orf69,24195,-0.0179727378337353,0.00413878529518921,-0.0260847570123061,-0.0098607186551644,1.41433422157955e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,24938,0.00994227224025995,0.00229002351941099,0.00545382614221441,0.0144307183383055,1.42032780508102e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL28,C-C motif chemokine 28,29327,-0.0176711764528212,0.00408319916926799,-0.0256742468245865,-0.00966810608105598,1.51120167320525e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMARCA2,Probable global transcription activator SNF2L2,28774,-0.0217268235014677,0.00504767677375226,-0.0316202699780221,-0.0118333770249132,1.68051706052031e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP10,Inactive dipeptidyl peptidase 10,29434,-0.0104552478627913,0.00242974255787273,-0.0152175432762219,-0.00569295244936077,1.69023821179154e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX3,Syntaxin-3,24845,-0.0114537745702401,0.00266266204526544,-0.0166725921789604,-0.00623495696151989,1.70197204937142e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STXBP3,Syntaxin-binding protein 3,28797,-0.0129817727590801,0.00302454272401242,-0.0189098764981444,-0.00705366902001572,1.77534064870096e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFCAB2,Dynein regulatory complex protein 8,24445,-0.0104161313432508,0.00243046819638313,-0.0151798490081617,-0.00565241367833984,1.82904399419571e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL3,C-X-C motif chemokine 3,29453,-0.0275806946228632,0.00647762644187936,-0.0402768424489467,-0.0148845467967796,2.07051121721686e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,-0.0146313542096429,0.00343842830039366,-0.0213706736784144,-0.00789203474087129,2.09604574822384e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,-0.0140489343129743,0.00330170225783251,-0.020520270738326,-0.00757759788762255,2.09657028827275e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,-0.0140658920868511,0.00331156559475711,-0.0205565606525751,-0.00757522352112718,2.16950616740321e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX6,Peroxiredoxin-6,29725,0.0174823946771193,0.00412013930256388,0.00940692164409408,0.0255578677101445,2.21065310325697e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNU13,NHP2-like protein 1,24111,-0.0183834347356649,0.00434122421876074,-0.0268922342044359,-0.0098746352668938,2.29787014858352e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACHE,Acetylcholinesterase,24381,-0.00969835836129258,0.00229553525120734,-0.014197607453659,-0.00519910926892619,2.39937867831553e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MESD,LRP chaperone MESD,29443,-0.0352305662937209,0.00834161067701076,-0.051580123220662,-0.0188810093667798,2.41288906780787e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,-0.0275627361950039,0.00653081814548678,-0.040363139760158,-0.0147623326298498,2.44587230920774e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCHE,Cholinesterase,24528,-0.00821690596666571,0.00194800034605487,-0.0120349866449333,-0.00439882528839815,2.47228101715693e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESM1,Endothelial cell-specific molecule 1,29454,0.00993673596183282,0.00236085228284146,0.00530946548746355,0.0145640064362021,2.57307521314852e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,-0.0178137839883811,0.00424364590709048,-0.0261313299662784,-0.00949623801048374,2.70537528401961e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,-0.00833765576181559,0.00198675281196557,-0.0122316912732681,-0.00444362025036308,2.71865854736928e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,28797,-0.0217043763292653,0.0052146939309135,-0.0319251764338558,-0.0114835762246748,3.16170814326847e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCRN1,Secernin-1,29434,-0.0159537465725407,0.00384438694982484,-0.0234887449941974,-0.00841874815088403,3.33583598807464e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BDNF,Brain-derived neurotrophic factor,24938,-0.0238359897354444,0.00576029311056144,-0.0351261642321449,-0.012545815238744,3.51523468592843e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,24111,-0.0285368670747402,0.0068998305310033,-0.0420605349155067,-0.0150131992339737,3.54795735962106e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSHB,Thyrotropin subunit beta,29478,-0.0218961922308714,0.00530190065723144,-0.032287917519045,-0.0115044669426978,3.6395882457915e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSBP1,Heat shock factor-binding protein 1,24240,-0.0273308173297441,0.00663886261616447,-0.0403429880574264,-0.0143186466020617,3.85454291714251e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB37,Ras-related protein Rab-37,28931,-0.0231520527936967,0.00566447194235836,-0.0342544178007191,-0.0120496877866743,4.37714587778567e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,-0.0162816065240966,0.00398768979330262,-0.0240974785189697,-0.00846573452922344,4.46083140460155e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXNL1,Thioredoxin-like protein 1,24069,-0.0278789986619545,0.00683052084304558,-0.0412668195143239,-0.0144911778095852,4.48839424469336e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,28931,-0.0184111699743213,0.00451811551542558,-0.0272666763845555,-0.0095556635640872,4.61437187366023e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53BP1,TP53-binding protein 1,24229,-0.0247501477343783,0.00607424445940523,-0.0366556668748126,-0.0128446285939441,4.62393040662653e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRR4,Proline-rich protein 4,24203,-0.0197044426409978,0.00484814232889746,-0.0292068016056368,-0.0102020836763588,4.83230991830664e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,-0.0274738448225624,0.0067673747964027,-0.0407378994235117,-0.0142097902216131,4.92759338674445e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,-0.022805651688754,0.0056267310617415,-0.0338340445697673,-0.0117772588077407,5.06752375055794e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSF2RB,Cytokine receptor common subunit beta,24229,-0.0122149016491018,0.00301725195521543,-0.018128715481324,-0.00630108781687954,5.17395813420465e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAA4,Serum amyloid A-4 protein,24966,-0.00918199412141539,0.00227147743268632,-0.0136340898894806,-0.00472989835335021,5.30881074684358e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPSD1,Tryptase delta,24867,-0.0104875704339352,0.00259866399439404,-0.0155809518629475,-0.00539418900492288,5.45899399485909e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRADD,Death domain-containing protein CRADD,29163,-0.0210013011229432,0.00520731235684404,-0.0312076333423575,-0.0107949689035289,5.51999192127179e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,24445,-0.0163238676030687,0.00404923351010368,-0.0242603652828719,-0.00838736992326552,5.56261015551701e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,-0.0277711131172205,0.00689823328773427,-0.0412916503611797,-0.0142505758732614,5.69430737229275e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMTN,Smoothelin,24776,-0.0263349347116391,0.00655221965132081,-0.0391772852282279,-0.0134925841950503,5.85591658234416e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA7,Carbonic anhydrase 7,24445,0.00959061115547452,0.00239106597799798,0.00490412183859849,0.0142771004723506,6.06370501448383e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL12,Stromal cell-derived factor 1,28931,-0.0110317047214707,0.00275884107259073,-0.0164390332237485,-0.00562437621919285,6.38566553984579e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHIT1,Chitotriosidase-1,29579,-0.0420048305342342,0.0105061952757323,-0.0625969732746696,-0.0214126877937988,6.4007688491736e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBPMS,RNA-binding protein with multiple splicing,24229,-0.0178863321439852,0.0044756376161899,-0.0266585818717174,-0.00911408241625304,6.45098173684425e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RALB,Ras-related protein Ral-B,24229,-0.00820315895672048,0.00205410979161689,-0.0122292141482896,-0.00417710376515137,6.52876491325171e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDRG1,Protein NDRG1,28774,-0.0185201816922203,0.00464951993719885,-0.02763324076913,-0.00940712261531054,6.8147590598264e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,24229,-0.0180992394685587,0.00455960126197694,-0.0270360579420335,-0.00916242099508385,7.22378760872803e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SATB1,DNA-binding protein SATB1,24867,-0.00817787627832488,0.002062125072795,-0.0122196414210031,-0.00413611113564667,7.33698682775403e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,-0.015094957542177,0.00380963817707055,-0.0225618483692353,-0.00762806671511873,7.44362727172699e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTX3,Pentraxin-related protein PTX3,29434,-0.0134776568520284,0.00340464757990053,-0.0201507661086335,-0.00680454759542337,7.55657407279903e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,28797,-0.0128237885935934,0.0032417801250043,-0.0191776776386018,-0.00646989954858497,7.64661097286724e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDHR1,Cadherin-related family member 1,28774,-0.0116493932707301,0.00294834391815254,-0.0174281473503091,-0.00587063919115113,7.79572735172643e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VASN,Vasorin,29065,0.00750034313165877,0.00189861283752337,0.00377906197011298,0.0112216242932046,7.81940422095639e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G1B,Phospholipase A2,29787,-0.0117361922106859,0.00297139651596386,-0.0175601293819751,-0.00591225503939673,7.84218971411475e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL6ST,Interleukin-6 receptor subunit beta,29478,-0.00479842917271056,0.00121499958020082,-0.00717982834990417,-0.00241702999551695,7.85538548309633e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NINJ1,Ninjurin-1,28797,-0.0150738684107704,0.00382366596407508,-0.0225682537003575,-0.00757948312118324,8.09097328558865e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,24111,-0.0152262830124972,0.00386534860182977,-0.0228023662720836,-0.00765019975291087,8.19926604951321e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00651770700329812,0.00165504271370053,-0.00976159072215116,-0.00327382328444509,8.23568346088029e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOSB,Protein fosB,28774,-0.0104869291283379,0.00267090985934795,-0.0157219124526599,-0.00525194580401592,8.64453017555484e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,28916,-0.0167252666162995,0.00426445609996253,-0.0250836005722261,-0.00836693266037298,8.80137850493293e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,-0.0217791860501448,0.00555676790724717,-0.0326704511483493,-0.0108879209519404,8.90144210621867e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,-0.00703724646915445,0.00179595783147263,-0.0105573238188408,-0.0035171691194681,8.93834616230037e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,-0.00525577347649653,0.00134186715661107,-0.00788583310345423,-0.00262571384953884,8.99494923394267e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBC1D5,TBC1 domain family member 5,29434,-0.0209847512628791,0.00537574163654432,-0.031521204870506,-0.0104482976552522,9.49830984547297e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCGB2A2,Mammaglobin-A,24111,0.00854863542840567,0.00219209046321884,0.00425213812049675,0.0128451327363146,9.65475341488227e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EGF,Pro-epidermal growth factor,29379,-0.0277219833585876,0.0071168495070407,-0.0416710083923874,-0.0137729583247879,9.831044688066e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,-0.0161206498420015,0.00413840839504138,-0.0242319302962826,-0.00800936938772043,9.83105696274633e-05
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,24805,-0.00702883929503225,0.00180877032133563,-0.0105740291248501,-0.00348364946521441,0.000102184277128579
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,24793,-0.0141415732293862,0.00363933506819794,-0.0212746699630542,-0.00700847649571823,0.000102276633465659
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBN1,Drebrin,24229,-0.0138273364154828,0.00356256124527007,-0.0208099564562121,-0.00684471637475342,0.000104178802470395
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,-0.031046315537905,0.00800982301166951,-0.0467455686407773,-0.0153470624350328,0.000106405542798889
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPK13,Mitogen-activated protein kinase 13,24016,-0.0113842759388432,0.00294042526217617,-0.0171475094527085,-0.00562104242497791,0.00010839064120781
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.0233413482533082,0.00603358932885973,-0.0351671833378733,-0.0115155131687432,0.000109756567958474
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,24177,-0.0157067799733354,0.00406061918215198,-0.0236655935703533,-0.00774796637631752,0.000109985452992605
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,-0.00606942232261922,0.00157015418983743,-0.00914692453470057,-0.00299192011053786,0.000111101810886339
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRNN,Cornulin,28580,0.0177939937404174,0.00460589512155617,0.00876643930216736,0.0268215481786675,0.000112108454487842
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTN2,Dynactin subunit 2,29349,-0.0250852117430013,0.00649866057233738,-0.0378225864647826,-0.01234783702122,0.000113602587548783
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,29349,-0.00556497792587061,0.00144601772602614,-0.00839917266888184,-0.00273078318285939,0.000119102162827747
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAD51,DNA repair protein RAD51 homolog 1,24445,-0.014300243339368,0.00371602983371894,-0.0215836618134571,-0.00701682486527885,0.000119263005400121
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,28797,-0.0108496803313605,0.00282180060404637,-0.0163804095152914,-0.00531895114742965,0.000120836734154626
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,-0.0251576686785537,0.0065477525073639,-0.037991263592987,-0.0123240737641205,0.000122248375921918
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDLIM5,PDZ and LIM domain protein 5,24867,-0.0314496553495265,0.00821400129899748,-0.0475490978955615,-0.0153502128034914,0.000129092585565459
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN2,Ataxin-2,24101,-0.0295189183984949,0.00771737372099417,-0.0446449708916435,-0.0143928659053463,0.000131104244458337
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNMA1,Paraneoplastic antigen Ma1,24240,-0.0149828039556756,0.0039184122907873,-0.0226628920456187,-0.0073027158657325,0.000131796921541068
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,-0.00973646334671893,0.00254706668089865,-0.0147287140412803,-0.00474421265215759,0.000132364303768718
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHCY,Adenosylhomocysteinase,29478,-0.0177692440376331,0.0046540038277704,-0.0268910915400631,-0.00864739653520314,0.000134783043445659
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPS10,40S ribosomal protein S10,24111,0.0111156713463189,0.00291201667952222,0.00540811865445534,0.0168232240381824,0.00013532708374
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUCA1,Tissue alpha-L-fucosidase,29623,-0.0216367298327773,0.00567113534579896,-0.0327521551105432,-0.0105213045550113,0.000136328157874516
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F12,Coagulation factor XII,24966,-0.0109874371019967,0.00288219643886533,-0.0166365421221728,-0.00533833208182069,0.000138080304532062
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA4,Carbonic anhydrase 4,29820,-0.0062429969694109,0.00163926151985528,-0.00945594954832724,-0.00303004439049456,0.0001401376181359
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTF4,Neurotrophin-4,28797,-0.0103755683523313,0.00272660713496534,-0.0157197183368634,-0.00503141836779925,0.000141923266338517
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED8,Protein TMED8,24805,-0.0271615439223716,0.00713824210647219,-0.0411524984510571,-0.0131705893936861,0.000142101891014769
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SULT1A1,Sulfotransferase 1A1,29694,0.0336023563547893,0.00884025450627361,0.016275457522493,0.0509292551870856,0.000144365012062258
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA5,Protein disulfide-isomerase A5,24016,-0.0161718889251235,0.00426749096580135,-0.0245361712180942,-0.00780760663215289,0.000151286434449001
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JPT2,Jupiter microtubule associated homolog 2,24805,-0.0230227776649694,0.00608450999914517,-0.0349484172632939,-0.0110971380666449,0.000154793788340956
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD177,CD177 antigen,29413,-0.0332419178131452,0.00881553702983332,-0.0505203703916185,-0.0159634652346719,0.000163021967771367
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTD,Biotinidase,24966,-0.00540328672804672,0.00143529820834303,-0.00821647121639906,-0.00259010223969439,0.000167215412810811
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSRP3,Cysteine and glycine-rich protein 3,24111,-0.0257233401311315,0.00684153641634569,-0.039132751507169,-0.0123139287550939,0.000170397988918695
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,-0.0117380386555978,0.00312324958247961,-0.0178596078372578,-0.00561646947393773,0.000171479429066007
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COPB2,Coatomer subunit beta',24111,-0.0112054406027156,0.00298542037426208,-0.0170568645362693,-0.0053540166691619,0.000174870007163913
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,-0.0102591043097932,0.00273515264817954,-0.0156200035002251,-0.00489820511936132,0.000176659711380232
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,-0.0191047139693047,0.00511324477497556,-0.0291266737282568,-0.00908275421035263,0.000187158567626121
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA11,Serpin A11,29820,-0.0105336615438427,0.00282360527921327,-0.0160679278911007,-0.00499939519658471,0.000191400060118635
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,-0.0225674983239436,0.00604919945431134,-0.0344239292543938,-0.0107110673934933,0.000191411889930804
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPMT,Thiopurine S-methyltransferase,28797,-0.0187363192922947,0.00502646631938911,-0.0285881932782974,-0.00888444530629208,0.000193733315490739
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTB,Lymphotoxin-beta,24793,-0.00903504755080957,0.00242414315195092,-0.0137863681286334,-0.00428372697298576,0.000194118626304856
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX5,Sorting nexin-5,24240,-0.00771273156075855,0.00207128364330492,-0.0117724475016362,-0.0036530156198809,0.000196809371229999
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,-0.0148887244263276,0.00399990087173643,-0.022728530134931,-0.00704891871772423,0.000197813005027846
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,-0.0181709121723767,0.00490118489711079,-0.0277772345707138,-0.00856458977403955,0.000209816986362556
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,24764,-0.0180487094976767,0.00487486160298733,-0.0276034382395319,-0.00849398075582154,0.000214029257658767
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKG1,cGMP-dependent protein kinase 1,24381,-0.0322263935509354,0.00871858619381447,-0.0493148224908118,-0.0151379646110591,0.000219255246218883
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRG3,Proteoglycan 3,24938,0.0127929906060944,0.00346175801923655,0.00600794488839076,0.019578036323798,0.000219908162331177
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX1B,Syntaxin-1B,24195,-0.010687844137998,0.00289463408638972,-0.0163613269473219,-0.00501436132867418,0.00022272773647983
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFAP,Glial fibrillary acidic protein,28753,0.0117874870370514,0.00319449777941764,0.00552627138939285,0.01804870268471,0.000224725867448503
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDZD2,PDZ domain-containing protein 2,24111,-0.01534630763451,0.00417494899587488,-0.0235292076664248,-0.00716340760259526,0.000237612924722223
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD69,Early activation antigen CD69,29344,-0.0221948613869914,0.0060397984576433,-0.0340328663639722,-0.0103568564100105,0.000238488969763188
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP45,Rho GTPase-activating protein 45,24381,-0.0210504291825683,0.00573393420718218,-0.0322889402286453,-0.00981191813649119,0.000241928215255135
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD40LG,CD40 ligand,29786,-0.019632645507452,0.00535118088276612,-0.0301209600376736,-0.00914433097723045,0.000244074868872699
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RHOC,Rho-related GTP-binding protein RhoC,29089,-0.0294163790742922,0.00802468990274807,-0.0451447712836784,-0.013687986864906,0.000247068990898247
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PER3,Period circadian protein homolog 3,24229,-0.0304271084019707,0.00833177604452835,-0.0467573894492462,-0.0140968273546951,0.000260819648369853
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNX18,Sorting nexin-18,24805,-0.0113142091690439,0.00309921442542535,-0.0173886694428776,-0.0052397488952102,0.000262094651883193
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,0.0159705110818494,0.00438119929842874,0.00738336045692911,0.0245576617067698,0.000267704940472117
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATXN10,Ataxin-10,28774,-0.0182336667933697,0.00501343229728712,-0.0280599940960525,-0.00840733949068698,0.000276353578356286
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPA4,Carboxypeptidase A4,23902,-0.0110619391279343,0.003052338612854,-0.0170445228091282,-0.00507935544674049,0.000290586355251656
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENDOU,Poly(U)-specific endoribonuclease,23037,-0.0133860078011124,0.00370146195701522,-0.0206408732368622,-0.00613114236536253,0.000299354067965782
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWF,von Willebrand factor,29820,-0.0180318460596879,0.00500178570971797,-0.0278353460507351,-0.00822834606864072,0.000312563583003608
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDNRB,Endothelin receptor type B,24229,-0.0114080715286704,0.00317626516207204,-0.0176335512463316,-0.00518259181100919,0.000329225969385741
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSTN,Growth/differentiation factor 8,28916,-0.0130193017516749,0.00362781507264924,-0.0201298192940674,-0.00590878420928236,0.000332823482693369
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EFNB2,Ephrin-B2,24195,-0.014373411868725,0.00401631025621807,-0.0222453799709124,-0.00650144376653758,0.000345903027154084
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RLN1,Prorelaxin H1,24867,-0.017107708804319,0.00478476327560097,-0.0264858448244969,-0.00772957278414113,0.000350281424851833
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GMFG,Glia maturation factor gamma,24922,-0.017785268325263,0.00497558688386528,-0.027537418617639,-0.00803311803288707,0.000351552154758264
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALM3,Paralemmin-3,24111,-0.0183092038019873,0.00512776391352085,-0.0283596210724882,-0.00825878653148644,0.000356854837783294
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP2,Caspase-2,29434,-0.016642809228135,0.00467172617748961,-0.0257993925360146,-0.00748622592025538,0.00036798492910406
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPHS1,Nephrin,24229,0.00842348702583865,0.00236655649982315,0.00378503628618527,0.013061937765492,0.00037243484284814
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA3,Alpha-1-antichymotrypsin,24883,-0.00365724570771976,0.00102795495323937,-0.00567203741606891,-0.0016424539993706,0.000374686788696758
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPQ,Carboxypeptidase Q,24920,-0.00908297091351136,0.00255663488663669,-0.0140939752913193,-0.00407196653570344,0.000381995477765086
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,-0.0214024396179649,0.00604110691701557,-0.0332430091753154,-0.00956187006061434,0.000396645858356876
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINA6,Corticosteroid-binding globulin,24966,0.00412974154302258,0.00116909168326244,0.0018383218438282,0.00642116124221696,0.000412493150634961
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,-0.00836565033776164,0.0023692434449796,-0.0130093674899217,-0.00372193318560163,0.000414724643016418
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOP56,Nucleolar protein 56,24111,-0.0271837546808015,0.00770898925965614,-0.0422933736297275,-0.0120741357318755,0.000422285809203003
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NAA10,N-alpha-acetyltransferase 10,24111,-0.0124112982093578,0.00353290413329405,-0.0193357903106142,-0.00548680610810151,0.000443791448439782
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.0119244012274448,0.00340646489416186,-0.0186010724200021,-0.00524773003488757,0.000465186130475397
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BOC,Brother of CDO,28916,0.00564290591133384,0.00161722190703066,0.00247315097355374,0.00881266084911394,0.000485082720606269
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,-0.00774306005505831,0.00222254343959507,-0.0120992451966647,-0.00338687491345197,0.000494947510574797
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HRG,Histidine-rich glycoprotein,24833,-0.00758101112981987,0.00217770200802031,-0.0118493070655397,-0.00331271519410006,0.000500034809867855
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,-0.00931277460108468,0.00267900149409722,-0.0145636175295152,-0.00406193167265414,0.0005094428856961
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPESP1,Sperm equatorial segment protein 1,24922,-0.00730803877714172,0.00210716524695189,-0.0114380826611674,-0.00317799489311602,0.00052487135297317
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLNS1A,Methylosome subunit pICln,24195,-0.00808033120422528,0.0023308673849942,-0.0126488312788139,-0.00351183112963665,0.000527877655800357
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,29674,-0.0159377987512204,0.0046021444315504,-0.0249580018370592,-0.00691759566538167,0.000534694432581329
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,24845,-0.0112071934563074,0.00323628616827126,-0.017550314346119,-0.00486407256649569,0.000535128455690634
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,-0.0102886657922027,0.00297237717405891,-0.0161145250533582,-0.00446280653104724,0.000538096183490464
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STXBP1,Syntaxin-binding protein 1,24867,-0.018625673501719,0.00538284083648052,-0.0291760415412208,-0.00807530546221716,0.000540692056411334
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP2,"Fatty acid-binding protein, intestinal",29478,0.0187102264668691,0.0054081447927743,0.00811026267303149,0.0293101902607067,0.000541665836391259
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPR1,Atrial natriuretic peptide receptor 1,24111,0.00989663564284212,0.00286724792897882,0.00427682970204363,0.0155164415836406,0.000558197907731863
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,-0.0276296536565393,0.00802407774121121,-0.0433568460293132,-0.0119024612837653,0.000575516307474207
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,28797,-0.0137332099360976,0.00399121435475458,-0.0215559900714166,-0.0059104298007786,0.000580691105769358
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,-0.00909576235210254,0.00264434177709826,-0.0142786722352151,-0.00391285246898995,0.000583325388989399
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPB41L5,Band 4.1-like protein 5,24195,-0.015014576022861,0.00437327619543407,-0.0235861973659117,-0.00644295467981019,0.000597378035678869
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,-0.0064628676206972,0.00188266003639039,-0.0101528812920224,-0.00277285394937203,0.000598134664390313
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,-0.0054787011981504,0.0015960463596763,-0.00860695206311594,-0.00235045033318485,0.000598479632362931
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,-0.018070054291882,0.00526580355985504,-0.0283910292691978,-0.00774907931456607,0.000600907127618269
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,-0.0133231099942026,0.00388622351812076,-0.0209401080897193,-0.00570611189868596,0.00060837663988532
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STX5,Syntaxin-5,24229,-0.00969824375953116,0.00283822200395427,-0.0152611588872815,-0.00413532863178078,0.000634161188840276
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,-0.010395424437089,0.00305463677719872,-0.0163825125203985,-0.0044083363537795,0.000667185511602567
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CABP2,Calcium-binding protein 2,24195,-0.0154261959866293,0.00453658031895045,-0.0243178934117722,-0.00653449856148639,0.000673956420258726
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,29169,-0.00787051424112877,0.00231600413624921,-0.0124098823481772,-0.00333114613408031,0.000678926903258789
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VIT,Vitrin,24922,-0.00886912697948786,0.00261166996595212,-0.013988000112754,-0.0037502538462217,0.000684951102736251
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCND2,G1/S-specific cyclin-D2,24445,0.00870656059883459,0.00256395126656366,0.00368121611636983,0.0137319050812994,0.00068547511387753
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMOD1,Leiomodin-1,24867,-0.00835737963539936,0.00246487402767069,-0.0131885327296339,-0.0035262265411648,0.000698505980996952
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP3,Caspase-3,29820,-0.0205383025599137,0.00605983210406207,-0.0324155734838753,-0.00866103163595203,0.000701741508725676
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,-0.00660777058891479,0.00195184264919539,-0.0104333821813378,-0.00278215899649182,0.000711870584848822
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,-0.0228467408355141,0.00677991249854444,-0.0361353693326612,-0.00955811233836701,0.000753299084770739
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPEP2,Dipeptidase 2,29349,-0.00679598728349536,0.00202066428158791,-0.0107564892754077,-0.00283548529158306,0.000771307205876337
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NELL2,Protein kinase C-binding protein NELL2,29581,-0.00662129637514777,0.00196953176301576,-0.0104815786306587,-0.00276101411963688,0.000775165440723388
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,-0.0125376065116738,0.00373581423032779,-0.0198598024031162,-0.00521541062023132,0.000791838927284568
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,0.00674015113069349,0.00201127880691132,0.00279804466914731,0.0106822575922397,0.000805925500824986
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.00558726048094508,0.00167212419775739,0.00230989705334059,0.00886462390854957,0.000834563225161497
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,-0.00627237299353675,0.00187796194322086,-0.00995317840224963,-0.00259156758482387,0.000838843556695523
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACRV1,Acrosomal protein SP-10,24229,-0.0178212107328973,0.00533622322647939,-0.0282802082567969,-0.00736221320899767,0.000840053923725164
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",24195,-0.00900266628234498,0.00270851684940057,-0.0143113593071701,-0.00369397325751985,0.000889202036802203
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLHL41,Kelch-like protein 41,24867,-0.0114815827760126,0.00345529707365173,-0.01825396504037,-0.00470920051165523,0.000892176489030842
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTT2B,Glutathione S-transferase theta-2B,24845,-0.0551448712922972,0.0166132964863126,-0.0877069324054698,-0.0225828101791246,0.00090366343186845
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,-0.0193573170703417,0.0058374890884634,-0.03079879568373,-0.00791583845695346,0.000914388795140769
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,-0.0112236467149063,0.00340096820558739,-0.0178895443978575,-0.00455774903195498,0.00096778662393988
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AFP,Alpha-fetoprotein,29132,0.0154228242131231,0.00468316681552269,0.00624381725469863,0.0246018311715476,0.000991555207802699
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFRA3,GDNF family receptor alpha-3,29157,-0.00638755024615855,0.00194101210334167,-0.0101919339687082,-0.00258316652360888,0.00100009163882594
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GTPBP2,GTP-binding protein 2,24195,-0.0184693755930144,0.00561226409174613,-0.0294694132128368,-0.00746933797319198,0.00100011895909933
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TTN,Titin,24111,-0.0152926255197766,0.00466345946035617,-0.0244330060620747,-0.00615224497747855,0.00104232833171319
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,-0.013533596515349,0.00413154804940495,-0.0216314306921827,-0.00543576233851532,0.0010555971678738
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,24229,-0.0131181847662672,0.00401571125809069,-0.0209889788321249,-0.00524739070040946,0.00108954435317104
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOA4,Apolipoprotein A-IV,24966,0.00806469623294473,0.00248100917990649,0.00320191824032801,0.0129274742255614,0.00115326189208153
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF5,Eukaryotic translation initiation factor 5,24111,-0.00993968858011919,0.00305879423012118,-0.0159349252711567,-0.00394445188908167,0.00115748355782569
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VASP,Vasodilator-stimulated phosphoprotein,24951,-0.0163578070554148,0.00504029182766599,-0.0262367790376401,-0.00647883507318942,0.00117436775765459
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC12A2,Solute carrier family 12 member 2,24111,0.00618547448811892,0.00191452251630858,0.0024330103561541,0.00993793862008373,0.00123601984896873
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DYNLT3,Dynein light chain Tctex-type 3,24793,-0.009761834345714,0.00302664936031393,-0.0156940670919293,-0.0038296015994987,0.00126006491330866
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,24805,-0.0124440965944972,0.00385850221941257,-0.0200067609445458,-0.00488143224444851,0.00126087155525377
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRP2,Neuropilin-2,29443,-0.00634440747861926,0.00197263865186026,-0.0102107792362654,-0.00247803572097315,0.00130038993475136
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,0.00714076876926198,0.0022248824052497,0.00277999925497257,0.0115015382835514,0.00133138420291275
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,0.0130615103637026,0.00407179306937775,0.00508079594772217,0.0210422247796829,0.00133927843156218
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL2L1,Bcl-2-like protein 1,24845,-0.0220228513488836,0.00690927512031319,-0.0355650305846974,-0.00848067211306971,0.00143719541103166
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,-0.0148419769018156,0.00465941665152711,-0.0239744335388087,-0.00570952026482244,0.00144721999174668
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TF,Serotransferrin,24966,-0.00477426966252717,0.00149919992891992,-0.00771270152321022,-0.00183583780184412,0.00145159894776743
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REXO2,"Oligoribonuclease, mitochondrial",24111,0.0105635273224628,0.00332106931281625,0.00405423146934298,0.0170728231755827,0.00147074890176317
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGT,Angiotensinogen,24951,-0.00509290322338254,0.00160478350619633,-0.00823827889552734,-0.00194752755123774,0.00150755995427771
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VGF,Neurosecretory protein VGF,24867,-0.0066867123559539,0.00210757914315503,-0.0108175674765378,-0.00255585723537005,0.00151213247049083
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPM1F,Protein phosphatase 1F,24922,-0.011582566699903,0.00365621178944146,-0.0187487418072082,-0.00441639159259771,0.00153721987072525
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",24195,-0.0185842861456004,0.00586679864574123,-0.0300832114912532,-0.00708536079994757,0.00153838492906107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCP2,Non-specific lipid-transfer protein,28797,-0.0166686091313961,0.00526413513077486,-0.0269863139877148,-0.0063509042750774,0.00154473980722129
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,-0.0146529544439254,0.00464176922676429,-0.0237508221283834,-0.00555508675946735,0.00159723352574901
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCNE1,G1/S-specific cyclin-E1,24229,-0.0202975818341257,0.00643001075929,-0.0329004029223341,-0.00769476074591727,0.00159763836728701
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEB,Nebulin,24111,-0.00828601736414841,0.00263288789043602,-0.013446477629403,-0.00312555709889381,0.00165087435879836
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LACRT,Extracellular glycoprotein lacritin,24732,-0.0108435619183433,0.00345575057686292,-0.0176168330489946,-0.00407029078769198,0.00170402805717194
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP30,Rho GTPase-activating protein 30,24445,-0.00844823979138331,0.002698566951946,-0.0137374310171975,-0.00315904856556914,0.00174631804207921
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRIM26,Tripartite motif-containing protein 26,24016,-0.012169955465612,0.00389629507347883,-0.0198066938096305,-0.00453321712159347,0.00178945514011142
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLASP1,CLIP-associating protein 1,24016,-0.0158527668095419,0.00507608369205558,-0.0258018908459708,-0.00590364277311295,0.00179211692402811
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.00614686769368156,0.00197225173317135,0.00228125429666572,0.0100124810906974,0.00183077069390931
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBX2,Chromobox protein homolog 2,24111,0.00871439170673766,0.00279852055086809,0.00322929142703621,0.0141994919864391,0.00184830777100385
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD109,CD109 antigen,29443,-0.00721194371841154,0.00232326606886039,-0.0117655452133779,-0.00265834222344519,0.00190958243243102
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,-0.00478453805183965,0.0015414020551726,-0.00780568607997794,-0.00176339002370136,0.00191096063596151
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,0.00678820555881634,0.00218888506103682,0.00249799083918417,0.0110784202784485,0.00192950021106333
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCIN,Adseverin,24101,-0.0158471526212759,0.00511627848747771,-0.0258750584567322,-0.00581924678581959,0.00195451718264204
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,-0.0165804032500444,0.00535874449201254,-0.0270835424543889,-0.00607726404569978,0.00197646598519709
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RABEPK,Rab9 effector protein with kelch motifs,28797,-0.0124940676874734,0.00407189956370864,-0.0204749908323423,-0.00451314454260444,0.00215434675939756
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTNAP4,Contactin-associated protein-like 4,24195,-0.0219674770081493,0.00717187031661731,-0.0360243428287193,-0.00791061118757943,0.00219366974945526
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM171B,Protein FAM171B,24793,-0.00574889365133581,0.00188504630711704,-0.00944358441328522,-0.00205420288938641,0.0022928434168855
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX1,ATP-dependent RNA helicase DDX1,24805,-0.0105722555118163,0.00347881144797856,-0.0173907259498543,-0.00375378507377835,0.00237578641482469
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,-0.00623905865067599,0.00206260104789051,-0.0102817567045414,-0.00219636059681059,0.00249010019238148
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSAPL1,Proactivator polypeptide-like 1,24805,0.0105818704942913,0.00349896763356408,0.00372389393250567,0.0174398470560768,0.00249477681527354
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,-0.00776361683936995,0.0025743810289274,-0.0128094036560677,-0.00271783002267224,0.00256628144868526
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,0.0052017291681566,0.00173130885038055,0.00180836382141073,0.00859509451490247,0.00266283768656106
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL3,Myosin light chain 3,24240,-0.0152450031057539,0.00507551210100436,-0.0251930068237224,-0.00529699938778536,0.00267044595065064
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP9,Caspase-9,24229,-0.0131324494078946,0.00437276736645984,-0.0217030734461559,-0.00456182536963333,0.00267398566341838
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFAT5,Nuclear factor of activated T-cells 5,24229,-0.0179716825024239,0.00599645479696439,-0.0297247339044741,-0.00621863110037374,0.00272881138526745
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCN,Decorin,28916,-0.00473343532597995,0.00157987530963786,-0.00782999093287015,-0.00163687971908975,0.00273705184380319
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,0.00536010448214034,0.0017975510480249,0.00183690442801153,0.00888330453626914,0.00286758723918605
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNW1,Interferon omega-1,24111,0.00744431767327916,0.00250350651054894,0.00253744491260324,0.0123511904339551,0.00294661671449365
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,24445,-0.00907379126070782,0.00305320419522405,-0.015058071483347,-0.00308951103806868,0.00296259671831753
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,-0.0183554350902474,0.00617806847856783,-0.0304644493082403,-0.00624642087225445,0.0029705975452532
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,24101,-0.0204606713582774,0.00690161085832562,-0.0339878286405956,-0.00693351407595915,0.00303351248485886
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP112,Centrosomal protein of 112 kDa,24111,-0.00943938337073958,0.00318454764076484,-0.0156810967466387,-0.0031976699948405,0.00303846206662718
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMC3,26S proteasome regulatory subunit 6A,24016,0.00623851401953807,0.00210508607113796,0.00211254532010767,0.0103644827189685,0.00304417597789671
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,-0.0192038046011902,0.00648591989043279,-0.0319162075864385,-0.00649140161594196,0.00307041651821439
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,0.00772392366613497,0.0026146025712054,0.0025993026265724,0.0128485447056975,0.00313836294188364
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPLA2,Acyl-protein thioesterase 2,24101,-0.0222558450175817,0.00753559421983852,-0.0370256096884652,-0.00748608034669819,0.00314568081271508
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL20RB,Interleukin-20 receptor subunit beta,24229,0.00860964570987908,0.00293587726796285,0.00285532626467189,0.0143639651550863,0.0033649121467348
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FST,Follistatin,29536,-0.01018729837618,0.00348156953758099,-0.0170111746698388,-0.00336342208252128,0.00343540824195211
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN3,Neuronal-specific septin-3,24867,-0.0153732002564847,0.00526111186278414,-0.0256849795075416,-0.0050614210054278,0.00348055531631718
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,24867,-0.00775477730156915,0.00266282136110317,-0.0129739071693314,-0.00253564743380694,0.00359164933660592
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP3,Microfibril-associated glycoprotein 3,28916,-0.00977441126277851,0.00336980970949319,-0.0163792382933852,-0.00316958423217185,0.00372750460661841
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,-0.0212702116212837,0.00734817652601312,-0.0356726376122695,-0.00686778563029801,0.00379948363208311
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AOC3,Membrane primary amine oxidase,29594,-0.00602759176406381,0.00208360289231371,-0.0101114534329987,-0.00194373009512894,0.00382018014107361
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLAU,Urokinase-type plasminogen activator,29443,-0.00578613953303181,0.00200272124751506,-0.00971147317816134,-0.00186080588790229,0.00386580486734841
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,-0.00737319503689266,0.0025660745740853,-0.0124027012020999,-0.00234368887168547,0.00406457290562115
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB7,Integrin beta-7,29725,-0.00903492442044963,0.00315918265937364,-0.015226922432822,-0.0028429264080773,0.00424079161980992
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,24016,0.0050543465470167,0.00176984176251953,0.00158545669247843,0.00852323640155498,0.00429628938481151
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BAG3,BAG family molecular chaperone regulator 3,29169,-0.00787207725494253,0.00275899911337088,-0.0132797155171494,-0.00246443899273561,0.00433068511504709
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,-0.0123236536500251,0.0043273186599388,-0.0208051982235051,-0.00384210907654506,0.00440484911654632
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD84,SLAM family member 5,29434,-0.00611779177489881,0.00215218597894449,-0.01033607629363,-0.0018995072561676,0.00447787761867313
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,0.00482666634154647,0.00169816159782824,0.00149826960980311,0.00815506307328983,0.00448212581210466
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFP,Properdin,24966,-0.00453887541253182,0.00159790042684687,-0.00767076024915169,-0.00140699057591195,0.00450758568148298
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANSC4,MANSC domain-containing protein 4,24111,-0.0131034375704876,0.00462393476854752,-0.0221663497168408,-0.00404052542413451,0.00460322443214418
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL9A2,Collagen alpha-2(IX) chain,24445,-0.00894216636854067,0.00316535887836528,-0.0151462697701366,-0.00273806296694473,0.00473176475906609
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,-0.015226458553879,0.00539204044178687,-0.0257948578197813,-0.00465805928797674,0.00474790557904513
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,-0.00550957419673973,0.00195694614330017,-0.00934518863760807,-0.0016739597558714,0.0048756785000447
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRING1,SREBP regulating gene protein,24016,-0.0116618467071958,0.0041440595107546,-0.0197842033482748,-0.00353949006611677,0.0048952004077787
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,-0.0280688631503822,0.00999451255985981,-0.0476581077677074,-0.00847961853305696,0.00498243048400382
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPP1,Osteopontin,29757,-0.00890804516367533,0.00317855589237357,-0.0151380147127275,-0.00267807561462314,0.00507339699087612
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,-0.00639080568718133,0.00229112823803923,-0.0108814170337382,-0.00190019434062443,0.00528518262262683
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL9A1,Collagen alpha-1(IX) chain,29434,0.00899900123689936,0.0032263607977699,0.00267533407327037,0.0153226684005284,0.00528705752418613
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,24381,-0.0168587774024252,0.00606047449011442,-0.0287373074030495,-0.00498024740180094,0.00541067783324472
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMM2,Phosphomannomutase 2,24111,-0.0116000828847644,0.00417125914382307,-0.0197757508066576,-0.00342441496287121,0.00542413690978876
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOM3,Myomesin-3,24381,0.0180393290275567,0.00648830842034283,0.00532224452368476,0.0307564135314286,0.00543533222756819
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCT,Secretin,24195,-0.00904694666142741,0.00325906880258552,-0.015434721514495,-0.0026591718083598,0.00550863753302108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EVPL,Envoplakin,24445,0.00655255390254924,0.00236212122988457,0.00192279629197549,0.011182311513123,0.00554115612976333
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMVK,Phosphomevalonate kinase,28757,-0.0209547751094937,0.00755684570459211,-0.0357661926904942,-0.00614335752849313,0.00555859873939743
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD1C,T-cell surface glycoprotein CD1c,29566,0.00463943350305441,0.00167395379622679,0.00135848406244991,0.00792038294365892,0.00558263358443911
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKD2,Serine/threonine-protein kinase D2,24111,-0.00878311110927218,0.00317220324975779,-0.0150006294787975,-0.00256559273974692,0.00563107981462623
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCL24,C-C motif chemokine 24,29536,-0.0157942427430889,0.00570668609276258,-0.0269793474849036,-0.00460913800127427,0.00564931820023648
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTC,Probetacellulin,28797,-0.0142026916825442,0.00513660888662077,-0.024270445100321,-0.00413493826476753,0.00569601155837187
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UBQLN3,Ubiquilin-3,24111,-0.00966396206294455,0.00349660715857677,-0.016517312093755,-0.00281061203213409,0.00571739579930146
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNLZ,DNL-type zinc finger protein,24101,0.0173786274266967,0.00628977998543348,0.00505065865524709,0.0297065961981463,0.00573171889151654
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SDC4,Syndecan-4,29478,0.00878430014066683,0.00319129605334746,0.0025293598761058,0.0150392404052279,0.00591637379192587
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DGKZ,Diacylglycerol kinase zeta,28931,-0.0067256888451559,0.00244501005326678,-0.0115179085495588,-0.001933469140753,0.00594902324815559
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,-0.0185339004481875,0.00674702861062582,-0.0317580765250141,-0.00530972437136092,0.00601916637895457
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEZ6L,Seizure 6-like protein,29566,-0.00520272187557455,0.00189444641196004,-0.00891583684301623,-0.00148960690813287,0.0060307731320847
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD93,Complement component C1q receptor,28353,-0.00595801568556734,0.00217180452510861,-0.0102147525547802,-0.00170127881635447,0.00608544137109742
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTP1,Glutathione S-transferase P,28604,0.0131882003587358,0.00481001556407337,0.00376056985315199,0.0226158308643196,0.00611376683805608
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSG4,Desmoglein-4,29242,0.00936461757259663,0.00342055690976554,0.00266032602945618,0.0160689091157371,0.00618991705142765
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB10,Ras-related protein Rab-10,24922,-0.0101595115881846,0.0037116068572304,-0.0174342610283562,-0.00288476214801299,0.00620034213429293
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GC,Vitamin D-binding protein,24966,-0.00490646469022123,0.00179577112017284,-0.00842617608575999,-0.00138675329468246,0.00629509368407315
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOX9,Transcription factor SOX-9,24195,-0.00517721393372337,0.00189905117923104,-0.00889935424501621,-0.00145507362243054,0.00641121990905289
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLA2G4A,Cytosolic phospholipase A2,29581,-0.0164178251425669,0.00602812505913838,-0.0282329502584782,-0.0046027000266557,0.00646247750142744
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUC2,Mucin-2,24938,-0.0172623041117665,0.0063463806963548,-0.0297012102766219,-0.00482339794691108,0.00653225347429109
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,-0.0146235546282974,0.00541291595792984,-0.0252328699058399,-0.00401423935075491,0.00690463728690421
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLG,Plasminogen,24421,-0.00413908900697826,0.00153877712666791,-0.00715509217524736,-0.00112308583870916,0.00715314486963499
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,0.00572256292710858,0.00212757750570947,0.00155251101591802,0.00989261483829915,0.00715639356258086
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PODXL,Podocalyxin,29349,0.00279681025563206,0.00104525521044699,0.000748110043155962,0.00484551046810817,0.00746103168963951
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR2,Toll-like receptor 2,24445,-0.00427953806110196,0.00160157811519758,-0.0074186311668892,-0.00114044495531471,0.00754336355430375
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FMR1,Synaptic functional regulator FMR1,28797,-0.0065592804923911,0.00245516965662907,-0.0113714130193841,-0.00174714796539813,0.00755285429243423
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,-0.0230914917387549,0.00864347117269891,-0.0400326952372448,-0.00615028824026509,0.00755436209748
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAD1,Glutamate decarboxylase 1,24016,0.00483015303010632,0.00181128756254281,0.00128002940752241,0.00838027665269024,0.007665231275663
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUSP29,Dual specificity phosphatase 29,24195,-0.0123816389059935,0.00464805694047192,-0.0214918305093185,-0.00327144730266858,0.00773075398981675
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ICOSLG,ICOS ligand,29349,0.00350523237769753,0.0013173957663023,0.000923136675745014,0.00608732807965005,0.0078014242703019
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CXCL14,C-X-C motif chemokine 14,28931,-0.0109068819082761,0.00410209837737387,-0.0189469947279289,-0.00286676908862336,0.00784500339091246
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.00473703449015032,0.00178403924283158,0.00124031757420042,0.00823375140610022,0.00792966196177694
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,24938,0.00394438734481328,0.00149465129847895,0.00101487079979453,0.00687390388983203,0.00832022753755671
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DBH,Dopamine beta-hydroxylase,24919,0.0200201688389251,0.00759548964254784,0.00513300913953131,0.0349073285383188,0.00839919514966449
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH5,Cadherin-5,29820,0.0055021102953642,0.00209412839161747,0.00139761864779396,0.00960660194293445,0.00860844950725971
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2RB,Interleukin-2 receptor subunit beta,28931,-0.00680763714514355,0.00259561225591069,-0.0118950371667285,-0.0017202371235586,0.00872694704678693
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINC1,Antithrombin-III,24914,0.00268089464839371,0.00102578185605651,0.000670362210522943,0.00469142708626447,0.00896704568744661
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPC5,Glypican-5,29218,0.0101061188421629,0.00386889421778752,0.0025230861752993,0.0176891515090264,0.00900217126341342
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECE1,Endothelin-converting enzyme 1,28774,0.00634532509281379,0.0024319811428669,0.00157864205279466,0.0111120081328329,0.00908229887061844
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,0.020597199932782,0.00790136394849601,0.00511052659372981,0.0360838732718342,0.00914417124908612
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,-0.0214339305379736,0.00822509086985012,-0.0375551086428799,-0.00531275243306741,0.00916737288884793
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOS,Proto-oncogene c-Fos,23970,-0.00640789255027618,0.0024702233743913,-0.0112495303640831,-0.00156625473646924,0.00949093512010278
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VIM,Vimentin,28916,-0.0208279159422856,0.008048384367519,-0.0366027493026228,-0.00505308258194833,0.00966286641631051
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRGN,Neurogranin,24951,-0.0163900458796629,0.0063397062145496,-0.0288158700601801,-0.00396422169914568,0.00973503587068488
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STK4,Serine/threonine-protein kinase 4,29478,-0.0153231454532047,0.00596240392793111,-0.0270094571519497,-0.00363683375445975,0.0101758660697897
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,-0.0121706682510785,0.00473739217813844,-0.0214559569202298,-0.00288537958192711,0.0102031143082471
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LXN,Latexin,29117,0.0118883618286635,0.00463422261143332,0.00280528551025419,0.0209714381470728,0.0103124052367932
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.009899253798724,0.00386851911696583,-0.017481551267977,-0.00231695632947096,0.0105056434606972
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSLP,Thymic stromal lymphopoietin,28916,-0.0106720465975457,0.00417635257456975,-0.0188576976437024,-0.00248639555138899,0.0106131510155367
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FADD,FAS-associated death domain protein,29478,-0.0133991788144935,0.00525626853272532,-0.0237014651386352,-0.00309689249035191,0.0108026528999313
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NCLN,Nicalin,28931,-0.00917322541015005,0.00360602845830423,-0.0162410411884263,-0.00210540963187376,0.0109687127167454
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL6B,Myosin light chain 6B,24195,-0.0162234893071002,0.0063816044834354,-0.0287314340946336,-0.0037155445195668,0.0110210333983711
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,-0.00619147180119104,0.00244101255440493,-0.0109758564078247,-0.00140708719455738,0.0112048099430636
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACTN4,Alpha-actinin-4,28931,-0.00556879245939274,0.00220577083894815,-0.00989210330373111,-0.00124548161505437,0.0115867636890427
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WAS,Wiskott-Aldrich syndrome protein,28931,-0.0116207131091223,0.00461035625408546,-0.0206570113671299,-0.00258441485111484,0.0117219190161933
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,-0.00800103616116677,0.0031812628744754,-0.0142363113951385,-0.00176576092719499,0.0119079934291117
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROBO4,Roundabout homolog 4,24240,-0.00313954908512552,0.00124998288227295,-0.00558951553438051,-0.000689582635870526,0.0120224647754557
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,-0.0082347275747847,0.00328189651840293,-0.0146672447508544,-0.00180221039871496,0.012108967847222
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MGLL,Monoglyceride lipase,29536,-0.0149873386592446,0.00597341864396024,-0.0266952392014067,-0.00327943811708254,0.0121124819389547
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCARB1,Scavenger receptor class B member 1,28774,-0.00987360062342889,0.00396582373274652,-0.0176466151396121,-0.00210058610724572,0.012791704916551
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NTF3,Neurotrophin-3,29434,-0.00595180904603927,0.00239186179751793,-0.0106398581691744,-0.00126375992290412,0.0128389270701364
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECM1,Extracellular matrix protein 1,24349,0.00634000969633001,0.00255403072424515,0.00133410947680952,0.0113459099158505,0.013058426634579
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP170,Centrosomal protein of 170 kDa,24240,-0.0132711265400438,0.00535268541608283,-0.0237623899555662,-0.00277986312452147,0.0131693301030136
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,0.00589828493280531,0.00238923713915834,0.00121538014005496,0.0105811897255557,0.0135677668978552
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1R,Complement C1r subcomponent,24966,-0.00332091114838911,0.00134615381751214,-0.00595937263071291,-0.000682449666065312,0.0136331236901757
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRTAP,Cartilage-associated protein,24195,-0.00835679294702603,0.00338842114212566,-0.0149980983855923,-0.00171548750845974,0.0136593675007927
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F10,Coagulation factor X,24951,-0.0046885100865671,0.00191176053360832,-0.00843556073243941,-0.000941459440694788,0.0141952441521916
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NENF,Neudesin,24793,-0.0187020598068235,0.00763401538215542,-0.0336647299558482,-0.00373938965779892,0.0142991335866607
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCTD,Deoxycytidylate deaminase,24381,-0.0161163739127735,0.0065940262467225,-0.0290406653563496,-0.00319208246919737,0.0145289631882256
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSTN,Osteocrin,24195,-0.00709928522419641,0.00290781620325762,-0.0127986049825813,-0.00139996546581147,0.0146355693896887
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB5,Serpin B5,28916,-0.00819692742660701,0.00335988839190616,-0.0147823086747431,-0.00161154617847094,0.0147077620994237
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCS,Copper chaperone for superoxide dismutase,29218,-0.00796327104644039,0.00326444018004135,-0.0143615737993214,-0.00156496829355935,0.0147176380659519
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLB,Beta-klotho,28774,0.0124420678468125,0.00510522693709852,0.00243582305009941,0.0224483126435256,0.0148106473780798
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRK1,Protein BRICK1,28774,-0.00747178453800573,0.00308470009089416,-0.0135177967161583,-0.00142577235985319,0.0154326663413483
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,24445,0.00474980066631568,0.0019648096272088,0.000898773796986432,0.00860082753564493,0.0156375728018229
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHP1,Calcineurin B homologous protein 1,24101,-0.0123255509673629,0.00510042054972876,-0.0223223752448313,-0.00232872668989456,0.0156746635519568
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCLRE1C,Protein artemis,24016,0.00522898255927455,0.00216530241965342,0.000984989816753844,0.00947297530179526,0.0157470810469767
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,24229,-0.00682148325899428,0.00283793855276167,-0.0123838428224072,-0.00125912369558142,0.0162386433518206
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSCA,Prostate stem cell antigen,24805,-0.0432802864070171,0.0180246165323041,-0.0786085348103332,-0.00795203800370099,0.0163497673779338
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,-0.00872728532603173,0.00363761004223734,-0.0158570010088169,-0.00159756964324656,0.0164392290387156
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRTG,Protogenin,29725,-0.00411524790353668,0.00171752857056709,-0.00748160390184817,-0.000748891905225189,0.0165799341384999
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHPK,Sedoheptulokinase,24445,-0.00691334268783975,0.00288838371635269,-0.012574574771891,-0.00125211060378848,0.0166960381717952
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COPE,Coatomer subunit epsilon,28774,-0.00781453683704898,0.00326705620444801,-0.0142179669977671,-0.00141110667633088,0.0167668805557778
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNPO1,Transportin-1,24445,0.00589226085085312,0.00246429984930638,0.00106223314621261,0.0107222885554936,0.0168078473103484
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CREBZF,CREB/ATF bZIP transcription factor,24016,0.00435211046706246,0.00182327615160149,0.000778489209923528,0.00792573172420138,0.0169954459639328
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,0.0067145040808502,0.00281743946957859,0.00119232272047617,0.0122366854412242,0.0171695323613427
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,-0.0125209549546437,0.00525766279792612,-0.0228259740385789,-0.00221593587070846,0.01725009494216
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB39B,Ras-related protein Rab-39B,24111,-0.0149292604388724,0.00627217488752069,-0.0272227232184129,-0.0026357976593318,0.0173092531643828
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,0.0101375755814154,0.00427491740601677,0.0017587374656225,0.0185164136972082,0.0177282502829488
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNAR1,Interferon alpha/beta receptor 1,24805,-0.00421835331705749,0.0017800653165633,-0.00770728133752156,-0.000729425296593423,0.017806550422294
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F2,Prothrombin,24966,0.00242880649102627,0.00102738074957527,0.000415140221858742,0.00444247276019381,0.0180827040953265
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCUN1D1,DCN1-like protein 1,24101,-0.0123025041347057,0.00521832319981736,-0.0225304176063477,-0.0020745906630637,0.0184034898057954
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100G,Protein S100-G,24867,0.0076031095357516,0.00322731220098883,0.00127757762181349,0.0139286414496897,0.0184873902252632
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC13A1,Solute carrier family 13 member 1,24793,-0.00994537053776662,0.0042404223867224,-0.0182565984157425,-0.00163414265979072,0.0190159164544275
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NOS2,"Nitric oxide synthase, inducible",24111,-0.00643626411000592,0.0027553425491606,-0.0118367355063607,-0.00103579271365115,0.019503486280426
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOK1,Docking protein 1,24845,-0.0219970606627233,0.00947208177700313,-0.0405623409456495,-0.00343178037979722,0.0202245745947221
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTNNA1,Catenin alpha-1,24101,0.00566787020758175,0.00244657216945467,0.000872588755450603,0.0104631516597129,0.0205307331370585
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RILPL2,RILP-like protein 2,24922,-0.0157002088523938,0.00678770232973123,-0.029004105418667,-0.00239631228612061,0.0207286922015847
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,29349,-0.00853359692038707,0.00368960698761342,-0.0157652266161094,-0.00130196722466477,0.0207364383315206
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EHD3,EH domain-containing protein 3,24240,-0.0188376065492841,0.00814668149678715,-0.0348051022829869,-0.0028701108155813,0.0207692610657693
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM172A,Cotranscriptional regulator FAM172A,24240,-0.00983645455165573,0.00426358802659429,-0.0181930870837805,-0.00147982201953094,0.0210585435534698
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CORO1A,Coronin-1A,28847,-0.0141915642875868,0.00615294393761132,-0.026251334405305,-0.00213179416986858,0.0210915873629206
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,-0.0085729804071434,0.003717618513993,-0.0158595126945697,-0.00128644811971713,0.0211154222896064
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDSN,Corneodesmosin,29676,-0.00687452297328115,0.0029907432090428,-0.012736379663005,-0.00101266628355727,0.0215345707800329
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYB5A,Cytochrome b5,24016,-0.0115539908118015,0.00502917377600828,-0.0214111714127777,-0.00169681021082522,0.0216048986810533
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,0.00471146185156041,0.00205391522407191,0.00068578801237947,0.00873713569074135,0.0218051638305978
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARFIP1,Arfaptin-1,24867,-0.0109535896115449,0.00477975811019729,-0.0203219155075316,-0.00158526371555826,0.0219334828610372
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN2B,Sodium channel subunit beta-2,24195,0.00461174903807241,0.00201341149935698,0.00066546249933272,0.0085580355768121,0.0220000511973137
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,0.00834793726118046,0.00364657978248124,0.00120064088751723,0.0154952336348437,0.0220733667853815
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.041802877382032,0.0183288186255121,-0.0777273618880358,-0.00587839287602827,0.0225737475527791
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUGT1,Protein SGT1 homolog,28797,-0.0126893097374333,0.00556725743682258,-0.0236011343136056,-0.00177748516126105,0.0226580197213209
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,-0.0126131885698738,0.00555196153390967,-0.0234950331763367,-0.0017313439634108,0.0231047646952444
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,-0.0132504560368622,0.00585429724043085,-0.0247248786281066,-0.00177603344561771,0.0236201437123174
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAT1,Diamine acetyltransferase 1,24111,0.00792192755272998,0.00350188134140138,0.00105824012358328,0.0147856149818767,0.0236944177702682
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,-0.0186680494594801,0.00828203047232512,-0.0349008291852373,-0.00243526973372288,0.0242008151736018
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,24240,-0.0114502324983583,0.00509397898611438,-0.0214344313111425,-0.00146603368557409,0.0245980715299243
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,24016,0.00730871171090921,0.00325883713365245,0.000921390928950406,0.013696032492868,0.0249229257724921
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.00650328786581061,0.00291305080574877,0.00079370828654303,0.0122128674450782,0.0255930301874878
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RASA1,Ras GTPase-activating protein 1,28774,-0.00500738038945554,0.00224367626366415,-0.00940498586623727,-0.00060977491267381,0.0256375161509306
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUK1,Guanylate kinase,24111,0.00619683527702292,0.00278552453202446,0.000737207194254977,0.0116564633597909,0.0261135311402345
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,-0.00731455183116253,0.003293869346904,-0.0137705357510944,-0.000858567911230698,0.0263832550282841
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IKZF2,Zinc finger protein Helios,28797,-0.0140012142726463,0.00631452832713556,-0.026377689793832,-0.00162473875146057,0.0266102645096572
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSMA1,Proteasome subunit alpha type-1,28797,-0.00709936887536153,0.00320407625510437,-0.0133793583353661,-0.000819379415356959,0.026717771554396
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAD2,Glutamate decarboxylase 2,24229,0.00702617743450898,0.00322127392441863,0.000712480542648474,0.0133398743263695,0.0291797107980346
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C4BPB,C4b-binding protein beta chain,29566,-0.00601157728642315,0.00276178816072662,-0.0114246820814473,-0.000598472491398981,0.0295110366057856
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.00493252099166638,0.00227103479106197,0.000481292801184923,0.00938374918214784,0.0298705984221338
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FOLR3,Folate receptor gamma,29461,-0.0280298317716366,0.0129238995280324,-0.0533606748465801,-0.0026989886966931,0.0301030360167304
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL4,Interleukin-4,28931,-0.0136627239936271,0.00632791466467241,-0.026065436736385,-0.00126001125086913,0.0308490940036363
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGSF21,Immunoglobulin superfamily member 21,24240,0.00595194641317051,0.00275743099436307,0.000547381664218894,0.0113565111621221,0.0308978783501325
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEZ6L2,Seizure 6-like protein 2,29349,0.00355201805523369,0.001653839380405,0.000310492869639888,0.00679354324082749,0.0317425307504608
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERVV_1,,24111,0.00687665873916027,0.00320585512207309,0.000593182699897016,0.0131601347784235,0.0319603313626376
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GBP6,Guanylate-binding protein 6,24111,0.00686542659586211,0.00320480802836455,0.000584002860267589,0.0131468503314566,0.0321852034658189
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OPTC,Opticin,29349,0.00666333720647367,0.00311440092683084,0.000559111389885224,0.0127675630230621,0.0324014381565707
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FRZB,Secreted frizzled-related protein 3,29123,-0.00379387212148479,0.00177330969924226,-0.00726955913199963,-0.000318185110969954,0.0324091445350792
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,24867,-0.0187557748334405,0.00877927415595562,-0.0359631521791136,-0.00154839748776752,0.0326590349254389
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYGD,Gamma-crystallin D,24845,-0.0143220528929778,0.00671477457618076,-0.0274830110622921,-0.00116109472366354,0.032941361590187
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPN1,Epsin-1,24445,-0.00648175335132934,0.00304162449993306,-0.0124433373711981,-0.000520169331460542,0.0330977009359754
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERC2,ERC protein 2,24195,-0.0111517401400818,0.00523960454776293,-0.0214213650536972,-0.000882115226466508,0.0333177173725798
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROS1,Vitamin K-dependent protein S,24966,0.00375792009377213,0.00176967432075375,0.000289358425094778,0.00722648176244948,0.0337209988356439
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UGDH,UDP-glucose 6-dehydrogenase,24111,-0.0143997199806353,0.00681734666420612,-0.0277617194424793,-0.00103772051879132,0.0346780458151704
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LPA,Apolipoprotein(a),24484,0.0261693375206687,0.012407443782598,0.00185074770677671,0.0504879273345607,0.0349405330906491
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,0.00411665081375829,0.00195206611527863,0.00029060122781218,0.0079427003997044,0.0349661710288518
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,24016,-0.00869000100066736,0.00412988555598172,-0.0167845766903915,-0.000595425310943191,0.0353735772110315
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CORO6,Coronin-6,24101,-0.00549083493768519,0.00261722562432148,-0.0106205971613553,-0.000361072714015098,0.0359190610003411
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD1,Sushi domain-containing protein 1,28916,-0.0070798516895958,0.00337519127550442,-0.0136952265895845,-0.000464476789607125,0.0359478354498024
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC1A4,Neutral amino acid transporter A,24195,-0.00752192751512416,0.00359254486149849,-0.0145633154436612,-0.000480539586587113,0.0362917328039665
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPT1,Palmitoyl-protein thioesterase 1,24195,-0.0112892287176197,0.00539853021028272,-0.0218703479297739,-0.000708109505465614,0.0365234979910179
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLINT1,Clathrin interactor 1,24016,0.00689653177122548,0.00332016729113632,0.000389003880598281,0.0134040596618527,0.0377970399991413
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOM2,Myomesin-2,24111,-0.00735447117941539,0.00354229133363894,-0.0142973621933477,-0.000411580165483073,0.0378869226496782
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,-0.0125888990379744,0.00608525994504383,-0.0245160085302603,-0.000661789545688529,0.0385781527023646
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSB,Lupus La protein,28774,-0.00845676868243272,0.00411130824533767,-0.0165149328432946,-0.000398604521570893,0.0396997252418563
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,-0.00882969264891722,0.00429931740544544,-0.0172563547635903,-0.000403030534244158,0.0400113517210277
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,-0.0123166498773589,0.00601878990359341,-0.024113478088402,-0.000519821666315777,0.0407311988321305
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,28916,-0.00808469992416779,0.00396952056642286,-0.0158649602343566,-0.000304439613978975,0.0416897803339265
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.00575584471787463,0.00283360675287911,-0.0113097139535177,-0.000201975482231567,0.0422376948977735
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,-0.00459040627289288,0.00226075540280798,-0.00902148686239651,-0.000159325683389245,0.0423192862502241
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAP1A,Ras-related protein Rap-1A,24229,-0.00978191949615591,0.00481789524738327,-0.0192249941810271,-0.000338844811284706,0.0423338663842006
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP6,Platelet glycoprotein VI,29400,-0.0122821306575456,0.00604941387468127,-0.0241389818519209,-0.000425279463170303,0.0423349467944097
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DHODH,Dihydroorotate dehydrogenase,24111,-0.00666995444371525,0.0032917293742418,-0.0131217440172292,-0.000218164870201331,0.0427474336210125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,-0.00679254668366886,0.00335374589513945,-0.0133658886381422,-0.000219204729195543,0.0428412930910981
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLL4,Delta-like protein 4,24240,-0.0120718797927391,0.00596635758929482,-0.0237659406677569,-0.000377818917721264,0.0430506212440956
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.00558501420518042,0.00276559399299352,-0.0110055784314477,-0.000164449978913113,0.0434501877601104
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESR1,Estrogen receptor,24229,-0.00807591624141954,0.00400374954957302,-0.0159232653585827,-0.000228567124256418,0.043697316344712
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,-0.0103417247161544,0.00513249480826801,-0.0204014145403597,-0.000282034891949109,0.0439208896410887
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASP4,Caspase-4,24445,-0.0235918433487362,0.0117175168727216,-0.0465581764192705,-0.000625510278201843,0.0440853512134389
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPB2,Carboxypeptidase B2,24914,0.00315503519215903,0.00156794826911781,8.1856584688116e-05,0.00622821379962995,0.0442089559894475
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HSP90B1,Endoplasmin,28626,-0.00928027943608183,0.00462586979965331,-0.0183469842434023,-0.000213574628761344,0.044847548748596
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHD,SH2 domain-containing adapter protein D,24059,-0.0118641757445957,0.00592136285381871,-0.0234700469380803,-0.000258304551111014,0.045121714332853
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGR,Progesterone receptor,24229,-0.0141606453413053,0.00707792493101467,-0.0280333782060941,-0.000287912476516548,0.0454382960414736
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,-0.00492550896542392,0.00246597636500021,-0.00975882264082432,-9.21952900235171e-05,0.0457942364066489
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TUBB3,Tubulin beta-3 chain,24101,0.00390973310603114,0.001959107951917,6.9881520273814e-05,0.00774958469178847,0.0459810884037312
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,-0.00935267288716993,0.00469173063761327,-0.0185484649368919,-0.000156880837447923,0.0462229650177184
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,-0.00985249113413454,0.00495831581124051,-0.0195707901241659,-0.000134192144103148,0.0469265629206991
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NGF,Beta-nerve growth factor,29218,0.00166472630550156,0.000837911995251911,2.24187948078176e-05,0.00330703381619531,0.0469588215980357
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,REST,RE1-silencing transcription factor,24016,0.00484553378449284,0.00244070839322764,6.17453337666725e-05,0.00962932223521901,0.0471226749950414
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPC1,Glypican-1,29725,-0.00402658985762115,0.00202969985768988,-0.00800480157869331,-4.83781365489848e-05,0.0472834115251756
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRX,Cone-rod homeobox protein,28916,-0.0146771850383291,0.00740938319542787,-0.0291995761013678,-0.000154793975290496,0.0476128933921896
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FES,Tyrosine-protein kinase Fes/Fps,28797,-0.00648402695004432,0.00327739367304723,-0.0129077185492169,-6.03353508717456e-05,0.0478920415905357
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,-0.00681182419514941,0.00345371175794971,-0.0135810992407308,-4.25491495679737e-05,0.0485826718191678
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,-0.00432706953831321,0.00219608449232347,-0.00863139514326722,-2.27439333592098e-05,0.0488068659834502
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DSG3,Desmoglein-3,29589,-0.00462427194551866,0.00235685998044719,-0.00924371750719515,-4.82638384215976e-06,0.0497662827258335
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP2BP,LRP2-binding protein,24195,-0.0112779688496624,0.00575055333403999,-0.0225490533843808,-6.88431494403827e-06,0.0498674869990091
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,0.00690623852466352,0.00352836120573807,-9.34943858310177e-06,0.0138218264879101,0.050317835634163
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,0.00561595357520641,0.00287233469906209,-1.38224349552794e-05,0.0112457295853681,0.050572463124638
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,29594,-0.00464379276979046,0.00237554658512225,-0.00929986407663006,1.2278537049144e-05,0.0506123931159218
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,-0.00428674633207061,0.00219404578908927,-0.00858707607868558,1.35834145443669e-05,0.0507331535862456
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,24805,-0.00587574975853097,0.00302757739944687,-0.0118098014614468,5.83019443849021e-05,0.0523007741292669
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,0.0059584854167521,0.00308045204848166,-7.92005982719543e-05,0.0119961714317762,0.0530893076295313
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TG,Thyroglobulin,24793,-0.01500133743808,0.0077556417291577,-0.0302023952272291,0.0001997203510691,0.0530939677563357
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MST1,Hepatocyte growth factor-like protein,24615,-0.00863099152655909,0.00446304124522114,-0.0173785523671925,0.000116569314074349,0.0531391927489223
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORC3,MORC family CW-type zinc finger protein 3,24845,-0.00376298042955043,0.00195205400624771,-0.00758900628179596,6.30454226950858e-05,0.0539034660724683
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COMMD9,COMM domain-containing protein 9,24793,0.00527271073225218,0.00274023078865483,-9.81416135112908e-05,0.0106435630780157,0.0543428490450898
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF9,Fibroblast growth factor 9,23970,0.00546243208789252,0.00284019442888005,-0.000104348992712384,0.0110292131684974,0.0544592548811863
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MSLNL,Mesothelin-like protein,24195,0.00501854097572435,0.00262007049786364,-0.000116797200088374,0.0101538791515371,0.055450474629537
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,-0.00595161949418192,0.00311935734393443,-0.0120655598882934,0.000162320899929555,0.0564074991533149
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDAC8,Histone deacetylase 8,24229,-0.00812366414157656,0.00426485927184708,-0.0164827883143968,0.000235460031243718,0.0568191233648517
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBP2,Retinol-binding protein 2,29349,0.0100851478080896,0.00529849908736447,-0.000299910403144789,0.0204702060193239,0.0569985265844092
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TXK,Tyrosine-protein kinase TXK,24445,-0.00987456279030407,0.0051880910446549,-0.0200432212378277,0.000294095657219532,0.0570114147484634
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EP300,Histone acetyltransferase p300,24229,-0.00398782412222652,0.00209855877214254,-0.0081009993156259,0.000125351071172869,0.0574098215095032
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,-0.00256275398947561,0.00134943934996473,-0.00520765511540648,8.2147136455268e-05,0.0575595666988249
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGFR4,Fibroblast growth factor receptor 4,24381,-0.00694011322272493,0.0036792235608241,-0.0141513914019402,0.000271164956490307,0.0592666462157958
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK1,Kallikrein-1,29199,0.0165305069464181,0.00877894820656679,-0.000676231538452851,0.033737245431289,0.0597142030383267
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ABO,Histo-blood group ABO system transferase,24951,0.0188636274260213,0.0100284500269518,-0.000792134626804167,0.0385193894788468,0.059982028449858
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMI,N-myc-interactor,24706,-0.00939150490051681,0.00500200597962672,-0.0191954366205852,0.000412426819551552,0.0604548419705402
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HRAS,GTPase Hras,24421,-0.0128614816018089,0.00685980968282748,-0.0263067085801508,0.000583745376532942,0.0608179237801381
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,0.00657663147984788,0.00350939545823859,-0.000301783618299764,0.0134550465779955,0.0609414165503393
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAG,S-arrestin,24101,0.00689026624817376,0.00367749066828729,-0.000317615461669325,0.0140981479580168,0.0609931853599087
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BIN2,Bridging integrator 2,29443,-0.0115879202189409,0.0061893516299857,-0.0237190494137129,0.000543208975831051,0.0611840197363601
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,-0.0132392841078725,0.00709220925865499,-0.0271400142548363,0.000661446039091263,0.0619504995185683
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD70,CD70 antigen,29434,-0.00549547168002711,0.00294528235837681,-0.0112682251024457,0.000277281742391447,0.0620715101186293
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,24938,-0.00793742426125254,0.00425424997185482,-0.016275754206088,0.000400905683582902,0.0620862010451447
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GKN1,Gastrokine-1,28114,-0.0036146017906177,0.00193944885211166,-0.00741592154075655,0.000186717959521154,0.062370575112481
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMEM132A,Transmembrane protein 132A,24240,0.00809262073330764,0.0043522213453246,-0.000437733103528586,0.0166229745701439,0.0629793097158766
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC2L,C-type lectin domain family 2 member L,24195,-0.00649462608332662,0.00349442356038736,-0.0133436962616859,0.000354444095032609,0.0631004457208865
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEX33,Testis-expressed protein 33,24445,0.00501244023959583,0.00271448884553092,-0.000307957897644765,0.0103328383768364,0.0648244268654911
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,-0.0110960012291912,0.0060145624245943,-0.0228845435813961,0.000692541123013601,0.0650705931026983
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,29038,0.0218318817582139,0.0118384602129223,-0.00137150025911375,0.0450352637755415,0.0651716482111741
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NECTIN1,Nectin-1,24229,-0.00413090108268672,0.00224852666474843,-0.00853801334559364,0.000276211180220204,0.0661986679366499
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.0110872831145445,0.00604611234212718,-0.000763097076024817,0.0229376633051137,0.066695712695745
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,24101,0.00423563927461699,0.00231083873814251,-0.000293604652142336,0.00876488320137631,0.0668231529511851
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL11,Interleukin-11,28931,-0.00788454767938758,0.00430230683936558,-0.0163170690845441,0.000547973725768959,0.0668675063579733
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCC,Netrin receptor DCC,24195,-0.00291152169868281,0.00159006440779045,-0.00602804793795209,0.00020500454058648,0.0671021622216294
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SH3GL3,Endophilin-A3,24307,-0.0106695363068464,0.00583040185900987,-0.0220971239505058,0.000758051336812914,0.0672647274050235
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,24195,-0.0066319518302486,0.00363322618906226,-0.0137530751608106,0.000489171500313424,0.0679587979270312
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD200,OX-2 membrane glycoprotein,29434,0.00332761748407762,0.00182829667811494,-0.000255844005027663,0.00691107897318291,0.0687593722884629
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,29454,-0.00314959561818733,0.00173826184808882,-0.00655658884044142,0.000257397604066749,0.0700083685605499
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HCG22,Protein PBMUCL2,24111,0.00696783096189857,0.00385108820108814,-0.000580301912234192,0.0145159638360313,0.0704145634319981
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FABP9,Fatty acid-binding protein 9,29434,-0.00696675502373525,0.0038592987085695,-0.0145309804925315,0.000597470445060967,0.0710556776234827
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADAMTSL5,ADAMTS-like protein 5,24922,-0.00491033699307001,0.00273550561791723,-0.0102719280041878,0.000451254018047752,0.0726597380132837
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTX1,Neuronal pentraxin-1,29443,0.00502334009154983,0.0027996819166119,-0.000464036465009499,0.0105107166481092,0.0727829189780335
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,24111,-0.00850597662704271,0.0047409931676189,-0.0177983232355758,0.000786369981490341,0.0728043284348038
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,-0.00606396754154043,0.00338343941492668,-0.0126955087947967,0.000567573711715863,0.0731055518080342
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CADPS,Calcium-dependent secretion activator 1,24195,0.00535932026095356,0.00299719180599361,-0.000515175678793917,0.011233816200701,0.0737701536172141
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD86,T-lymphocyte activation antigen CD86,24805,-0.00371748024388554,0.00208003582798768,-0.0077943504667414,0.000359389978970313,0.0739142584890954
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYH4,Myosin-4,24111,0.00579447320947052,0.00324322385392112,-0.000562245544214879,0.0121511919631559,0.0740082721846167
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP164,Centrosomal protein of 164 kDa,28931,-0.00774505307230978,0.00434696013812327,-0.0162650949430314,0.000774988798411824,0.0748058735538909
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,0.00459371946761022,0.00257891002542423,-0.000460944182221282,0.00964838311744172,0.0748819323546635
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKK3,Dickkopf-related protein 3,29820,-0.00360929759555132,0.00202988247734178,-0.00758786725114121,0.000369272060038572,0.0754005721532798
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,24229,-0.00451913149757879,0.0025416633504326,-0.00950079166442668,0.000462528669269111,0.075412907147454
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPA33,Cell surface A33 antigen,29349,-0.0165431679444368,0.0093087037151034,-0.0347882272260395,0.00170189133716581,0.0755502977424546
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,24195,0.00455173278238739,0.00256716705303136,-0.000479914641554065,0.00958338020632885,0.0762318948881655
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,24101,-0.00606374471438616,0.00342288024175456,-0.0127725899882251,0.000645100559452782,0.0764847799983853
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBM25,RNA-binding protein 25,24016,0.00571998371297411,0.00323393766912793,-0.000618534118516629,0.0120585015444648,0.0769505504303066
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.00571267521044546,0.0032385739351516,-0.000634929702451685,0.0120602801233426,0.0777530600925973
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTLA,B- and T-lymphocyte attenuator,24016,-0.0107151332880114,0.00607534036948491,-0.0226228004122018,0.00119253383617901,0.0777936832625679
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,0.00492911719558943,0.00279531304981369,-0.00054969638204541,0.0104079307732243,0.0778539651421213
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTN,Neuroplastin,28797,0.00986711630807681,0.00564208575568562,-0.00119137177306702,0.0209256043892206,0.0803290006949991
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,0.00369244540991854,0.00211456961560911,-0.000452111036675315,0.0078370018565124,0.0807881914944021
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,-0.00548781604453991,0.00315117768794173,-0.0116641243129057,0.000688492223825877,0.081606437471816
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STAM,Signal transducing adapter molecule 1,24793,-0.00444362619905615,0.00255854575657682,-0.00945837588194672,0.000571123483834415,0.0824387759885797
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RUVBL1,RuvB-like 1,28797,-0.0124118071133229,0.00715101011242205,-0.0264277869336702,0.00160417270702429,0.082632571604501
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MELTF,Melanotransferrin,24922,-0.00356576207467024,0.00205565800297185,-0.00759485176049506,0.000463327611154583,0.0828225238920868
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMY2A,Pancreatic alpha-amylase,28334,-0.00572494219792432,0.00330346150409866,-0.0121997267459577,0.000749842350109058,0.0831042185244593
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYH7B,Myosin-7B,24016,0.00534163998130981,0.0030875458458935,-0.000709949876641444,0.0113932298392611,0.0836323864806762
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH22,Cadherin-22,24445,0.0034301718498441,0.0019891646523849,-0.000468590868830305,0.00732893456851851,0.0846431985323378
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCG3,Secretogranin-3,29497,-0.00393051666798413,0.00229371721245793,-0.00842620240440167,0.000565169068433409,0.0866124969296135
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYO6,Unconventional myosin-VI,24867,-0.0044324741300143,0.00259647148818207,-0.00952155824685116,0.000656609986822568,0.0878132631078949
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNF75D,Zinc finger protein 75D,24445,-0.00711973002360881,0.00418606326713659,-0.0153244140271965,0.0010849539799789,0.0889899719518312
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX25,ATP-dependent RNA helicase DDX25,24195,0.00444698820691201,0.00261869805065048,-0.000685659972362931,0.00957963638618695,0.0894889978938496
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDAN1,Codanin-1,24845,0.00265894942583352,0.00156697766983744,-0.000412326807047851,0.00573022565871489,0.0897347358779391
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTF,Ciliary neurotrophic factor,24101,0.00400872866701088,0.00237652534286417,-0.000649261005002886,0.00866671833902465,0.0916543017813449
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TERF1,Telomeric repeat-binding factor 1,24229,0.00343722008117069,0.00204059636528292,-0.000562348794783843,0.00743678895712522,0.0921135337335783
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL17F,Interleukin-17F,28931,-0.008894725304842,0.00528311143743055,-0.0192496237222059,0.00146017311252187,0.0922669046528127
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,-0.0125561235165326,0.00747959304948357,-0.0272161258935204,0.00210387886045522,0.0932197285794098
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,24016,0.00340797713452244,0.00204121489832672,-0.000592804066197931,0.00740875833524282,0.0950149908810446
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGFL4,Insulin growth factor-like family member 4,24229,-0.00874431710807825,0.00523766113843223,-0.0190101329394054,0.00152149872324892,0.0950296746290134
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEX101,Testis-expressed protein 101,24195,-0.0058380105863294,0.00352197728989481,-0.0127410860745232,0.00106506490186443,0.097412289323792
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TJP3,Tight junction protein ZO-3,24101,0.00493904044009998,0.00298331566442835,-0.000908258262179583,0.0107863391423795,0.0978251815595997
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB6B,Ras-related protein Rab-6B,28774,-0.00546534319160167,0.00331424294376387,-0.0119612593613788,0.0010305729781755,0.099148878068446
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,24101,0.00719073269413588,0.0043749216790849,-0.00138411379687052,0.0157655791851423,0.100266641086936
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAS6,Growth arrest-specific protein 6,29639,-0.00287898603355686,0.00175446375940969,-0.00631773500199986,0.00055976293488614,0.10081856087989
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IFNL2,Interferon lambda-2,24101,-0.00698527037528417,0.00431243614593589,-0.0154376452213185,0.00146710447075018,0.10528901970421
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNPY2,Protein canopy homolog 2,28916,-0.00680362877306908,0.00420434988169505,-0.0150441545411914,0.00143689699505322,0.105622739283845
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,0.00991001032240355,0.0061420260576246,-0.00212836075054067,0.0219483813953478,0.1066518676964
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FIS1,Mitochondrial fission 1 protein,29453,-0.00855865041758996,0.00530792103704104,-0.0189621756501904,0.00184487481501048,0.106879148911644
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRDT,Bromodomain testis-specific protein,24111,-0.00408664228108586,0.00255734373696491,-0.00909903600553709,0.000925751443365368,0.110055480339904
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,-0.0057014086095383,0.00356906308923917,-0.0126967722644471,0.00129395504537047,0.110177998835413
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NMRK2,Nicotinamide riboside kinase 2,24016,0.00461774076938449,0.00289097252563115,-0.00104856538085256,0.0102840469196215,0.110212758271223
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOC2B,Double C2-like domain-containing protein beta,24195,-0.00401761539734191,0.00252189872100883,-0.00896053689051922,0.000925306095835391,0.111152737964551
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOM1,Myomesin-1,24101,-0.00529212834063028,0.00332266997150826,-0.0118045614847865,0.00122030480352591,0.111233072293734
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EDDM3B,Epididymal secretory protein E3-beta,24793,0.00575963416050062,0.00361662529685246,-0.00132895142133019,0.0128482197423314,0.111275327189591
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,-0.00537216124402624,0.00337629306312788,-0.0119896956477569,0.0012453731597044,0.111590769986259
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMBN,Ameloblastin,28931,0.00313366904587804,0.00197048597816049,-0.000728483471316517,0.00699582156307259,0.11177753630965
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HIP1,Huntingtin-interacting protein 1,24111,-0.00367717859723378,0.00232477510691113,-0.0082337378067796,0.000879380612312034,0.113723159745428
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIF20B,Kinesin-like protein KIF20B,24101,-0.00841913699363355,0.00532787240514481,-0.0188617669077174,0.00202349292045027,0.114072783521107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTR,Methionine synthase,24111,-0.00713640920069373,0.00453207341447252,-0.0160192730930599,0.0017464546916724,0.115351412281598
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PYDC1,Pyrin domain-containing protein 1,24240,-0.00458072553045234,0.00291499274660958,-0.0102941113138071,0.00113266025290243,0.11609439004278
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINB9,Serpin B9,29218,-0.00358415699548943,0.00228406459680801,-0.00806092360523313,0.000892609614254265,0.116611889594403
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DAND5,DAN domain family member 5,24229,0.00593719208610547,0.00378398840197207,-0.00147942518175978,0.0133538093539707,0.116653967994916
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,29349,0.00218720531902407,0.00140056763598303,-0.000557907247502664,0.0049323178855508,0.118379758061788
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBLN4,Cerebellin-4,29725,0.00339642740496614,0.00218783540426036,-0.000891729987384163,0.00768458479731645,0.120573727396428
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP290,Centrosomal protein of 290 kDa,24445,-0.00572039245805893,0.00369379198780324,-0.0129602247541533,0.00151943983803541,0.121478734875053
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.00401139733039429,0.00260596378995075,-0.00109629169790918,0.00911908635869776,0.123740714622448
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK3,Prostate-specific antigen,24938,0.00944346121460057,0.00616908776332642,-0.00264795080151922,0.0215348732307204,0.125838667726881
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,24111,-0.0034682877825362,0.00226783041752171,-0.00791323540087874,0.00097665983580635,0.126192866141928
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMY2B,Alpha-amylase 2B,27585,-0.00516642848029583,0.00338247771112478,-0.0117960847941004,0.00146322783350874,0.126670694943974
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,-0.00472404412203168,0.00309949603905059,-0.0107990563585708,0.00135096811450747,0.127488258533704
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BLMH,Bleomycin hydrolase,29820,-0.00333708717685844,0.00219176566225308,-0.00763294787487449,0.000958773521157604,0.127880294624994
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,-0.00432639723547782,0.00285717083691248,-0.00992645207582628,0.00127365760487065,0.129981921226986
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA1549,UPF0606 protein KIAA1549,24445,-0.00730782454897207,0.00484626321129958,-0.0168065004431192,0.0021908513451751,0.131585434008009
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,-0.00600934094516282,0.0039957907480752,-0.0138410908113902,0.00182240892106457,0.132615683227821
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.00310282862143159,0.00206526753006624,-0.000945095737498239,0.00715075298036141,0.133008419726756
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,-0.0125045395448182,0.00835319164206143,-0.0288767951632586,0.00386771607362215,0.134409852758567
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARG2,"Arginase-2, mitochondrial",24793,-0.00450580401219289,0.00301098062832218,-0.0104073260437044,0.00139571801931858,0.134547257399919
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GID8,Glucose-induced degradation protein 8 homolog,24867,-0.00351700227209825,0.00235109078743692,-0.00812514021547461,0.00109113567127812,0.134691797322909
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FH,"Fumarate hydratase, mitochondrial",24101,-0.00872023954138039,0.00584813551767771,-0.0201825851560287,0.00274210607326792,0.135944536935487
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLP1R,Glucagon-like peptide 1 receptor,24101,0.00393392834833126,0.00264014945568696,-0.00124076458481519,0.00910862128147771,0.136226807162094
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL20,Interleukin-20,28931,-0.00502387634314572,0.00337619098571026,-0.0116412106751378,0.00159345798884638,0.13675366226392
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TET2,Methylcytosine dioxygenase TET2,24421,-0.0103868334761817,0.00698822967564522,-0.0240837636404463,0.00331009668808292,0.137204088697973
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRR1B,Cornifin-B,24445,-0.00884976877583598,0.00595729707787564,-0.0205260710484722,0.00282653349680026,0.13741526362019
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.00503241718695042,0.00339024854223298,-0.0116773043297271,0.00161246995582623,0.137718811814039
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMA1,Laminin subunit alpha-1,24111,0.00555521196072787,0.00375466442156654,-0.00180393030554254,0.0129143542269983,0.13900657777504
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,0.00189928505663118,0.00129649369125231,-0.00064184257822335,0.0044404126914857,0.142949974238318
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,-0.0112789743027663,0.00770607302315817,-0.0263828774281563,0.00382492882262376,0.143301223501232
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSPN,Claspin,28719,-0.00348541890645741,0.00239402740241152,-0.00817771261518399,0.00120687480226917,0.145436467221174
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,-0.0104654889805084,0.00719847974941043,-0.0245745092893528,0.00364353132833606,0.146001677289691
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF5,Fibroblast growth factor 5,28931,-0.00328595605623059,0.00228153338370421,-0.00775776148829085,0.00118584937582967,0.149810284705445
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CALY,Neuron-specific vesicular protein calcyon,24111,0.00383994720743029,0.00267023199753857,-0.0013937075077453,0.00907360192260588,0.150430720258051
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NEO1,Neogenin,24867,-0.00218753299684285,0.00152340339448203,-0.00517340365002763,0.000798337656341927,0.151028801850658
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPA2,Replication protein A 32 kDa subunit,24229,-0.0031619330352582,0.00221058721639753,-0.00749468397939736,0.00117081790888096,0.152626949173337
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RTKN2,Rhotekin-2,24111,0.00514343742797693,0.00359670680429264,-0.00190610790843664,0.0121929827643905,0.152718278520217
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN3B,Sodium channel subunit beta-3,24101,0.00458443000124805,0.00321307819307166,-0.00171320325717241,0.0108820632596685,0.153649612456323
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL7,Interleukin-7,29434,-0.0063277793011654,0.00443563122907026,-0.0150216165101431,0.00236605790781232,0.153711831541148
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPM1B,Protein phosphatase 1B,24229,-0.00616478884588196,0.00434419547055109,-0.0146794119681621,0.00234983427639818,0.155886690677982
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,-0.00624911986840841,0.00440871142843785,-0.0148901942681466,0.00239195453132978,0.156364729103314
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,24229,-0.00289124354175933,0.00204459747658289,-0.00689865459586178,0.00111616751234313,0.157348522558596
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BPIFB2,BPI fold-containing family B member 2,24852,-0.00635920245150414,0.00450110580934067,-0.0151813698378119,0.00246296493480358,0.157724444034724
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEZ6,Seizure protein 6 homolog,24195,0.00304946656923677,0.00217174047897052,-0.00120714476954545,0.007306077908019,0.16028467595859
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ACTN2,Alpha-actinin-2,24111,-0.00577142301558812,0.00411337149720166,-0.0138336311501034,0.00229078511892713,0.16060342360668
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GH2,Growth hormone variant,28797,-0.0160179913850595,0.0114379358931182,-0.0384363457355711,0.00640036296545205,0.161396343889905
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,-0.0029116715448877,0.0020826562709219,-0.00699367783589462,0.00117033474611922,0.162106823876418
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FZD10,Frizzled-10,24195,-0.00583877652238961,0.00418845431950777,-0.0140481469886248,0.00237059394384562,0.163325280547418
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NME1,Nucleoside diphosphate kinase A,24229,0.00211245703520834,0.00152215030070039,-0.000870957554164434,0.00509587162458111,0.165207352857297
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DKKL1,Dickkopf-like protein 1,29349,0.00821933716904629,0.00592500721775112,-0.00339367697774591,0.0198323513158385,0.165382724278303
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,-0.00483068362440591,0.0034831417708289,-0.0116576414952306,0.00199627424641873,0.165492926958132
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CENPJ,Centromere protein J,24445,-0.00692127208670211,0.00499738274164859,-0.0167161422603333,0.00287359808692913,0.166071416663476
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,-0.00473440841978974,0.00342707550674029,-0.0114514764130007,0.00198265957342123,0.167146684304013
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUMF1,Formylglycine-generating enzyme,24229,-0.00632254638656486,0.00462087017805952,-0.0153794519355615,0.0027343591624318,0.171243770287512
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARHGAP1,Rho GTPase-activating protein 1,28797,-0.00435469707794593,0.0031885498912027,-0.0106042548647032,0.00189486070881136,0.172034510986049
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,-0.0051614898593757,0.0037854241070488,-0.0125809211091914,0.00225794139043996,0.172732328184173
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,0.00495445843999026,0.00364562800567516,-0.00219097245113306,0.0120998893311136,0.1741550384456
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,-0.00649296169941903,0.00478671684467891,-0.0158749267149897,0.00288900331615163,0.174967263971185
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZPR1,Zinc finger protein ZPR1,24101,-0.00909888075564257,0.00673247694258871,-0.0222945355631164,0.00409677405183131,0.176550952048182
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,0.002389795513524,0.00178408184451245,-0.0011070049017204,0.00588659592876841,0.180416953064097
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.00400310708601003,0.00299903952765757,-0.00187501038819879,0.00988122456021886,0.181955186842787
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK14,Kallikrein-14,29725,0.0042142413547942,0.00317803021310603,-0.00201469786289363,0.010443180572482,0.184831830432154
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BMP4,Bone morphogenetic protein 4,29169,-0.00420327387752717,0.00318555868545405,-0.0104469689010171,0.00204042114596276,0.187019797842694
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,-0.00716949816061711,0.00543823981691827,-0.0178284482017769,0.00348945188054269,0.187399323620787
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AIF1L,Allograft inflammatory factor 1-like,24240,-0.00520916937619168,0.00397924757742564,-0.0130084946279459,0.00259015587556257,0.190518311414867
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.00320317634432178,0.00244897536568385,-0.00159681537241856,0.00800316806106213,0.190895310814046
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,28916,0.00301269454508635,0.00230507822704749,-0.00150525877992673,0.00753064787009943,0.191229400943494
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ODAM,Odontogenic ameloblast-associated protein,28722,-0.00483255168173883,0.00369869680232421,-0.0120819974142943,0.00241689405081662,0.191374274005738
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,0.00393198894638947,0.00301132977082969,-0.00197021740443673,0.00983419529721567,0.191656255877653
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP13,Collagenase 3,28774,0.00294260477307217,0.00225823959778787,-0.00148354483859205,0.00736875438473639,0.192567267889487
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,0.00430970346930063,0.00332572603969893,-0.00220871956850927,0.0108281265071105,0.195033220311477
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOH,Beta-2-glycoprotein 1,29443,-0.00320533573911396,0.00247450421476877,-0.00805536400006075,0.00164469252183283,0.195211531550113
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFDN2,Prefoldin subunit 2,28774,-0.00494989972700216,0.00383482511956295,-0.0124661569613455,0.00256635750734122,0.196791783501649
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RYR1,Ryanodine receptor 1,24111,0.00305280546638751,0.00236982072376939,-0.00159204315220049,0.00769765408497551,0.197688367301165
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRD2,Bromodomain-containing protein 2,24101,-0.00310832348300269,0.00241698751894101,-0.00784561902012706,0.00162897205412168,0.198444228579491
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL4A4,Collagen alpha-4(IV) chain,24405,0.00473222981300291,0.00368124490375738,-0.00248301019836156,0.0119474698243674,0.198630818806751
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLEC4C,C-type lectin domain family 4 member C,29434,-0.00414907023695362,0.00323120908493485,-0.0104822400434259,0.00218409956951869,0.19913065221541
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.0109415663413678,0.00852552297764862,-0.00576845869482345,0.0276515913775591,0.199365996731153
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC50,Coiled-coil domain-containing protein 50,24867,-0.00681191546462416,0.00531617117129374,-0.0172316109603599,0.00360778003111156,0.200080102108994
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,28662,-0.00507867852184606,0.00397821098683593,-0.0128759720560445,0.00271861501235237,0.201745470469901
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.00498619947140743,0.00391992001735154,-0.00269684376260159,0.0126692427054165,0.203379851588328
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL1A,Interleukin-1 alpha,28931,-0.00487187225524432,0.00383583369484552,-0.0123901062971415,0.00264636178665289,0.204061099445303
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSH1,Chorionic somatomammotropin hormone 1,24951,-0.00282481277225079,0.00223406851681009,-0.00720358706519857,0.00155396152069699,0.206089231411221
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GJA8,Gap junction alpha-8 protein,24016,-0.00546406924732864,0.0043304360527744,-0.0139517239107665,0.00302358541610918,0.207039254425031
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN15,Tetraspanin-15,24111,0.00441904197623148,0.00351422015481488,-0.00246882952720569,0.0113069134796686,0.208594079916262
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SOX2,Transcription factor SOX-2,24826,0.00208243303976914,0.00165645375205292,-0.00116421631425458,0.00532908239379285,0.208706304861368
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,-0.00745138497947771,0.00594083978442186,-0.0190954309569446,0.00419266099798913,0.209758016133859
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,-0.00243051601240677,0.00195554938572039,-0.00626339280841874,0.0014023607836052,0.213921421092151
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,-0.0062424253226967,0.00503398727779317,-0.0161090403871713,0.00362418974177792,0.214964723207999
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP15,Matrix metalloproteinase-15,24922,-0.00420750499488005,0.00341655449229451,-0.0109039517997773,0.00248894181001718,0.218145559193923
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VEGFD,Vascular endothelial growth factor D,29732,0.00303369176647085,0.00246712474236652,-0.00180187272856753,0.00786925626150923,0.218839173757884
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF16,Fibroblast growth factor 16,24229,-0.00407515231089148,0.00332696070172906,-0.0105959952862804,0.00244569066449747,0.220629555754125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UNG,Uracil-DNA glycosylase,24793,-0.00291055935308046,0.00239136477577824,-0.00759763431360581,0.00177651560744489,0.223573103524856
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ID4,DNA-binding protein inhibitor ID-4,24445,0.00371506522587511,0.00305383552294464,-0.00227045239909639,0.0097005828508466,0.223796999588228
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENSA,Alpha-endosulfine,24793,-0.00444479794883523,0.00366622517204712,-0.0116305992860476,0.00274100338837713,0.225384787069835
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSTN1,Calsyntenin-1,28774,0.00430329140127549,0.00356236829115277,-0.00267895044938395,0.0112855332519349,0.227062539588873
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,0.00251859029499897,0.00209519331843533,-0.00158798860913428,0.00662516919913222,0.229344294429472
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAPT,Microtubule-associated protein tau,28774,-0.00438280579254413,0.00364911394861163,-0.0115350691318229,0.00276945754673467,0.229737713421647
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA2013,Uncharacterized protein KIAA2013,24793,-0.00464691596501154,0.00387059171418959,-0.0122332757248231,0.00293944379480005,0.229929553926013
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUP50,Nuclear pore complex protein Nup50,24111,0.00281015644451083,0.00234712147319678,-0.00179020164295486,0.00741051453197652,0.231210070237328
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CFHR5,Complement factor H-related protein 5,24623,-0.00346720159728892,0.00290356939380966,-0.00915819760915585,0.00222379441457801,0.232443710898128
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRISP3,Cysteine-rich secretory protein 3,24738,0.002228687681402,0.00188382411918112,-0.001463607592193,0.00592098295499701,0.236794490070599
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH23,Cadherin-23,24845,0.00216731273025312,0.00184181990090611,-0.00144265427552286,0.0057772797360291,0.239317171419577
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,0.0150154401313736,0.0127836762683931,-0.0100405653546768,0.040071445617424,0.240172648233545
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA8,Carbonic anhydrase-related protein,24229,-0.00221769551650096,0.00189338147460641,-0.00592872320672952,0.00149333217372759,0.241494448907995
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-0.00679061278766063,0.0058417172398529,-0.0182403785777723,0.00465915300245105,0.245070634576679
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,24729,-0.0035690027910617,0.00307512906834728,-0.00959625576502237,0.00245825018289897,0.245814757960987
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB118,Beta-defensin 118,24101,-0.00465441669203679,0.0040115932968104,-0.0125171395537852,0.00320830616971159,0.24596202820683
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMEM25,Transmembrane protein 25,24867,-0.00363763870353989,0.00314056755501848,-0.00979315111137611,0.00251787370429634,0.246763243548683
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENOPH1,Enolase-phosphatase E1,24793,0.00444331665377671,0.00385038959592621,-0.00310344695423868,0.0119900802617921,0.248514806215903
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SELL,L-selectin,24966,0.00184313113584003,0.00161062834607972,-0.00131370042247621,0.00499996269415628,0.25248728199871
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEMA6C,Semaphorin-6C,24229,-0.00207406807285028,0.00182059490504634,-0.00564243408674112,0.00149429794104055,0.254620397286406
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,0.00265787241378578,0.00233855334786143,-0.00192569214802262,0.00724143697559418,0.255739613466245
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,0.00521983203049013,0.00459503390813682,-0.00378643442945803,0.0142260984904383,0.255979382668198
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,-0.00549111336394938,0.0048348968127553,-0.0149675111169498,0.003985284389051,0.25608291481516
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSTM4,Glutathione S-transferase Mu 4,24111,0.00574586675092924,0.00506187608788986,-0.00417541038133488,0.0156671438831934,0.256333853206092
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HBZ,Hemoglobin subunit zeta,24922,-0.00826410222388485,0.00735048468432157,-0.0226710522051551,0.00614284775738543,0.260899365554117
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,0.00281578637161014,0.00250955744935807,-0.00210294622913167,0.00773451897235195,0.261861097432106
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,0.00548995882926978,0.00489694990150197,-0.00410806297767408,0.0150879806362136,0.262257175443321
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TNC,Tenascin,29594,0.0036852556241956,0.00329209361508147,-0.00276724786136409,0.0101377591097553,0.2629674771195
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAPS,Calcyphosin,24845,-0.00734784056190385,0.00657794755941243,-0.0202406177783522,0.00554493665454451,0.263987379634383
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,0.00421735566577164,0.00378498684026813,-0.0032012185411539,0.0116359298726972,0.265190538124629
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.00508369679907098,0.00457201729310843,-0.0140448506935635,0.00387745709542154,0.266185585749988
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,-0.00205024838232105,0.0018460423495284,-0.00566849138739672,0.00156799462275462,0.266743815914701
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,-0.00909387762124775,0.00822158270973866,-0.0252081797323355,0.00702042448984003,0.268693045698077
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL24,Interleukin-24,28931,-0.00367993992876311,0.00335973664239672,-0.0102650237478607,0.00290514389033447,0.273391692749922
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGS10,Regulator of G-protein signaling 10,24867,-0.00453225835360825,0.00414294756460555,-0.0126524355802351,0.00358791887301862,0.27397894950448
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,F13B,Coagulation factor XIII B chain,24833,0.00195084460650296,0.00179319487032881,-0.00156381733934151,0.00546550655234743,0.276642949473022
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRD3,Bromodomain-containing protein 3,24111,-0.0035628598324206,0.00332550925503786,-0.0100808579722948,0.00295513830745361,0.284012612623471
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B4,Protein ATP1B4,24016,0.00312978966060941,0.00292617236317479,-0.00260550817121318,0.00886508749243201,0.284816968497967
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NXPH3,Neurexophilin-3,24229,0.00224168060558944,0.00210204561611689,-0.00187832880199967,0.00636169001317856,0.286240777070748
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNMA2,Paraneoplastic antigen Ma2,24101,-0.00325406030724823,0.00305374757159502,-0.00923940554757448,0.00273128493307802,0.286617121043722
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYT1,Synaptotagmin-1,24845,-0.00292149189408431,0.00274356746109839,-0.00829888411783716,0.00245590032966854,0.28695349521772
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLSTN2,Calsyntenin-2,29786,0.0028968297177906,0.00272874171889381,-0.00245150405124126,0.00824516348682246,0.288426339677689
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SAP18,Histone deacetylase complex subunit SAP18,24445,-0.00542511519924716,0.00511343680848299,-0.0154474513438738,0.0045972209453795,0.288721831173977
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDCL2,Phosducin-like protein 2,24016,-0.00391497657753624,0.00369319419620076,-0.0111536372020897,0.00332368404701725,0.289131772239492
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,24111,-0.0044566759990625,0.00423601034683978,-0.0127592562788685,0.00384590428074347,0.292767523771497
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUOX2,Dual oxidase 2,28916,0.0051767906683419,0.00492809014054917,-0.00448226600713447,0.0148358473438183,0.293512741933041
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PVALB,Parvalbumin alpha,29599,0.00811793190741769,0.00773242906503664,-0.00703762906005411,0.0232734928748895,0.293793205224619
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,-0.00325224602771528,0.00309788662182389,-0.00932410380649011,0.00281961175105955,0.293807986560623
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FN1,Fibronectin,24966,-0.00194799513795222,0.00185631980137375,-0.00558638194864477,0.00169039167274034,0.294010879070857
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRXN3,Neurexin-3,24195,-0.0025639431892647,0.00245374256365427,-0.00737327861402708,0.00224539223549767,0.296074438817872
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",24016,-0.00672498089696263,0.00643968340199614,-0.0193467603648751,0.00589679857094981,0.29635572820245
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A16,Protein S100-A16,28722,0.00441270875004168,0.00424242111553889,-0.00390243663641453,0.0127278541364979,0.298283966823633
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMPRSS11B,Transmembrane protease serine 11B,24101,-0.00557615758910167,0.00538120550156154,-0.0161233203721623,0.00497100519395895,0.300106035720568
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENG,Endoglin,29820,0.00122922333149628,0.00118725952314285,-0.0010978053338637,0.00355625199685627,0.300516173751725
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,0.00303757839682528,0.0029353555396091,-0.00271571846080856,0.00879087525445912,0.300760857390394
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FRMD7,FERM domain-containing protein 7,24195,0.00240801802819741,0.0023324011098281,-0.00216348814706567,0.00697952420346049,0.301885636936531
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.00461507160047471,0.0044923359325867,-0.0134200500283446,0.00418990682739522,0.304279449552472
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,24195,-0.00549215973744522,0.00534959156768223,-0.0159773592101024,0.00499303973521196,0.304595433728962
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MYOC,Myocilin,29443,0.00322797190860827,0.00314494422056133,-0.00293611876369194,0.00939206258090848,0.304711340374023
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,INSL3,Insulin-like 3,24845,0.00537391592651635,0.00523933266804134,-0.00489517610284466,0.0156430079558774,0.305049088766425
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGA6,Integrin alpha-6,29434,-0.00366892059835715,0.0035883928640321,-0.0107021706118601,0.00336432941514576,0.306580550352467
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD164L2,CD164 sialomucin-like 2 protein,24195,-0.00260191972172947,0.00254821321480755,-0.00759641762275227,0.00239257817929333,0.307228580077426
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DOCK9,Dedicator of cytokinesis protein 9,24101,-0.0084193674923533,0.00824560600116618,-0.024580755254639,0.00774202026993241,0.307230003560235
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BEX3,Protein BEX3,24016,0.0033403551315196,0.00328763095036387,-0.00310340153119359,0.00978411179423279,0.309621944780397
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRP1,Neuropilin-1,29628,0.00194516727613749,0.00191577062380727,-0.00180974314652475,0.00570007769879974,0.309949906755334
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINI1,Neuroserpin,24329,-0.00214435223693304,0.0021266061494472,-0.00631250028984956,0.00202379581598348,0.313299000450707
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,-0.00345363221479156,0.00343263074409039,-0.0101815884732087,0.00327432404362561,0.314368686433956
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CPLX2,Complexin-2,24016,0.00214232244416564,0.00214248772657278,-0.002056953499917,0.00634159838824829,0.317357923399978
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORF4L2,Mortality factor 4-like protein 2,24016,-0.00255408179448156,0.00257209607085041,-0.00759539009334836,0.00248722650438524,0.320721784419408
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,0.00254120149213667,0.00256426366435174,-0.00248475528999275,0.00756715827426609,0.321692335723118
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LMOD2,Leiomodin-2,24101,-0.00435353819533157,0.00441172898805139,-0.0130005270119123,0.00429345062124915,0.323745713419444
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPM3,Tropomyosin alpha-3 chain,24111,0.00301827229415025,0.00306456461926877,-0.00298827435961655,0.00902481894791704,0.324685871125261
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENO2,Gamma-enolase,29694,-0.00442626555037071,0.00450843790293032,-0.0132628038401141,0.00441027273937272,0.326219373335122
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,24229,0.00329783769699261,0.00336068163376972,-0.00328909830519603,0.00988477369918126,0.326454507898204
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MATN3,Matrilin-3,29169,0.00216216370607585,0.00221474842823793,-0.0021787432132705,0.00650307062542219,0.328945211918073
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,24751,-0.00273363905528018,0.00280272019652877,-0.00822697064047657,0.0027596925299162,0.329395168240422
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MZT1,Mitotic-spindle organizing protein 1,28797,0.00353681857683994,0.00363088223157591,-0.00357971059704884,0.0106533477507287,0.330018330680872
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BGLAP,Osteocalcin,24938,-0.0059527944483988,0.00614334453430303,-0.0179937497356327,0.00608816083883515,0.33256323372958
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UNC5D,Netrin receptor UNC5D,24229,0.00177507683189444,0.00183533473259348,-0.00182217924398877,0.00537233290777766,0.333469767554348
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPBGL,Trophoblast glycoprotein-like,24195,0.00275368382070397,0.00286394453904702,-0.00285964747582818,0.00836701511723612,0.336310238576917
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,24111,-0.00756471642038671,0.00787241085283623,-0.0229946416919457,0.0078652088511723,0.336604629854176
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RANGAP1,Ran GTPase-activating protein 1,28797,-0.00325221029057898,0.00338520524179185,-0.00988721256449101,0.00338279198333304,0.336704621520149
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,0.00264079387952615,0.00278802494669528,-0.0028237350159966,0.00810532277504889,0.343550640402472
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB2B,Ras-related protein Rab-2B,24793,-0.00403225373612727,0.00428699828905373,-0.0124347703826726,0.00437026291041803,0.346930633150872
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BSND,Barttin,24016,0.00221758959884778,0.00235904090363462,-0.00240613057227608,0.00684130976997164,0.34720720181241
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DUSP3,Dual specificity protein phosphatase 3,28774,-0.00551496127110224,0.00587220889141111,-0.017024490698268,0.00599456815606353,0.347654953941133
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CBLN1,Cerebellin-1,24101,0.00624368930918508,0.00665449055230961,-0.00679911217334175,0.0192864907917119,0.348116589478412
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,-0.00246368524238426,0.00262797255082418,-0.00761451144199965,0.00268714095723112,0.348516712762665
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR158,Probable G-protein coupled receptor 158,24867,-0.00233588254116422,0.00249223499385626,-0.00722066312912249,0.00254889804679404,0.348631800783319
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,24845,-0.00199218534400551,0.00213846835084641,-0.00618358331166448,0.00219921262365347,0.3515551863395
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TREML1,Trem-like transcript 1 protein,24951,0.00340867767815909,0.00366620221310252,-0.00377707865952185,0.01059443401584,0.352505842947437
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,-0.00412315940516669,0.00444200972478944,-0.012829498465754,0.00458317965542061,0.353303130160939
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,-0.00214459356242839,0.00231270723936582,-0.0066774997515854,0.00238831262672862,0.353773903518732
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,METAP1,Methionine aminopeptidase 1,28774,-0.00191118085184397,0.00206255144460214,-0.00595378168326417,0.00213141997957623,0.354136821912112
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,-0.00297895033065324,0.00323907126378517,-0.00932753000767217,0.00336962934636569,0.357740821194587
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGS8,Regulator of G-protein signaling 8,28931,-0.0041252325986337,0.00449394386263022,-0.0129333625693889,0.00468289737212153,0.358650738525216
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RELB,Transcription factor RelB,24229,-0.00314658717044301,0.003433289526955,-0.00987583464327482,0.0035826603023888,0.359417297926108
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,STEAP4,Metalloreductase STEAP4,24101,0.0046980696032037,0.00516009385538222,-0.00541571435334544,0.0148118535597529,0.362588000321605
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPHA2,Glycoprotein hormone alpha-2,24805,-0.00293851764503346,0.00323646706666877,-0.00928199309570424,0.00340495780563732,0.363918791229972
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB2,Integrin beta-2,29274,-0.00179990164087935,0.00198321605618124,-0.00568700511099458,0.00208720182923588,0.364114458468046
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.00196108119507734,0.00216224827857207,-0.00227692543092392,0.00619908782107859,0.364433433667586
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,0.00139911839471707,0.00154301753928454,-0.00162519598228064,0.00442343277171477,0.364552151171525
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDH4,Cadherin-4,24101,-0.00298804321454052,0.0033509103670739,-0.00955582753400537,0.00357974110492432,0.3725568306294
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,24111,0.00307131440603575,0.00344913710231396,-0.00368899431449961,0.00983162312657111,0.373228483934458
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,-0.00258851420387355,0.00292378736848213,-0.00831913744609853,0.00314210903835142,0.37598653100204
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTTG1,Securin,24445,-0.00252764586474588,0.00288001165106232,-0.00817246870082802,0.00311717697133626,0.380141630823823
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,0.00148043196535697,0.00170669532621218,-0.00186469087401891,0.00482555480473285,0.385715663499105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TLR4,Toll-like receptor 4,24229,-0.00169587404597048,0.00197086590466665,-0.00555877121911711,0.00216702312717615,0.389537677184185
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MLLT1,Protein ENL,24016,0.00414135349099013,0.00481546366325179,-0.00529695528898338,0.0135796622709636,0.389791366014688
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EXOSC10,Exosome component 10,24111,-0.00361952488864258,0.00421484161583908,-0.0118806144556872,0.00464156467840202,0.390483118406621
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAGEA3,Melanoma-associated antigen 3,24445,-0.00507145708666002,0.00592404398047392,-0.0166825832883889,0.00653966911506885,0.391961784951752
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTXR,Neuronal pentraxin receptor,29478,-0.00200044650084611,0.00234782596927847,-0.00660218540063191,0.00260129239893969,0.394197667409094
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.00324187001802761,0.0038318929479833,-0.0107523801960749,0.00426864016001967,0.397548282222326
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCUN1D2,DCN1-like protein 2,24016,0.00472343822368026,0.00558531409899091,-0.00622377741034192,0.0156706538577024,0.397734738717583
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGLON5,IgLON family member 5,24016,0.00549322436053166,0.00649659325561286,-0.00724009842046954,0.0182265471415329,0.397809686137229
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,0.00206101002905825,0.00245243636810299,-0.00274576525242361,0.0068677853105401,0.400696485855577
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAGLN3,Transgelin-3,24016,-0.00352845194386058,0.00420737113550252,-0.0117748993694455,0.00471799548172435,0.401682081684485
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KHDC3L,KH domain-containing protein 3,24016,0.00393421886978101,0.00470500489318845,-0.00528759072086835,0.0131560284604304,0.403063421398687
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDA1,DET1- and DDB1-associated protein 1,24111,-0.00230811204865748,0.00277486839245991,-0.00774685409787891,0.00313063000056395,0.405534863417934
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,0.00327662579839538,0.003954648249209,-0.00447448477005425,0.011027736366845,0.407367044590671
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL5,Interleukin-5,28931,-0.00810082629314917,0.00979825213533605,-0.0273054004784078,0.0111037478921095,0.408378576379848
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA11,Carbonic anhydrase-related protein 11,28797,-0.00182230256827365,0.00220419015711262,-0.00614251527621438,0.00249791013966709,0.408388623365211
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,-0.00151885346033823,0.0018406610230479,-0.00512654906551211,0.00208884214483565,0.40928323818768
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,24229,-0.0013195951966759,0.00162210669467412,-0.00449892431823717,0.00185973392488537,0.415935417138606
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TEF,Thyrotroph embryonic factor,24111,-0.00241302072786895,0.00297647642616506,-0.00824691452315247,0.00342087306741457,0.417547660836433
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ALMS1,Alstrom syndrome protein 1,24445,0.00250215684012625,0.00310989491300612,-0.00359323718936574,0.00859755086961824,0.421070363602613
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FAM171A2,Protein FAM171A2,24867,-0.00883809556057205,0.0110118950011922,-0.0304214097629087,0.0127452186417646,0.422216340079313
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,-0.00602190077731794,0.00751770490079279,-0.0207566023828718,0.00871280082823594,0.423122830830393
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CX3CL1,Fractalkine,29218,0.00184577773656079,0.0023265158762389,-0.00271419338086745,0.00640574885398904,0.427571274351678
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,-0.00346973295061866,0.00438385048063511,-0.0120620798926635,0.00512261399142615,0.428671230996287
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LEG1,Protein LEG1 homolog,23603,-0.00384633907980054,0.00486343756475228,-0.013378676706715,0.00568599854711393,0.429028741981616
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC123,Cell division cycle protein 123 homolog,24016,-0.00348888773999486,0.00441244900671799,-0.0121372877931621,0.0051595123131724,0.429131609526912
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PMCH,Pro-MCH,24111,-0.00459025172012051,0.00581293595957411,-0.0159836062008858,0.00680310276064475,0.4297332521897
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,-0.00340449741829783,0.0043309980568108,-0.011893253609647,0.00508425877305133,0.431829967994181
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.00187887422840836,0.00239781742152102,-0.00282084791777283,0.00657859637458955,0.43329466869526
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL13,Interleukin-13,28931,-0.0025934868711635,0.00332078113233497,-0.00910221789054005,0.00391524414821305,0.434816538167035
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGAX,Integrin alpha-X,24445,-0.00289719330391141,0.00372698796042092,-0.0102020897063364,0.0044077030985136,0.436956789513154
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD82,CD82 antigen,24445,0.00224523400569332,0.0028953349431882,-0.00342962248295555,0.00792009049434219,0.438071814011822
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,-0.00629930370427621,0.00813223338732722,-0.0222384811434376,0.00963987373488516,0.438576886931423
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,-0.00304621528152362,0.00393403910258618,-0.0107569319225925,0.00466450135954529,0.438747658105134
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK12,Kallikrein-12,28797,-0.00739647257861006,0.00957898758817466,-0.0261712882514324,0.0113783430942123,0.440028387807719
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,24445,-0.00288292045944627,0.00375904540737936,-0.0102506494579098,0.00448480853901729,0.443131216456806
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OMP,Olfactory marker protein,24101,-0.0026369269841795,0.00343833988138016,-0.00937607315168461,0.0041022191833256,0.443137400251614
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNF174,Zinc finger protein 174,24229,-0.00201076830988461,0.0026292098306035,-0.00716401957786747,0.00314248295809825,0.444409736555052
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HBQ1,Hemoglobin subunit theta-1,29725,0.00315899669608223,0.00414621468369803,-0.0049675840839659,0.0112855774761304,0.446126352711129
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANXA4,Annexin A4,29341,-0.00375875266009939,0.00496395571775803,-0.0134881058669051,0.00597060054670634,0.448930656269807
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPCAM,Epithelial cell adhesion molecule,29457,0.00505358492167198,0.00668095445298079,-0.00804108580617037,0.0181482556495143,0.449405504291419
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PALLD,Palladin,24229,0.00208812308742422,0.0027758103348079,-0.00335246516879926,0.0075287113436477,0.451903761430627
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIPC3,PDZ domain-containing protein GIPC3,24805,-0.005127104653394,0.00681901481666067,-0.0184923736940489,0.00823816438726091,0.452128266094299
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,0.00401489014659353,0.00540632153318369,-0.0065815000584465,0.0146112803516336,0.457713652736062
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF20,Fibroblast growth factor 20,24229,0.0022606600081259,0.00305297888953574,-0.00372317861536414,0.00824449863161594,0.459017918954419
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SEPTIN7,Septin-7,24445,-0.00270358766688475,0.00366886756620364,-0.00989456809664389,0.00448739276287438,0.461190379925863
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DEFB116,Beta-defensin 116,24101,-0.00394895305465796,0.00537615212212628,-0.0144862112140255,0.00658830510470955,0.462632022840135
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TP73,Tumor protein p73,24195,0.00174846500282674,0.00240517739635546,-0.00296568269402996,0.00646261269968343,0.467258199483754
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HEBP1,Heme-binding protein 1,28916,0.00267063660705957,0.00367851887007776,-0.00453926037829284,0.00988053359241198,0.467839332044068
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,0.00245817789665398,0.00339958825154761,-0.00420501507637933,0.00912137086968729,0.469637127000459
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,-0.00280127364009264,0.00387949822721677,-0.0104050901654375,0.00480254288525222,0.470257662317723
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UPK3A,Uroplakin-3a,24101,0.0024662350134699,0.00343077645661275,-0.0042580868414911,0.0091905568684309,0.472236483734156
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.00186881400031587,0.00260536017579113,-0.00323769194423476,0.00697531994486649,0.473197500134402
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OBP2B,Odorant-binding protein 2b,29137,-0.00308707177803181,0.00431446328974419,-0.0115434198259304,0.00536927626986681,0.474295383794848
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.0019741391610696,0.0027638224123496,-0.00739123108927481,0.0034429527671356,0.475061850527718
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LHB,Lutropin subunit beta,28797,-0.00429019131977268,0.00600879673263226,-0.0160674329157319,0.00748705027618655,0.475242184264415
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,-0.00295873034511449,0.00414857984468659,-0.0110899468407002,0.00517248615047122,0.475734403927396
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OTOA,Otoancorin,24101,-0.00265894516570213,0.00374106476274035,-0.00999143210067322,0.00467354176926896,0.477248803868282
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,-0.00171640498087893,0.00244191968030165,-0.00650256755427017,0.0030697575925123,0.482130022269773
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHC1,SHC-transforming protein 1,24016,-0.00566603511318308,0.00812193249719017,-0.0215850228076758,0.0102529525813096,0.485420660337596
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,24793,0.00195286243134117,0.00283588963938381,-0.00360548126185109,0.00751120612453344,0.491066191306662
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DNM1,Dynamin-1,24805,0.00546505035512949,0.00793988826477172,-0.0100971306438231,0.0210272313540821,0.491268318924229
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,24016,-0.00302627873376034,0.00441102077726835,-0.0116718794572063,0.00561932198968563,0.492674206700819
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTRC,Chymotrypsin-C,29456,0.00301439425703446,0.00440645341834391,-0.00562225444291959,0.0116510429569885,0.493926079165561
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TFAP2A,Transcription factor AP-2-alpha,24101,-0.00284128700768365,0.00418145733313112,-0.0110369433806206,0.00535436936525334,0.496829644311095
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYTH3,Cytohesin-3,24016,-0.00344325646341819,0.00510556808596585,-0.0134501699119113,0.00656365698507488,0.500055901129813
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,-0.00235044217355927,0.00349778890673153,-0.00920610843075306,0.00450522408363452,0.50160324082033
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPHS2,Podocin,24229,0.00482512600118317,0.00718255001202509,-0.009252672022386,0.0189029240247523,0.501727285958937
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,24445,-0.00306903948284063,0.00460995813397931,-0.0121045574254401,0.00596647845975881,0.505582761123959
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APOB,Apolipoprotein B-100,24951,0.001035889656248,0.0015641605778204,-0.00202986507627998,0.00410164438877599,0.507807174924246
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,-0.00178483537674723,0.00270279225089615,-0.00708230818850369,0.00351263743500922,0.509023498216095
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCARE,Photoreceptor cilium actin regulator,24101,-0.00386982441341477,0.00589963565440899,-0.0154331102960564,0.00769346146922685,0.511867097486016
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,0.00292746825512576,0.00452738382657087,-0.00594620404495315,0.0118011405552047,0.517888171955562
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DIPK1C,Divergent protein kinase domain 1C,24195,0.00189772923701993,0.00295105074347375,-0.00388633022018861,0.00768178869422848,0.520185429249012
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFDN4,Prefoldin subunit 4,24016,0.00239141830301133,0.00372658686041116,-0.00491269194339454,0.0096955285494172,0.521062351904796
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXDC2,Plexin domain-containing protein 2,24845,-0.00120088082469364,0.00187825130928217,-0.00488225339088669,0.00248049174149941,0.522593946355421
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF3,Fibroblast growth factor 3,24229,-0.00131231053217335,0.002087313096656,-0.00540344420161911,0.00277882313727241,0.52954614174162
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DIPK2B,Divergent protein kinase domain 2B,24381,-0.00122147117198284,0.00195836055412163,-0.00505985785806122,0.00261691551409555,0.532816476930901
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL31,Interleukin-31,24229,0.00246170573144072,0.00395707865308802,-0.00529416842861181,0.0102175798914932,0.533880792291219
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,0.0010892293301882,0.00176305643744917,-0.00236636128721217,0.00454481994758857,0.536707943420465
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDKL5,Cyclin-dependent kinase-like 5,24101,-0.00229091151061134,0.00371026548127672,-0.00956303185391371,0.00498120883269104,0.536942350383912
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL2,Interleukin-2,28931,0.00133971989306756,0.00217657261959338,-0.00292636244133547,0.00560580222747059,0.538217448807274
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HDAC9,Histone deacetylase 9,24101,-0.00276631316142493,0.00451595212565114,-0.0116175793277012,0.0060849530048513,0.540169943682932
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.00300283306000696,0.00490214976953061,-0.00660538048827304,0.012611046608287,0.540175757820708
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,24101,0.00300792884105522,0.00493273911510624,-0.00666023982455301,0.0126760975066634,0.542007504023559
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,0.00114013654288686,0.00187244689277645,-0.00252985936695497,0.0048101324527287,0.542595004627895
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,POMC,Pro-opiomelanocortin,24240,-0.00296122742614805,0.00490496770180072,-0.0125749641216774,0.00665250926938136,0.546035423443017
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PFDN6,Prefoldin subunit 6,24195,-0.00274283564725427,0.00455064723098349,-0.0116621042199819,0.00617643292547337,0.546690457904973
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGM2,Phosphoglucomutase-2,24195,0.00249800653012284,0.00418558358103956,-0.0057057372887147,0.0107017503489604,0.550638489225958
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SKIV2L,Helicase SKI2W,24111,-0.00165926301152925,0.00278140307766238,-0.00711081304374752,0.00379228702068902,0.550809383093156
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNTN2,Contactin-2,29725,-0.00183353075170731,0.00307613901622728,-0.00786276322351277,0.00419570172009816,0.551146780201983
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,-0.00192959286174965,0.0032758027695586,-0.00835016629008451,0.0044909805665852,0.555836201014709
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK7,Kallikrein-7,23801,0.00160283020815416,0.00272678819400317,-0.00374167465209204,0.00694733506840036,0.556666189096511
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,24101,0.00285899548438118,0.00488550946796535,-0.0067166030728309,0.0124345940415933,0.558419367617836
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BRD1,Bromodomain-containing protein 1,24445,0.0012334081961051,0.00213506508345603,-0.00295131936746872,0.00541813575967892,0.563477981428713
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,0.0019604660859983,0.00344026422820069,-0.00478245180127505,0.00870338397327164,0.568778559412124
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,-0.00314170223642697,0.00553778521864494,-0.0139957612649711,0.00771235679211711,0.570501277028232
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PROC,Vitamin K-dependent protein C,29545,-0.00100853892284334,0.00178255278943467,-0.00450234239013529,0.00248526454444861,0.571545275879854
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDM1,Nuclear protein MDM1,24195,-0.00122275336576237,0.00217575206562518,-0.00548722741438773,0.00304172068286299,0.574127270261196
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,-0.00192710723049268,0.0034649097452551,-0.00871833033119268,0.00486411587020732,0.578094211604875
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL36A,Interleukin-36 alpha,24229,0.00223678000450079,0.00404876082009335,-0.00569879120288218,0.0101723512118838,0.580638060613648
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSC1,Hamartin,24229,-0.00287901652265178,0.00521707178668744,-0.0131044772245592,0.00734644417925561,0.581059443291837
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANK2,Ankyrin-2,24111,0.00274110452725712,0.00501233323178784,-0.00708306860704704,0.0125652776615613,0.58447176092868
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,24195,-0.00247705065170394,0.0045769548508008,-0.0114478821592735,0.00649378085586563,0.588374318647959
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC4A1,Band 3 anion transport protein,24938,-0.00174838882987494,0.00324487934111939,-0.00810835233846894,0.00461157467871907,0.59001950175178
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF7,Fibroblast growth factor 7,24016,-0.00294033402020743,0.00552786912959501,-0.0137749575142136,0.00789428947379879,0.59479260852816
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,0.00345279449532942,0.00651080752059737,-0.00930838824504142,0.0162139772357003,0.595896792831061
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EXTL1,Exostosin-like 1,24111,0.00174022271296005,0.00330489098274749,-0.00473736361322503,0.00821780903914512,0.598504165670199
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,-0.00132917357467367,0.00253154888000517,-0.00629100937948379,0.00363266223013646,0.59955678151766
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP152,Centrosomal protein of 152 kDa,24016,-0.00151589729583836,0.00290217352645892,-0.00720415740769784,0.00417236281602113,0.601444206669491
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLU,Clusterin,24966,0.00113825485281243,0.00220326054234167,-0.00318013581017724,0.00545664551580211,0.605424004648055
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SHH,Sonic hedgehog protein,24229,0.00154262987320127,0.00298887270065213,-0.00431556062007691,0.00740082036647945,0.605772299752841
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,0.00162815123111754,0.0031549867665831,-0.00455562283138533,0.00781192529362041,0.605818836464934
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORN4,MORN repeat-containing protein 4,24016,-0.00281412956675235,0.00546216281432147,-0.0135199686828224,0.00789170954931772,0.606415035175787
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,0.00158814116475924,0.00308400062521137,-0.00445650006065505,0.00763278239017353,0.606584720037151
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL25,Interleukin-25,23913,0.00123896031219532,0.00240828222344834,-0.00348127284576343,0.00595919347015408,0.606936500348771
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,0.00182237746006984,0.00355563713223862,-0.00514667131911785,0.00879142623925754,0.608283515771715
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,24404,-0.00193496427639774,0.00378237019401286,-0.00934840985666295,0.00547848130386748,0.608953442106523
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,0.00204867376790517,0.00401607172792804,-0.00582282681883378,0.00992017435464412,0.609972912218176
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLK,STE20-like serine/threonine-protein kinase,24445,-0.00274641778787797,0.00543778147778122,-0.0134044694843292,0.00791163390857321,0.613519716844824
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,-0.00141918919556521,0.00280994447755046,-0.00692668037156411,0.00408830198043369,0.613521654193105
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FRMD4B,FERM domain-containing protein 4B,24111,-0.00245753100527365,0.00487453954448441,-0.0120116285124631,0.00709656650191579,0.614155985137701
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,-0.00121276731629383,0.0024572818103762,-0.00602903966463119,0.00360350503204353,0.621635430046187
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,24134,-0.00134893188482556,0.00274679780786192,-0.00673265558823493,0.00403479181858382,0.623365472764831
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,24101,0.00248799368931922,0.00510611698909361,-0.00751999560930425,0.0124959829879427,0.626080311183274
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SPINT3,Kunitz-type protease inhibitor 3,24805,0.00490771118319036,0.0102359050812345,-0.0151546627760293,0.02497008514241,0.631615360156859
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PCNA,Proliferating cell nuclear antigen,24016,-0.00211108119318423,0.00440588778947381,-0.0107466212605529,0.00652445887418444,0.631836277290937
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAMT,Guanidinoacetate N-methyltransferase,24111,0.00123633164218773,0.00259008299273261,-0.0038402310235682,0.00631289430794365,0.63312946658952
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SNAP25,Synaptosomal-associated protein 25,24101,0.00156377625986962,0.00329308078759154,-0.00489066208380979,0.00801821460354903,0.6348858920419
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PLXDC1,Plexin domain-containing protein 1,28797,0.00108541671068885,0.00229298904443599,-0.00340884181640569,0.00557967523778338,0.635957645096151
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,24445,-0.00143577333474671,0.00303779844823343,-0.00738985829328424,0.00451831162379082,0.636477015590714
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GLI2,Zinc finger protein GLI2,24229,0.00108662139163321,0.00231968890760617,-0.00345996886727489,0.00563321165054131,0.639478401822824
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GIPR,Gastric inhibitory polypeptide receptor,24229,-0.00153307610756575,0.00327785506336389,-0.00795767203175897,0.00489151981662747,0.639998267325942
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP5,Platelet glycoprotein V,24381,-0.00115139474693711,0.00251290756709911,-0.00607669357845137,0.00377390408457715,0.646818420527917
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL21R,Interleukin-21 receptor,24229,-0.00173590605791759,0.00382648891170235,-0.0092358243248542,0.00576401220901902,0.650081182506743
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,24016,-0.00154741604336144,0.00341299113884192,-0.0082368786754916,0.00514204658876872,0.650272036636384
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HMMR,Hyaluronan mediated motility receptor,23975,-0.00151011863320814,0.00337191346587228,-0.00811906902631781,0.00509883175990152,0.654263965973955
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,-0.00260830082361989,0.00590634028308711,-0.0141847277784706,0.00896812613123085,0.658774566985222
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAPN3,Calpain-3,24793,0.00114563074565843,0.00263565331818115,-0.00402024975797661,0.00631151124929348,0.663808153590443
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,-0.0011019961572973,0.00253889598557344,-0.00607823228902124,0.00387423997442663,0.664259231345538
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RBM19,Probable RNA-binding protein 19,24111,-0.0014424764994133,0.00332359223972216,-0.00795671728926874,0.00507176429044213,0.664284140469803
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,0.00141967674981888,0.00329232777927434,-0.00503328569755882,0.00787263919719659,0.666321274558233
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,-0.00162830410644353,0.00378208667912621,-0.0090411939975309,0.00578458578464384,0.666813553080493
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TSPAN7,Tetraspanin-7,24101,0.00281097765625363,0.00656062609634854,-0.0100478494925895,0.0156698048050968,0.668318771767716
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RRP15,RRP15-like protein,24101,0.00270938608900211,0.00634072578034837,-0.00971843644048069,0.0151372086184849,0.669165345737635
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKCQ,Protein kinase C theta type,28931,-0.00126967235827312,0.00300301952196509,-0.00715559062132469,0.00461624590477846,0.672445375281407
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IMPA1,Inositol monophosphatase 1,29218,0.00176245005730011,0.00419706741359845,-0.00646380207335284,0.00998870218795307,0.674543938267433
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MTPN,Myotrophin,28916,0.000945503816345155,0.00226298580916181,-0.00348994836961198,0.00538095600230229,0.676087296068415
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KDM3A,Lysine-specific demethylase 3A,24229,-0.00261613802884182,0.00630114684641391,-0.0149663858478131,0.00973410979012945,0.678010578279566
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,0.0018045550163985,0.0043475517592232,-0.00671664643167897,0.010325756464476,0.678091542438452
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NLGN1,Neuroligin-1,24195,-0.00194241598137069,0.00475945156889688,-0.0112709410564086,0.00738610909366719,0.683190948237613
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SUSD5,Sushi domain-containing protein 5,24273,0.000969257382281041,0.00238487633631131,-0.00370510023688913,0.00564361500145121,0.684438862140561
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENPEP,Glutamyl aminopeptidase,24111,-0.00125521497189843,0.00309426441898472,-0.00731997323310848,0.00480954328931162,0.684997067106204
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.00100530030853521,0.00248102791498177,-0.00385751440482906,0.00586811502189949,0.685337704576916
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,0.00127566467494874,0.00317367263967081,-0.00494473369880604,0.00749606304870353,0.687722777123861
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MUCL3,Mucin-like protein 3,24016,0.00121599140263565,0.00305572321103329,-0.00477322609098959,0.00720520889626089,0.690678699034415
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NRN1,Neuritin,24867,0.000986802741605004,0.00248342081951925,-0.00388070206465273,0.00585430754786274,0.691108197836412
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,0.00196744394574515,0.00497664278374108,-0.00778677591038736,0.0117216638018777,0.692598698468041
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ROBO2,Roundabout homolog 2,29694,0.000629561587003432,0.00159465533649555,-0.00249596287252785,0.00375508604653472,0.692997191825423
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CLIC5,Chloride intracellular channel protein 5,24195,-0.000869213449797035,0.00221552850147645,-0.00521164931269088,0.00347322241309681,0.694819474220296
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,-0.00082626977113974,0.00210810631628313,-0.00495815815105468,0.0033056186087752,0.695099417442515
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMOD4,Tropomodulin-4,24016,-0.00110719531508571,0.00285241993810836,-0.00669793839377811,0.00448354776360668,0.697901076934254
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,-0.00147154505953151,0.00383749898725445,-0.00899304307455023,0.00604995295548721,0.701378123302048
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MORF4L1,Mortality factor 4-like protein 1,24445,-0.00107077873262319,0.00279407453002958,-0.00654716481148117,0.00440560734623479,0.701551097716409
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,-0.000770090406451431,0.00202595429347202,-0.00474096082165659,0.00320078000875372,0.703865294222158
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRYBB2,Beta-crystallin B2,24845,-0.00182212601265242,0.00480291672603328,-0.0112358427956777,0.00759159077037281,0.704409645355049
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,24195,0.000996141122000866,0.00262857471206412,-0.0041558653136448,0.00614814755764653,0.704716247948341
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PXDNL,Peroxidasin-like protein,24793,0.00151167282936051,0.00401984625406471,-0.00636722582860632,0.00939057148732735,0.706881160432488
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ENO1,Alpha-enolase,29392,-0.00204330611440982,0.00543446449370943,-0.0126948565220803,0.00860824429326067,0.70692679775661
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PITHD1,PITH domain-containing protein 1,23970,0.00205984557792469,0.00555351967352555,-0.00882505298218539,0.0129447441380348,0.710709241817948
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ADRA2A,Alpha-2A adrenergic receptor,24111,-0.00180497163697943,0.00491062389721273,-0.0114297944755164,0.00781985120155751,0.713201123361964
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PAPPA,Pappalysin-1,28931,-0.00118385844929558,0.00325028572696802,-0.0075544184741529,0.00518670157556174,0.71568734944449
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AFAP1,Actin filament-associated protein 1,24381,0.00211008079338867,0.00584435478100179,-0.00934485457737484,0.0135650161641522,0.718068205710576
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TBR1,T-box brain protein 1,24195,0.00120818213643527,0.00336082490424182,-0.0053790346758787,0.00779539894874924,0.719231876428417
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,0.00167280974885523,0.00465462217941194,-0.00745024972279217,0.0107958692205026,0.719308900652264
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,-0.0008307230823609,0.00239449377896897,-0.00552393088914008,0.00386248472441828,0.72864651878626
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRC1,Protein regulator of cytokinesis 1,24793,-0.00109180773865878,0.00315541981420085,-0.00727643057449245,0.0050928150971749,0.729337915913371
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,0.00150107337035358,0.00435755856411357,-0.00703974141530902,0.0100418881560162,0.730491517433902
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,-0.00157592449124829,0.00458759443656303,-0.0105676095869118,0.00741576060441525,0.731211281721754
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MN1,Transcriptional activator MN1,24195,0.00141137394802404,0.00411806609622269,-0.00666003560057243,0.0094827834966205,0.731806551887543
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,-0.00159937204304982,0.00469582395846961,-0.0108031870016503,0.00760444291555062,0.733411321389832
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GHRHR,Growth hormone-releasing hormone receptor,28774,0.00126990030918957,0.00379375264136279,-0.00616585486788149,0.00870565548626063,0.737827732465339
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERCC1,DNA excision repair protein ERCC-1,24016,0.000771288513387081,0.0023285142632818,-0.00379259944264525,0.00533517646941942,0.740468873787799
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,0.00108368177882342,0.00342089412634261,-0.0056212707088081,0.00778863426645494,0.751410860080125
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,24101,-0.00086876440715647,0.00279715712424654,-0.00635119237067968,0.00461366355636674,0.756116274580475
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AMIGO1,Amphoterin-induced protein 1,24195,-0.00107352799994208,0.00349126424702155,-0.00791640592410432,0.00576934992422016,0.758473265405084
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,0.00106747197383735,0.00349815218614049,-0.00578890631099801,0.00792385025867271,0.760252188374424
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZP4,Zona pellucida sperm-binding protein 4,24016,-0.000657491554314614,0.00221994593161319,-0.00500858558027647,0.00369360247164724,0.767099322907399
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,-0.00174085792002504,0.00599588866379572,-0.0134927997010647,0.0100110838610146,0.771557158347268
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,-0.00168456518572313,0.00580517811331235,-0.0130627142878153,0.00969358391636907,0.771678176921844
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.000665159452848407,0.00234114409780544,-0.00392348297885025,0.00525380188454706,0.776322879765988
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT14,"Keratin, type I cytoskeletal 14",27986,-0.000562773232443384,0.00201245576345715,-0.00450718652881939,0.00338164006393263,0.779751931121662
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,29820,0.000608535406334015,0.00218394597311552,-0.00367199870097241,0.00488906951364044,0.780522799239864
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,-0.00333689618557635,0.0119871540930442,-0.026831718207943,0.0201579258367903,0.780728612447087
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP6V1D,V-type proton ATPase subunit D,29349,-0.000496269439557482,0.0018001732675695,-0.00402460904399371,0.00303207016487874,0.782796792930371
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ZNF830,Zinc finger protein 830,24793,-0.00150765893217169,0.00550501854578076,-0.012297495281902,0.00928217741755859,0.784186879118661
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEP350,Centrosome-associated protein 350,24016,0.000696034843987749,0.00257519859306366,-0.00435135439841703,0.00574342408639253,0.786944137036502
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,-0.00106775726692306,0.00399197808466253,-0.00889203431286162,0.00675651977901551,0.789105185588976
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANKRA2,Ankyrin repeat family A protein 2,24016,0.000996252976014628,0.00387765951602947,-0.00660395967540313,0.00859646562743239,0.797241798789662
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,-0.00123512577168023,0.00481859140523897,-0.0106795649259486,0.00820931338258816,0.797702030022488
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,-0.00060312190759186,0.00236845247094165,-0.00524528875063749,0.00403904493545377,0.79899709128085
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMC3,Structural maintenance of chromosomes protein 3,24016,-0.000953142142028819,0.00376409430410969,-0.00833076697808382,0.00642448269402618,0.800100754088463
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,0.00158484057797029,0.00630708770221966,-0.0107770513183802,0.0139467324743208,0.801600310857982
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,24111,0.000979677878738967,0.00393972250789823,-0.00674217823674155,0.00870153399421949,0.803620712092486
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,0.000499617504126186,0.00206774383613948,-0.00355316041470719,0.00455239542295957,0.809073148902152
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,AGBL2,Cytosolic carboxypeptidase 2,24101,0.00152009379977181,0.00635796827406997,-0.0109415240174053,0.0139817116169489,0.811041834369099
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.00103919134938869,0.00445677887614986,-0.00977447794664242,0.00769609524786504,0.815630623903334
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ESPL1,Separin,24016,0.000897086706612047,0.00386052195168021,-0.00666953631868117,0.00846370973190526,0.816249164677264
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DLGAP5,Disks large-associated protein 5,24867,0.000821886277567591,0.00359582057007906,-0.00622592203978737,0.00786969459492255,0.819207279087336
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ANPEP,Aminopeptidase N,29531,0.000442117020941989,0.00193690288911194,-0.00335421264171742,0.0042384466836014,0.819445873863535
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,-0.000919134018604852,0.00402690243347505,-0.00881186278821594,0.00697359475100624,0.819455077713408
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,-0.000869996057504018,0.00384064166577375,-0.00839765372242058,0.00665766160741254,0.820795798248934
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPGN,Epigen,24793,-0.000753071780430905,0.00333386392296161,-0.00728744506943567,0.00578130150857386,0.821292277765993
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF6,Fibroblast growth factor 6,24229,0.000643299433755003,0.00286301094151068,-0.00496820201160593,0.00625480087911593,0.82221975746357
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TCP11,T-complex protein 11 homolog,24445,-0.000915485297837739,0.0041325218534542,-0.00901522813060798,0.0071842575349325,0.824680175084363
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MMP3,Stromelysin-1,29443,0.000745309495129839,0.0033762205871299,-0.00587208285564476,0.00736270184590444,0.825286598995803
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GAGE2A,G antigen 2A,24016,-0.00094393244827662,0.0044244168975308,-0.00961578956743698,0.00772792467088374,0.831058767386891
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,VCAN,Versican core protein,29694,-0.000439996476407295,0.00207028492454717,-0.00449775492851975,0.00361776197570516,0.831695479320743
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,24845,0.000577103276545318,0.00271783989301227,-0.00474986291375874,0.00590406946684938,0.83184435126269
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,28916,-0.000880825825980344,0.00421692922555631,-0.00914600710807072,0.00738435545611003,0.834544565171211
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EVI2B,Protein EVI2B,24016,0.000590661188865313,0.00286037915940518,-0.00501568196356883,0.00619700434129946,0.836404057066163
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,24101,-0.000708927971465341,0.00348229328187917,-0.00753422280394852,0.00611636686101784,0.838682836179272
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CDC25A,M-phase inducer phosphatase 1,24016,-0.000567029419319783,0.00281764925158919,-0.0060896219524346,0.00495556311379503,0.840511043738434
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,0.00106081507385776,0.00532473256023731,-0.00937566074420736,0.0114972908919229,0.842089079632796
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DENND2B,DENN domain-containing protein 2B,24111,0.000700816768713625,0.00353062079982914,-0.00621919999895149,0.00762083353637874,0.842658098623277
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PPM1A,Protein phosphatase 1A,28797,0.000423421701578272,0.00215157830232479,-0.00379367177097832,0.00464051517413486,0.843988680766587
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAG,Myelin-associated glycoprotein,24195,-0.000632634587451606,0.00330012201540671,-0.00710087373764876,0.00583560456274555,0.84797853143741
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,24195,0.00039019998504127,0.00206682873011966,-0.00366078432599327,0.0044411842960758,0.850257708897289
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KLK15,Kallikrein-15,24754,-0.000676623481521325,0.00359485438730887,-0.00772253808064671,0.00636929111760406,0.850705741124959
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RGMA,Repulsive guidance molecule A,29694,0.000405238232321161,0.00216814682346055,-0.00384432954166152,0.00465480600630384,0.851736125030968
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL3,Interleukin-3,24016,0.000785605778635596,0.00421586564994764,-0.00747749089526178,0.00904870245253297,0.852175740641754
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,-0.000413649636705426,0.0022830522744275,-0.00488843209458332,0.00406113282117247,0.856225676608881
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,-0.000778528165210539,0.00430496957370778,-0.00921626852967778,0.0076592121992567,0.85649149377468
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CD99L2,CD99 antigen-like protein 2,29443,0.000297056933475116,0.00166547921884354,-0.00296728233545823,0.00356139620240846,0.858440517334337
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,0.000574814966396449,0.00325495677112113,-0.00580490030500097,0.00695453023779387,0.859826587932041
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,-0.000760141870845095,0.00439063025350717,-0.00936577716771915,0.00784549342602896,0.862552100968708
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,0.000497110927594364,0.00288291218287886,-0.0051533969508482,0.00614761880603693,0.863098101497076
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NXPE4,NXPE family member 4,24111,0.000411129967280834,0.00238876050766818,-0.0042708406277488,0.00509310056231047,0.863352366116811
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPSG1,Tryptase gamma,24229,0.000314778928004848,0.0018590591871305,-0.00332897707877094,0.00395853493478064,0.86554507930482
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CASQ2,Calsequestrin-2,24111,0.000570248806265581,0.00339616233905954,-0.00608622937829111,0.00722672699082227,0.866655680188021
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL9,Interleukin-9,24445,-0.000640916294757308,0.00395254416298218,-0.00838790285420237,0.00710607026468776,0.87118683074898
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,24445,-0.000746890724981139,0.00466455397224565,-0.00988941651058261,0.00839563506062033,0.872787474819518
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LTO1,Protein LTO1 homolog,28931,-0.000446779086494122,0.00283689538226279,-0.00600709403572918,0.00511353586274094,0.874860778914988
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ISM2,Isthmin-2,24938,-0.000478686721387675,0.00305102496227959,-0.00645869564745566,0.00550132220468031,0.875329863237274
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,0.000603153792510616,0.00390814866394281,-0.00705681758881729,0.00826312517383852,0.877348979218522
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,24101,0.000818130081698648,0.00536630423677737,-0.009699826222385,0.0113360863857823,0.878827862685065
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NLGN2,Neuroligin-2,24101,-0.000503521684796903,0.0033101750148928,-0.0069914647139868,0.00598442134439299,0.879098838944308
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRR5,Proline-rich protein 5,24229,-0.000491501421841171,0.00331298215681223,-0.00698494644919314,0.0060019436055108,0.882062905277983
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDIA2,Protein disulfide-isomerase A2,24016,0.000411070167050313,0.00283917188381589,-0.00515370672522882,0.00597584705932945,0.884881656182162
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,0.000514058567710828,0.00356781755149362,-0.00647886383321666,0.00750698096863832,0.885436857201443
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,-0.000694776446235749,0.00482950767777282,-0.0101606114946705,0.00877105860219898,0.885611427334658
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,BTNL10,Butyrophilin-like protein 10,24016,0.000389548097958522,0.00284703607566094,-0.00519064261033692,0.00596973880625397,0.89116960723509
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,0.00028213369850398,0.00220603774162919,-0.00404170027508923,0.00460596767209719,0.898235821449588
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,H2AP,Huntingtin-interacting protein M,24016,0.000455659724793041,0.00356644033727923,-0.00653456333627425,0.00744588278586033,0.898337467189119
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ITGB6,Integrin beta-6,28931,-0.000265865916385059,0.00209437022553978,-0.00437083155844303,0.00383909972567291,0.898986290844863
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HK2,Hexokinase-2,28916,-0.000233959263789866,0.00189525387420069,-0.00394865685722323,0.00348073832964349,0.901755729611507
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,DIABLO,"Diablo homolog, mitochondrial",29395,-0.000893830353188015,0.00754081000990097,-0.0156738179725939,0.0138861572662179,0.90564663017397
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GSAP,Gamma-secretase-activating protein,28797,0.000650979521794603,0.00600733202756659,-0.0111233912522359,0.0124253502958251,0.913707580876681
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GUCY2C,Heat-stable enterotoxin receptor,24445,0.000627572254425747,0.00580380438329671,-0.0107478843368358,0.0120030288456873,0.913892517867628
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.000502248673357724,0.00481039419491027,-0.00892612394866641,0.00993062129538186,0.916845460487757
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,APPL2,DCC-interacting protein 13-beta,24381,-0.000758282968609767,0.00778487655482777,-0.0160166410160722,0.0145000750788527,0.922405874408965
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,-0.000664896173085068,0.0068811171238797,-0.0141518857358893,0.0128220933897191,0.923023910468432
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,EPHA10,Ephrin type-A receptor 10,28774,0.000400649286856369,0.00451333559993662,-0.0084454884890194,0.00924678706273214,0.929265232647171
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,FGF12,Fibroblast growth factor 12,24229,-0.000285402918977084,0.00325460777893163,-0.00666443416568308,0.00609362832772891,0.930122239070698
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,S100A3,Protein S100-A3,24793,-0.000266407195907605,0.00308501494269089,-0.00631303648358175,0.00578022209176654,0.931184727540821
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TAP1,Antigen peptide transporter 1,24445,-0.000357382906306548,0.00418057593675619,-0.00855131174234868,0.00783654592973558,0.931875308824705
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,24195,-0.000212007201232453,0.00252221367793467,-0.00515554600998441,0.0047315316075195,0.933012600893322
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KCNIP4,Kv channel-interacting protein 4,28774,0.000295021187531382,0.00352193875299005,-0.00660797876832912,0.00719802114339189,0.933242507359592
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.000147093530629623,0.00179698584614921,-0.00337499872782282,0.00366918578908207,0.934762147783058
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CA13,Carbonic anhydrase 13,29114,-0.000584483285234587,0.00719529601131721,-0.0146872634674163,0.0135182968969471,0.935258562581036
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,-0.000232232457500195,0.00290209452044449,-0.0059203377175714,0.00545587280257101,0.93622013312061
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NPTX2,Neuronal pentraxin-2,24938,0.000183805152157037,0.00231325642549143,-0.00435017744180616,0.00471778774612023,0.936669517182358
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,0.000210511042246458,0.00267605577797152,-0.00503455828257772,0.00545558036707064,0.937299999840987
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,GPR101,Probable G-protein coupled receptor 101,24101,0.000336439177464552,0.00429328197654842,-0.00807839349657035,0.00875127185149946,0.937539080792107
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,0.000218319254609624,0.00289555739377988,-0.00545697323719895,0.0058936117464182,0.93989866828675
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,YY1,Transcriptional repressor protein YY1,24229,-0.000132709567435806,0.00194204368128372,-0.0039391151827519,0.00367369604788029,0.945519522367314
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,-0.000287140745708818,0.00423689979845819,-0.00859146435068687,0.00801718285926924,0.945968151626099
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,24229,0.000284529821138948,0.00422175066658222,-0.0079901014853622,0.0085591611276401,0.946266875430856
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SLC44A4,Choline transporter-like protein 4,24195,0.000300345348401826,0.00482444106336981,-0.00915555913580301,0.00975624983260666,0.950360316223477
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,24101,-0.000167823843039229,0.00299442880858324,-0.00603690430786238,0.00570125662178392,0.95530613606516
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,9.82623953360539e-05,0.00181554656462259,-0.00346020887132423,0.00365673366199633,0.9568378033375
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,-0.000197334957436561,0.00378502816696659,-0.00761599016469108,0.00722132024981796,0.958421026340027
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,24845,-0.000242016093805591,0.00472510472806884,-0.00950322136082052,0.00901918917320933,0.959151262885828
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,C1QL2,Complement C1q-like protein 2,24229,0.000151157645293275,0.00298373222585804,-0.00569695751738848,0.00599927280797503,0.959596396015152
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KRT17,"Keratin, type I cytoskeletal 17",24111,-0.000130147708032588,0.00272127673706588,-0.00546385011268172,0.00520355469661654,0.961855333040137
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,0.000121950791192552,0.00263342028934605,-0.0050395529759257,0.0052834545583108,0.963064420639619
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TPT1,Translationally-controlled tumor protein,28931,-0.000154258228276039,0.00450089472456297,-0.00897601188841946,0.00866749543186738,0.9726598575879
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,0.00010650327374913,0.00356305775054339,-0.00687708991731592,0.00709009646481418,0.976154250276854
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,-0.00012462018537682,0.00435580625595743,-0.00866200044705337,0.00841276007629973,0.977175730941366
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,-9.78971710356917e-05,0.00410562852054992,-0.00814492907131353,0.00794913472924215,0.980976742349678
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,9.62313652855459e-05,0.00467468686884792,-0.00906615489765637,0.00925861762822746,0.983576343117996
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,SERPINF2,Alpha-2-antiplasmin,24515,-1.49945342561408e-05,0.000945208056564099,-0.00186760232512178,0.00183761325660949,0.987343227322062
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,KIRREL1,Kin of IRRE-like protein 1,24101,2.98742898486712e-05,0.0041117023650705,-0.00802906234568951,0.00808881092538685,0.994202941896381
NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,TOP1,DNA topoisomerase 1,24805,-4.46917080844464e-05,0.00787128531867137,-0.0154724109326803,0.0153830275165114,0.995469828466012
